,Efficacy_x,Experiment used to check activity,Target gene,siRNA concentration,Cell or Organism used,Transfection method,siRNA sense,siRNA antisense,Modification sense,Modification antisense,Position sense,Position antisense,Concentration new,id_,Duration after transfection new
0,EC-50 = 0.02 nM for target mRNA,Real-time quantitative PCR,SSB gene,,Hepa1-6 cells,Lipofectamine RNAiMax,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Methoxy,5-phosphate ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.02,5329,24
1,EC-50 = 0.6 nM for target mRNA,Real-time quantitative PCR,Luciferase gene,,Hepa1-6 cells,Lipofectamine RNAiMax,AUAAGGCUAUGAAGAGAUATT,UAUCUCUUCAUAGCCUUAUTT,Inverted abasic* 2-Deoxy,5-phosphate ribose* 2-Deoxy,"1,21 * 20,21","1 * 20,21",0.6,5328,24
2,EC-50 = 0.14 nM for target mRNA,Real-time quantitative PCR,PHD3 gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CAGUCAGCAAAGACGUCUAUU,UAGACGUCUUUGCUGACUGUU,Inverted abasic* 2-Methoxy,5-phosphate ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.14,5327,24
3,EC-50 = 0.05 nM for target mRNA,Real-time quantitative PCR,PHD2 gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CAUUGAACCCAAAUUUGAUUU,AUCAAAUUUGGGUUCAAUGUU,Inverted abasic* 2-Methoxy,5-phosphate ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.05,5326,24
4,EC-50 = 0.51 nM for target mRNA,Real-time quantitative PCR,ApoB gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,Inverted abasic* 2-Methoxy,5-phosphate ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.51,5325,24
5,EC-50 = 0.44 nM for target mRNA,Real-time quantitative PCR,ApoB gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Methoxy,5-phosphate ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.44,5324,24
6,EC-50 = 0.02 nM for target mRNA,Real-time quantitative PCR,SSB gene,,Hepa1-6 cells,Lipofectamine RNAiMax,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Methoxy,5-hydroxy ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.02,5323,24
7,EC-50 = 0.19 nM for target mRNA,Real-time quantitative PCR,Luciferase gene,,Hepa1-6 cells,Lipofectamine RNAiMax,AUAAGGCUAUGAAGAGAUATT,UAUCUCUUCAUAGCCUUAUTT,Inverted abasic* 2-Deoxy,5-hydroxy ribose* 2-Deoxy,"1,21 * 20,21","1 * 20,21",0.19,5322,24
8,EC-50 = 0.13 nM for target mRNA,Real-time quantitative PCR,PHD3 gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CAGUCAGCAAAGACGUCUAUU,UAGACGUCUUUGCUGACUGUU,Inverted abasic* 2-Methoxy,5-hydroxy ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.13,5321,24
9,EC-50 = 0.05 nM for target mRNA,Real-time quantitative PCR,PHD2 gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CAUUGAACCCAAAUUUGAUUU,AUCAAAUUUGGGUUCAAUGUU,Inverted abasic* 2-Methoxy,5-hydroxy ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.05,5320,24
10,EC-50 = 0.5 nM for target mRNA,Real-time quantitative PCR,ApoB gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,Inverted abasic* 2-Methoxy,5-hydroxy ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.5,5319,24
11,EC-50 = 0.3 nM for target mRNA,Real-time quantitative PCR,ApoB gene,,Hepa1-6 cells,Lipofectamine RNAiMax,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Methoxy,5-hydroxy ribose* 2-Methoxy,"1,21 * 20,21","1 * 20,21",0.3,5318,24
12,40.77 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,14,15,16,17,18 * 2,7,10,12,13 * 11",10.0,5317,24
13,42.17 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",10.0,5316,24
14,44.11 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",10.0,5315,24
15,65.16 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13,17,18",10.0,5314,24
16,60.4 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",10.0,5313,24
17,5.72 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",10.0,5312,24
18,32.24 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",10.0,5311,24
19,64.71 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5310,24
20,26.16 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5309,24
21,39.8 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5308,24
22,87.07 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,17,18,19,20,21 * 5,10,13,15,16 * 14",10.0,5307,24
23,74.7 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",10.0,5306,24
24,93.72 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",10.0,5305,24
25,93.28 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19* 5,10,13,15,16,20,21",10.0,5304,24
26,92.24 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",10.0,5303,24
27,93.43 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",10.0,5302,24
28,69.9 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5301,24
29,93.42 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5300,24
30,42.39 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5299,24
31,93.16 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5298,24
32,89.08 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,17,18,19,20,21 * 5,10,13,15,16 * 14",10.0,5297,24
33,73.8 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19* 5,10,13,15,16 * 20,21",10.0,5296,24
34,91.47 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",10.0,5295,24
35,92.98 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16,20,21",10.0,5294,24
36,92.8 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",10.0,5293,24
37,94.18 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",10.0,5292,24
38,72.84 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5291,24
39,92.8 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5290,24
40,46.52 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5289,24
41,93.09 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5288,24
42,48.19 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,13,14,16,17,18 * 2,5,6,7,8,12,15 * 11",10.0,5287,24
43,67.94 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",10.0,5286,24
44,73.27 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",10.0,5285,24
45,79.41 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15,17,18",10.0,5284,24
46,50.27 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",10.0,5283,24
47,67.46 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",10.0,5282,24
48,49.92 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",10.0,5281,24
49,78.85 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5280,24
50,49.9 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5279,24
51,48.47 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5278,24
52,84.46 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,16,17,19,20,21 * 3,5,8,9,10,11,15,18 * 14",10.0,5277,24
53,64.22 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5276,24
54,91.31 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5275,24
55,92.98 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18,20,21",10.0,5274,24
56,75.59 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5273,24
57,90.82 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5272,24
58,86.05 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5271,24
59,88.41 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5270,24
60,58.6 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5269,24
61,90.57 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5268,24
62,85.88 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,16,17,19,20,21 * 3,5,8,9,10,11,15,18 * 14",10.0,5267,24
63,68.97 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5266,24
64,89.06 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5265,24
65,91.97 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18,20,21",10.0,5264,24
66,80.03 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5263,24
67,90.87 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",10.0,5262,24
68,88.19 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5261,24
69,89.3 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5260,24
70,78.74 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5259,24
71,89.4 percent target mRNA inhibition,Real-time PCR,SSB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5258,24
72,41.89 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,14,17,18 * 11",10.0,5257,24
73,14.87 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",10.0,5256,24
74,4.33 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",10.0,5255,24
75,30.2 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16,17,18 * 2,4,5,6,9,11,14",10.0,5254,24
76,23.44 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",10.0,5253,24
77,22.46 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",10.0,5252,24
78,30.38 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",10.0,5251,24
79,56.38 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5250,24
80,28.43 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5249,24
81,18.48 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5248,24
82,89.54 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,17,20,21 * 3,4,6,10,11,13,15,16,18,19 * 14",10.0,5247,24
83,90.36 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",10.0,5246,24
84,90.43 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",10.0,5245,24
85,89.04 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19,20,21",10.0,5244,24
86,79.86 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",10.0,5243,24
87,94.45 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",10.0,5242,24
88,94.55 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5241,24
89,92.48 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5240,24
90,43.07 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5239,24
91,95.13 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5238,24
92,96.28 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,17,20,21 * 3,4,6,10,11,13,15,16,18,19 * 14",10.0,5237,24
93,92.38 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 *20,21",10.0,5236,24
94,87.46 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methyl,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",10.0,5235,24
95,93.87 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19,20,21",10.0,5234,24
96,79.47 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",10.0,5233,24
97,93 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",10.0,5232,24
98,94.42 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5231,24
99,93.32 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5230,24
100,43.28 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5229,24
101,94.24 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5228,24
102,49.21 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,12,17,18 * 3,4,5,6,7,10,13,14,15,16 * 11",10.0,5227,24
103,70.88 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,TCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",10.0,5226,24
104,71.62 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",10.0,5225,24
105,0 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16,17,18",10.0,5224,24
106,1.51 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",10.0,5223,24
107,21.59 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",10.0,5222,24
108,0 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",10.0,5221,24
109,89.33 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5220,24
110,32.68 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,TCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5219,24
111,0 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5218,24
112,95.36 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,15,20,21 * 14",10.0,5217,24
113,93.27 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5216,24
114,93.1 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5215,24
115,94.13 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19,20,21 * 2,3,4,5,11,12,14,15",10.0,5214,24
116,22.31 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5213,24
117,91.48 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5212,24
118,93.06 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5211,24
119,95.9 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5210,24
120,5.13 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5209,24
121,92.16 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5208,24
122,96.89 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,15,20,21 * 14",10.0,5207,24
123,44.02 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5206,24
124,97.5 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5205,24
125,93.72 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19,20,21* 2,3,4,5,11,12,14,15",10.0,5204,24
126,27.13 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5203,24
127,91.9 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",10.0,5202,24
128,92.56 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5201,24
129,97.21 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5200,24
130,13.91 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5199,24
131,95.04 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5198,24
132,43.98 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,14,16 * 2,3,4,8,10,12,13,15,17,18 * 11",10.0,5197,24
133,37.16 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,ATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",10.0,5196,24
134,70.83 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",10.0,5195,24
135,42.73 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16,17,18 * 2,3,4,8,10,12,13,15",10.0,5194,24
136,78.86 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",10.0,5193,24
137,87.3 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",10.0,5192,24
138,23.02 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",10.0,5191,24
139,94.42 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5190,24
140,14.94 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,ATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5189,24
141,28.67 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5188,24
142,96.92 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18,20,21* 3,4,8,9,10,12,17,19 * 14",10.0,5187,24
143,36.81 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5186,24
144,98.54 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5185,24
145,73.77 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19,20,21",10.0,5184,24
146,75.25 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5183,24
147,97.55 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5182,24
148,94.03 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5181,24
149,97.82 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5180,24
150,1.58 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5179,24
151,95.75 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5178,24
152,97.42 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18,20,21 * 3,4,8,9,10,12,17,19 * 14",10.0,5177,24
153,26.18 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5176,24
154,98.76 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5175,24
155,85.47 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19,20,21",10.0,5174,24
156,73.48 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5173,24
157,97.85 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",10.0,5172,24
158,95.14 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5171,24
159,97.59 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5170,24
160,18.58 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5169,24
161,96.51 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5168,24
162,93.68 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,13,14,17,18 * 11",10.0,5167,24
163,84.36 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14 * 17,18",10.0,5166,24
164,94.57 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14 * 17,18",10.0,5165,24
165,30.04 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16,17,18 * 8,9,10,11,13,14",10.0,5164,24
166,39.34 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14 * 17,18",10.0,5163,24
167,92.41 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14,17,18",10.0,5162,24
168,3.41 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1* 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",10.0,5161,24
169,94 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5160,24
170,6.69 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5159,24
171,80.56 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",10.0,5158,24
172,95.94 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,16,17,20,21 * 3,4,5,6,7,8,9,10,15,18,19 * 14",10.0,5157,24
173,96.51 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",10.0,5156,24
174,98.31 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",10.0,5155,24
175,97.68 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19,20,21",10.0,5154,24
176,84.66 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",10.0,5153,24
177,98.1 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",10.0,5152,24
178,88.17 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5151,24
179,98.7 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5150,24
180,0 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5149,24
181,98.15 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 *20,21",10.0,5148,24
182,96.74 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,11,12,13,16,17,20,21 * 3,4,5,6,7,8,9,10,15,18,19 * 14",10.0,5147,24
183,96.21 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,11,12,13,14,16,17 * 20,21 * 3,4,5,6,7,8,9,10,15,18,19",10.0,5146,24
184,98.4 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 20,21 * 3,4,5,6,7,8,9,10,15,18,19",10.0,5145,24
185,97.87 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 3,4,5,6,7,8,9,10,15,18,19,20,21 * 1,2,11,12,13,14,16,17",10.0,5144,24
186,84.59 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",10.0,5143,24
187,98.81 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",10.0,5142,24
188,85.84 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Deoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",10.0,5141,24
189,97.96 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5140,24
190,21.62 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5139,24
191,98.52 percent target mRNA inhibition,Real-time PCR,ApoB gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",10.0,5138,24
192,58.65 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,14,15,16,17,18 * 2,7,10,12,13 * 11",100.0,5137,24
193,28.25 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",100.0,5136,24
194,41.97 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",100.0,5135,24
195,66.52 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13,17,18",100.0,5134,24
196,52.1 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",100.0,5133,24
197,1.88 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,5,6,8,9,11,14,15,16 * 2,7,10,12,13 * 17,18",100.0,5132,24
198,60.06 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",100.0,5131,24
199,61.82 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5130,24
200,12.07 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5129,24
201,47.26 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5128,24
202,91.78 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,17,18,19,20,21 * 5,10,13,15,16 * 14",100.0,5127,24
203,76.93 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",100.0,5126,24
204,96.07 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",100.0,5125,24
205,95.72 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19* 5,10,13,15,16,20,21",100.0,5124,24
206,95.96 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",100.0,5123,24
207,96.51 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",100.0,5122,24
208,79.33 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5121,24
209,95.96 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5120,24
210,31.27 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5119,24
211,95.16 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5118,24
212,91.11 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,17,18,19,20,21 * 5,10,13,15,16 * 14",100.0,5117,24
213,78.67 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19* 5,10,13,15,16 * 20,21",100.0,5116,24
214,95.54 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",100.0,5115,24
215,95.54 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16,20,21",100.0,5114,24
216,95.34 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",100.0,5113,24
217,96.2 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,6,7,8,9,11,12,14,17,18,19 * 5,10,13,15,16 * 20,21",100.0,5112,24
218,79.02 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5111,24
219,95.82 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5110,24
220,30.09 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,TTTTATTTCACCATGATTTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5109,24
221,95.08 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,AAAUCAUGGUGAAAUAAAAUU,UUUUAUUUCACCAUGAUUUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5108,24
222,59.81 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,13,14,16,17,18 * 2,5,6,7,8,12,15 * 11",100.0,5107,24
223,31.5 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",100.0,5106,24
224,70.54 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",100.0,5105,24
225,81.1 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15,17,18",100.0,5104,24
226,32.43 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",100.0,5103,24
227,65.06 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,4,9,10,11,13,14,16 * 2,5,6,7,8,12,15 * 17,18",100.0,5102,24
228,69.98 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",100.0,5101,24
229,77.39 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5100,24
230,18.64 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5099,24
231,54 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,CAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5098,24
232,89.08 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,16,17,19,20,21 * 3,5,8,9,10,11,15,18 * 14",100.0,5097,24
233,67.24 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5096,24
234,92.73 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5095,24
235,94.37 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18,20,21",100.0,5094,24
236,76.42 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5093,24
237,92.62 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5092,24
238,89.53 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5091,24
239,91.35 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5090,24
240,36.37 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5089,24
241,92.95 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5088,24
242,87.66 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,16,17,19,20,21 * 3,5,8,9,10,11,15,18 * 14",100.0,5087,24
243,63.24 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5086,24
244,91.2 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5085,24
245,92.8 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18,20,21",100.0,5084,24
246,74.93 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5083,24
247,91.63 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,4,6,7,12,13,14,16,17,19 * 3,5,8,9,10,11,15,18 * 20,21",100.0,5082,24
248,88.27 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5081,24
249,90.57 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5080,24
250,64.3 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,TTACATTAAAGTCTGTTGTUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5079,24
251,91.33 percent target mRNA inhibition,Real-time PCR,SSB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,ACAACAGACUUUAAUGUAAUU,UUACAUUAAAGUCUGUUGUUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5078,24
252,83.22 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,14,17,18 * 11",100.0,5077,24
253,58.32 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",100.0,5076,24
254,66.88 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",100.0,5075,24
255,74.71 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16,17,18 * 2,4,5,6,9,11,14",100.0,5074,24
256,60.63 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",100.0,5073,24
257,59.99 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,3,7,8,10,12,13,15,16 * 2,4,5,6,9,11,14 * 17,18",100.0,5072,24
258,84.93 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",100.0,5071,24
259,81.11 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5070,24
260,53.9 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1* 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5069,24
261,70.58 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,GUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5068,24
262,94.94 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,17,20,21 * 3,4,6,10,11,13,15,16,18,19 * 14",100.0,5067,24
263,93.97 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",100.0,5066,24
264,87.9 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",100.0,5065,24
265,93.59 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19,20,21",100.0,5064,24
266,92.58 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",100.0,5063,24
267,94.33 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",100.0,5062,24
268,96.57 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5061,24
269,91.93 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5060,24
270,83.65 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5059,24
271,95.39 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5058,24
272,95.29 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,17,20,21 * 3,4,6,10,11,13,15,16,18,19 * 14",100.0,5057,24
273,93.6 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 *20,21",100.0,5056,24
274,88.23 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",100.0,5055,24
275,93.62 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19,20,21",100.0,5054,24
276,92.16 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",100.0,5053,24
277,94.3 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,7,8,9,12,14,17 * 3,4,6,10,11,13,15,16,18,19 * 20,21",100.0,5052,24
278,95.91 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5051,24
279,92.19 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5050,24
280,70.29 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,TTGGTATTCAGTGTGATGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5049,24
281,95.33 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,UCAUCACACUGAAUACCAAUU,UUGGUAUUCAGUGUGAUGAUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5048,24
282,61.59 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,12,17,18 * 3,4,5,6,7,10,13,14,15,16 * 11",100.0,5047,24
283,88.92 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,TCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",100.0,5046,24
284,90.42 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",100.0,5045,24
285,68.81 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16,17,18",100.0,5044,24
286,45.7 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1* 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",100.0,5043,24
287,60.53 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,8,9,11,12 * 3,4,5,6,7,10,13,14,15,16 * 17,18",100.0,5042,24
288,62.3 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",100.0,5041,24
289,94.62 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5040,24
290,53.94 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,TCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5039,24
291,46.66 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,UCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5038,24
292,97.78 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,15,20,21 * 14",100.0,5037,24
293,96.43 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5036,24
294,98.43 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5035,24
295,97.14 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19,20,21 * 2,3,4,5,11,12,14,15",100.0,5034,24
296,64.82 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5033,24
297,96.81 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5032,24
298,97.63 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5031,24
299,97.3 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5030,24
300,54.79 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5029,24
301,98.32 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5028,24
302,97.99 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,15,20,21 * 14",100.0,5027,24
303,69.03 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5026,24
304,98.23 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5025,24
305,96.81 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19,20,21* 2,3,4,5,11,12,14,15",100.0,5024,24
306,54.35 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5023,24
307,96.62 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,6,7,8,9,10,13,16,17,18,19 * 2,3,4,5,11,12,14,15 * 20,21",100.0,5022,24
308,97.78 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5021,24
309,97.54 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5020,24
310,57.97 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,ATTTCAGGAATTGTTAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5019,24
311,97.86 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CUUUAACAAUUCCUGAAAUUU,AUUUCAGGAAUUGUUAAAGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5018,24
312,51.92 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,14,16 * 2,3,4,8,10,12,13,15,17,18 * 11",100.0,5017,24
313,33.35 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,ATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",100.0,5016,24
314,67.37 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",100.0,5015,24
315,29.77 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16,17,18 * 2,3,4,8,10,12,13,15",100.0,5014,24
316,66.94 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",100.0,5013,24
317,81.01 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,5,6,7,9,11,14,16 * 2,3,4,8,10,12,13,15 * 17,18",100.0,5012,24
318,15.3 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",100.0,5011,24
319,91.54 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5010,24
320,10.62 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,ATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5009,24
321,32.12 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,AUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,5008,24
322,95.77 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18,20,21* 3,4,8,9,10,12,17,19 * 14",100.0,5007,24
323,34.12 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,5006,24
324,97.07 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,5005,24
325,74.3 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19,20,21",100.0,5004,24
326,76.22 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,5003,24
327,96.14 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,5002,24
328,93.25 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,5001,24
329,95.54 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,5000,24
330,18.38 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4999,24
331,94.32 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4998,24
332,96.35 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18,20,21 * 3,4,8,9,10,12,17,19 * 14",100.0,4997,24
333,44.66 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,4996,24
334,96.63 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,4995,24
335,69.79 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19,20,21",100.0,4994,24
336,74.77 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,4993,24
337,95.94 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,5,6,7,11,13,15,16,18 * 3,4,8,9,10,12,14,17,19 * 20,21",100.0,4992,24
338,91.97 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,4991,24
339,96 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4990,24
340,12.26 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,TTGATCTAAATGCATTGTGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4989,24
341,94.66 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CACAAUGCAUUUAGAUCAAUU,UUGAUCUAAAUGCAUUGUGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4988,24
342,90.4 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,13,14,17,18 * 11",100.0,4987,24
343,82.24 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14 * 17,18",100.0,4986,24
344,93.1 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14 * 17,18",100.0,4985,24
345,45.99 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16,17,18 * 8,9,10,11,13,14",100.0,4984,24
346,34.45 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14 * 17,18",100.0,4983,24
347,90.34 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,12,15,16 * 8,9,10,11,13,14,17,18",100.0,4982,24
348,0 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1* 1,2,3,4,5,6,7,8,9,10,12,13,14,15,16,17,18 * 11",100.0,4981,24
349,93.3 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,4980,24
350,0.11 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,4979,24
351,79.75 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,AGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* Inverted abasic* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16 * 17,18",100.0,4978,24
352,94.21 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,16,17,20,21 * 3,4,5,6,7,8,9,10,15,18,19 * 14",100.0,4977,24
353,95.29 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",100.0,4976,24
354,97.16 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",100.0,4975,24
355,96.84 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19,20,21",100.0,4974,24
356,91.55 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",100.0,4973,24
357,97.53 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",100.0,4972,24
358,84.92 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,4971,24
359,96.02 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4970,24
360,0 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4969,24
361,97.62 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 *20,21",100.0,4968,24
362,94.35 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro* 2-Hydroxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,11,12,13,16,17,20,21 * 3,4,5,6,7,8,9,10,15,18,19 * 14",100.0,4967,24
363,95.64 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Hydroxy* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 1,2,11,12,13,14,16,17 * 20,21 * 3,4,5,6,7,8,9,10,15,18,19",100.0,4966,24
364,96.85 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 20,21 * 3,4,5,6,7,8,9,10,15,18,19",100.0,4965,24
365,96.65 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,5-phosphate ribose* 2-Methoxy* 2-Fluoro,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1 * 3,4,5,6,7,8,9,10,15,18,19,20,21 * 1,2,11,12,13,14,16,17",100.0,4964,24
366,80.8 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",100.0,4963,24
367,97.14 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,11,12,13,14,16,17 * 3,4,5,6,7,8,9,10,15,18,19 * 20,21",100.0,4962,24
368,88.15 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Methoxy* 2-Deoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,15,16,17,18,19,20,21 * 14",100.0,4961,24
369,96.82 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Fluoro* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4960,24
370,12 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,TTAAGAGAAGCCTTACTGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Hydroxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4959,24
371,96.95 percent target mRNA inhibition,Real-time PCR,ApoB gene,100 nM,Hepa1-6 cells,Lipofectamine RNAiMAX,CCAGUAAGGCUUCUCUUAAUU,UUAAGAGAAGCCUUACUGGUU,Inverted abasic* 2-Deoxy* 2-Methoxy,2-Deoxy* 2-Methoxy,"1,21 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 20,21",100.0,4958,24
375,80.8 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUACCUTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","1,2,18,19",25.0,4954,24
376,87.3 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCCUTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","16,17,18,19",25.0,4953,24
377,87.7 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCCUTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","18,19",25.0,4952,24
378,66.3 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","1,2,18,19",25.0,4950,24
379,60.2 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4","1,2,18,19",25.0,4949,24
380,44.8 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2","1,2,18,19",25.0,4948,24
381,84.4 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4,5,6,14,15,16,17,18,19","16,17,18,19",25.0,4947,24
382,91 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","16,17,18,19",25.0,4946,24
383,80.7 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4","16,17,18,19",25.0,4945,24
384,70.9 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2","16,17,18,19",25.0,4944,24
385,87 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,0,"1,2,3,4,5,6,14,15,16,17,18,19",0,25.0,4943,24
386,85.5 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","18,19",25.0,4942,24
387,76.5 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2,3,4","18,19",25.0,4941,24
388,72.4 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,4-Thioribose,"1,2","18,19",25.0,4940,24
389,42.5 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,0,4-Thioribose,0,"1,2,18,19",25.0,4939,24
390,52.7 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,0,4-Thioribose,0,"16,17,18,19",25.0,4938,24
391,57.2 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,0,4-Thioribose,0,"18,19",25.0,4937,24
392,75.4 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,0,"1,2,3,4,5,6,14,15,16,17,18,19",0,25.0,4936,24
393,79.1 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,0,"1,2,3,4,16,17,18,19",0,25.0,4935,24
394,70.4 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,0,"1,2,3,4",0,25.0,4934,24
395,69.5 percent target mRNA inhibition,Dual luciferase assay,Renilla luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,4-Thioribose,0,"1,2",0,25.0,4933,24
396,28.6 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,5,6,14,15,16,17,18,19","1,2,18,19",25.0,4931,24
397,87.7 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","1,2,18,19",25.0,4930,24
398,85.4 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4","1,2,18,19",25.0,4929,24
399,90.4 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2","1,2,18,19",25.0,4928,24
400,44.4 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,5,6,14,15,16,17,18,19","16,17,18,19",25.0,4927,24
401,88.1 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","16,17,18,19",25.0,4926,24
402,83.4 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"16,17,18,19","16,17,18,19",25.0,4925,24
403,74.2 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,GCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,5,6,14,15,16,17,18,19","18,19",25.0,4924,24
404,92 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","18,19",25.0,4923,24
405,92.1 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,18,19","18,19",25.0,4922,24
406,85.3 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,18,19","1,2,18,19",25.0,4921,24
407,0 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,16,17,18,19","1,2,3,4,16,17,18,19",25.0,4920,24
408,0 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,5,6,14,15,16,17,18,19","1,2,3,4,5,6,14,15,16,17,18,19",25.0,4919,24
409,91.3 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2","18,19",25.0,4918,24
410,86.1 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4","16,17,18,19",25.0,4917,24
411,47.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"1,2,3,4,5,6","14,15,16,17,18,19",25.0,4916,24
412,91.2 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"18,19","1,2",25.0,4915,24
413,35.1 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"16,17,18,19","1,2,3,4",25.0,4914,24
414,10.9 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,4-Thioribose,"14,15,16,17,18,19","1,2,3,4,5,6",25.0,4913,24
415,88.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,18,19",25.0,4911,24
416,20 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,3,4,16,17,18,19",25.0,4910,24
417,22.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,3,4,5,6,14,15,16,17,18,19",25.0,4909,24
418,90.2 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"18,19",25.0,4908,24
419,85.6 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"16,17,18,19",25.0,4907,24
420,72.2 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"14,15,16,17,18,19",25.0,4906,24
421,95 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2",25.0,4905,24
422,76.7 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,3,4",25.0,4904,24
423,70.9 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,3,4,5,6",25.0,4903,24
424,95.3 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,18,19",0,25.0,4902,24
425,94.7 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,3,4,16,17,18,19",0,25.0,4901,24
426,91.5 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,3,4,5,6,14,15,16,17,18,19",0,25.0,4900,24
427,95.5 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2",0,25.0,4899,24
428,94.2 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,3,4",0,25.0,4898,24
429,94 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,3,4,5,6",0,25.0,4897,24
430,95.4 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"18,19",0,25.0,4896,24
431,94.3 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"16,17,18,19",0,25.0,4895,24
432,93.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"14,15,16,17,18,19",0,25.0,4894,24
447,30.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,2-O-Methyl,0,"14,15,16,17,18,19",25.0,4876,24
448,10.3 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,2-O-Methyl,0,"1,2,3,4,5,6",25.0,4875,24
449,94.2 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,2-O-Methyl,0,"14,15,16,17,18,19",0,25.0,4874,24
450,94.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,2-O-Methyl,0,"1,2,3,4,5,6",0,25.0,4873,24
451,22.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,3,4,5,6,14,15,16,17,18,19",25.0,4872,24
452,36.5 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"7,8,9,10,11,12,13",25.0,4871,24
453,72.2 percent target mRNA inhibition (IC-50 = 1.98 nM),Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"14,15,16,17,18,19",25.0,4870,24
454,70.9 percent target mRNA inhibition (IC-50 = 2.62 nM),Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,3,4,5,6",25.0,4869,24
455,91.5 percent target mRNA inhibition (IC-50 = 0.16 nM),Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,3,4,5,6,14,15,16,17,18,19",0,25.0,4868,24
456,87.4 percent target mRNA inhibition (IC-50 = 0.31 nM),Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"7,8,9,10,11,12,13",0,25.0,4867,24
457,93.8 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"14,15,16,17,18,19",0,25.0,4866,24
458,94 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,3,4,5,6",0,25.0,4865,24
459,16.6 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",25.0,4864,24
460,27.5 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,2,7,9,10,11,12,14,16,18",25.0,4863,24
461,68.5 percent target mRNA inhibition (IC-50 = 2.09 nM),Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"2,11,12,14,18",25.0,4862,24
462,79.5 percent target mRNA inhibition (IC-50 = 1.65 nM),Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,0,4-Thioribose,0,"1,7,9,10,16",25.0,4861,24
463,60.3 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",0,25.0,4860,24
464,92.9 percent target mRNA inhibition (IC-50 = 0.12 nM),Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,3,5,7,12,14,15,16,17",0,25.0,4859,24
465,93.6 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"1,5,7,14,17",0,25.0,4858,24
466,96.3 percent target mRNA inhibition,Dual luciferase assay,Photinus luciferase gene,25 nM,NIH/3T3 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGATT,UCGAAGUAUUCCGCGUACGTT,4-Thioribose,0,"3,12,15,16",0,25.0,4857,24
483,0 percent target mRNA inhibition,Dual luciferase assay,Sensor for S strand luciferase gene,2 nmol/l,HEK293 cells,RNAiMAX,UGAAUCAGAAGAUGAAGUCAA,GACUUCAUCUUCUGAUUCAAG,unlocked nucleic acid,unlocked nucleic acid,1,1,2.0,4835,24
484,50 percent target mRNA inhibition,Dual luciferase assay,Sensor for S strand luciferase gene,2 nmol/l,HEK293 cells,RNAiMAX,UGAAUCAGAAGAUGAAGUCAA,GACUUCAUCUUCUGAUUCAAG,unlocked nucleic acid,0,1,0,2.0,4834,24
485,92 percent target mRNA inhibition,Dual luciferase assay,Sensor for S strand luciferase gene,2 nmol/l,HEK293 cells,RNAiMAX,UGAAUCAGAAGAUGAAGUCAA,GACUUCAUCUUCUGAUUCAAG,0,unlocked nucleic acid,0,1,2.0,4833,24
486,0 percent target mRNA inhibition,Dual luciferase assay,Sensor for AS strand luciferase gene,2 nmol/l,HEK293 cells,RNAiMAX,UGAAUCAGAAGAUGAAGUCAA,GACUUCAUCUUCUGAUUCAAG,unlocked nucleic acid,unlocked nucleic acid,1,1,2.0,4831,24
487,85 percent target mRNA inhibition,Dual luciferase assay,Sensor for AS strand luciferase gene,2 nmol/l,HEK293 cells,RNAiMAX,UGAAUCAGAAGAUGAAGUCAA,GACUUCAUCUUCUGAUUCAAG,unlocked nucleic acid,0,1,0,2.0,4830,24
488,94 percent target mRNA inhibition,Dual luciferase assay,Sensor for AS strand luciferase gene,2 nmol/l,HEK293 cells,RNAiMAX,UGAAUCAGAAGAUGAAGUCAA,GACUUCAUCUUCUGAUUCAAG,0,unlocked nucleic acid,0,1,2.0,4829,24
504,IC-50 = 0.01 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* Xylo-3-fluororibose* Phosphorothioate,2-Fluororibose* Phosphorothioate,"4,7,8,9,10,15,16,17,19 * 5,14 * 20","4,5,7,8,9,10,14,15,16,17,19 * 20",0.01,4812,24
505,IC-50 = 0.0246 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* 3-O-methylribose* Phosphorothioate,2-Fluororibose* 3-O-methylribose* Phosphorothioate,"4,7,8,9,10,15,16,17,19 * 5,14 * 20","4,7,8,9,10,15,16,17,19 * 5,14 * 20",0.0246,4811,24
507,IC-50 = 0.1822 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* Xylo-O-methylribose* Phosphorothioate,2-Fluororibose* Xylo-O-methylribose* Phosphorothioate,"4,7,8,9,10,15,16,17,19 * 5,14 * 20","4,7,8,9,10,15,16,17,19 * 5,14 * 20",0.1822,4809,24
508,IC-50 = 0.0086 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* Xylo-3-fluororibose* Phosphorothioate,2-Fluororibose* Xylo-3-fluororibose* Phosphorothioate,"4,5,7,8,9,10,15,16,17,19 * 14 * 20","4,5,7,8,9,10,15,16,17,19 * 14 * 20",0.0086,4808,24
509,IC-50 = 0.0083 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* 3-O-methylribose* Phosphorothioate,2-Fluororibose* 3-O-methylribose* Phosphorothioate,"4,5,7,8,9,10,15,16,17,19 * 14 * 20","4,5,7,8,9,10,15,16,17,19 * 14 * 20",0.0083,4807,24
510,IC-50 = 0.1247 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* Xylo-3-fluororibose* Phosphorothioate,2-Fluororibose* Xylo-3-fluororibose* Phosphorothioate,"4,5,7,8,9,10,15,16,17,19 * 14 * 20","4,5,7,8,9,10,15,16,17,19 * 14 * 20",0.1247,4806,24
511,IC-50 = 0.0076 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* Xylo-O-methylribose* Phosphorothioate,2-Fluororibose* Xylo-O-methylribose* Phosphorothioate,"4,5,7,8,9,10,15,16,17,19 * 14 * 20","4,5,7,8,9,10,15,16,17,19 * 14 * 20",0.0076,4805,24
512,IC-50 = 0.0074 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,2-Fluororibose* Phosphorothioate,2-Fluororibose* Phosphorothioate,"4,5,7,8,9,10,14,15,16,17,19 * 20","4,5,7,8,9,10,14,15,16,17,19 * 20",0.0074,4804,24
513,IC-50 = 0.0095 nM for target mRNA,4 parameter fit model,Target gene,10 nM,Hep3B cells or rat H.II.4.E cells,Lipofectamine RNAiMax,GGAUCAUCUCAAGUCUUACTT,GUAAGACUUGAGAUGAUCCTT,Phosphorothioate,Phosphorothioate,20,20,0.0095,4803,24
514,51 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,8,16",50.0,4802,16
515,25 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,8,16",50.0,4801,16
516,61 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,8,16",50.0,4800,16
517,40 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,2-O-methoxyethylribose,2-O-methoxyethylribose,"4,9,14,18","4,8,16",50.0,4799,16
518,60 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,8,16",50.0,4798,16
519,70 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,10,19",50.0,4797,16
520,80 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,2-O-methoxyethylribose,2-O-methoxyethylribose,"4,9,14,18","4,10,19",50.0,4796,16
521,70 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,2-O-methoxyethylribose,2-O-methoxyethylribose,"2,4,6,8,10,12,14,18","4,10,19",50.0,4795,16
522,80 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,10,19",50.0,4794,16
523,83 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,10,19",50.0,4793,16
524,85 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,11,19",50.0,4792,16
525,57 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,8,16",50.0,4791,16
526,60.8 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,8,16",50.0,4790,16
527,56.2 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,8,16",50.0,4789,16
528,81.7 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,0,2-O-methoxyethylribose,0,"4,10,19",50.0,4788,16
529,50 percent target mRNA inhibition,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAA,UUUGUCUCUGGUCCUUACUU,2-O-methoxyethylribose,2-O-methoxyethylribose,"2,4,6,8,10,12,14,16,18","4,8,16",50.0,4787,16
531,IC-50 = 0.68552 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 9,10,11",0.68552,4785,16
532,IC-50 = 1.0933 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 18,19,20",1.0933,4784,16
533,IC-50 = 1.5416 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 6,7,8",1.5416,4783,16
534,IC-50 = 0.30815 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 12,13,14",0.30815,4782,16
535,IC-50 = 1.3 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 15,16,17",1.3,4781,16
536,IC-50 = 3.39 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,TTTGTCUCUGGUCCUUACUU,0,2-O-methoxyethylribose* Phosphorothioate,0,"1,2,3 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",3.39,4780,16
537,IC-50 = 29.4 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUTGTCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-methoxyethylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 3,4,5",29.4,4779,16
538,IC-50 = 0.031541 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,2-O-Methylribose,0,"15,16,17,18,19",0.031541,4778,16
539,IC-50 = 0.144 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"1,2,3",0.144,4777,16
540,IC-50 = 7.08 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"8,9,10",7.08,4776,16
541,IC-50 = 0.122 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"12,13,14",0.122,4775,16
542,IC-50 = 0.428 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"13,14,15",0.428,4774,16
543,IC-50 = 0.131 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,20,0.131,4773,16
544,IC-50 = 0.363 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"16,18,19,20",0.363,4772,16
545,IC-50 = 0.273 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"18,19,20",0.273,4771,16
546,IC-50 = 0.46 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Phosphorothioate,0,"3,9,12,17,18,19",0.46,4770,16
547,IC-50 = 0.491 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Phosphorothioate,0,"3,9,12,17,18,19",0.491,4769,16
548,IC-50 = 0.022046 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Locked nucleic acid* 2-O-Methylribose,0,"5,8,11,14 * 17,18,19",0.022046,4768,16
549,IC-50 = 5.58 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Locked nucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 19",5.58,4767,16
550,IC-50 = 0.27688 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Locked nucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 18,19,20",0.27688,4766,16
551,IC-50 = 0.5627 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Locked nucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 9,10,11",0.5627,4765,16
552,IC-50 = 0.020825 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Locked nucleic acid* Phosphorothioate,0,"4,9,19 * 4,9,19",0.020825,4764,16
553,IC-50 = 18.4 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Locked nucleic acid* Phosphorothioate,0,"1,2,3 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",18.4,4763,16
554,IC-50 = 0.769 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Locked nucleic acid,0,"1,2,3,6,9,12,15,18,19,20",0.769,4762,16
555,IC-50 = 1.57 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose* Phosphorothioate,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 6,7,8",1.57,4761,16
556,IC-50 = 0.809 nM for target mRNA,RT-PCR,PTEN,50 nM,HeLa cells,LIPOFECTIN,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19* 9,10,11",0.809,4760,16
557,IC-50 = 0.025677 nM for target mRNA,RT-PCR,eIF4E,50 nM,HeLa cells,LIPOFECTIN,AGAAGACACCUUCUGAGUAU,AUACUCAGAAGGUGUCUUCU,2-O-Methylribose,2-O-Methylribose,"2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,20","6,7,10,11,18,19,20",0.025677,4759,16
558,IC-50 = 0.075608 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methlyribose,2-O-Methylribose,"2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","5,8,11,14,17,18,19",0.075608,4758,16
559,IC-50 = 0.11759 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-methoxyethylribose,2-O-Methylribose,"2,4,6,8,10,12,14,16,19","6,7,10,11,17,18,19",0.11759,4757,16
560,IC-50 = 0.47593 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-methoxyethylribose,2-O-Methylribose,"2,4,6,8,10,12,14,16,18","5,8,11,14,17,18,19",0.47593,4756,16
561,IC-50 = 0.045167 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methylribose,2-O-Methylribose,"2,4,6,8,10,12,14,16,18","6,7,10,11,17,18,19",0.045167,4755,16
562,IC-50 = 0.12453 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methylribose,2-O-Methylribose,"2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","5,8,11,14,17,18,21",0.12453,4754,16
563,IC-50 = 0.21527 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methylribose,2-O-Methylribose,"2,4,6,8,10,12,14,16,18","5,8,11,14,17,18,20",0.21527,4753,16
564,IC-50 = 0.96445 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,4-Thioribose* Phosphorothioate,2-O-Methylribose,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","5,8,11,14,17,18,19",0.96445,4752,16
565,IC-50 = 0.11222 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,4-Thioribose* Phosphorothioate,2-O-Methylribose,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","6,7,10,11,17,18,19",0.11222,4751,16
566,IC-50 = 0.055386 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,2-O-Methylribose,0,"6,7,10,11,17,18,19",0.055386,4750,16
567,IC-50 = 0.17024 nM for target mRNA,RT-PCR,Survivin,50 nM,HeLa cells,LIPOFECTIN,GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,2-O-Methylribose,0,"5,8,11,14,17,18,19",0.17024,4749,16
568,IC-50 = 0.075517 nM for target mRNA,RT-PCR,eIF4E,50 nM,HeLa cells,LIPOFECTIN,AGAAGACACCUUCUGAGUAU,AUACUCAGAAGGUGUCUUCU,0,2-O-Methylribose,0,"6,7,10,11,18,19,20",0.075517,4748,16
569,IC-50 = 0.01205 nM for target mRNA,RT-PCR,eIF4E,50 nM,HeLa cells,LIPOFECTIN,CAUUGGUGAAGGAUCCAGGA,CCUGGAUCCUUCACCAAUG,0,2-O-Methylribose,0,"5,6,9,10,17,18,19",0.01205,4747,16
570,IC-50 = 0.022859 nM for target mRNA,RT-PCR,eIF4E,50 nM,HeLa cells,LIPOFECTIN,CAUUGGUGAAGGAUCCAGGA,UCCUGGAUCCUUCACCAAUG,0,2-O-Methylribose,0,"6,12,15,18,19,20",0.022859,4746,16
571,72 percent target mRNA inhibition,Real-time PCR,NPY gene,1 - 100 nM,PC12 cells,Lipofectamine 2000,TGAGAGAAAGCACAGAAAATT,TUUUCUGUGCUUUCUCUCATT,Locked nucleic acid,Locked nucleic acid,"1,20,21","1,20,21",1.0,4745,24
572,34 percent target mRNA inhibition,Real-time PCR,NPY gene,1 - 100 nM,PC12 cells,Lipofectamine 2000,UGAGAGAAAGCACAGAAAATT,TUUUCUGUGCUUUCUCUCATT,2-Deoxy,Locked nucleic acid,"20,21","1,20,21",1.0,4744,24
573,64 percent target mRNA inhibition,Real-time PCR,NPY gene,1 - 100 nM,PC12 cells,Lipofectamine 2000,TGAGAGAAAGCACAGAAAATT,UGAGAGAAAGCACAGAAAATT,Locked nucleic acid,2-Deoxy,"1,3,5,9,12,14,17,20,21","20,21",1.0,4743,24
574,70 percent target mRNA inhibition,Real-time PCR,NPY gene,1 - 100 nM,PC12 cells,Lipofectamine 2000,TGAGAGAAAGCACAGAAAATT,UUUUCUGUGCUUUCUCUCATT,Locked nucleic acid,2-Deoxy,"1,20,21","20,21",1.0,4742,24
575,93 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,1 - 100 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACTCAGCGUAAGTT,2-Deoxy,Locked nucleic acid,"20,21","10,20,22",1.0,4741,24
576,52 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,1 - 100 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACTCAGCGUAAGTT,2-Deoxy,Locked nucleic acid,"20,21","10,20,21",1.0,4740,24
577,96 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,1 - 100 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxy,2-Deoxy,"20,21","20,21",1.0,4739,24
578,75 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,TUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"1,20,21","1,20,21",13.0,4738,24
579,63 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,TUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"20,21","1,20,21",13.0,4737,24
580,45 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,TUUUUCUCCUUCUUCAGAUTT,2-Deoxy,Locked nucleic acid,"20,21","1,20,21",13.0,4736,24
581,95 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"1,20,21","20,21",13.0,4735,24
582,93 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",13.0,4734,24
583,93 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,2-Deoxy,Locked nucleic acid,"20,21","20,21",13.0,4733,24
584,95 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,2-Deoxy,2-Deoxy,"20,21","20,21",13.0,4732,24
585,15 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,2-Deoxy,Locked nucleic acid,"20,21","1,8,11,17,20,21",13.0,4731,24
586,73 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CTTACGCTGAGTACTTCGATT,UCGAAGUACUCAGCGUAAGTT,5-Methylcytosine* Locked nucleic acid,Locked nucleic acid,"2 * 2,3,8,12,15,16,20,21","20,21",13.0,4730,24
587,80 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CTTACGCTGAGTACTTCGATT,UCGAAGUACUCAGCGUAAGTT,5-Methylcytosine* Locked nucleic acid,2-Deoxy,"1 * 2,3,8,12,15,16,20,21","20,21",13.0,4729,24
588,35 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,5-Methylcytosine* Locked nucleic acid,Locked nucleic acid,"1 * 20,21","1,20,21",13.0,4728,24
589,91 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,5-Methylcytosine* Locked nucleic acid,Locked nucleic acid,"1 * 20,21","20,21",13.0,4727,24
590,95 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,5-Methylcytosine* Locked nucleic acid,2-Deoxy,"1 * 20,21","20,21",13.0,4726,24
591,27 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,Locked nucleic acid,Locked nucleic acid,"20,21","1,20,21",13.0,4725,24
592,92 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",13.0,4724,24
593,96 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid,2-Deoxy,"20,21","20,21",13.0,4723,24
594,55 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,2-Deoxy,Locked nucleic acid,"20,21","1,20,21",13.0,4722,24
595,92 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxy,Locked nucleic acid,"20,21","20,21",13.0,4721,24
596,95 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Renilla luciferase,13 nM,HEK293 cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxy,2-Deoxy,"20,21","20,21",13.0,4720,24
597,49 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid* Phosphate,Locked nucleic acid,2 * 1,"1,2",30.0,4719,48
598,35 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,0,Locked nucleic acid,0,"1,20, 21",30.0,4718,48
599,44 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"20,21","1,20, 21",30.0,4717,48
600,35 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,0,Locked nucleic acid,0,"1,2",30.0,4716,48
601,51 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,0,Locked nucleic acid,0,"1,2,13,14",30.0,4715,48
602,17 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid* Phosphate,Locked nucleic acid,2 * 1,"1,2",30.0,4714,48
603,8 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,0,Locked nucleic acid,0,"1,20, 21",30.0,4713,48
604,14 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"20,21","1,20, 21",30.0,4712,48
605,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,0,Locked nucleic acid,0,"1,2",30.0,4711,48
606,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,0,Locked nucleic acid,0,"1,2,13,14",30.0,4710,48
607,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,11,13",0,30.0,4709,48
608,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,2-O-Methyl* Phosphate,"1,2",2 * 1,30.0,4708,48
609,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,10,14",0,30.0,4707,48
610,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,10,12",0,30.0,4706,48
611,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,14,15",0,30.0,4705,48
612,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,13,14",0,30.0,4704,48
613,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,12,13",0,30.0,4703,48
614,68 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,2-O-Methyl* Phosphate,"1,2",2 * 1,30.0,4702,48
615,70 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,10,14",0,30.0,4701,48
616,70 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,10,12",0,30.0,4700,48
617,70 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,14,15",0,30.0,4699,48
618,75 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,13,14",0,30.0,4698,48
619,70 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,2-O-Methyl,0,"1,2,12,13",0,30.0,4697,48
620,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,0,"1,2",0,30.0,4696,48
621,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,2",2 * 1,30.0,4695,48
622,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,0,"1,2,10,14",0,30.0,4694,48
623,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,2,10,14","11,12,19,20",30.0,4693,48
624,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,0,"1,2,13,14",0,30.0,4692,48
625,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,2,13,14","9,10,19,20",30.0,4691,48
626,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,20,21","20,21",30.0,4690,48
627,0 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Reverse orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,0,"1,20,21",0,30.0,4689,48
628,72 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,2",0,30.0,4687,48
629,70 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,2",2 * 1,30.0,4686,48
630,69 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,0,"1,2,10,14",0,30.0,4685,48
631,10 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,2,10,14","11,12,19,20",30.0,4684,48
632,80 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,0,"1,2,13,14",0,30.0,4683,48
633,60 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,2,13,14","9,10,19,20",30.0,4682,48
634,70 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,20,21","20,21",30.0,4681,48
635,80 percent target mRNA inhibition,Dual luciferase reporter assayÂ,Forward orientation fLuc mRNA,30 nM,HeLa cells,siPROT Amine transfection agent,NNNNNNNNNNNNNNNNNNNNNN,NNNNNNNNNNNNNNNNNNNNNN,Locked nucleic acid,Locked nucleic acid,"1,20,21",0,30.0,4680,48
655,40 percent target mRNA inhibition,Real-time PCR,VEGF,100 nM,HeLa cells,No transfection agent,CUUCCUACAGCACAACAAAUGUGAAUG,CAUUCACAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,100.0,4658,48
656,15 percent target mRNA inhibition,Real-time PCR,VEGF,100 nM,HeLa cells,No transfection agent,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,100.0,4656,48
657,95 percent target mRNA inhibition,Real-time PCR,VEGF,100 nM,HeLa cells,Lipofectamine 2000,CUUCCUACAGCACAACAAAUGUGAAUG,CAUUCACAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,100.0,4654,48
658,85 percent target mRNA inhibition,Real-time PCR,VEGF,100 nM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,100.0,4652,48
659,10 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,50 nM,HeLa cells,No transfection agent,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,50.0,4650,48
660,0 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,50 nM,HeLa cells,No transfection agent,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,50.0,4649,48
661,40 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,50 nM,HeLa cells,No transfection agent,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,50.0,4648,48
662,0 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,50 nM,HeLa cells,No transfection agent,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,50.0,4646,48
663,0 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,50 nM,HeLa cells,No transfection agent,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,50.0,4645,48
664,20 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,50 nM,HeLa cells,No transfection agent,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,50.0,4644,48
665,45 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,600 nM,HeLa cells,No transfection agent,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,600.0,4642,48
666,2 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,600 nM,HeLa cells,No transfection agent,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,600.0,4641,48
667,58 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,600 nM,HeLa cells,No transfection agent,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,600.0,4640,48
668,16 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,600 nM,HeLa cells,No transfection agent,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,600.0,4638,48
669,19 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,600 nM,HeLa cells,No transfection agent,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,600.0,4637,48
670,56 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,600 nM,HeLa cells,No transfection agent,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,600.0,4636,48
671,66 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,0.2,4634,48
672,68 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,0.2,4633,48
673,78 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,0.2,4632,48
674,67 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,0.2,4630,48
675,65 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,0.2,4629,48
676,71 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,0.2,4628,48
677,83 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,1.0,4626,48
678,81 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,1.0,4625,48
679,90 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,1.0,4624,48
680,84 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,1.0,4622,48
681,85 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,1.0,4621,48
682,92 percent target mRNA inhibition,Dual-Glo Luciferase Assay System,Renilla luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,1.0,4620,48
691,94 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACT,AGUAGGAGUAGUGAAAGGCCUT,0,2-O-Methyl,0,"3,21",33.0,4605,48
692,55 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACTT,AGUAGGAGUAGUGAAAGGCCUT,4-C- Aminomethyl-2-O-Methylribose,4-C- Aminomethyl-2-O-Methylribose,"5,7","3,21",33.0,4604,48
693,96 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACTT,AGUAGGAGUAGUGAAAGGCCTT,4-C- Aminomethyl-2-O-Methylribose,0,"5,7",0,33.0,4603,48
694,96 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACTT,AGUAGGAGUAGUGAAAGGCCUT,4-C- Aminomethyl-2-O-Methylribose,0,19,0,33.0,4602,48
695,66 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACTT,AGUAGGAGUAGUGAAAGGCCUT,0,4-C- Aminomethyl-2-O-Methylribose,0,"3,21",33.0,4601,48
696,95 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACTT,AGUAGGAGUAGUGAAAGGCCTT,0,4-C- Aminomethyl-2-O-Methylribose,0,20,33.0,4600,48
697,98 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACUT,AGUAGGAGUAGUGAAAGGCCTT,4-C- Aminomethyl-2-O-Methylribose,0,"17,20",0,33.0,4599,48
698,93 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,33 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACTT,AGUAGGAGUAGUGAAAGGCCTT,4-C- Aminomethyl-2-O-Methylribose,0,17,0,33.0,4598,48
752,82 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,1-Aminohexane* 2-Deoxyribonucleotide* N-hexylhexadecanamide,1-Aminohexane,"1 * 24,25 * 25",1,0.2,4543,48
753,56 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,1-Aminohexane* 2-Deoxyribonucleotide,1-Aminohexane,"1 * 24,25",1,0.2,4542,48
754,45 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,1-Aminohexane* 2-Deoxyribonucleotide,1-Aminohexane,"1 * 24,25",27,0.2,4541,48
755,69 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,1-Aminohexane* 2-Deoxyribonucleotide,0,"1 * 24,25",0,0.2,4540,48
756,45 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,2-Deoxyribonucleotide* 1-Aminohexane,1-Aminohexane,"24,25 * 25",1,0.2,4539,48
757,78 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,2-Deoxyribonucleotide,1-Aminohexane,"24,25",1,0.2,4538,48
758,45 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,2-Deoxyribonucleotide* 1-Aminohexane,1-Aminohexane,"24,25 * 25",27,0.2,4537,48
759,53 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,2-Deoxyribonucleotide,1-Aminohexane,"24,25",27,0.2,4536,48
760,79 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,2-Deoxyribonucleotide* 1-Aminohexane,0,"24,25 * 25",0,0.2,4535,48
761,70 percent target mRNA inhibition,Luciferase gene reporter assay,Renilla luciferase gene,0.2 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,2-Deoxyribonucleotide,0,"24,25",0,0.2,4534,48
762,56 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GAACUCUUAGCGUAUGCAATT,UUGCAUACGCUAAGAGUUCTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",50.0,4532,72
763,43 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GAACUCUUAGCGUAUGCAATT,UUGCAUACGCUAAGAGUUCTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"9,18 * 20,21","7 * 20,22",50.0,4531,72
764,43 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GAACUCUUAGCGUAUGCAATT,UUGCAUACGCUAAGAGUUCTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"9,18 * 20,21","7 * 20,22",50.0,4530,72
765,36 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GAACUCUUAGCGUAUGCAATT,UUGCAUACGCUAAGAGUUCTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"18 * 20,21","15 * 20,21",50.0,4529,72
766,46 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GAACUCUUAGCGUAUGCAATT,UUGCAUACGCUAAGAGUUCTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"18 * 20,21","15 * 20,21",50.0,4528,72
767,43 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"18 * 20,21","12 * 20,21",50.0,4527,72
768,39 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"18 * 20,21","12 * 20,21",50.0,4526,72
769,40 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"17 * 20,21","12 * 20,21",50.0,4525,72
770,42 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"17 * 20,21","12 * 20,21",50.0,4524,72
775,65 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"20,21","12 * 20,21",50.0,4519,72
776,77 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"20,21","18 * 20,21",50.0,4518,72
777,74 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"20,21","12,18 * 20,21",50.0,4517,72
778,64 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,2-Deoxythymidine,Cyclohexenyl nucleic acid* 2-Deoxythymidine,"20,21","12 * 20,21",50.0,4516,72
779,73 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"1,3 * 20,21","20,21",50.0,4515,72
780,55 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"18 * 20,21","20,21",50.0,4514,72
781,74 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"3,7 * 20,21","20,21",50.0,4513,72
782,59 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"17 * 20,21","20,21",50.0,4512,72
783,57 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"10 * 20,21","20,21",50.0,4511,72
784,63 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"6 * 20,21","20,21",50.0,4510,72
785,76 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Cyclohexenyl nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","20,21",50.0,4509,72
786,73 percent target mRNA inhibition,Immunostaining and Flow cytometry,P-glycoprotein expression,50 nM,NIH 3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",50.0,4508,72
787,86 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine* Biotin,"1 * 20,21","20,21 * 21",50.0,4507,66
788,56 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine* Puromycin,2-Deoxythymidine* Puromycin,"1 * 20,21","20,21 * 21",50.0,4506,66
789,62 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine* Puromycin,"20,21","20,21 * 21",50.0,4505,66
790,69 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine* Puromycin,2-Deoxythymidine,"1 * 20,21","20,21",50.0,4504,66
791,20 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,5-Amino* 2-Deoxythymidine,5-Amino* 2-Deoxythymidine,"1 * 20,21","1 * 20,21",50.0,4503,66
792,17 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,5-Amino* 2-Deoxythymidine,"20,21","1 * 20,21",50.0,4502,66
793,83 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,5-Amino* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","1 * 20,21",50.0,4501,66
794,78 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",50.0,4500,66
795,95 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine* Biotin,"1 * 20,21","20,21 * 21",50.0,4499,42
796,73 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine* Puromycin,2-Deoxythymidine* Puromycin,"1 * 20,21","20,21 * 21",50.0,4498,42
797,76 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine* Puromycin,"20,21","20,21 * 21",50.0,4497,42
798,85 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine* Puromycin,2-Deoxythymidine,"1 * 20,21","20,21",50.0,4496,42
799,25 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,5-Amino* 2-Deoxythymidine,5-Amino* 2-Deoxythymidine,"1 * 20,21","1 * 20,21",50.0,4495,42
800,8 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,5-Amino* 2-Deoxythymidine,"20,21","1 * 20,21",50.0,4494,42
801,91 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,5-Amino* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","1 * 20,21",50.0,4493,42
802,92 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",50.0,4492,42
803,61 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine* Biotin,"1 * 20,21","20,21 * 21",50.0,4491,6
804,50 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine* Puromycin,2-Deoxythymidine* Puromycin,"1 * 20,21","20,21 * 21",50.0,4490,6
805,67 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine* Puromycin,"20,21","20,21 * 21",50.0,4489,6
806,83 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine* Puromycin,2-Deoxythymidine,"1 * 20,21","20,21",50.0,4488,6
807,18 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,5-Amino* 2-Deoxythymidine,5-Amino* 2-Deoxythymidine,"1 * 20,21","1 * 20,21",50.0,4487,6
808,8 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,5-Amino* 2-Deoxythymidine,"20,21","1 * 20,21",50.0,4486,6
809,67 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,5-Amino* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","1 * 20,21",50.0,4485,6
810,62 percent target mRNA inhibition,Dual Fluorescence Reporter Gene Assays,GFP,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",50.0,4484,6
811,4 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid* 2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,1 * 20 * 21,20 * 21,1.0,4483,120
812,0 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,20 * 21,20 * 21,1.0,4482,120
813,6 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid* 2-Deoxyribonucleotide,2-Deoxyribonucleotide,"1 * 20,21","20,21",1.0,4481,120
814,0 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",1.0,4480,120
815,8 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,1.0,4479,120
816,30 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid* 2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,1 * 20 * 21,20 * 21,1.0,4477,48
817,12 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,20 * 21,20 * 21,1.0,4476,48
818,18 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid* 2-Deoxyribonucleotide,2-Deoxyribonucleotide,"1 * 20,21","20,21",1.0,4475,48
819,0 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",1.0,4474,48
820,7 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,1 uM,HeLa cells,Absence of Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,1.0,4473,48
821,85 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid* 2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,1 * 20 * 21,20 * 21,50.0,4471,120
822,55 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,20 * 21,20 * 21,50.0,4470,120
823,73 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid* 2-Deoxyribonucleotide,2-Deoxyribonucleotide,"1 * 20,21","20,21",50.0,4469,120
824,25 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",50.0,4468,120
825,48 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,50.0,4467,120
826,88 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGATT,Palmitic acid* 2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,1 * 20 * 21,20 * 21,50.0,4465,48
827,65 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGATT,2-Deoxyribonucleotide* Inverted thymidine,2-Deoxyribonucleotide* Inverted thymidine,20 * 21,20 * 21,50.0,4464,48
828,90 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGATT,Palmitic acid* 2-Deoxyribonucleotide,2-Deoxyribonucleotide,"1 * 20,21","20,21",50.0,4463,48
829,54 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGATT,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",50.0,4462,48
830,83 percent target mRNA inhibition,Real-time PCR,vascular endothelial growth factor (VEGF) gene,50 uM,HeLa cells,Lipofectamine 2000,UCCUACAGCACAACAAAUGUG,CAUUUGUUGUGCUGUAGGAAG,Palmitic acid,0,1,0,50.0,4461,48
831,42 percent target mRNA inhibition,Real-time PCR,Renilla luciferase,100 nM,HeLa cells,Absence of Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,100.0,4459,48
832,6 percent target mRNA inhibition,Real-time PCR,Renilla luciferase,100 nM,HeLa cells,Absence of Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,100.0,4458,48
833,82 percent target mRNA inhibition,Real-time PCR,Renilla luciferase,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,0,Palmitic Acid,0,21,1.0,4456,48
834,87 percent target mRNA inhibition,Real-time PCR,Renilla luciferase,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Lauric acid,0,1,0,1.0,4455,48
835,83 percent target mRNA inhibition,Real-time PCR,Renilla luciferase,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Cholesterol,0,1,0,1.0,4454,48
836,94 percent target mRNA inhibition,Real-time PCR,Renilla luciferase,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Palmitic acid,0,1,0,1.0,4453,48
843,71 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),UAAGAUGUUCAUCGAGUCCTT,GGACUCGAUGAACAUCUUATT,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* [3-(hydroxymethyl)phenyl]methanol,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol,"1 * 21,22","21,22",1.0,4445,24
844,58 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),UAAGAUGUUCAUCGAGUCCTT,GGACUCGAUGAACAUCUUATT,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* [3-(hydroxymethyl)phenyl]methanol,"[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* 1,3-Benzenedimethanol","1 * 21,22",20 * 21,1.0,4444,24
845,0 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),UAAGAUGUUCAUCGAGUCCTT,GGACUCGAUGAACAUCUUATT,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",1.0,4443,24
846,31 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),UUUCACUACUCCUACGAGCTT,GCUCGUAGGAGUAGUGAAATT,5-O-methylthymidine,2-Deoxyribonucleotide,1,"20,21",1.0,4442,24
847,43 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),UUUCACUACUCCUACGAGCTT,GCUCGUAGGAGUAGUGAAATT,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* [3-(hydroxymethyl)phenyl]methanol,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol,"1 * 20,21","20,21",1.0,4441,24
848,67 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),UUUCACUACUCCUACGAGCTT,GCUCGUAGGAGUAGUGAAATT,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* [3-(hydroxymethyl)phenyl]methanol,"[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* 1,3-Benzenedimethanol","1 * 20,21","20,21",1.0,4440,24
849,0 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),UUUCACUACUCCUACGAGCTT,GCUCGUAGGAGUAGUGAAATT,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",1.0,4439,24
850,25 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),CUUCUUCGUCGAGACCAUGTT,CAUGGUCUCGACGAAGAAGTT,2-Deoxyribonucleotide,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* 2-Deoxyribonucleotide,"20,21","1 * 21,22",1.0,4438,24
851,34 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),CUUCUUCGUCGAGACCAUGTT,CAUGGUCUCGACGAAGAAGTT,2-Deoxyribonucleotide,"[1,1-Biphenyl]-3,5-dimethanol* 2-Deoxyribonucleotide","20,21","1 * 21,22",1.0,4437,24
852,25 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),CUUCUUCGUCGAGACCAUGTT,CAUGGUCUCGACGAAGAAGTT,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol* 2-Deoxyribonucleotide,2-Deoxyribonucleotide,"1 * 20,21","20,21",1.0,4436,24
853,45 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),CUUCUUCGUCGAGACCAUGTT,CAUGGUCUCGACGAAGAAGTT,"[1,1-Biphenyl]-3,5-dimethanol* 2-Deoxyribonucleotide",2-Deoxyribonucleotide,"1 * 20,21","20,21",1.0,4435,24
854,45 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),CUUCUUCGUCGAGACCAUGTT,CAUGGUCUCGACGAAGAAGTT,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",1.0,4434,24
857,0 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),GGCCUUUCACUACUCCUACTT,GUAGGAGUAGUGAAAGGCCTT,[3-(hydroxymethyl)-5-pyren-1-ylphenyl]methanol,[3-(hydroxymethyl)-5-pyren-1-ylphenyl]methanol,"20,21","20,21",1.0,4431,24
858,22 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),GGCCUUUCACUACUCCUACTT,GUAGGAGUAGUGAAAGGCCTT,[3-(hydroxymethyl)-5-phenanthren-9-ylphenyl]methanol,[3-(hydroxymethyl)-5-phenanthren-9-ylphenyl]methanol,"20,21","20,21",1.0,4430,24
859,30 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),GGCCUUUCACUACUCCUACTT,GUAGGAGUAGUGAAAGGCCTT,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol,[3-(hydroxymethyl)-5-naphthalen-1-ylphenyl]methanol,"20,21","20,21",1.0,4429,24
860,43 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),GGCCUUUCACUACUCCUACTT,GUAGGAGUAGUGAAAGGCCTT,"[1,1-Biphenyl]-3,5-dimethanol","[1,1-Biphenyl]-3,5-dimethanol","20,21","20,21",1.0,4428,24
861,36 percent target mRNA inhibition,Dual luciferase reporter assay,Renilla luciferase,1 nM,HeLa cells,Lipofectamine RNAiMAX (Invitrogen) and Opti-MEM (GIBCO-BRL),GGCCUUUCACUACUCCUACTT,GUAGGAGUAGUGAAAGGCCTT,2-Deoxyribonucleotide,2-Deoxyribonucleotide,"20,21","20,21",1.0,4427,24
862,79 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,3000 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine* Cholesterol,2-Deoxythymidine,"1 * 20,21","20,21",3000.0,4426,48
863,84 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,3000 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol,2-Deoxythymidine,20 * 21,"20,21",3000.0,4425,48
864,63 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,3000 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl,2-Deoxythymidine,20 * 21,"20,21",3000.0,4424,48
865,75 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,3000 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",3000.0,4423,48
866,60 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,200 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine* Cholesterol,2-Deoxythymidine,"1 * 20,21","20,21",200.0,4422,48
867,82 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,200 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol,2-Deoxythymidine,20 * 21,"20,21",200.0,4421,48
868,34 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,200 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl,2-Deoxythymidine,20 * 21,"20,21",200.0,4420,48
869,33 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,200 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",200.0,4419,48
870,40 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,50 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine* Cholesterol,2-Deoxythymidine,"1 * 20,21","20,21",50.0,4418,48
871,30 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,50 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol,2-Deoxythymidine,20 * 21,"20,21",50.0,4417,48
872,20 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,50 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl,2-Deoxythymidine,20 * 21,"20,21",50.0,4416,48
873,30 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,50 nM,HeLa cells,No transfection agent,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",50.0,4415,48
874,75 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,10 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,2-Deoxythymidine* Cholesterol,2-Deoxythymidine,"20,21 * 21","20,21",10.0,4414,48
875,10 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,10 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCCU,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Cholesterol,2-Deoxythymidine,20 * 21,"20,21",10.0,4413,48
876,82 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,10 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCCU,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Phenyl,2-Deoxythymidine,20 * 21,"20,21",10.0,4412,48
877,87 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,10 nM,HeLa cells,Lipofectamine 2000,GCCUUCUUUGAGUUCGGUGUU,CACCGAACUCAAAGAAGGCTT,Triazole-linked nucleic acid,2-Deoxythymidine,20,"20,21",10.0,4411,48
878,80 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,10 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Cholesterol* 2-Deoxythymidine,2-Deoxythymidine,"16 * 17 * 20,21","20,21",10.0,4410,48
879,83 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,10 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"16 * 17 * 20,21","20,21",10.0,4409,48
880,70 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,10 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",10.0,4408,48
881,64 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,1 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,2-Deoxythymidine* Cholesterol,2-Deoxythymidine,"20,21 * 21","20,21",1.0,4407,48
882,76 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,1 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCCU,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Cholesterol,2-Deoxythymidine,20 * 21,"20,21",1.0,4406,48
883,75 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,1 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCCU,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Phenyl,2-Deoxythymidine,20 * 21,"20,21",1.0,4405,48
884,71 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,1 nM,HeLa cells,Lipofectamine 2000,GCCUUCUUUGAGUUCGGUGUU,CACCGAACUCAAAGAAGGCTT,Triazole-linked nucleic acid,2-Deoxythymidine,20,"20,21",1.0,4404,48
885,73 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,1 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Cholesterol* 2-Deoxythymidine,2-Deoxythymidine,"16 * 17 * 20,21","20,21",1.0,4403,48
886,85 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,1 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"16 * 17 * 20,21","20,21",1.0,4402,48
887,50 percent target mRNA inhibition,Dual luciferase reporter assay,Anti-bcl-2 (aB) gene,1 nM,HeLa cells,Lipofectamine 2000,GUGAAGUCAACAUGCCUGCTT,GCAGGCAUGUUGACUUCACTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",1.0,4401,48
888,90 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine* Cholesterol,2-Deoxythymidine,"1 * 20,21","20,21",0.08,4400,48
889,95 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol,2-Deoxythymidine,20 * 21,"20,21",0.08,4399,48
890,97 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl,2-Deoxythymidine,20 * 21,"20,21",0.08,4398,48
891,95 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGAUU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid,2-Deoxythymidine,20,"20,21",0.08,4397,48
892,94 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol* 2-Deoxythymidine,2-Deoxythymidine,"14 * 15 * 20,21","20,21",0.08,4396,48
893,96 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"14 * 15 * 20,21","20,21",0.08,4395,48
894,88 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"14 * 20,21","20,21",0.08,4394,48
895,86 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUCUGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol* 2-Deoxythymidine,2-Deoxythymidine,"9 * 10 * 20,21","20,21",0.08,4393,48
896,90 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUCUGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"9 * 10 * 20,21","20,21",0.08,4392,48
897,94 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUCUGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",0.08,4391,48
898,95 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"7 * 8 * 20,21","20,21",0.08,4390,48
899,75 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"7 * 20,21","20,21",0.08,4389,48
900,85 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"1 * 2 * 20,21","20,21",0.08,4388,48
901,87 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","20,21",0.08,4387,48
902,89 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.08 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",0.08,4386,48
903,65 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine* Cholesterol,2-Deoxythymidine,"1 * 20,21","20,21",0.008,4385,48
904,85 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol,2-Deoxythymidine,20 * 21,"20,21",0.008,4384,48
905,92 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGACU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl,2-Deoxythymidine,20 * 21,"20,21",0.008,4383,48
906,93 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGAUU,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid,2-Deoxythymidine,20,"20,21",0.008,4382,48
907,60 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol* 2-Deoxythymidine,2-Deoxythymidine,"14 * 15 * 20,21","20,21",0.008,4381,48
908,67 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"14 * 15 * 20,21","20,21",0.008,4380,48
909,67 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"14 * 20,21","20,21",0.008,4379,48
910,44 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUCUGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Cholesterol* 2-Deoxythymidine,2-Deoxythymidine,"9 * 10 * 20,21","20,21",0.008,4378,48
911,50 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUCUGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"9 * 10 * 20,21","20,21",0.008,4377,48
912,92 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUCUGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",0.008,4376,48
913,86 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"7 * 8 * 20,21","20,21",0.008,4375,48
914,70 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"7 * 20,21","20,21",0.008,4374,48
915,43 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* Phenyl* 2-Deoxythymidine,2-Deoxythymidine,"1 * 2 * 20,21","20,21",0.008,4373,48
916,80 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Triazole-linked nucleic acid* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","20,21",0.008,4372,48
917,69 percent target mRNA inhibition,Dual luciferase reporter assay,Firefly luciferase gene,0.008 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",0.008,4371,48
918,80 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"18,19,20","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",20.0,4370,20
919,77 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"12,13,14","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",20.0,4369,20
920,73 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"6,7,8","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",20.0,4368,20
921,75 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"1,2,3","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",20.0,4367,20
922,63 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"18,19,20","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",2.0,4366,20
923,56 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"12,13,14","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",2.0,4365,20
924,45 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"6,7,8","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",2.0,4364,20
925,56 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,Phosphorothioate,"1,2,3","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",2.0,4363,20
926,75 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"18,19,20",0,20.0,4362,20
927,77 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"12,13,14",0,20.0,4361,20
928,70 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"6,7,8",0,20.0,4360,20
929,70 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,20 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"1,2,3",0,20.0,4359,20
930,68 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"18,19,20",0,2.0,4358,20
931,65 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"12,13,14",0,2.0,4357,20
932,40 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"6,7,8",0,2.0,4356,20
933,67 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,2 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,2-O-(2-methoxyethyl)ribose,0,"1,2,3",0,2.0,4355,20
934,17 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 18,19,20",15.0,4354,20
935,44 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 15,16,17",15.0,4353,20
936,36 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 12,13,14",15.0,4352,20
937,50 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 9,10,11",15.0,4351,20
938,45 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 6,7,8",15.0,4350,20
939,20 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 3,4,5",15.0,4349,20
940,15 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 1,2,3",15.0,4348,20
941,10 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 18,19,20",1.5,4347,20
942,20 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 15,16,17",1.5,4346,20
943,15 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 12,13,14",1.5,4345,20
944,30 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 9,10,11",1.5,4344,20
945,20 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 6,7,8",1.5,4343,20
946,10 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 3,4,5",1.5,4342,20
947,4 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-(2-methoxyethyl)ribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 1,2,3",1.5,4341,20
948,72 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 18,19,20",15.0,4340,20
949,80 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 15,16,17",15.0,4339,20
950,68 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 12,13,14",15.0,4338,20
951,83 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 9,10,11",15.0,4337,20
952,75 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 6,7,8",15.0,4336,20
953,62 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 3,4,5",15.0,4335,20
954,68 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 1,2,3",15.0,4334,20
955,33 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 18,19,20",1.5,4333,20
956,34 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 15,16,17",1.5,4332,20
957,40 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 12,13,14",1.5,4331,20
958,43 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 9,10,11",1.5,4330,20
959,34 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 6,7,8",1.5,4329,20
960,28 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 3,4,5",1.5,4328,20
961,29 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-Deoxy-2-fluororibose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 1,2,3",1.5,4327,20
962,63 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 18,19,20",1.5,4326,20
963,60 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 15,16,17",1.5,4325,20
964,53 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 12,13,14",1.5,4324,20
965,73 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 9,10,11",1.5,4323,20
966,69 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 6,7,8",1.5,4322,20
967,47 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 3,4,5",1.5,4321,20
968,40 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 1,2,3",1.5,4320,20
969,42 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 18,19,20",1.5,4319,20
970,38 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 15,16,17",1.5,4318,20
971,30 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 12,13,14",1.5,4317,20
972,55 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 9,10,11",1.5,4316,20
973,45 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 6,7,8",1.5,4315,20
974,28 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 3,4,5",1.5,4314,20
975,20 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* 2-O-Methylribose,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 * 1,2,3",1.5,4313,20
976,82 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"18,19,20",15.0,4312,20
977,78 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"15,16,17",15.0,4311,20
978,47 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"12,13,14",15.0,4310,20
979,82 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"9,10,11",15.0,4309,20
980,77 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"6,7,8",15.0,4308,20
981,75 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"3,4,5",15.0,4307,20
982,52 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,15 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"1,2,3",15.0,4306,20
983,57 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"18,19,20",1.5,4305,20
984,52 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"15,16,17",1.5,4304,20
985,12 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"12,13,14",1.5,4303,20
986,49 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"9,10,11",1.5,4302,20
987,50 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"6,7,8",1.5,4301,20
988,26 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"3,4,5",1.5,4300,20
989,19 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,2-O-Methyl,0,"1,2,3",1.5,4299,20
990,30 percent target mRNA inhibition,Real-time PCR,PTEN mRNA,1.5 nM,HeLa cells,Lipofectin,AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21",1.5,4298,20
991,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Phosphate* Serinol nucleic acid,"1,2,22,23","1 * 20,21",17.0,4296,48
992,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","20,21",17.0,4295,48
993,5 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Phosphate,"1,2,22,23",1,17.0,4294,48
994,5 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,22,23",0,17.0,4293,48
995,78 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Phosphate* Serinol nucleic acid,"1,2,22,23","1 * 20,21",17.0,4292,48
996,81 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","20,21",17.0,4291,48
997,80 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Phosphate,"1,2,22,23",1,17.0,4290,48
998,78 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,22,23",0,17.0,4289,48
999,8 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,3,4,5,6,7,17,18,19,20,21,22,23","17,18,19,20,21,22,23",17.0,4288,48
1000,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,3,4,5,19,20,21,22,23","19,20,21,22,23",17.0,4287,48
1001,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,3,21,22,23","21,22,23",17.0,4286,48
1002,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","22,23",17.0,4285,48
1003,20 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,23",23,17.0,4284,48
1004,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,4,5,6,7,17,18,19,20,21,22,23",0,17.0,4283,48
1005,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,4,5,19,20,21,22,23",0,17.0,4282,48
1006,35 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,21,22,23",0,17.0,4281,48
1007,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,22,23",0,17.0,4280,48
1008,10 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,23",0,17.0,4279,48
1009,20 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,3,4,5,6,7,17,18,19,20,21,22,23","17,18,19,20,21,22,23",17.0,4278,48
1010,50 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,3,4,5,19,20,21,22,23","19,20,21,22,23",17.0,4277,48
1011,88 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,3,21,22,23","21,22,23",17.0,4276,48
1012,94 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","22,23",17.0,4275,48
1013,96 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,23",23,17.0,4274,48
1014,78 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,4,5,6,7,17,18,19,20,21,22,23",0,17.0,4273,48
1015,90 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,4,5,19,20,21,22,23",0,17.0,4272,48
1016,96 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,21,22,23",0,17.0,4271,48
1017,96 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,22,23",0,17.0,4270,48
1018,93 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,23",0,17.0,4269,48
1019,98 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,2-O-Methyl ribose,0,"1,2,22,23",17.0,4268,48
1020,56 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,2-O-Methyl ribose,0,"1,2,22,23",0,17.0,4267,48
1021,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23",0,17.0,4266,48
1022,25 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","1,2,22,23",17.0,4265,48
1023,99 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"22,23","1,2,22,23",17.0,4264,48
1024,90 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2","1,2,22,23",17.0,4263,48
1025,96 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,Serinol nucleic acid,0,"1,2,22,23",17.0,4262,48
1026,20 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","1,2",17.0,4261,48
1027,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","22,23",17.0,4260,48
1028,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,22,23",0,17.0,4259,48
1029,98 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"22,23","1,2",17.0,4258,48
1030,97 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"22,23","22,23",17.0,4257,48
1031,90 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2","1,2",17.0,4256,48
1032,87 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2","22,23",17.0,4255,48
1033,91 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,Serinol nucleic acid,0,"1,2",17.0,4254,48
1034,91 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,Serinol nucleic acid,0,"22,23",17.0,4253,48
1035,91 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"22,23",0,17.0,4252,48
1036,96 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2",0,17.0,4251,48
1037,62 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,2-O-Methyl ribose,0,"1,2,22,23",17.0,4249,48
1038,96 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,2-O-Methyl ribose,0,"1,2,22,23",0,17.0,4248,48
1039,0 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23",0,17.0,4247,48
1040,50 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","1,2,22,23",17.0,4246,48
1041,55 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"22,23","1,2,22,23",17.0,4245,48
1042,76 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2","1,2,22,23",17.0,4244,48
1043,40 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,Serinol nucleic acid,0,"1,2,22,23",17.0,4243,48
1044,70 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","1,2",17.0,4242,48
1045,97 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2,22,23","22,23",17.0,4241,48
1046,98 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2,22,23",0,17.0,4240,48
1047,74 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"22,23","1,2",17.0,4239,48
1048,82 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"22,23","22,23",17.0,4238,48
1049,78 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2","1,2",17.0,4237,48
1050,89 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,Serinol nucleic acid,"1,2","22,23",17.0,4236,48
1051,62 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,Serinol nucleic acid,0,"1,2",17.0,4235,48
1052,60 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,0,Serinol nucleic acid,0,"22,23",17.0,4234,48
1053,90 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"22,23",0,17.0,4233,48
1054,93 percent target mRNA inhibition,Dual luciferase assay,Firefly luciferase expression,17 nM,293FT cells,Lipofectamine 2000,AACCUUACCCACCUCAUGUAUCU,AGAUACAUGAGGUGGGUAAGGUU,Serinol nucleic acid,0,"1,2",0,17.0,4232,48
1055,89 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand A,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,L-isonucleoside adenosine* 2-Deoxythymidine,"20,21","2 * 20,21",13.0,4230,24
1056,90 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand A,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,L-isonucleoside adenosine* 2-Deoxythymidine,"20,21","19 * 20,21",13.0,4229,24
1057,70 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand A,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,L-isonucleoside thymidine* 2-Deoxythymidine,"20,21","4 * 20,21",13.0,4228,24
1058,36 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand A,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,L-isonucleoside adenosine* 2-Deoxythymidine,2-Deoxythymidine,"19 * 20,21","20,21",13.0,4227,24
1059,13 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand A,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,L-isonucleoside thymidine* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","20,21",13.0,4226,24
1060,80 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand A,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",13.0,4225,24
1061,74 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand B,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,L-isonucleoside adenosine* 2-Deoxythymidine,"20,21","2 * 20,21",13.0,4224,24
1062,90 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand B,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,L-isonucleoside adenosine* 2-Deoxythymidine,"20,21","19 * 20,21",13.0,4223,24
1063,69 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand B,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,L-isonucleoside thymidine* 2-Deoxythymidine,"20,21","4 * 20,21",13.0,4222,24
1064,95 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand B,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,L-isonucleoside adenosine* 2-Deoxythymidine,2-Deoxythymidine,"19 * 20,21","20,21",13.0,4221,24
1065,92 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand B,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,L-isonucleoside thymidine* 2-Deoxythymidine,2-Deoxythymidine,"1 * 20,21","20,21",13.0,4220,24
1066,94 percent target mRNA inhibition,Dual luciferase assay,Cdc-gene strand B,13 nM,HEK293 cells,Lipofectamine 2000,UCGGGAAAUUUCUCUAUUATT,UAAUAGAGAAAUUUCCCGATT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",13.0,4219,24
1067,71 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CCGAAGACGAAGCUAUGAATT,UUCAUAGCUUCGUCUUCGGTT,2-O-Methyl,2-O-Methyl,14,3,13.0,4218,4
1068,69 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CCGAAGACGAAGCUAUGAATT,UUCAUAGCUUCGUCUUCGGTT,2-O-Methyl,2-O-Methyl,"10,11,14,16","3,5",13.0,4217,4
1069,51 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CCGAAGACGAAGCUAUGAATT,UUCAUAGCUUCGUCUUCGGTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","7,12,18,19",13.0,4216,4
1070,88 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAGGUGGAGGUAUCUCTT,GAGAUACCUCCACCUCUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,8,5,13.0,4214,4
1071,85 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAGGUGGAGGUAUCUCTT,GAGAUACCUCCACCUCUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"8,14,18","5,11,12",13.0,4213,4
1072,68 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAGGUGGAGGUAUCUCTT,GAGAUACCUCCACCUCUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","2,4,6,12",13.0,4212,4
1073,71 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,UCCAAGCUUCCUCGUUGGUTT,ACCAACGAGGAAGCUUGGATT,0,2-Deoxy-2-Fluoro,0,"3,16",13.0,4210,4
1074,65 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,UCCAAGCUUCCUCGUUGGUTT,ACCAACGAGGAAGCUUGGATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"3,16,17","3,4,16",13.0,4209,4
1075,51 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,UCCAAGCUUCCUCGUUGGUTT,ACCAACGAGGAAGCUUGGATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","15,16",13.0,4208,4
1076,67 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AAAGCGGUGGAUCAGCUCUTT,AGAGCUGAUCCACCGCUUUTT,0,2-O-Methyl,0,"6,11",13.0,4206,4
1077,63 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AAAGCGGUGGAUCAGCUCUTT,AGAGCUGAUCCACCGCUUUTT,2-O-Methyl,2-O-Methyl,"8,9,13","6,11,12",13.0,4205,4
1078,43 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AAAGCGGUGGAUCAGCUCUTT,AGAGCUGAUCCACCGCUUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,4,15",13.0,4204,4
1079,57 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AAACGAGAGAGCCCACCUUTT,AAGGUGGGCUCUCUCGUUUTT,0,2-O-Methyl,0,5,13.0,4202,4
1080,56 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AAACGAGAGAGCCCACCUUTT,AAGGUGGGCUCUCUCGUUUTT,2-O-Methyl,2-O-Methyl,"7,14","5,6",13.0,4201,4
1081,37 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AAACGAGAGAGCCCACCUUTT,AAGGUGGGCUCUCUCGUUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","9,11,13,15",13.0,4200,4
1082,74 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACAAAGGAUCUCCUCCCTT,GGGAGGAGAUCCUUUGUAATT,2-O-Methyl,2-O-Methyl,"3,4",17,13.0,4198,4
1083,72 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACAAAGGAUCUCCUCCCTT,GGGAGGAGAUCCUUUGUAATT,2-O-Methyl,2-O-Methyl,"2,4,8,9","15,17",13.0,4197,4
1084,51 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACAAAGGAUCUCCUCCCTT,GGGAGGAGAUCCUUUGUAATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","4,7,9,18,19",13.0,4196,4
1085,86 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,GUUCUAGCUGUGGUGGGUUUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,14","5,6,9",13.0,4194,4
1086,79 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,GUUCUAGCUGUGGUGGGUUUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,10,14","5,9,11,14",13.0,4193,4
1087,57 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,GUUCUAGCUGUGGUGGGUUUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","1,7,10,12,13,15,16,17",13.0,4192,4
1088,74 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UCCUCGUCGUCUGUUCUAATT,UUAGAACAGACGACGAGGATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,17,"2,7",13.0,4190,4
1089,77 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UCCUCGUCGUCUGUUCUAATT,UUAGAACAGACGACGAGGATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"9,12,13,17","2,7",13.0,4189,4
1090,49 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UCCUCGUCGUCUGUUCUAATT,UUAGAACAGACGACGAGGATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","7,11,14",13.0,4188,4
1091,74 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AUCCUGCAGAAGAAGCCUCTT,GAGGCUUCUUCUGCAGGAUTT,2-O-Methyl,0,"5,7",0,13.0,4186,4
1092,50 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AUCCUGCAGAAGAAGCCUCTT,GAGGCUUCUUCUGCAGGAUTT,2-O-Methyl,2-O-Methyl,"5,7,12","12,14",13.0,4185,4
1093,37 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AUCCUGCAGAAGAAGCCUCTT,GAGGCUUCUUCUGCAGGAUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","5,8,11,14",13.0,4184,4
1094,74 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAGAGAGACGGUGGAAGAATT,UUCUUCCACCGUCUCUCUCTT,0,2-O-Methyl,0,8,13.0,4182,4
1095,72 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAGAGAGACGGUGGAAGAATT,UUCUUCCACCGUCUCUCUCTT,2-O-Methyl,2-O-Methyl,"12,13",7,13.0,4181,4
1096,56 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAGAGAGACGGUGGAAGAATT,UUCUUCCACCGUCUCUCUCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19",11,13.0,4180,4
1097,74 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,GCUUUAAGGAACUGGAAGGTT,CCUUCCAGUUCCUUAAAGCTT,2-O-Methyl,2-O-Methyl,"6,13",6,13.0,4178,4
1098,72 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,GCUUUAAGGAACUGGAAGGTT,CCUUCCAGUUCCUUAAAGCTT,2-O-Methyl,2-O-Methyl,"5,6,13","6,14,15",13.0,4177,4
1099,51 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,GCUUUAAGGAACUGGAAGGTT,CCUUCCAGUUCCUUAAAGCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","8,18",13.0,4176,4
1100,42 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,CGGAUCUACACCUUCAAGATT,UCUUGAAGGUGUAGAUCCGTT,2-O-Methyl,2-O-Methyl,"7,16","4,10,12",13.0,4174,4
1101,40 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,CGGAUCUACACCUUCAAGATT,UCUUGAAGGUGUAGAUCCGTT,2-O-Methyl,2-O-Methyl,"7,8,9,15","4,10,12",13.0,4173,4
1102,29 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,CGGAUCUACACCUUCAAGATT,UCUUGAAGGUGUAGAUCCGTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","1,3,4,10,12,16",13.0,4172,4
1103,71 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUAAGGACCACCGGAUTT,AUCCGGUGGUCCUUAAGGUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,5,7,13.0,4170,4
1104,70 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUAAGGACCACCGGAUTT,AUCCGGUGGUCCUUAAGGUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,12,13","7,8,14,15",13.0,4169,4
1105,41 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUAAGGACCACCGGAUTT,AUCCGGUGGUCCUUAAGGUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","1,15,16",13.0,4168,4
1106,72 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGGAGACCGUGACAUUUCGTT,CGAAAUGUCACGGUCUCCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"10,13",6,13.0,4166,4
1107,69 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGGAGACCGUGACAUUUCGTT,CGAAAUGUCACGGUCUCCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"10,13","6,10",13.0,4165,4
1108,33 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGGAGACCGUGACAUUUCGTT,CGAAAUGUCACGGUCUCCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","2,7,12,13",13.0,4164,4
1109,64 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACAGAAAGAGUUCGAGGAGTT,CUCCUCGAACUCUUUCUGUTT,2-O-Methyl,2-O-Methyl,2,17,13.0,4162,4
1110,61 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACAGAAAGAGUUCGAGGAGTT,CUCCUCGAACUCUUUCUGUTT,2-O-Methyl,2-O-Methyl,"2,3,9",17,13.0,4161,4
1111,37 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,CACAGAAAGAGUUCGAGGAGTT,CUCCUCGAACUCUUUCUGUTT,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18,20","7,18",13.0,4160,4
1112,74 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAGCCUACACAACCCUTT,AGGGUUGUGUAGGCUCUUCTT,2-O-Methyl,2-O-Methyl,"11,13","6,10",13.0,4158,4
1113,74 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAGCCUACACAACCCUTT,AGGGUUGUGUAGGCUCUUCTT,2-O-Methyl,2-O-Methyl,"9,10,11,13","6,8,10",13.0,4157,4
1114,43 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAGCCUACACAACCCUTT,AGGGUUGUGUAGGCUCUUCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,3,4,7,9,12,13",13.0,4156,4
1115,87 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUGACCGGAAGCGCUUAAATT,UUUAAGCGCUUCCGGUCAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,2,3,13.0,4154,4
1116,85 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUGACCGGAAGCGCUUAAATT,UUUAAGCGCUUCCGGUCAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,11,16","3,17",13.0,4153,4
1117,59 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUGACCGGAAGCGCUUAAATT,UUUAAGCGCUUCCGGUCAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","4,5,18",13.0,4152,4
1118,80 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGACCUAGAGGAGUCACTT,GUGACUCCUCUAGGUCCUUTT,2-O-Methyl,2-O-Methyl,8,2,13.0,4150,4
1119,78 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGACCUAGAGGAGUCACTT,GUGACUCCUCUAGGUCCUUTT,2-O-Methyl,2-O-Methyl,"8,17,18","2,11",13.0,4149,4
1120,36 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGACCUAGAGGAGUCACTT,GUGACUCCUCUAGGUCCUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","1,3,13,14",13.0,4148,4
1121,72 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUCCGACAGAUGAAGGAAATT,UUUCCUUCAUCUGUCGGAGTT,2-O-Methyl,2-O-Methyl,11,12,13.0,4146,4
1122,70 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUCCGACAGAUGAAGGAAATT,UUUCCUUCAUCUGUCGGAGTT,2-O-Methyl,2-O-Methyl,"7,8,11","8,12,13",13.0,4145,4
1123,46 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUCCGACAGAUGAAGGAAATT,UUUCCUUCAUCUGUCGGAGTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","9,18",13.0,4144,4
1124,54 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGUCCACCUUCUCCGATT,UCGGAGAAGGUGGACUUCCTT,2-O-Methyl,2-O-Methyl,9,11,13.0,4142,4
1125,51 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGUCCACCUUCUCCGATT,UCGGAGAAGGUGGACUUCCTT,2-O-Methyl,2-O-Methyl,"8,9,12,13",11,13.0,4141,4
1126,27 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGUCCACCUUCUCCGATT,UCGGAGAAGGUGGACUUCCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","1,11,16,17",13.0,4140,4
1127,82 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAAACGCAGUAAUCCGGATT,UCCGGAUUACUGCGUUUCUTT,2-O-Methyl,2-O-Methyl,11,11,13.0,4138,4
1128,78 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAAACGCAGUAAUCCGGATT,UCCGGAUUACUGCGUUUCUTT,2-O-Methyl,2-O-Methyl,"8,11,12","8,11",13.0,4137,4
1129,36 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAAACGCAGUAAUCCGGATT,UCCGGAUUACUGCGUUUCUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","4,5,12,14",13.0,4136,4
1130,72 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AACUCUACUGUGGAGUCGGTT,CCGACUCCACAGUAGAGUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,9,"8,13",13.0,4134,4
1131,65 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AACUCUACUGUGGAGUCGGTT,CCGACUCCACAGUAGAGUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"6,9,11","8,10,13",13.0,4133,4
1132,25 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AACUCUACUGUGGAGUCGGTT,CCGACUCCACAGUAGAGUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","3,12,15,17",13.0,4132,4
1133,90 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCUUCGGAAACUGGACAUCTT,GAUGUCCAGUUUCCGAAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,16,"3,7",13.0,4130,4
1134,87 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCUUCGGAAACUGGACAUCTT,GAUGUCCAGUUUCCGAAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"12,13,16","3,7,8",13.0,4129,4
1135,29 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCUUCGGAAACUGGACAUCTT,GAUGUCCAGUUUCCGAAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","1,4,9,15,18",13.0,4128,4
1136,95 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AAGGCAUGCUUCGGAAACUTT,AGUUUCCGAAGCAUGCCUUTT,2-O-Methyl,2-O-Methyl,5,12,13.0,4126,4
1137,87 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AAGGCAUGCUUCGGAAACUTT,AGUUUCCGAAGCAUGCCUUTT,2-O-Methyl,2-O-Methyl,"5,7,8","12,14",13.0,4125,4
1138,60 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AAGGCAUGCUUCGGAAACUTT,AGUUUCCGAAGCAUGCCUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,11,15",13.0,4124,4
1139,82 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,UUGGGGAAGCGGCCGGCGGTT,CCGCCGGCCGCUUCCCCAATT,2-O-Methyl,2-O-Methyl,2,17,13.0,4122,4
1140,78 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,UUGGGGAAGCGGCCGGCGGTT,CCGCCGGCCGCUUCCCCAATT,2-O-Methyl,2-O-Methyl,"2,3,7,8",17,13.0,4121,4
1141,36 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,UUGGGGAAGCGGCCGGCGGTT,CCGCCGGCCGCUUCCCCAATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","18,19",13.0,4120,4
1142,72 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AUACUUGGCGGGCUCUUUCTT,GAAAGAGCCCGCCAAGUAUTT,2-O-Methyl,2-O-Methyl,3,13,13.0,4118,4
1143,70 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AUACUUGGCGGGCUCUUUCTT,GAAAGAGCCCGCCAAGUAUTT,2-O-Methyl,2-O-Methyl,"2,6,7,13","13,17",13.0,4117,4
1144,25 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AUACUUGGCGGGCUCUUUCTT,GAAAGAGCCCGCCAAGUAUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","1,5,7,11,16",13.0,4116,4
1145,70 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGCCUCCAAACUCCUAGCUTT,AGCUAGGAGUUUGGAGGCUTT,0,2-O-Methyl,0,"4,12",13.0,4114,4
1146,65 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGCCUCCAAACUCCUAGCUTT,AGCUAGGAGUUUGGAGGCUTT,2-O-Methyl,2-O-Methyl,"7,15","4,12",13.0,4113,4
1147,47 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGCCUCCAAACUCCUAGCUTT,AGCUAGGAGUUUGGAGGCUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","3,18",13.0,4112,4
1148,85 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCAAAUCAAGGCCGGAGUTT,ACUCCGGCCUUGAUUUGAGTT,0,2-O-Methyl,0,"11,16",13.0,4110,4
1149,82 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCAAAUCAAGGCCGGAGUTT,ACUCCGGCCUUGAUUUGAGTT,2-O-Methyl,2-O-Methyl,"3,8","11,16",13.0,4109,4
1150,36 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCAAAUCAAGGCCGGAGUTT,ACUCCGGCCUUGAUUUGAGTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","6,7,12,17,19",13.0,4108,4
1151,85 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CCAGCGAGCCCAAAAGAAATT,UUUCUUUUGGGCUCGCUGGTT,2-Deoxy-2-Fluoro,0,"2,11",0,13.0,4106,4
1152,82 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CCAGCGAGCCCAAAAGAAATT,UUUCUUUUGGGCUCGCUGGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,11,16","8,17",13.0,4105,4
1153,35 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CCAGCGAGCCCAAAAGAAATT,UUUCUUUUGGGCUCGCUGGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,6,8,16","1,3,5,7,9,11,13,15,17,19",13.0,4104,4
1154,73 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AACUUCUGGGAGCCUCCAATT,UUGGAGGCUCCCAGAAGUUTT,2-O-Methyl,2-O-Methyl,17,12,13.0,4102,4
1155,69 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AACUUCUGGGAGCCUCCAATT,UUGGAGGCUCCCAGAAGUUTT,2-O-Methyl,2-O-Methyl,"7,17","2,12",13.0,4101,4
1156,42 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AACUUCUGGGAGCCUCCAATT,UUGGAGGCUCCCAGAAGUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","5,13,15,16",13.0,4100,4
1157,83 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAGGAGAAGCUGACGGCTT,GCCGUCAGCUUCUCCUUAATT,2-O-Methyl,2-O-Methyl,2,"6,17",13.0,4098,4
1158,82 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAGGAGAAGCUGACGGCTT,GCCGUCAGCUUCUCCUUAATT,2-O-Methyl,2-O-Methyl,"2,13,14","6,17",13.0,4097,4
1159,45 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAGGAGAAGCUGACGGCTT,GCCGUCAGCUUCUCCUUAATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","1,4,8",13.0,4096,4
1160,70 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCUCAGCCCUAACGGUTT,ACCGUUAGGGCUGAGGUUUTT,2-O-Methyl,2-O-Methyl,8,6,13.0,4094,4
1161,70 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCUCAGCCCUAACGGUTT,ACCGUUAGGGCUGAGGUUUTT,2-O-Methyl,2-O-Methyl,"7,13","6,12",13.0,4093,4
1162,28 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCUCAGCCCUAACGGUTT,ACCGUUAGGGCUGAGGUUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,3,11",13.0,4092,4
1163,60 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGUACCAGGAGGCGUUTT,AACGCCUCCUGGUACUUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,6,10,13.0,4090,4
1164,57 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGUACCAGGAGGCGUUTT,AACGCCUCCUGGUACUUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"6,9","10,13",13.0,4089,4
1165,39 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGUACCAGGAGGCGUUTT,AACGCCUCCUGGUACUUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","4,11,12",13.0,4088,4
1166,80 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACGUCACCGAGGAGAAGUATT,UACUUCUCCUCGGUGACGUTT,2-O-Methyl,2-O-Methyl,5,"1,14",13.0,4086,4
1167,74 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACGUCACCGAGGAGAAGUATT,UACUUCUCCUCGGUGACGUTT,2-O-Methyl,2-O-Methyl,"5,18,19","1,2,14",13.0,4085,4
1168,31 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACGUCACCGAGGAGAAGUATT,UACUUCUCCUCGGUGACGUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","12,13,18",13.0,4084,4
1169,71 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAUAACCUGAACGUCACCTT,GGUGACGUUCAGGUUAUUCTT,2-O-Methyl,2-O-Methyl,"4,16",10,13.0,4082,4
1170,69 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAUAACCUGAACGUCACCTT,GGUGACGUUCAGGUUAUUCTT,2-O-Methyl,2-O-Methyl,"4,9,16","3,10,15",13.0,4081,4
1171,21 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAUAACCUGAACGUCACCTT,GGUGACGUUCAGGUUAUUCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","5,11,16",13.0,4080,4
1172,83 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACGUGACUUUGGUUCCUTT,AGGAACCAAAGUCACGUUUTT,2-O-Methyl,2-O-Methyl,12,13,13.0,4078,4
1173,82 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACGUGACUUUGGUUCCUTT,AGGAACCAAAGUCACGUUUTT,2-O-Methyl,2-O-Methyl,"6,12,18","7,13",13.0,4077,4
1174,37 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACGUGACUUUGGUUCCUTT,AGGAACCAAAGUCACGUUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,3,11,16",13.0,4076,4
1175,76 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAAGGGGAGUUGCUGGAAGTT,CUUCCAGCAACUCCCCUUUTT,2-O-Methyl,2-O-Methyl,"11,14",5,13.0,4074,4
1176,74 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAAGGGGAGUUGCUGGAAGTT,CUUCCAGCAACUCCCCUUUTT,2-O-Methyl,2-O-Methyl,"11,14","5,8",13.0,4073,4
1177,47 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAAGGGGAGUUGCUGGAAGTT,CUUCCAGCAACUCCCCUUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","9,10",13.0,4072,4
1178,83 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AACCCAAAGGGGAGUUGCUTT,AGCAACUCCCCUUUGGGUUTT,2-O-Methyl,2-O-Methyl,16,14,13.0,4070,4
1179,92 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AACCCAAAGGGGAGUUGCUTT,AGCAACUCCCCUUUGGGUUTT,2-O-Methyl,2-O-Methyl,"5,12,16","3,14",13.0,4069,4
1180,37 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AACCCAAAGGGGAGUUGCUTT,AGCAACUCCCCUUUGGGUUTT,2-O-Methyl,2-O-Methyl,"3,4,5,18","1,3,5,7,9,11,13,15,17,19",13.0,4068,4
1181,85 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UGAACGUCACCGAGGAGAATT,UUCUCCUCGGUGACGUUCATT,2-O-Methyl,2-O-Methyl,8,18,13.0,4066,4
1182,82 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UGAACGUCACCGAGGAGAATT,UUCUCCUCGGUGACGUUCATT,2-O-Methyl,2-O-Methyl,"1,8","11,18",13.0,4065,4
1183,65 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UGAACGUCACCGAGGAGAATT,UUCUCCUCGGUGACGUUCATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","13,19",13.0,4064,4
1184,65 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GGAACCUCACAUCAACGCGCATT,UGCGCGUUGAUGUGAGGUUCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,8,"2,8,11",13.0,4062,4
1185,52 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GGAACCUCACAUCAACGCGCATT,UGCGCGUUGAUGUGAGGUUCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"8,10,13,20","1,8,11,13",13.0,4061,4
1186,21 percent target mRNA inhibition,Dual luciferase reporter assay,SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GGAACCUCACAUCAACGCGCATT,UGCGCGUUGAUGUGAGGUUCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","10,15",13.0,4060,4
1187,83 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCCCUAGAGGGCAAGUTT,ACUUGCCCUCUAGGGGUUUTT,2-Deoxy-2-Fluoro,0,"8,15",0,13.0,4058,4
1188,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCCCUAGAGGGCAAGUTT,ACUUGCCCUCUAGGGGUUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"8,14","4,11",13.0,4057,4
1189,37 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCCCUAGAGGGCAAGUTT,ACUUGCCCUCUAGGGGUUUTT,0,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",13.0,4056,4
1190,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCACAAACCCCUAGAGGGTT,CCCUCUAGGGGUUUGUGAUTT,2-O-Methyl,2-O-Methyl,"3,5","6,16",13.0,4054,4
1191,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCACAAACCCCUAGAGGGTT,CCCUCUAGGGGUUUGUGAUTT,2-O-Methyl,2-O-Methyl,"3,5,13","6,14,16",13.0,4053,4
1192,35 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCACAAACCCCUAGAGGGTT,CCCUCUAGGGGUUUGUGAUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","7,18",13.0,4052,4
1193,91 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUAACCCGGGACUUGGATT,UCCAAGUCCCGGGUUAACUTT,2-O-Methyl,2-O-Methyl,4,3,13.0,4050,4
1194,90 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUAACCCGGGACUUGGATT,UCCAAGUCCCGGGUUAACUTT,2-O-Methyl,2-O-Methyl,"4,16","3,15",13.0,4049,4
1195,45 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUAACCCGGGACUUGGATT,UCCAAGUCCCGGGUUAACUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","6,11,12,13",13.0,4048,4
1196,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UUUGAUCAGCGGAGACUCGTT,CGAGUCUCCGCUGAUCAAATT,2-O-Methyl,0,"4,7",0,13.0,4046,4
1197,89 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UUUGAUCAGCGGAGACUCGTT,CGAGUCUCCGCUGAUCAAATT,2-O-Methyl,2-O-Methyl,"3,7","12,16",13.0,4045,4
1198,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UUUGAUCAGCGGAGACUCGTT,CGAGUCUCCGCUGAUCAAATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","10,15",13.0,4044,4
1199,73 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CCCUCCCCUGUCCCCGCUUTT,AAGCGGGGACAGGGGAGGGTT,2-Deoxy-2-Fluoro,0,9,0,13.0,4042,4
1200,72 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CCCUCCCCUGUCCCCGCUUTT,AAGCGGGGACAGGGGAGGGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"9,17",10,13.0,4041,4
1201,41 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CCCUCCCCUGUCCCCGCUUTT,AAGCGGGGACAGGGGAGGGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","1,2,9,11,16",13.0,4040,4
1202,30 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGACCUGAAGGAGUACGTT,CGUACUCCUUCAGGUCGAUTT,2-O-Methyl,2-O-Methyl,"8,16",3,13.0,4038,4
1203,29 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGACCUGAAGGAGUACGTT,CGUACUCCUUCAGGUCGAUTT,2-O-Methyl,2-O-Methyl,"4,8,16","3,11",13.0,4037,4
1204,19 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGACCUGAAGGAGUACGTT,CGUACUCCUUCAGGUCGAUTT,2-O-Methyl,2-O-Methyl,"2,3,6,7,8,16,18","1,3,5,6,7,8,9,10,11,15,16,19",13.0,4036,4
1205,95 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,0,2-Deoxy-2-Fluoro,0,"7,17",13.0,4034,4
1206,91 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,12","7,17",13.0,4033,4
1207,38 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","1,2,10,19",13.0,4032,4
1208,54 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AAUAAGCAGCUCGCGCUCCTT,GGAGCGCGAGCUGCUUAUUTT,2-O-Methyl,2-O-Methyl,"3,7",16,13.0,4030,4
1209,51 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AAUAAGCAGCUCGCGCUCCTT,GGAGCGCGAGCUGCUUAUUTT,2-O-Methyl,2-O-Methyl,"3,7,14","12,16",13.0,4029,4
1210,32 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AAUAAGCAGCUCGCGCUCCTT,GGAGCGCGAGCUGCUUAUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","3,9,17",13.0,4028,4
1211,37 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCUCUUUGUCACCUCUCUTT,AGAGAGGUGACAAAGAGCUTT,2-O-Methyl,2-O-Methyl,12,"11,12",13.0,4026,4
1212,34 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCUCUUUGUCACCUCUCUTT,AGAGAGGUGACAAAGAGCUTT,2-O-Methyl,2-O-Methyl,"8,11,14,16","8,11",13.0,4025,4
1213,19 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCUCUUUGUCACCUCUCUTT,AGAGAGGUGACAAAGAGCUTT,2-O-Methyl,2-O-Methyl,"1,12","1,3,5,7,9,11,13,15,17,19",13.0,4024,4
1214,71 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGCUGCUCCUCCUCCUCTT,GAGGAGGAGGAGCAGCGAUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,6,13,13.0,4022,4
1215,69 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGCUGCUCCUCCUCCUCTT,GAGGAGGAGGAGCAGCGAUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"6,9,12",13,13.0,4021,4
1216,39 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGCUGCUCCUCCUCCUCTT,GAGGAGGAGGAGCAGCGAUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19",19,13.0,4020,4
1217,88 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAACUGGUACUUUCCCCCTT,GGGGGAAAGUACCAGUUUCTT,2-O-Methyl,2-O-Methyl,"6,7,9",10,13.0,4018,4
1218,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAACUGGUACUUUCCCCCTT,GGGGGAAAGUACCAGUUUCTT,2-O-Methyl,2-O-Methyl,"6,7,9,12","10,13,14",13.0,4017,4
1219,57 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAACUGGUACUUUCCCCCTT,GGGGGAAAGUACCAGUUUCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,4016,4
1220,84 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGGAGGAUGACAAAGAAGCTT,GCUUCUUUGUCAUCCUCCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"9,12",8,13.0,4014,4
1221,78 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGGAGGAUGACAAAGAAGCTT,GCUUCUUUGUCAUCCUCCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"8,9,11","8,11",13.0,4013,4
1222,37 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGGAGGAUGACAAAGAAGCTT,GCUUCUUUGUCAUCCUCCCTT,0,2-Deoxy-2-Fluoro,0,"2,5,11,14,15,17,18,19",13.0,4012,4
1223,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGGGGAAAUCUGUGGUUTT,AACCACAGAUUUCCCCUUCTT,2-O-Methyl,2-O-Methyl,12,4,13.0,4010,4
1224,61 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGGGGAAAUCUGUGGUUTT,AACCACAGAUUUCCCCUUCTT,2-O-Methyl,2-O-Methyl,"13,14,15,16","4,5,6,7",13.0,4009,4
1225,41 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGGGGAAAUCUGUGGUUTT,AACCACAGAUUUCCCCUUCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,4008,4
1226,64 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCAGGAAGGGGAAAUCTT,GAUUUCCCCUUCCUGGUUUTT,2-Deoxy-2-Fluoro,0,"5,6",0,13.0,4006,4
1227,61 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCAGGAAGGGGAAAUCTT,GAUUUCCCCUUCCUGGUUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,6,9,12","14,15",13.0,4005,4
1228,42 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCAGGAAGGGGAAAUCTT,GAUUUCCCCUUCCUGGUUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19",2,13.0,4004,4
1229,81 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UCUCCCACCCAAUGGAGAU,AUCUCCAUUGGGUGGGAGATT,2-O-Methyl,0,"6,11",0,13.0,4002,4
1230,78 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UCUCCCACCCAAUGGAGAU,AUCUCCAUUGGGUGGGAGATT,2-O-Methyl,2-O-Methyl,"6,10,11,13",13,13.0,4001,4
1231,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UCUCCCACCCAAUGGAGAU,AUCUCCAUUGGGUGGGAGATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17","1,7,17,19",13.0,4000,4
1232,47 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CCGAAGACGAAGCUAUGAATT,UUCAUAGCUUCGUCUUCGGTT,0,2-Deoxy-2-Fluoro,0,5,13.0,3998,4
1233,46 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CCGAAGACGAAGCUAUGAATT,UUCAUAGCUUCGUCUUCGGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"14,16","3,5",13.0,3997,4
1234,23 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CCGAAGACGAAGCUAUGAATT,UUCAUAGCUUCGUCUUCGGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","7,12,18,19",13.0,3996,4
1235,69 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CGAAAGUGUAUCCGAAGACTT,GUCUUCGGAUACACUUUCGTT,0,2-Deoxy-2-Fluoro,0,10,13.0,3994,4
1236,75 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CGAAAGUGUAUCCGAAGACTT,GUCUUCGGAUACACUUUCGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"7,9","10,12",13.0,3993,4
1237,41 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CGAAAGUGUAUCCGAAGACTT,GUCUUCGGAUACACUUUCGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","1,7,8,19",13.0,3992,4
1238,85 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGCGAUCCCGAACAAGUAUTT,AUACUUGUUCGGGAUCGCUTT,0,2-O-Methyl,0,2,13.0,3990,4
1239,84 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGCGAUCCCGAACAAGUAUTT,AUACUUGUUCGGGAUCGCUTT,2-O-Methyl,2-O-Methyl,"10,13,17","2,6",13.0,3989,4
1240,34 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGCGAUCCCGAACAAGUAUTT,AUACUUGUUCGGGAUCGCUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","4,10,16,18",13.0,3988,4
1241,77 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AUCUACCCAGCUCUCCCUUTT,AAGGGAGAGCUGGGUAGAUTT,2-O-Methyl,2-O-Methyl,4,15,13.0,3986,4
1242,75 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AUCUACCCAGCUCUCCCUUTT,AAGGGAGAGCUGGGUAGAUTT,2-O-Methyl,2-O-Methyl,"4,8,14","11,15",13.0,3985,4
1243,43 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AUCUACCCAGCUCUCCCUUTT,AAGGGAGAGCUGGGUAGAUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","11,15,19",13.0,3984,4
1244,37 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGAAGAUAGAGCAUCCTT,GGAUGCUCUAUCUUCUUCCTT,0,2-Deoxy-2-Fluoro,0,9,13.0,3982,4
1245,37 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGAAGAUAGAGCAUCCTT,GGAUGCUCUAUCUUCUUCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"10,15","4,9",13.0,3981,4
1246,13 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGAAGAUAGAGCAUCCTT,GGAUGCUCUAUCUUCUUCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","4,9",13.0,3980,4
1247,79 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GCUGAACUAGUCGAAAGAATT,UUCUUUCGACUAGUUCAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,8,11,13.0,3978,4
1248,78 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GCUGAACUAGUCGAAAGAATT,UUCUUUCGACUAGUUCAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"3,8","11,16",13.0,3977,4
1249,49 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GCUGAACUAGUCGAAAGAATT,UUCUUUCGACUAGUUCAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","9,12,17",13.0,3976,4
1250,56 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GAAAACGCUUGUAAAGCCGTT,CGGCUUUACAAGCGUUUUCTT,0,2-O-Methyl,0,7,13.0,3974,4
1251,54 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GAAAACGCUUGUAAAGCCGTT,CGGCUUUACAAGCGUUUUCTT,2-O-Methyl,2-O-Methyl,"10,12","7,9",13.0,3973,4
1252,23 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GAAAACGCUUGUAAAGCCGTT,CGGCUUUACAAGCGUUUUCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","8,10,11",13.0,3972,4
1253,90 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAGGUGGAGGUAUCUCTT,GAGAUACCUCCACCUCUCUTT,2-O-Methyl,2-O-Methyl,14,5,13.0,3970,4
1254,87 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAGGUGGAGGUAUCUCTT,GAGAUACCUCCACCUCUCUTT,2-O-Methyl,2-O-Methyl,"3,8,14","5,11,16",13.0,3969,4
1255,67 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAGGUGGAGGUAUCUCTT,GAGAUACCUCCACCUCUCUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","12,16,18",13.0,3968,4
1256,95 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GUAUCCGAAGACGAAGCUATT,UAGCUUCGUCUUCGGAUACTT,2-O-Methyl,2-O-Methyl,18,"1,17",13.0,3966,4
1257,92 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GUAUCCGAAGACGAAGCUATT,UAGCUUCGUCUUCGGAUACTT,2-O-Methyl,2-O-Methyl,"2,10,11,18","1,17",13.0,3965,4
1258,30 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,GUAUCCGAAGACGAAGCUATT,UAGCUUCGUCUUCGGAUACTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,16,18",13.0,3964,4
1259,46 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGGACGGUACUUUCGAAAGTT,CUUUCGAAAGUACCGUCCUTT,0,2-O-Methyl,0,12,13.0,3962,4
1260,44 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGGACGGUACUUUCGAAAGTT,CUUUCGAAAGUACCGUCCUTT,2-O-Methyl,2-O-Methyl,"8,13,16",11,13.0,3961,4
1261,17 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,AGGACGGUACUUUCGAAAGTT,CUUUCGAAAGUACCGUCCUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,3,4,11,16,19",13.0,3960,4
1262,56 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CUAGUCGAAAGAAAACGGGTT,CCCGUUUUCUUUCGACUAGTT,2-O-Methyl,2-O-Methyl,2,17,13.0,3958,4
1263,55 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CUAGUCGAAAGAAAACGGGTT,CCCGUUUUCUUUCGACUAGTT,2-O-Methyl,2-O-Methyl,"2,9,13,14",17,13.0,3957,4
1264,23 percent target mRNA inhibition,Dual luciferase reporter assay,Aspergillus AF293 protein,13 nM,HEK293 cells,Lipofectamine 2000,CUAGUCGAAAGAAAACGGGTT,CCCGUUUUCUUUCGACUAGTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","15,18",13.0,3956,4
1265,73 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UAACCCCAAGAACGGGCUUTT,AAGCCCGUUCUUGGGGUUATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,1,18,13.0,3954,4
1266,72 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UAACCCCAAGAACGGGCUUTT,AAGCCCGUUCUUGGGGUUATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,7,13","7,12,18",13.0,3953,4
1267,47 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UAACCCCAAGAACGGGCUUTT,AAGCCCGUUCUUGGGGUUATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","1,2,19",13.0,3952,4
1268,69 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACCCCGAUUCAGCCUCUTT,AGAGGCUGAAUCGGGGUAATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,2,18,13.0,3950,4
1269,82 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACCCCGAUUCAGCCUCUTT,AGAGGCUGAAUCGGGGUAATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,12","7,17",13.0,3949,4
1270,67 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACCCCGAUUCAGCCUCUTT,AGAGGCUGAAUCGGGGUAATT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3948,4
1271,69 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACAGCCUUACCCCGAUUCTT,GAAUCGGGGUAAGGCUGUUTT,0,2-O-Methyl,0,10,13.0,3946,4
1272,68 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACAGCCUUACCCCGAUUCTT,GAAUCGGGGUAAGGCUGUUTT,2-O-Methyl,2-O-Methyl,"3,9","10,16",13.0,3945,4
1273,32 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACAGCCUUACCCCGAUUCTT,GAAUCGGGGUAAGGCUGUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,3,11,12",13.0,3944,4
1274,69 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACAAAGGAUCUCCUCCCTT,GGGAGGAGAUCCUUUGUAATT,2-O-Methyl,2-O-Methyl,2,17,13.0,3942,4
1275,78 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACAAAGGAUCUCCUCCCTT,GGGAGGAGAUCCUUUGUAATT,2-O-Methyl,2-O-Methyl,"2,4,10","9,15,17",13.0,3941,4
1276,57 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUACAAAGGAUCUCCUCCCTT,GGGAGGAGAUCCUUUGUAATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","11,12",13.0,3940,4
1277,69 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AGAGUUGGGAUUAGGGCUUTT,AAGCCCUAAUCCCAACUCUTT,0,2-O-Methyl,0,7,13.0,3938,4
1278,68 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AGAGUUGGGAUUAGGGCUUTT,AAGCCCUAAUCCCAACUCUTT,2-O-Methyl,2-O-Methyl,"6,12","7,13",13.0,3937,4
1279,45 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AGAGUUGGGAUUAGGGCUUTT,AAGCCCUAAUCCCAACUCUTT,0,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",13.0,3936,4
1280,69 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GUUCACGUCCUACCCCUUUTT,AAAGGGGUAGGACGUGAACTT,0,2-Deoxy-2-Fluoro,0,8,13.0,3934,4
1281,65 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GUUCACGUCCUACCCCUUUTT,AAAGGGGUAGGACGUGAACTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,11","8,15",13.0,3933,4
1282,23 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GUUCACGUCCUACCCCUUUTT,AAAGGGGUAGGACGUGAACTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","13,19",13.0,3932,4
1283,69 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGCCAACCGAUACUUCUTT,AGAAGUAUCGGUUGGCCUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,13,6,13.0,3930,4
1284,68 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGCCAACCGAUACUUCUTT,AGAAGUAUCGGUUGGCCUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,6,13","6,13",13.0,3929,4
1285,46 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGCCAACCGAUACUUCUTT,AGAAGUAUCGGUUGGCCUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17,19","6,8,12,13,18,19",13.0,3928,4
1286,44 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGUAAGGACCAGAGACTT,GUCUCUGGUCCUUACUUCCTT,2-O-Methyl,2-O-Methyl,5,13,13.0,3926,4
1287,41 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGUAAGGACCAGAGACTT,GUCUCUGGUCCUUACUUCCTT,2-O-Methyl,2-O-Methyl,"6,13","6,13",13.0,3925,4
1288,23 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGAAGUAAGGACCAGAGACTT,GUCUCUGGUCCUUACUUCCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","1,7,8",13.0,3924,4
1289,67 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UAAAGCUGGAAAGGGACGGTT,CCGUCCCUUUCCAGCUUUATT,2-O-Methyl,2-O-Methyl,1,18,13.0,3922,4
1290,65 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UAAAGCUGGAAAGGGACGGTT,CCGUCCCUUUCCAGCUUUATT,2-O-Methyl,2-O-Methyl,"1,7","12,18",13.0,3921,4
1291,29 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UAAAGCUGGAAAGGGACGGTT,CCGUCCCUUUCCAGCUUUATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","13,19",13.0,3920,4
1292,94 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAGGAUGGAUUCGACUUAGTT,CUAAGUCGAAUCCAUCCUCTT,0,2-O-Methyl,0,2,13.0,3918,4
1293,91 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAGGAUGGAUUCGACUUAGTT,CUAAGUCGAAUCCAUCCUCTT,2-O-Methyl,2-O-Methyl,"6,14,17","2,5,13",13.0,3917,4
1294,23 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GAGGAUGGAUUCGACUUAGTT,CUAAGUCGAAUCCAUCCUCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17","2,6,11",13.0,3916,4
1295,72 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUCUAACCGGGCAGCUUCUTT,AGAAGCUGCCCGGUUAGAATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,4,15,13.0,3914,4
1296,71 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUCUAACCGGGCAGCUUCUTT,AGAAGCUGCCCGGUUAGAATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,12","7,15",13.0,3913,4
1297,61 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUCUAACCGGGCAGCUUCUTT,AGAAGCUGCCCGGUUAGAATT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3912,4
1298,84 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UCCUCGUCGUCUGUUCUAATT,UUAGAACAGACGACGAGGATT,2-O-Methyl,2-O-Methyl,17,2,13.0,3910,4
1299,82 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UCCUCGUCGUCUGUUCUAATT,UUAGAACAGACGACGAGGATT,2-O-Methyl,2-O-Methyl,"8,12,17","2,7",13.0,3909,4
1300,63 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UCCUCGUCGUCUGUUCUAATT,UUAGAACAGACGACGAGGATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","3,5,17,19",13.0,3908,4
1301,37 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,GCUUUAAGGAACUGGAAGGTT,CCUUCCAGUUCCUUAAAGCTT,0,2-O-Methyl,0,14,13.0,3906,4
1302,37 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,GCUUUAAGGAACUGGAAGGTT,CCUUCCAGUUCCUUAAAGCTT,2-O-Methyl,2-O-Methyl,"5,13","6,14",13.0,3905,4
1303,25 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,GCUUUAAGGAACUGGAAGGTT,CCUUCCAGUUCCUUAAAGCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,4,6,8,10",13.0,3904,4
1304,55 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,UACCGAGAAUGAGCCUGAUTT,AUCAGGCUCAUUCUCGGUATT,2-O-Methyl,2-O-Methyl,1,18,13.0,3902,4
1305,54 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,UACCGAGAAUGAGCCUGAUTT,AUCAGGCUCAUUCUCGGUATT,2-O-Methyl,2-O-Methyl,"1,10,16","3,9,18",13.0,3901,4
1306,23 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,UACCGAGAAUGAGCCUGAUTT,AUCAGGCUCAUUCUCGGUATT,2-O-Methyl,2-O-Methyl,"12,14,16,18","1,3,5,7,9,11,13,15,17,19",13.0,3900,4
1307,69 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,CGGAUCUACACCUUCAAGATT,UCUUGAAGGUGUAGAUCCGTT,2-O-Methyl,2-O-Methyl,7,12,13.0,3898,4
1308,68 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,CGGAUCUACACCUUCAAGATT,UCUUGAAGGUGUAGAUCCGTT,2-O-Methyl,2-O-Methyl,"7,9,15","4,10,12",13.0,3897,4
1309,46 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,CGGAUCUACACCUUCAAGATT,UCUUGAAGGUGUAGAUCCGTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","13,15,17,19",13.0,3896,4
1310,74 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUAAGGACCACCGGAUTT,AUCCGGUGGUCCUUAAGGUTT,2-O-Methyl,2-O-Methyl,5,14,13.0,3894,4
1311,72 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUAAGGACCACCGGAUTT,AUCCGGUGGUCCUUAAGGUTT,2-O-Methyl,2-O-Methyl,"5,12","7,14",13.0,3893,4
1312,52 percent target mRNA inhibition,Dual luciferase reporter assay,BIRC5 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUAAGGACCACCGGAUTT,AUCCGGUGGUCCUUAAGGUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","4,13,15,17,19",13.0,3892,4
1313,69 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGCUUAGUCACUCCUCUUCTT,GAAGAGGAGUGACUAAGCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,5,14,13.0,3890,4
1314,68 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGCUUAGUCACUCCUCUUCTT,GAAGAGGAGUGACUAAGCCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,9","10,14",13.0,3889,4
1315,23 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGCUUAGUCACUCCUCUUCTT,GAAGAGGAGUGACUAAGCCTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3888,4
1316,82 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGGAGGUCUUAGAAAACACTT,GUGUUUUCUAAGACCUCCCTT,0,2-O-Methyl,0,9,13.0,3886,4
1318,17 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGGAGGUCUUAGAAAACACTT,GUGUUUUCUAAGACCUCCCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3884,4
1322,80 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CCUCCCCAUCCCCUUUUAATT,UUAAAAGGGGAUGGGGAGGTT,0,2-O-Methyl,0,3,13.0,3878,4
1325,47 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AGACUAAGCCCAAAAGGGCTT,GCCCUUUUGGGCUUAGUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,5,14,13.0,3874,4
1326,45 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AGACUAAGCCCAAAAGGGCTT,GCCCUUUUGGGCUUAGUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,11","8,14",13.0,3873,4
1327,26 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AGACUAAGCCCAAAAGGGCTT,GCCCUUUUGGGCUUAGUCUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3872,4
1330,34 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GACAAGGGAAGGUUAGCCUTT,AGGCUAACCUUCCCUUGUCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3868,4
1331,47 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUCUGGCCUUUCUCUCUAGTT,CUAGAGAGAAAGGCCAGAGTT,2-O-Methyl,0,17,0,13.0,3866,4
1333,24 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUCUGGCCUUUCUCUCUAGTT,CUAGAGAGAAAGGCCAGAGTT,2-O-Methyl,0,"1,3,5,7,9,10,13,15,17,19",0,13.0,3864,4
1337,89 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,ACAUAGAGGAAGACGCGGATT,UCCGCGUCUUCCUCUAUGUTT,0,2-Deoxy-2-Fluoro,0,15,13.0,3858,4
1338,86 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,ACAUAGAGGAAGACGCGGATT,UCCGCGUCUUCCUCUAUGUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,4,6","15,17",13.0,3857,4
1339,57 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,ACAUAGAGGAAGACGCGGATT,UCCGCGUCUUCCUCUAUGUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11","1,3,5,7,9,11,13,15,17",13.0,3856,4
1340,81 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,2,0,13.0,3854,4
1341,78 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,8,12",17,13.0,3853,4
1342,61 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17",0,13.0,3852,4
1348,67 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,UUAAAGGGCGAGAAGACCGTT,CGGUCUUCUCGCCCUUUAATT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3844,4
1352,88 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGACCUAGAGGAGUCACTT,GUGACUCCUCUAGGUCCUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,8,11,13.0,3838,4
1353,87 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGACCUAGAGGAGUCACTT,GUGACUCCUCUAGGUCCUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"8,17","2,11",13.0,3837,4
1354,31 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AAGGACCUAGAGGAGUCACTT,GUGACUCCUCUAGGUCCUUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17",0,13.0,3836,4
1355,48 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GCCUCUCUAUCCUUAGCUUTT,AAGCUAAGGAUAGAGAGGCTT,0,2-Deoxy-2-Fluoro,0,"5,11",13.0,3834,4
1356,47 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GCCUCUCUAUCCUUAGCUUTT,AAGCUAAGGAUAGAGAGGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,8,14","5,11",13.0,3833,4
1357,34 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GCCUCUCUAUCCUUAGCUUTT,AAGCUAAGGAUAGAGAGGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,3,5,7,9,11,13,15,17","7,12",13.0,3832,4
1358,90 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,GGCCUUUCUCUCUAGAUAUTT,AUAUCUAGAGAGAAAGGCCTT,0,2-O-Methyl,0,"2,6",13.0,3830,4
1363,49 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGATT,UCUUCUCGCCCUUUAAGCGCUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3824,4
1364,95 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GGUAGGGUUGAAGAGACUUTT,AAGUCUCUUCAACCCUACCTT,0,2-O-Methyl,0,16,13.0,3822,4
1365,94 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GGUAGGGUUGAAGAGACUUTT,AAGUCUCUUCAACCCUACCTT,2-O-Methyl,2-O-Methyl,"3,9","10,16",13.0,3821,4
1366,58 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GGUAGGGUUGAAGAGACUUTT,AAGUCUCUUCAACCCUACCTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17","13,17",13.0,3820,4
1367,69 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AAGUAGUCCCCCUUGAAGATT,UCUUCAAGGGGGACUACUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,5,15,13.0,3818,4
1368,64 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AAGUAGUCCCCCUUGAAGATT,UCUUCAAGGGGGACUACUUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,11,14","5,15",13.0,3817,4
1369,53 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AAGUAGUCCCCCUUGAAGATT,UCUUCAAGGGGGACUACUUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17",0,13.0,3816,4
1370,84 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AUGGGAGAAGUAGUCCCCCTT,GGGGGACUACUUCUCCCAUTT,2-O-Methyl,2-O-Methyl,11,8,13.0,3814,4
1371,82 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AUGGGAGAAGUAGUCCCCCTT,GGGGGACUACUUCUCCCAUTT,2-O-Methyl,2-O-Methyl,"2,11","8,17",13.0,3813,4
1372,71 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AUGGGAGAAGUAGUCCCCCTT,GGGGGACUACUUCUCCCAUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3812,4
1373,69 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCAAGUGGCAAGAGGAUUATT,UAAUCCUCUUGCCACUUGCTT,2-O-Methyl,2-O-Methyl,18,1,13.0,3810,4
1374,68 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCAAGUGGCAAGAGGAUUATT,UAAUCCUCUUGCCACUUGCTT,2-O-Methyl,2-O-Methyl,"2,18","1,10,13,17",13.0,3809,4
1375,55 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCAAGUGGCAAGAGGAUUATT,UAAUCCUCUUGCCACUUGCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3808,4
1376,85 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,CCUCGGAGAGUUCUACUCUTT,AGAGUAGAACUCUCCGAGGTT,0,2-O-Methyl,0,5,13.0,3806,4
1377,85 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,CCUCGGAGAGUUCUACUCUTT,AGAGUAGAACUCUCCGAGGTT,2-O-Methyl,2-O-Methyl,14,5,13.0,3805,4
1378,34 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,CCUCGGAGAGUUCUACUCUTT,AGAGUAGAACUCUCCGAGGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3804,4
1379,69 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCUGUAACCUCGGAGAGUUTT,AACUCUCCGAGGUUACAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,5,14,13.0,3802,4
1380,62 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCUGUAACCUCGGAGAGUUTT,AACUCUCCGAGGUUACAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"3,5","14,16",13.0,3801,4
1381,51 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GCUGUAACCUCGGAGAGUUTT,AACUCUCCGAGGUUACAGCTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17",0,13.0,3800,4
1382,55 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,UCUCGUAAGGACGAAACGATT,UCGUUUCGUCCUUACGAGATT,0,2-O-Methyl,0,13,13.0,3798,4
1383,52 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,UCUCGUAAGGACGAAACGATT,UCGUUUCGUCCUUACGAGATT,2-O-Methyl,2-O-Methyl,"6,7,15,17",13,13.0,3797,4
1384,34 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,UCUCGUAAGGACGAAACGATT,UCGUUUCGUCCUUACGAGATT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3796,4
1385,69 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAUGUUCUCGUAAGGACGTT,CGUCCUUACGAGAACAUCUTT,0,2-O-Methyl,0,7,13.0,3794,4
1386,60 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAUGUUCUCGUAAGGACGTT,CGUCCUUACGAGAACAUCUTT,2-O-Methyl,2-O-Methyl,"4,12","7,15",13.0,3793,4
1387,53 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAUGUUCUCGUAAGGACGTT,CGUCCUUACGAGAACAUCUTT,2-O-Methyl,0,"2,4,6,7,8,9,10,12,15,18",0,13.0,3792,4
1388,77 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GAGGAAGAUGAGUUGUACCTT,GGUACAACUCAUCUUCCUCTT,2-O-Methyl,2-O-Methyl,9,"5,10",13.0,3790,4
1389,76 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GAGGAAGAUGAGUUGUACCTT,GGUACAACUCAUCUUCCUCTT,2-O-Methyl,2-O-Methyl,"9,14,16","5,10",13.0,3789,4
1390,70 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GAGGAAGAUGAGUUGUACCTT,GGUACAACUCAUCUUCCUCTT,2-O-Methyl,0,"1,2,3,4,5,6,7,8,10,11,12,15,17",0,13.0,3788,4
1391,69 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGUAAUCCGGACUCAACUCTT,GAGUUGAGUCCGGAUUACUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,3,16,13.0,3786,4
1392,68 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGUAAUCCGGACUCAACUCTT,GAGUUGAGUCCGGAUUACUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"3,14","5,16",13.0,3785,4
1393,59 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGUAAUCCGGACUCAACUCTT,GAGUUGAGUCCGGAUUACUTT,2-Deoxy-2-Fluoro,0,"3,6,7,8,12,13,14,17,18,19",0,13.0,3784,4
1394,85 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAAACGCAGUAAUCCGGATT,UCCGGAUUACUGCGUUUCUTT,2-O-Methyl,2-O-Methyl,"11,12",8,13.0,3782,4
1395,81 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAAACGCAGUAAUCCGGATT,UCCGGAUUACUGCGUUUCUTT,2-O-Methyl,2-O-Methyl,"8,11","8,11",13.0,3781,4
1396,80 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAAACGCAGUAAUCCGGATT,UCCGGAUUACUGCGUUUCUTT,2-O-Methyl,2-O-Methyl,"6,8,11,14,15,16","1,2,3,7,8,10,11,13,15,16,17,18,19",13.0,3780,4
1397,69 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AACUCUACUGUGGAGUCGGTT,CCGACUCCACAGUAGAGUUTT,2-O-Methyl,2-O-Methyl,6,13,13.0,3778,4
1398,68 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AACUCUACUGUGGAGUCGGTT,CCGACUCCACAGUAGAGUUTT,2-O-Methyl,2-O-Methyl,"6,9,11","8,13",13.0,3777,4
1399,57 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AACUCUACUGUGGAGUCGGTT,CCGACUCCACAGUAGAGUUTT,2-O-Methyl,2-O-Methyl,"3,5,8,17","1,2,5,7,8,10",13.0,3776,4
1400,92 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAGGACCUAGAAGGCGGCTT,GCCGCCUUCUAGGUCCUCUTT,2-O-Methyl,0,10,0,13.0,3774,4
1401,89 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAGGACCUAGAAGGCGGCTT,GCCGCCUUCUAGGUCCUCUTT,2-O-Methyl,2-O-Methyl,9,10,13.0,3773,4
1402,72 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,AGAGGACCUAGAAGGCGGCTT,GCCGCCUUCUAGGUCCUCUTT,2-O-Methyl,2-O-Methyl,9,"7,8,10,14,17,19",13.0,3772,4
1403,83 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,ACGGCUCGCUACCCUCGACTT,GUCGAGGGUAGCGAGCCGUTT,2-Deoxy-2-Fluoro,0,11,0,13.0,3770,4
1404,78 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,ACGGCUCGCUACCCUCGACTT,GUCGAGGGUAGCGAGCCGUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,10,9,13.0,3769,4
1405,72 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,ACGGCUCGCUACCCUCGACTT,GUCGAGGGUAGCGAGCCGUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17",0,13.0,3768,4
1406,69 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,CGGGUACGAGCCGGAACCUTT,AGGUUCCGGCUCGUACCCGTT,0,2-Deoxy-2-Fluoro,0,14,13.0,3766,4
1407,68 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,CGGGUACGAGCCGGAACCUTT,AGGUUCCGGCUCGUACCCGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,6",14,13.0,3765,4
1408,61 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,CGGGUACGAGCCGGAACCUTT,AGGUUCCGGCUCGUACCCGTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17",0,13.0,3764,4
1409,81 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GGAGCUAGACGGGUACGAGTT,CUCGUACCCGUCUAGCUCCTT,2-O-Methyl,2-O-Methyl,"6,7,14",13,13.0,3762,4
1410,82 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GGAGCUAGACGGGUACGAGTT,CUCGUACCCGUCUAGCUCCTT,2-O-Methyl,2-O-Methyl,"6,14","5,13",13.0,3761,4
1411,75 percent target mRNA inhibition,Dual luciferase reporter assay,Cell Lymphoma,13 nM,HEK293 cells,Lipofectamine 2000,GGAGCUAGACGGGUACGAGTT,CUCGUACCCGUCUAGCUCCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3760,4
1412,69 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGAAAAGCAGCGAUACGCUTT,AGCGUAUCGCUGCUUUUCUTT,2-O-Methyl,0,14,0,13.0,3758,4
1413,68 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGAAAAGCAGCGAUACGCUTT,AGCGUAUCGCUGCUUUUCUTT,2-O-Methyl,2-O-Methyl,"8,14",11,13.0,3757,4
1414,34 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGAAAAGCAGCGAUACGCUTT,AGCGUAUCGCUGCUUUUCUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3756,4
1415,81 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCCUUCAUUCCAGCCUAUTT,AUAGGCUGGAAUGAAGGAGTT,2-O-Methyl,2-O-Methyl,17,2,13.0,3754,4
1416,78 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCCUUCAUUCCAGCCUAUTT,AUAGGCUGGAAUGAAGGAGTT,2-O-Methyl,2-O-Methyl,"7,12,17","2,7,12",13.0,3753,4
1417,51 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCCUUCAUUCCAGCCUAUTT,AUAGGCUGGAAUGAAGGAGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3752,4
1418,45 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GCUACCGCAACCACGAGCUTT,AGCUCGUGGUUGCGGUAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,3,16,13.0,3750,4
1419,42 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GCUACCGCAACCACGAGCUTT,AGCUCGUGGUUGCGGUAGCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"3,8,12","7,11,16",13.0,3749,4
1420,21 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GCUACCGCAACCACGAGCUTT,AGCUCGUGGUUGCGGUAGCTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3748,4
1421,76 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CGCCCCCCUCAAGCUACCGTT,CGGUAGCUUGAGGGGGGCGTT,2-O-Methyl,2-O-Methyl,15,4,13.0,3746,4
1422,72 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CGCCCCCCUCAAGCUACCGTT,CGGUAGCUUGAGGGGGGCGTT,2-O-Methyl,2-O-Methyl,"3,6,10,15","4,9",13.0,3745,4
1423,44 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CGCCCCCCUCAAGCUACCGTT,CGGUAGCUUGAGGGGGGCGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3744,4
1424,79 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,UCUACACCGCGCCCCCCUCTT,GAGGGGGGCGCGGUGUAGATT,2-O-Methyl,2-O-Methyl,3,16,13.0,3742,4
1425,73 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,UCUACACCGCGCCCCCCUCTT,GAGGGGGGCGCGGUGUAGATT,2-O-Methyl,2-O-Methyl,"3,5,10,13","14,16",13.0,3741,4
1426,39 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,UCUACACCGCGCCCCCCUCTT,GAGGGGGGCGCGGUGUAGATT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3740,4
1427,76 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GUCUAUGCCAAGAAGGGAGTT,CUCCCUUCUUGGCAUAGACTT,2-O-Methyl,2-O-Methyl,4,15,13.0,3738,4
1428,72 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GUCUAUGCCAAGAAGGGAGTT,CUCCCUUCUUGGCAUAGACTT,2-O-Methyl,2-O-Methyl,"4,6,9","10,13,15",13.0,3737,4
1429,24 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GUCUAUGCCAAGAAGGGAGTT,CUCCCUUCUUGGCAUAGACTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3736,4
1430,85 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGCCAAAGUAAUCGUGGUUTT,AACCACGAUUACUUUGGCCTT,2-O-Methyl,2-O-Methyl,9,10,13.0,3734,4
1431,86 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGCCAAAGUAAUCGUGGUUTT,AACCACGAUUACUUUGGCCTT,2-O-Methyl,2-O-Methyl,"4,9,15","4,10,15",13.0,3733,4
1432,37 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGCCAAAGUAAUCGUGGUUTT,AACCACGAUUACUUUGGCCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3732,4
1433,69 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GUACUCUGAUGAGGAAGAGTT,CUCUUCCUCAUCAGAGUACTT,2-O-Methyl,0,2,0,13.0,3730,4
1434,68 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GUACUCUGAUGAGGAAGAGTT,CUCUUCCUCAUCAGAGUACTT,2-O-Methyl,2-O-Methyl,"2,7,10","9,12,18",13.0,3729,4
1435,18 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GUACUCUGAUGAGGAAGAGTT,CUCUUCCUCAUCAGAGUACTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3728,4
1436,78 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GCUGAGGAAAGGGACAUCUTT,AGAUGUCCCUUUCCUCAGCTT,0,2-O-Methyl,0,"3,4",13.0,3726,4
1437,76 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GCUGAGGAAAGGGACAUCUTT,AGAUGUCCCUUUCCUCAGCTT,2-O-Methyl,2-O-Methyl,"3,13,15","4,16",13.0,3725,4
1438,61 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GCUGAGGAAAGGGACAUCUTT,AGAUGUCCCUUUCCUCAGCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3724,4
1439,75 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GAGUAUUUCCGCUGGAACUTT,AGUUCCAGCGGAAAUACUCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,4,15,13.0,3722,4
1440,73 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GAGUAUUUCCGCUGGAACUTT,AGUUCCAGCGGAAAUACUCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,13","6,15",13.0,3721,4
1441,21 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GAGUAUUUCCGCUGGAACUTT,AGUUCCAGCGGAAAUACUCTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3720,4
1442,72 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGGGCUCUUCUACAUUCCCTT,GGGAAUGUAGAAGAGCCCCTT,2-O-Methyl,2-O-Methyl,12,8,13.0,3718,4
1443,68 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGGGCUCUUCUACAUUCCCTT,GGGAAUGUAGAAGAGCCCCTT,2-O-Methyl,2-O-Methyl,"11,15","6,8",13.0,3717,4
1444,51 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGGGCUCUUCUACAUUCCCTT,GGGAAUGUAGAAGAGCCCCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3716,4
1445,48 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AUACUUGGCGGGCUCUUUCTT,GAAAGAGCCCGCCAAGUAUTT,2-O-Methyl,0,2,0,13.0,3714,4
1446,42 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AUACUUGGCGGGCUCUUUCTT,GAAAGAGCCCGCCAAGUAUTT,2-O-Methyl,2-O-Methyl,"2,6,10","13,17",13.0,3713,4
1447,19 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AUACUUGGCGGGCUCUUUCTT,GAAAGAGCCCGCCAAGUAUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3712,4
1448,71 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,UCCUAGCUGUCUUGUCCCUTT,AGGGACAAGACAGCUAGGATT,2-O-Methyl,2-O-Methyl,4,15,13.0,3710,4
1449,68 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,UCCUAGCUGUCUUGUCCCUTT,AGGGACAAGACAGCUAGGATT,2-O-Methyl,2-O-Methyl,"4,8,13","6,11,15",13.0,3709,4
1450,27 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,UCCUAGCUGUCUUGUCCCUTT,AGGGACAAGACAGCUAGGATT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3708,4
1451,69 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGCCUCCAAACUCCUAGCUTT,AGCUAGGAGUUUGGAGGCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"10,18",4,13.0,3706,4
1452,32 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGCCUCCAAACUCCUAGCUTT,AGCUAGGAGUUUGGAGGCUTT,2-Deoxy-2-Fluoro,0,"7,15",0,13.0,3705,4
1453,16 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,AGCCUCCAAACUCCUAGCUTT,AGCUAGGAGUUUGGAGGCUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3704,4
1454,69 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUACCUUCUCCUCUUCUCCTT,GGAGAAGAGGAGAAGGUAGTT,2-O-Methyl,2-O-Methyl,2,17,13.0,3702,4
1455,68 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUACCUUCUCCUCUUCUCCTT,GGAGAAGAGGAGAAGGUAGTT,2-O-Methyl,2-O-Methyl,"2,3","17,18",13.0,3701,4
1456,27 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUACCUUCUCCUCUUCUCCTT,GGAGAAGAGGAGAAGGUAGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3700,4
1457,78 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCUCCUACCUUCUCCUCUTT,AGAGGAGAAGGUAGGAGAGTT,2-Deoxy-2-Fluoro,0,8,0,13.0,3698,4
1458,73 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCUCCUACCUUCUCCUCUTT,AGAGGAGAAGGUAGGAGAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"7,12,17",12,13.0,3697,4
1459,69 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CUCUCCUACCUUCUCCUCUTT,AGAGGAGAAGGUAGGAGAGTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3696,4
1460,75 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CCGAGAGCUCUCCUACCUUTT,AAGGUAGGAGAGCUCUCGGTT,2-O-Methyl,2-O-Methyl,14,5,13.0,3694,4
1461,72 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CCGAGAGCUCUCCUACCUUTT,AAGGUAGGAGAGCUCUCGGTT,2-O-Methyl,2-O-Methyl,"8,11,14",5,13.0,3693,4
1462,34 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,CCGAGAGCUCUCCUACCUUTT,AAGGUAGGAGAGCUCUCGGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3692,4
1463,69 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGCGGGCUCUUUCCUAUUCTT,GAAUAGGAAAGAGCCCGCCTT,2-O-Methyl,2-O-Methyl,15,4,13.0,3690,4
1464,68 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGCGGGCUCUUUCCAUUCTT,GAAUAGGAAAGAGCCCGCCTT,2-O-Methyl,2-O-Methyl,"6,8,15",4,13.0,3689,4
1465,51 percent target mRNA inhibition,Dual luciferase reporter assay,Receptor,13 nM,HEK293 cells,Lipofectamine 2000,GGCGGGCUCUUUCCUAUUCTT,GAAUAGGAAAGAGCCCGCCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3688,4
1466,69 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GGAGCACGCUUACUACCUUTT,AAGGUAGUAAGCGUGCUCCTT,2-O-Methyl,2-O-Methyl,"11,14","5,8",13.0,3686,4
1467,68 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GGAGCACGCUUACUACCUUTT,AAGGUAGUAAGCGUGCUCCTT,2-O-Methyl,2-O-Methyl,"5,11,14","5,8,14",13.0,3685,4
1468,51 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GGAGCACGCUUACUACCUUTT,AAGGUAGUAAGCGUGCUCCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3684,4
1469,38 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAGGAACGGGGACACUUACTT,GUAAGUGUCCCCGUUCCUUTT,0,2-O-Methyl,0,2,13.0,3682,4
1470,35 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAGGAACGGGGACACUUACTT,GUAAGUGUCCCCGUUCCUUTT,2-O-Methyl,2-O-Methyl,"13,17","2,6",13.0,3681,4
1471,12 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAGGAACGGGGACACUUACTT,GUAAGUGUCCCCGUUCCUUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3680,4
1472,69 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAGGAGAAGCUGACGGCTT,GCCGUCAGCUUCUCCUUAATT,2-O-Methyl,2-O-Methyl,2,17,13.0,3678,4
1473,67 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAGGAGAAGCUGACGGCTT,GCCGUCAGCUUCUCCUUAATT,2-O-Methyl,2-O-Methyl,"2,13","6,17",13.0,3677,4
1474,24 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAGGAGAAGCUGACGGCTT,GCCGUCAGCUUCUCCUUAATT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3676,4
1475,69 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCUCAGCCCUAACGGUTT,ACCGUUAGGGCUGAGGUUUTT,2-O-Methyl,2-O-Methyl,"13,14",6,13.0,3674,4
1476,79 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCUCAGCCCUAACGGUTT,ACCGUUAGGGCUGAGGUUUTT,2-O-Methyl,2-O-Methyl,"5,7,13","6,12",13.0,3673,4
1477,51 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCUCAGCCCUAACGGUTT,ACCGUUAGGGCUGAGGUUUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3672,4
1478,69 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCCCAGAUAGCUCUUCAGTT,CUGAAGAGCUAUCUGGGCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,9,10,13.0,3670,4
1479,61 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCCCAGAUAGCUCUUCAGTT,CUGAAGAGCUAUCUGGGCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,9,17","2,10,14",13.0,3669,4
1480,35 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCCCAGAUAGCUCUUCAGTT,CUGAAGAGCUAUCUGGGCUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3668,4
1481,69 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGUACCAGGAGGCGUUTT,AACGCCUCCUGGUACUUCUTT,2-O-Methyl,2-O-Methyl,6,13,13.0,3666,4
1482,68 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGUACCAGGAGGCGUUTT,AACGCCUCCUGGUACUUCUTT,2-O-Methyl,2-O-Methyl,"6,9,15","10,13",13.0,3665,4
1483,24 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGUACCAGGAGGCGUUTT,AACGCCUCCUGGUACUUCUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3664,4
1484,69 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACGUCACCGAGGAGAAGUATT,UACUUCUCCUCGGUGACGUTT,2-O-Methyl,0,18,0,13.0,3662,4
1485,48 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACGUCACCGAGGAGAAGUATT,UACUUCUCCUCGGUGACGUTT,2-O-Methyl,2-O-Methyl,"5,18",14,13.0,3661,4
1486,36 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,ACGUCACCGAGGAGAAGUATT,UACUUCUCCUCGGUGACGUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3660,4
1487,55 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAUAACCUGAACGUCACCTT,GGUGACGUUCAGGUUAUUCTT,2-O-Methyl,2-O-Methyl,4,15,13.0,3658,4
1488,51 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAUAACCUGAACGUCACCTT,GGUGACGUUCAGGUUAUUCTT,2-O-Methyl,2-O-Methyl,"4,9,16","3,10,15",13.0,3657,4
1489,17 percent target mRNA inhibition,Dual luciferase reporter assay,Chimpanzee SOD2 gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAUAACCUGAACGUCACCTT,GGUGACGUUCAGGUUAUUCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3656,4
1490,69 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CUCCCCAGUCUCUCUUAAATT,UUUAAGAGAGACUGGGGAGTT,2-O-Methyl,2-O-Methyl,17,4,13.0,3654,4
1491,68 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CUCCCCAGUCUCUCUUAAATT,UUUAAGAGAGACUGGGGAGTT,2-O-Methyl,2-O-Methyl,"4,6,10,16","3,13",13.0,3653,4
1492,51 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CUCCCCAGUCUCUCUUAAATT,UUUAAGAGAGACUGGGGAGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3652,4
1493,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGGGGUAUGAAGAGCUUTT,AAGCUCUUCAUACCCCGCUTT,2-O-Methyl,2-O-Methyl,8,11,13.0,3650,4
1494,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGGGGUAUGAAGAGCUUTT,AAGCUCUUCAUACCCCGCUTT,2-O-Methyl,2-O-Methyl,"8,10,15","9,11",13.0,3649,4
1495,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGGGGUAUGAAGAGCUUTT,AAGCUCUUCAUACCCCGCUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3648,4
1496,72 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UAAACUUUGGGGAAGGGAGTT,CUCCCUUCCCCAAAGUUUATT,2-O-Methyl,2-O-Methyl,1,4,13.0,3646,4
1497,67 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UAAACUUUGGGGAAGGGAGTT,CUCCCUUCCCCAAAGUUUATT,2-O-Methyl,2-O-Methyl,"1,8","11,18",13.0,3645,4
1498,34 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UAAACUUUGGGGAAGGGAGTT,CUCCCUUCCCCAAAGUUUATT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3644,4
1499,67 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CGACGAUUCUUCUACUCAATT,UUGAGUAGAAGAAUCGUCGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,13,6,13.0,3642,4
1500,62 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CGACGAUUCUUCUACUCAATT,UUGAGUAGAAGAAUCGUCGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"5,13","2,6",13.0,3641,4
1501,56 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CGACGAUUCUUCUACUCAATT,UUGAGUAGAAGAAUCGUCGTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3640,4
1502,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UCCGGCUAACUCUGAGGACTT,GUCCUCAGAGUUAGCCGGATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,7,12,13.0,3638,4
1503,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UCCGGCUAACUCUGAGGACTT,GUCCUCAGAGUUAGCCGGATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"7,13","6,17",13.0,3637,4
1504,41 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UCCGGCUAACUCUGAGGACTT,GUCCUCAGAGUUAGCCGGATT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3636,4
1505,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCCCUAGAGGGCAAGUTT,ACUUGCCCUCUAGGGGUUUTT,2-O-Methyl,2-O-Methyl,8,11,13.0,3634,4
1506,78 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCCCUAGAGGGCAAGUTT,ACUUGCCCUCUAGGGGUUUTT,2-O-Methyl,2-O-Methyl,"8,15","4,11",13.0,3633,4
1507,62 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AAACCCCUAGAGGGCAAGUTT,ACUUGCCCUCUAGGGGUUUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3632,4
1508,29 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCACAAACCCCUAGAGGGTT,CCCUCUAGGGGUUUGUGAUTT,2-O-Methyl,2-O-Methyl,13,6,13.0,3630,4
1509,27 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCACAAACCCCUAGAGGGTT,CCCUCUAGGGGUUUGUGAUTT,2-O-Methyl,2-O-Methyl,"3,5,13","6,8,16",13.0,3629,4
1510,9 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCACAAACCCCUAGAGGGTT,CCCUCUAGGGGUUUGUGAUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3628,4
1511,86 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUAACCCGGGACUUGGATT,UCCAAGUCCCGGGUUAACUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,16","3,15",13.0,3626,4
1512,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUAACCCGGGACUUGGATT,UCCAAGUCCCGGGUUAACUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,16","3,15",13.0,3625,4
1513,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUAACCCGGGACUUGGATT,UCCAAGUCCCGGGUUAACUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3624,4
1514,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GACCACGAAGAGUUAACCCTT,GGGUUAACUCUUCGUGGUCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,14,5,13.0,3622,4
1515,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GACCACGAAGAGUUAACCCTT,GGGUUAACUCUUCGUGGUCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,14","5,15",13.0,3621,4
1516,51 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GACCACGAAGAGUUAACCCTT,GGGUUAACUCUUCGUGGUCTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3620,4
1517,68 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CGAGUGUCUAACGGGAGCCTT,GGCUCCCGUUAGACACUCGTT,0,2-O-Methyl,0,10,13.0,3618,4
1518,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CGAGUGUCUAACGGGAGCCTT,GGCUCCCGUUAGACACUCGTT,2-O-Methyl,2-O-Methyl,"5,9","10,14",13.0,3617,4
1519,25 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CGAGUGUCUAACGGGAGCCTT,GGCUCCCGUUAGACACUCGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3616,4
1520,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UCCCUUCCACCGCCAUAUUTT,AAUAUGGCGGUGGAAGGGATT,2-O-Methyl,2-O-Methyl,16,3,13.0,3614,4
1521,47 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UCCCUUCCACCGCCAUAUUTT,AAUAUGGCGGUGGAAGGGATT,2-O-Methyl,2-O-Methyl,"8,14,16","3,5,11",13.0,3613,4
1522,11 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,UCCCUUCCACCGCCAUAUUTT,AAUAUGGCGGUGGAAGGGATT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3612,4
1523,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GGUAGAAUAGGUUUUCCCCTT,GGGGAAAACCUAUUCUACCTT,2-O-Methyl,2-O-Methyl,3,11,13.0,3610,4
1524,45 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GGUAGAAUAGGUUUUCCCCTT,GGGGAAAACCUAUUCUACCTT,2-O-Methyl,2-O-Methyl,"3,4,8","11,16",13.0,3609,4
1525,11 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GGUAGAAUAGGUUUUCCCCTT,GGGGAAAACCUAUUCUACCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3608,4
1526,68 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCGACGAUUCUUCUACUCTT,GAGUAGAAGAAUCGUCGGUTT,0,2-O-Methyl,0,4,13.0,3606,4
1527,67 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCGACGAUUCUUCUACUCTT,GAGUAGAAGAAUCGUCGGUTT,2-O-Methyl,2-O-Methyl,15,"4,10,11",13.0,3605,4
1528,42 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCGACGAUUCUUCUACUCTT,GAGUAGAAGAAUCGUCGGUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3604,4
1529,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CCGCCCGGCGGCGCCUUUATT,UAAAGGCGCCGCCGGGCGGTT,2-O-Methyl,2-O-Methyl,19,"1,2",13.0,3602,4
1530,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CCGCCCGGCGGCGCCUUUATT,UAAAGGCGCCGCCGGGCGGTT,2-O-Methyl,2-O-Methyl,"13,18,19","1,2",13.0,3601,4
1531,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,CCGCCCGGCGGCGCCUUUATT,UAAAGGCGCCGCCGGGCGGTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3600,4
1532,51 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAGUUAACCCGGGACUTT,AGUCCCGGGUUAACUCUUCTT,2-O-Methyl,2-O-Methyl,8,11,13.0,3598,4
1533,47 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAGUUAACCCGGGACUTT,AGUCCCGGGUUAACUCUUCTT,2-O-Methyl,2-O-Methyl,"8,14,17",11,13.0,3597,4
1534,17 percent target mRNA inhibition,Dual luciferase reporter assay,Human CDKN1B gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAGUUAACCCGGGACUTT,AGUCCCGGGUUAACUCUUCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3596,4
1535,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUUCUAGGGCCGUGGCCTT,GGCCACGGCCCUAGAAACUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"7,8",12,13.0,3594,4
1536,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUUCUAGGGCCGUGGCCTT,GGCCACGGCCCUAGAAACUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"7,15","4,8,12",13.0,3593,4
1537,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUUUCUAGGGCCGUGGCCTT,GGCCACGGCCCUAGAAACUTT,2-Deoxy-2-Fluoro,0,"1,3,5,7,9,11,12,14,17",0,13.0,3592,4
1538,69 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAAGGGCGUCUCUACATT,UGUAGAGACGCCCUUCUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,17,3,13.0,3590,4
1539,71 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAAGGGCGUCUCUACATT,UGUAGAGACGCCCUUCUCUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"10,16,18","1,3",13.0,3589,4
1540,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAGAAGGGCGUCUCUACATT,UGUAGAGACGCCCUUCUCUTT,2-Deoxy-2-Fluoro,0,"1,4,6,8,9,12,16,18",0,13.0,3588,4
1541,46 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUACUUCUGGUUCCCUCCTT,GGAGGGAACCAGAAGUAUCTT,2-O-Methyl,2-O-Methyl,3,16,13.0,3586,4
1542,45 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUACUUCUGGUUCCCUCCTT,GGAGGGAACCAGAAGUAUCTT,2-O-Methyl,2-O-Methyl,"3,9","10,16",13.0,3585,4
1543,45 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUACUUCUGGUUCCCUCCTT,GGAGGGAACCAGAAGUAUCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3584,4
1544,69 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUUCCAAACCCCACUAUCTT,GAUAGUGGGGUUUGGAAUCTT,2-O-Methyl,2-O-Methyl,16,4,13.0,3582,4
1545,67 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUUCCAAACCCCACUAUCTT,GAUAGUGGGGUUUGGAAUCTT,2-O-Methyl,0,"6,16",0,13.0,3581,4
1546,54 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUUCCAAACCCCACUAUCTT,GAUAGUGGGGUUUGGAAUCTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,13.0,3580,4
1547,29 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCCACAUUUCUAGGAGAUTT,AUCUCCUAGAAAUGUGGCUTT,2-O-Methyl,2-O-Methyl,"4,13",13,13.0,3578,4
1548,26 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCCACAUUUCUAGGAGAUTT,AUCUCCUAGAAAUGUGGCUTT,2-O-Methyl,2-O-Methyl,"4,6,12","7,9,15",13.0,3577,4
1549,19 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCCACAUUUCUAGGAGAUTT,AUCUCCUAGAAAUGUGGCUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17",0,13.0,3576,4
1550,62 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUCCCUGGAGCCUUAAACTT,GUUUAAGGCUCCAGGGACUTT,2-O-Methyl,2-O-Methyl,"15,16",5,13.0,3574,4
1551,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUCCCUGGAGCCUUAAACTT,GUUUAAGGCUCCAGGGACUTT,2-O-Methyl,2-O-Methyl,"7,15","4,12",13.0,3573,4
1552,68 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGUCCCUGGAGCCUUAAACTT,GUUUAAGGCUCCAGGGACUTT,2-O-Methyl,0,"1,3,5,7,9,11,13,17,19",0,13.0,3572,4
1553,41 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUAGGAAGGGGCUUCAGCTT,GCUGAAGCCCCUUCCUAUCTT,2-O-Methyl,2-O-Methyl,3,"16,17",13.0,3570,4
1554,42 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUAGGAAGGGGCUUCAGCTT,GCUGAAGCCCCUUCCUAUCTT,2-O-Methyl,2-O-Methyl,"3,12,16","3,16",13.0,3569,4
1555,12 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAUAGGAAGGGGCUUCAGCTT,GCUGAAGCCCCUUCCUAUCTT,0,2-O-Methyl,0,"2,3,8,9,10,11,12,13,14,15,16,18,19",13.0,3568,4
1556,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGACCUGAAGGAGUACGTT,CGUACUCCUUCAGGUCGAUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,16,4,13.0,3566,4
1557,46 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGACCUGAAGGAGUACGTT,CGUACUCCUUCAGGUCGAUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"8,16","3,11",13.0,3565,4
1558,21 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AUCGACCUGAAGGAGUACGTT,CGUACUCCUUCAGGUCGAUTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,9,10,11,12,13,14,15,17,19","2,4,12,13,14,17,18",13.0,3564,4
1559,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,3,17,13.0,3562,4
1560,67 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,12","7,17",13.0,3561,4
1561,12 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAGAGGAUCUUGAAGACCTT,GGUCUUCAAGAUCCUCUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,2,4,7,9,10,11,12,15,18,19","3,4,5,6,7,12,13,14,15,16,17",13.0,3560,4
1562,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AACAGUCCUUAGCUACGCUTT,AGCGUAGCUAAGGACUGUUTT,2-O-Methyl,2-O-Methyl,"10,14,19",5,13.0,3558,4
1563,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AACAGUCCUUAGCUACGCUTT,AGCGUAGCUAAGGACUGUUTT,2-O-Methyl,2-O-Methyl,"3,10,14,19","5,9,16",13.0,3557,4
1564,35 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AACAGUCCUUAGCUACGCUTT,AGCGUAGCUAAGGACUGUUTT,2-O-Methyl,0,"1,3,5,7,9,12,14,17",0,13.0,3556,4
1565,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,UAGCCAGAGCCAAAGAAGCTT,GCUUCUUUGGCUCUGGCUATT,2-O-Methyl,2-O-Methyl,1,18,13.0,3554,4
1566,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,UAGCCAGAGCCAAAGAAGCTT,GCUUCUUUGGCUCUGGCUATT,2-O-Methyl,2-O-Methyl,"1,5,11","10,16,17,18",13.0,3553,4
1567,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,UAGCCAGAGCCAAAGAAGCTT,GCUUCUUUGGCUCUGGCUATT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,16","3,4,6,7,8,12,14,18",13.0,3552,4
1568,69 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AAUAAGCAGCUCGCGCUCCTT,GGAGCGCGAGCUGCUUAUUTT,2-O-Methyl,2-O-Methyl,3,16,13.0,3550,4
1569,68 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AAUAAGCAGCUCGCGCUCCTT,GGAGCGCGAGCUGCUUAUUTT,2-O-Methyl,2-O-Methyl,"3,7","12,15",13.0,3549,4
1570,64 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AAUAAGCAGCUCGCGCUCCTT,GGAGCGCGAGCUGCUUAUUTT,2-O-Methyl,0,"1,2,4,5,6,8,9,13,15",0,13.0,3548,4
1571,56 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAUAGGAAGGGGCUUCTT,GAAGCCCCUUCCUAUCUUCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,6,13,13.0,3546,4
1572,45 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAUAGGAAGGGGCUUCTT,GAAGCCCCUUCCUAUCUUCTT,2-Deoxy-2-Fluoro,0,"6,16,17,18,19",0,13.0,3545,4
1573,5 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAGAUAGGAAGGGGCUUCTT,GAAGCCCCUUCCUAUCUUCTT,0,2-Deoxy-2-Fluoro,0,"5,6,7,8,9,10,11,12,13,15,16,17,18,19",13.0,3544,4
1574,82 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAAGCCUGUUUCUUCCUCTT,GAGGAAGAAACAGGCUUAGTT,2-Deoxy-2-Fluoro,0,2,0,13.0,3542,4
1575,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAAGCCUGUUUCUUCCUCTT,GAGGAAGAAACAGGCUUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"3,4,10",17,13.0,3541,4
1576,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,CUAAGCCUGUUUCUUCCUCTT,GAGGAAGAAACAGGCUUAGTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,4,6,8,10,12,14,16,18","2,5,6,8,9,10,12,18",13.0,3540,4
1577,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUUCCACUUCUAAGCCTT,GGCUUAGAAGUGGAAAGGUTT,2-O-Methyl,2-O-Methyl,"8,14","5,11",13.0,3538,4
1578,80 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUUCCACUUCUAAGCCTT,GGCUUAGAAGUGGAAAGGUTT,0,2-O-Methyl,0,"4,5,11,19",13.0,3537,4
1579,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,ACCUUUCCACUUCUAAGCCTT,GGCUUAGAAGUGGAAAGGUTT,2-O-Methyl,0,"2,3,4,5,6,7,8,10,11,12,13,14,18,19",0,13.0,3536,4
1580,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GCAGAGAAUCUACCUUUCCTT,GGAAAGGUAGAUUCUCUGCTT,2-O-Methyl,2-O-Methyl,"2,11","8,17",13.0,3534,4
1581,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GCAGAGAAUCUACCUUUCCTT,GGAAAGGUAGAUUCUCUGCTT,2-O-Methyl,0,"1,3,4,5,6,7,8,12",0,13.0,3533,4
1582,13 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GCAGAGAAUCUACCUUUCCTT,GGAAAGGUAGAUUCUCUGCTT,2-O-Methyl,2-O-Methyl,"2,9,10,11,13,14,15,16,17,18,19","8,12,13,14,15,16,17,19",13.0,3532,4
1583,90 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GCGAGCAGAGAAUCUACCUTT,AGGUAGAUUCUCUGCUCGCTT,2-O-Methyl,2-O-Methyl,15,4,13.0,3530,4
1584,90 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GCGAGCAGAGAAUCUACCUTT,AGGUAGAUUCUCUGCUCGCTT,2-O-Methyl,2-O-Methyl,"6,15","4,13",13.0,3529,4
1585,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GCGAGCAGAGAAUCUACCUTT,AGGUAGAUUCUCUGCUCGCTT,2-O-Methyl,0,"1,3,4,5,7,8,9,10,11,12,16",0,13.0,3528,4
1586,50 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGGAAACUGAAAGGCUAUGTT,CAUAGCCUUUCAGUUUCCCTT,2-Deoxy-2-Fluoro,0,16,0,13.0,3526,4
1587,51 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGGAAACUGAAAGGCUAUGTT,CAUAGCCUUUCAGUUUCCCTT,2-Deoxy-2-Fluoro,0,"7,8,15,16,18",0,13.0,3525,4
1588,6 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGGAAACUGAAAGGCUAUGTT,CAUAGCCUUUCAGUUUCCCTT,0,2-Deoxy-2-Fluoro,0,"1,3,6,7,8,9,10,11,14,15,16,17,18,19",13.0,3524,4
1589,70 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,CCCCAGGUAACGAUUUUCUTT,AGAAAAUCGUUACCUGGGGTT,2-O-Methyl,2-O-Methyl,8,11,13.0,3522,4
1590,79 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,CCCCAGGUAACGAUUUUCUTT,AGAAAAUCGUUACCUGGGGTT,2-O-Methyl,0,"5,6,7,8,9,10,11",0,13.0,3521,4
1591,69 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,CCCCAGGUAACGAUUUUCUTT,AGAAAAUCGUUACCUGGGGTT,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,16","8,13,14",13.0,3520,4
1592,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUUCCCCCAGGUAACGAUUTT,AAUCGUUACCUGGGGGAAATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,12,7,13.0,3518,4
1593,78 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUUCCCCCAGGUAACGAUUTT,AAUCGUUACCUGGGGGAAATT,2-Deoxy-2-Fluoro,0,"9,10,11,13,14,15,16",0,13.0,3517,4
1594,68 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUUCCCCCAGGUAACGAUUTT,AAUCGUUACCUGGGGGAAATT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"4,5,6,7,8,15","4,8,9",13.0,3516,4
1595,58 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAACUGGUACUUUCCCCCTT,GGGGGAAAGUACCAGUUUCTT,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,9,10,13.0,3514,4
1596,26 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAACUGGUACUUUCCCCCTT,GGGGGAAAGUACCAGUUUCTT,0,2-Deoxy-2-Fluoro,0,"10,16,17,18",13.0,3513,4
1597,60 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GAAACUGGUACUUUCCCCCTT,GGGGGAAAGUACCAGUUUCTT,2-Deoxy-2-Fluoro,0,"2,5,6,9,10,11,12,13,14,15,16,17,18,19",0,13.0,3512,4
1598,69 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGACUACUAACCUCCAGUUTT,AACUGGAGGUUAGUAGUCCTT,2-O-Methyl,2-O-Methyl,"5,8,15","4,11,14",13.0,3510,4
1599,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGACUACUAACCUCCAGUUTT,AACUGGAGGUUAGUAGUCCTT,2-O-Methyl,0,"1,2,3,6,9,10,16,17",0,13.0,3509,4
1600,7 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,GGACUACUAACCUCCAGUUTT,AACUGGAGGUUAGUAGUCCTT,2-O-Methyl,2-O-Methyl,"4,5,7,8,11,12,13,14,15,18,19","3,4,10,11,14,17,18,19",13.0,3508,4
1601,81 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGGACUACUAACCUCCTT,GGAGGUUAGUAGUCCUUCUTT,2-O-Methyl,2-O-Methyl,"9,12",10,13.0,3506,4
1602,80 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGGACUACUAACCUCCTT,GGAGGUUAGUAGUCCUUCUTT,2-O-Methyl,0,"8,9,11,12,15,16,17,18,19",0,13.0,3505,4
1603,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,AGAAGGACUACUAACCUCCTT,GGAGGUUAGUAGUCCUUCUTT,2-O-Methyl,2-O-Methyl,"9,12,17","6,7,10,13,16,17,19",13.0,3504,4
1604,72 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAAGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"2,8","14,20",13.0,3502,4
1605,70 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,2,"14,20",13.0,3501,4
1606,8 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"2,3,8,9","5,6,7,9,12,13,14,15,18,19,20,21,22,23,24",13.0,3500,4
1607,28 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,8,9","5,7,13,14,15,19,20,21,23",13.0,3499,4
1608,53 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,2,3,4,5,8,9,10,11,16,17,18,23,24","14,15,20,21",13.0,3498,4
1609,35 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"1,2,3,5,8,9,11,14,16,17,18,23,24","15,16,21,22",13.0,3497,4
1610,17 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"1,2,3,5,8,9,14,17,23,24","7,13,14,15,19,20,21,23",13.0,3496,4
1611,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,8,9","14,15,20,21",13.0,3495,4
1612,17 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"2,3,6,8,9,13,15,19,20,21,22","14,20",13.0,3494,4
1613,23 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"1,2,3,5,8,9,14,23,24","5,7,13,14,19,20,23",13.0,3493,4
1614,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"1,2,3,4,5,8,9,10,11,14,16,17,18,23,24","14,20",13.0,3492,4
1615,75 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"2,3,8,9","14,20",13.0,3491,4
1616,65 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,4,8,9,10,16,18","14,20",13.0,3490,4
1617,45 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,2,5,8,11,14,17,23,24","14,20",13.0,3489,4
1618,51 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"2,6,8,13,15,19,20,21,22","14,20",13.0,3488,4
1619,80 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,2-O-Methyl,"2,8","14,20",13.0,3487,4
1620,15 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,0,2-Deoxy-2-Fluoro,0,"5,6,7,9,12,13,14,15,18,19,20,21,22,23,24",13.0,3486,4
1621,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human BIC gene,13 nM,HEK293 cells,Lipofectamine 2000,UUAAUGCUAAUCGUGAUAGGGGUU,CCCCUAUCACGAUUAGCAUUAAUA,2-O-Methyl,0,"1,2,3,4,5,8,9,10,11,14,16,17,18,23,24",0,13.0,3485,4
1622,42 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-O-Methyl,0,"1,2,6,9,11,15,17,18,20,21",0,13.0,3484,4
1623,14 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,0,2-Deoxy-2-Fluoro,0,"4,5,7,13,16,20,21",13.0,3482,4
1624,82 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-O-Methyl,0,14,0,13.0,3481,4
1625,54 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-Deoxy-2-Fluoro,0,"1,2,6,9,11,14,15,17,18,20,21",0,13.0,3480,4
1626,81 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-O-Methyl,0,"14,20,21",0,13.0,3479,4
1627,84 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-O-Methyl,0,14,0,13.0,3478,4
1628,75 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-Deoxy-2-Fluoro,0,"12,14,15,16",0,13.0,3477,4
1629,51 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-O-Methyl,0,"1,2,6,9,11,14,15,17,18,20,21",0,13.0,3476,4
1630,79 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-O-Methyl,0,"14,15",0,13.0,3475,4
1637,57 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"14,15","7,8",13.0,3468,4
1638,37 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,2-Deoxy-2-Fluoro,0,"1,2,6,9,11,14,15,17,18,20,21",0,13.0,3467,4
1639,15 percent target mRNA inhibition,Dual luciferase reporter assay,0,13 nM,HEK293 cells,Lipofectamine 2000,AACCCACCACAGCUAGAACUU,AAGUUCUAGCUGUGGUGGGUU,0,2-O-Methyl,0,"3,4,5,7,9,11,12,13,14,15,16,17,18,20,21",13.0,3466,4
1640,51 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,7,15,13.0,3464,4
1641,45 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,Phosphodiester,Phosphodiester,7,14,13.0,3463,4
1642,79 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,8,15,13.0,3462,4
1643,50 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,7,14,13.0,3461,4
1644,78 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-Deoxy-2-Fluoro,0,7,0,13.0,3460,4
1645,53 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,0,7,0,13.0,3459,4
1646,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,0,8,0,13.0,3457,4
1647,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,0,2-Deoxy-2-Fluoro,0,14,13.0,3456,4
1648,59 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,0,"7,8",0,13.0,3455,4
1649,83 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,8,15,13.0,3454,4
1650,47 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,8,14,13.0,3453,4
1651,41 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,8,"14,15",13.0,3452,4
1652,23 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,"7,8",14,13.0,3451,4
1653,84 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,0,2-O-Methyl,0,15,13.0,3450,4
1654,85 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-Deoxy-2-Fluoro,0,7,0,13.0,3449,4
1655,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,0,2-Deoxy-2-Fluoro,0,"14,15",13.0,3448,4
1656,49 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,7,14,13.0,3447,4
1657,81 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,7,15,13.0,3446,4
1658,56 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,"7,8",15,13.0,3445,4
1659,44 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,7,"14,15",13.0,3444,4
1660,27 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-O-Methyl,2-O-Methyl,"7,8","14,15",13.0,3443,4
1661,0 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,0,2-O-Methyl,0,"1,3,4,6,8,12,13,14,17,19,21,22,23",13.0,3442,4
1662,27 percent target mRNA inhibition,Dual luciferase reporter assay,Human KAZRIN gene,13 nM,HEK293 cells,Lipofectamine 2000,AGCGCUUAAAGGGCGAGAAGAUU,UCUUCUCGCCCUUUAAGCGCUUU,2-Deoxy-2-Fluoro,0,"2,4,6,7,11,12,13,15,17",0,13.0,3441,4
1663,IC-50 = 132.16 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Phosphorothioate* Phosphodiester* 2-O-Methyl,0,"1,2,3,9,12 * 1,2,3,9,12,17,18 * 17,18,19",132.16,3439,16
1664,IC-50 = 122 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,2-O-Methyl* Phosphodiester,0,"15,16,17,18,19 * 15,16,17,18",122.0,3438,16
1665,IC-50 = 428 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Phosphodiester,0,"1,2,3 * 1,2,3",428.0,3437,16
1666,IC-50 = 131 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Phosphodiester,0,"7,8,9 * 7,8,9",131.0,3436,16
1667,IC-50 = 363 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Phosphodiester,0,"12,13,14 * 12,13,14",363.0,3435,16
1668,IC-50 = 273 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Phosphodiester,0,"13,14,15 * 13,14,15",273.0,3434,16
1669,IC-50 = 460 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,1,460.0,3433,16
1670,IC-50 = 491 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Phosphodiester,0,"16,18,19,20 * 16,18,19",491.0,3432,16
1671,IC-50 = 22.046 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate* Phosphodiester,0,"18,19,20 * 18,19",22.046,3431,16
1672,IC-50 = 5580 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,U-87 MG cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Phosphorothioate* Phosphodiester,0,"3,9,12,17,18,19 * 3,9,12,17,18",5580.0,3430,16
1673,IC-50 = 276.88 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Locked nucleic acid* Phosphodiester* 2-O-Methyl,0,"5,8,11,14 * 5,8,11,14,18,19 * 16,17,18",276.88,3429,16
1674,IC-50 = 769 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,Locked nucleic acid* Phosphodiester,0,"4,9,18 * 4,9,18",769.0,3428,16
1675,IC-50 = 1130 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Locked nucleic acid* Phosphodiester,0,"1,2,3,6,9,12,15,18,19,20 * 1,2,3,6,9,12,15,18,19",1130.0,3427,16
1676,IC-50 = 1570 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Locked nucleic acid* Phosphodiester,0,"3,4,10,11,17,18 * 3,4,10,11,17,18",1570.0,3426,16
1677,IC-50 = 809 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Locked nucleic acid* Phosphodiester,0,"3,8,17 * 3,8,17",809.0,3425,16
1678,IC-50 = 25.677 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methyl* Phosphodiester,2-O-Methyl* Phosphodiester,"2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18 * 2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","6,7,10,11,17,18,19 * 6,7,10,11,17,18",25.677,3424,16
1679,IC-50 = 75.608 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methyl* Phosphodiester,2-O-Methyl* Phosphodiester,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","6,7,10,11,17,18,19 * 6,7,10,11,17,18",75.608,3423,16
1680,IC-50 = 261 nM for target mRNA,Real-time PCR,eIF4E gene,200 nM,MH-S cells,Lipofectin (Invitrogen),AGAAGACACCUUCUGAGUAU,AUACUCAGAAGGUGUCUUCU,2-O-Methyl* Phosphodiester,2-O-Methyl* Phosphodiester,"2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","6,7,10,11,18,19,20 * 6,7,10,11,18,19",261.0,3422,16
1681,IC-50 = 376 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methyl* Phosphodiester,2-O-Methyl* Phosphodiester,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","5,8,11,14,17,18,19 * 5,8,11,14,17,18",376.0,3421,16
1682,IC-50 = 117.59 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,U-87 MG cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methyl* Phosphodiester,2-O-Methyl* Phosphodiester,"2,4,6,8,10,12,14,16,18 * 2,4,6,8,10,12,14,16,18","6,7,10,11,17,18,19 * 6,7,10,11,17,18",117.59,3420,16
1683,IC-50 = 475.93 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methyl* Phosphodiester,2-O-Methyl* Phosphodiester,"2,4,6,8,10,12,14,16,18 * 2,4,6,8,10,12,14,16,18","5,8,11,14,17,18,19 * 5,8,11,14,17,18",475.93,3419,16
1684,IC-50 = 45.167 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,2-O-Methyl* Phosphodiester,2-O-Methyl* Phosphodiester,"2,4,6,8,10,12,14,16,18 * 2,4,6,8,10,12,14,16,18","6,7,10,11,17,18,19 * 6,7,10,11,17,18",45.167,3418,16
1685,IC-50 = 124.53 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,4’-thioribose* Phosphothioate,2-O-Methyl* Phosphodiester,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","5,8,11,14,17,18,19 * 5,8,11,14,17,18",124.53,3417,16
1686,IC-50 = 215.27 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,4’-thioribose* Phosphothioate,2-O-Methyl* Phosphodiester,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18 * 1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18","6,7,10,11,17,18,19 * 6,7,10,11,17,18",215.27,3416,16
1687,IC-50 = 55.386 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,2-O-Methyl* Phosphodiester,0,"6,7,10,11,17,18,19 * 6,7,10,11,17,18",55.386,3415,16
1688,IC-50 = 170.24 nM for target mRNA,Real-time PCR,Survivin gene,200 nM,HeLa cells,Lipofectin (Invitrogen),GGAGAUCAACAUUUUCAAA,UUUGAAAAUGUUGAUCUCC,0,2-O-Methyl* Phosphodiester,0,"5,8,11,14,17,18,19 * 5,8,11,14,17,18",170.24,3414,16
1689,IC-50 = 75.517 nM for target mRNA,Real-time PCR,eIF4E gene,200 nM,MH-S cells,Lipofectin (Invitrogen),AGAAGACACCUUCUGAGUAU,AUACUCAGAAGGUGUCUUCU,0,2-O-Methyl* Phosphodiester,0,"6,7,10,11,18,19,20 * 6,7,10,11,18,19",75.517,3413,16
1690,IC-50 = 12.05 nM for target mRNA,Real-time PCR,eIF4E gene,200 nM,MH-S cells,Lipofectin (Invitrogen),CAUUGGUGAAGGAUCCAGGA,CCUGGAUCCUUCACCAAUG,0,2-O-Methyl* Phosphodiester,0,"5,6,9,10,17,18,19 * 5,6,9,10,17,18",12.05,3412,16
1691,IC-50 = 22.859 nM for target mRNA,Real-time PCR,Human PTEN gene,200 nM,MH-S cells,Lipofectin (Invitrogen),CAUUGGUGAAGGAUCCAGGA,UCCUGGAUCCUUCACCAAUG,0,2-O-Methyl* Phosphodiester,0,"6,12,15,18,19,20 * 6,12,15,18,19",22.859,3411,16
1693,IC-50 = 0.05 nM for target mRNA,Real-time PCR,VEGFR1 gene,125 nM,HeLa S3 cells,OptiMEM (Invitrogen),CUGAGUUUAAAAGGCACCCTT,TTGACUCAAAUUUUCCGUGGG,2-O-Methyl,2-O-Methyl* Cholesterol,"20,21","1,2 * 1",0.05,3409,4
1714,27 percent target mRNA inhibition,HPLC analysis,ICAM-1 gene,25 and 50 nM,ECV304,Lipofectamine 2000,TTAUCUCCAUGCACGACUCCG,UAGAGGUACGUGCUGAGGCTT,2-O-Lysylaminohexyl,2-O-Lysylaminohexyl,"4,10,18","1,7,14",25.0,3386,24
1715,37 percent target mRNA inhibition,HPLC analysis,ICAM-1 gene,25 and 50 nM,ECV304,Lipofectamine 2000,TTAUCUCCAUGCACGACUCCG,UAGAGGUACGUGCUGAGGCTT,2-O-Lysylaminohexyl,2-O-Lysylaminohexyl,"6,18","7,14",25.0,3385,24
1716,27 percent target mRNA inhibition,HPLC analysis,ICAM-1 gene,25 and 50 nM,ECV304,Lipofectamine 2000,TTAUCUCCAUGCACGACUCCG,UAGAGGUACGUGCUGAGGCTT,2-O-Lysylaminohexyl,2-O-Lysylaminohexyl,10,11,25.0,3384,24
1754,64 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,AUUCGUGCUCAUGGUGCACUUGUGCACCAUGAGCACGAAUTT,0,2-O-Methyl,0,"20,21,23,25,27,29,33,35,37,39",0,20.0,3339,48
1755,91 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,ACGAAUCCUAAACCUCA,UGAGGUUUAGGAUUCGUGC,0,2-O-Methyl,0,"17,19",20.0,3338,48
1756,57 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,GCACGAAUCCUAAACCUCACAAUAUGAGGUUUAGGAUUCGUGCUU,0,2-O-Methyl,0,"2,4,6,8,10,12,14,16,18,25",0,20.0,3336,48
1757,74 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,GCACGAAUCCUAAACCUCACAAUAUGAGGUUUAGGAUUCGUGCUU,0,2-O-Methyl,0,25,0,20.0,3335,48
1758,60 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,"20,21",0,20.0,3334,48
1759,70 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,2,0,20.0,3333,48
1760,87 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,"20,21",0,20.0,3332,48
1763,88 percent target mRNA inhibition (IC-50 = 0.0065 nM),Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,"19,21,23,25,27,29,31,33,35,37,39",0,20.0,3329,48
1764,54 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCTTGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,20.0,3328,48
1765,87 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCTTGCACGAAUCCUAAACCUCA,0,Phosphorothioate,0,"1,2,39,40",0,20.0,3327,48
1766,93 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,Phosphorothioate,0,"1,2,39,40",0,20.0,3326,48
1767,86 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,TGAGGTUUAGGAUUCGUGCUUGCACGAAUCCUAAACCTCA,0,2-Deoxy,0,"1,2,3,4,5,6,35,36,37,38,39,40",0,20.0,3325,48
1768,88 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCTCA,0,2-Deoxy,0,"35,36,37,38,39,40",0,20.0,3324,48
1769,70 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,TGAGGTUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,2-Deoxy,0,"1,2,3,4,5,6",0,20.0,3323,48
1770,50 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCTTGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,"1,6,8,14,17",0,20.0,3322,48
1771,67 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCTTGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19",0,20.0,3320,48
1772,90 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,2-O-Methyl,0,"20,21",0,20.0,3319,48
1773,40 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,GCACGAAUCCUAAACCUCACAAUAUGAGGUUUAGGAUUCGUGCUU,0,Conjugation bulky group,0,40,0,20.0,3318,48
1774,60 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,GCACGAAUCCUAAACCUCACAAUAUGAGGUUUAGGAUUCGUGCUU,0,Conjugation bulky group,0,1,0,20.0,3317,48
1775,90 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,Conjugation bulky group,0,40,0,20.0,3316,48
1776,25 percent target mRNA inhibition,Luciferase activity (MicroLumat LB 96P),Luciferase gene,20 nM,HEK293 cells,Lipofectamine 2000,UGAGGUUUAGGAUUCGUGCUUGCACGAAUCCUAAACCUCA,0,Conjugation bulky group,0,1,0,20.0,3315,48
1777,56 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,"18,19",50.0,3306,72
1778,43.3 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,19,50.0,3305,72
1779,7.4 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,"4,5,6,7,8,9,10,11,12,13,14,15,16,18",50.0,3304,72
1780,5.6 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,"5,8,11,14,17",50.0,3303,72
1781,0.5 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,"1,2,19,20",50.0,3302,72
1782,12 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,"9,10,11",50.0,3301,72
1783,0 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,"1,2",50.0,3300,72
1784,41 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,2,50.0,3299,72
1785,56 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,7,50.0,3298,72
1786,36 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,11,50.0,3297,72
1787,36 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,13,50.0,3296,72
1788,46 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,17,50.0,3295,72
1789,38 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,16,50.0,3294,72
1790,76 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,0,Altritol nucleic acid,0,18,50.0,3293,72
1791,36 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"1,2",0,50.0,3292,72
1792,33 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,1,0,50.0,3291,72
1793,22 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"4,5,6,7,8,9,10,11,12,13,14,15,16",0,50.0,3290,72
1794,46 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,18,0,50.0,3289,72
1795,50 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"9,10,11",0,50.0,3288,72
1796,53 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"1,2,18,19",0,50.0,3287,72
1797,33 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"5,9,11,14,17",0,50.0,3286,72
1798,29 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"2,3,4,5,7,9,12,13,14,15,18,19",0,50.0,3285,72
1799,29 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"3,5,9,12,15,18",0,50.0,3284,72
1800,47 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,"5,12,14,15",0,50.0,3283,72
1801,42 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,2,0,50.0,3282,72
1802,42 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,5,0,50.0,3281,72
1803,38 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,12,0,50.0,3280,72
1804,44 percent target mRNA inhibition,Flow cytometry assay,MDR1 gene,50 nM,NIH-3T3-MDR cells,Lipofectamine 2000,GUAUUGACAGCUAUUCGAATT,UUCGAAUAGCUGUCAAUACTT,Altritol nucleic acid,0,15,0,50.0,3279,72
1807,4 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGUCGUGCTGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"13,14,15,16,20,21","16,17,19,20,21",2.0,3275,42
1808,84 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGTCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"13,14,15,16,20,21","11,20,21",2.0,3274,42
1809,80 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGTCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"10,20,21","11,20,21",2.0,3273,42
1810,51 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"20,21","20,21",2.0,3272,42
1813,74 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGTCGUGCUGCTT,0,Tricyclodeoxyribonucleic acid,0,"11,20,21",2.0,3269,42
1814,46 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,Tricyclodeoxyribonucleic acid,0,"20,21",2.0,3268,42
1815,39 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"2,5,7,20,21",0,2.0,3267,42
1816,67 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"13,14,15,16,20,21",0,2.0,3266,42
1817,49 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"10,20,21",0,2.0,3265,42
1818,48 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,2 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"20,21",0,2.0,3264,42
1819,6 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGUCGUGCTGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"13,14,15,16,20,21","16,17,19,20,21",5.0,3261,42
1820,86 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGTCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"13,14,15,16,20,21","11,20,21",5.0,3260,42
1821,85 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGTCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"10,20,21","11,20,21",5.0,3259,42
1822,71 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"20,21","20,21",5.0,3258,42
1825,85 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGTCGUGCUGCTT,0,Tricyclodeoxyribonucleic acid,0,"11,20,21",5.0,3255,42
1826,70 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,Tricyclodeoxyribonucleic acid,0,"20,21",5.0,3254,42
1827,57 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"2,5,7,20,21",0,5.0,3253,42
1828,84 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"13,14,15,16,20,21",0,5.0,3252,42
1829,72 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"10,20,21",0,5.0,3251,42
1830,73 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,5 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"20,21",0,5.0,3250,42
1831,23 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGUCGUGCTGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"13,14,15,16,20,21","16,17,19,20,21",20.0,3247,42
1832,89 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGTCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"13,14,15,16,20,21","11,20,21",20.0,3246,42
1833,88 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGTCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"10,20,21","11,20,21",20.0,3245,42
1834,81 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,Tricyclodeoxyribonucleic acid,"20,21","20,21",20.0,3244,42
1835,12 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CTTGAAGAAGUCGUGCUGCTT,0,Tricyclodeoxyribonucleic acid,0,"1,2,3,20,21",20.0,3243,42
1836,25 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCTGCTT,0,Tricyclodeoxyribonucleic acid,0,"16,17,19,20,21",20.0,3242,42
1837,88 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGTCGUGCUGCTT,0,Tricyclodeoxyribonucleic acid,0,"11,20,21",20.0,3241,42
1838,79 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,Tricyclodeoxyribonucleic acid,0,"20,21",20.0,3240,42
1839,90 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"2,5,7,20,21",0,20.0,3239,42
1840,76 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"13,14,15,16,20,21",0,20.0,3238,42
1841,86 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"10,20,21",0,20.0,3237,42
1842,85 percent target mRNA inhibition,FACS and Real-time PCR,EGFP gene,20 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"20,21",0,20.0,3236,42
1843,79 percent target mRNA inhibition,FACS,GFP gene,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"2,5,7,20,21",0,50.0,3233,48
1844,90 percent target mRNA inhibition,FACS,GFP gene,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCTTCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"13,14,15,16,20,21",0,50.0,3232,48
1845,90 percent target mRNA inhibition,FACS,GFP gene,50 nM,HeLa cells,Lipofectamine,GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Tricyclodeoxyribonucleic acid,0,"20,21",0,50.0,3231,48
1846,83 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.025 nM,HCT116 cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCAUUCCAGAGAAAGCGUUUAAUTT,AAAUUAAACGCUUUCUCUGGAAUGCCU,0,2-O-Methyl,0,"11,13,15,17,19,21,23,25,26,27",0.025,3228,24
1848,85 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.0250 nM,HCT116 cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGUAAUUCAGCAGUUUGAACAA,UUGUUCAAACUGCUGAAUUACUGGCUG,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",0.025,3224,24
1849,76 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.05 nM,HCT116 cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCAUUCCAGAGAAAGCGUUUAAUTT,AAAUUAAACGCUUUCUCUGGAAUGCCU,0,2-O-Methyl,0,"11,13,15,17,19,21,23,25,26,27",0.05,3222,24
1851,75 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.05 nM,HCT116 cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGUAAUUCAGCAGUUUGAACAA,UUGUUCAAACUGCUGAAUUACUGGCUG,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",0.05,3218,24
1852,41 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.01 nM,HCT116 cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCAUUCCAGAGAAAGCGUUUAAUTT,AAAUUAAACGCUUUCUCUGGAAUGCCU,0,2-O-Methyl,0,"11,13,15,17,19,21,23,25,26,27",0.01,3216,24
1854,44 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.01 nM,HCT116 cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGUAAUUCAGCAGUUUGAACAA,UUGUUCAAACUGCUGAAUUACUGGCUG,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",0.01,3212,24
1855,94 percent target mRNA inhibition,Real-time PCR,Hprt gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGACUUUGUUGGAUUUUGAAATT,AAUUUCAAAUCCAACAAAGUCUGGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",10.0,3210,24
1856,95 percent target mRNA inhibition,Real-time PCR,Hprt gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGACUUUGUUGGAUUUUGAAATT,AAUUUCAAAUCCAACAAAGUCUGGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",10.0,3209,24
1857,13 percent target mRNA inhibition,Real-time PCR,Hprt gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGACUUUGUUGGAUUUUGAAATT,AAUUUCAAAUCCAACAAAGUCUGGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",1.0,3207,24
1858,90 percent target mRNA inhibition,Real-time PCR,Hprt gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGACUUUGUUGGAUUUUGAAATT,AAUUUCAAAUCCAACAAAGUCUGGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",1.0,3206,24
1859,60 percent target mRNA inhibition,Real-time PCR,Hprt gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGACUUUGUUGGAUUUUGAAATT,AAUUUCAAAUCCAACAAAGUCUGGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",0.1,3204,24
1860,73 percent target mRNA inhibition,Real-time PCR,Hprt gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCCAGACUUUGUUGGAUUUUGAAATT,AAUUUCAAAUCCAACAAAGUCUGGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",0.1,3203,24
1861,95 percent target mRNA inhibition,Real-time PCR,EGFP gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,0,2-O-Methyl,0,"1,2,9,11,13,15,17,19,21,23,25,26,27",10.0,3200,24
1862,29 percent target mRNA inhibition,Real-time PCR,EGFP gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","9,11,13,15,17,19,21,23,25,26,27",10.0,3199,24
1863,97 percent target mRNA inhibition,Real-time PCR,EGFP gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",10.0,3198,24
1864,97 percent target mRNA inhibition,Real-time PCR,EGFP gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,2-O-Methyl,0,"2,4,6,8,10,12,14,16,18",0,10.0,3197,24
1865,90 percent target mRNA inhibition,Real-time PCR,EGFP gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,0,2-O-Methyl,0,"1,2,9,11,13,15,17,19,21,23,25,26,27",1.0,3194,24
1866,0 percent target mRNA inhibition,Real-time PCR,EGFP gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","9,11,13,15,17,19,21,23,25,26,27",1.0,3193,24
1867,95 percent target mRNA inhibition,Real-time PCR,EGFP gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",1.0,3192,24
1868,97 percent target mRNA inhibition,Real-time PCR,EGFP gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,2-O-Methyl,0,"2,4,6,8,10,12,14,16,18",0,1.0,3191,24
1869,15 percent target mRNA inhibition,Real-time PCR,EGFP gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,0,2-O-Methyl,0,"1,2,9,11,13,15,17,19,21,23,25,26,27",0.1,3188,24
1870,0 percent target mRNA inhibition,Real-time PCR,EGFP gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","9,11,13,15,17,19,21,23,25,26,27",0.1,3187,24
1871,29 percent target mRNA inhibition,Real-time PCR,EGFP gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",0.1,3186,24
1872,31 percent target mRNA inhibition,Real-time PCR,EGFP gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",ACCCUGAAGUUCAUCUGCACCACCG,CGGUGGUGCAGAUGAACUUCAGGGUCA,2-O-Methyl,0,"2,4,6,8,10,12,14,16,18",0,0.1,3185,24
1873,3 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-Fluoro* 2-O-Methyl,"2,4,5,10,11,14,19,20","8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",0.1,3182,24
1874,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-Fluoro* 2-O-Methyl,"1,3,6,7,8,9,12,13,15,16,17,18","8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",0.1,3181,24
1875,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-Fluoro* 2-O-Methyl,0,"8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",0.1,3180,24
1876,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-Fluoro,"1,3,6,7,8,9,12,13,15,16,17,18","8,9,10,11,13,14,17,18,19,20,23,25,26",0.1,3179,24
1877,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-O-Methyl,"2,4,5,10,11,14,19,20","12,15,16,21,22,24",0.1,3178,24
1878,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-Fluoro,"2,4,5,10,11,14,19,20","8,9,10,11,13,14,17,18,19,20,23,25,26",0.1,3177,24
1879,14 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-Fluoro,0,"8,9,10,11,13,14,17,18,19,20,23,25,26",0.1,3176,24
1880,55 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,0,"2,4,5,10,11,14,19,20",0,0.1,3175,24
1881,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"1,3,6,7,8,9,12,13,15,16,17,18","12,15,16,21,22,24",0.1,3174,24
1882,45 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"12,15,16,21,22,24",0.1,3173,24
1883,40 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,0,"1,3,6,7,8,9,12,13,15,16,17,18",0,0.1,3172,24
1884,66 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,0,"2,4,6,8,10,12,14,16,18",0,0.1,3171,24
1885,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","7,9,11,13,15,17,19,21,23,25",0.1,3170,24
1886,45 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"7,9,11,13,15,17,19,21,23,25",0.1,3169,24
1887,0 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","9,11,13,15,17,19,21,23,25",0.1,3168,24
1888,62 percent target mRNA inhibition,Real-time PCR,STAT1 gene,0.1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",0.1,3167,24
1889,47 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-Fluoro* 2-O-Methyl,"2,4,5,10,11,14,19,20","8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",1.0,3164,24
1890,8 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-Fluoro* 2-O-Methyl,"1,3,6,7,8,9,12,13,15,16,17,18","8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",1.0,3163,24
1891,68 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-Fluoro* 2-O-Methyl,0,"8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",1.0,3162,24
1892,30 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-Fluoro,"1,3,6,7,8,9,12,13,15,16,17,18","8,9,10,11,13,14,17,18,19,20,23,25,26",1.0,3161,24
1893,78 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-O-Methyl,"2,4,5,10,11,14,19,20","12,15,16,21,22,24",1.0,3160,24
1894,78 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-Fluoro,"2,4,5,10,11,14,19,20","8,9,10,11,13,14,17,18,19,20,23,25,26",1.0,3159,24
1895,88 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-Fluoro,0,"8,9,10,11,13,14,17,18,19,20,23,25,26",1.0,3158,24
1896,90 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,0,"2,4,5,10,11,14,19,20",0,1.0,3157,24
1897,64 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"1,3,6,7,8,9,12,13,15,16,17,18","12,15,16,21,22,24",1.0,3156,24
1898,90 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"12,15,16,21,22,24",1.0,3155,24
1899,85 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,0,"1,3,6,7,8,9,12,13,15,16,17,18",0,1.0,3154,24
1900,95 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,0,"2,4,6,8,10,12,14,16,18",0,1.0,3153,24
1901,76 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","7,9,11,13,15,17,19,21,23,25",1.0,3152,24
1902,89 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"7,9,11,13,15,17,19,21,23,25",1.0,3151,24
1903,80 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","9,11,13,15,17,19,21,23,25",1.0,3150,24
1904,91 percent target mRNA inhibition,Real-time PCR,STAT1 gene,1 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",1.0,3149,24
1905,65 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-Fluoro* 2-O-Methyl,"2,4,5,10,11,14,19,20","8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",10.0,3146,24
1906,3 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-Fluoro* 2-O-Methyl,"1,3,6,7,8,9,12,13,15,16,17,18","8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",10.0,3145,24
1907,79 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-Fluoro* 2-O-Methyl,0,"8,9,10,11,13,14,17,18,19,20,23,25,26 * 12,15,16,21,22,24",10.0,3144,24
1908,14 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-Fluoro,"1,3,6,7,8,9,12,13,15,16,17,18","8,9,10,11,13,14,17,18,19,20,23,25,26",10.0,3143,24
1909,81 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-O-Methyl,"2,4,5,10,11,14,19,20","12,15,16,21,22,24",10.0,3142,24
1910,85 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,2-Fluoro,"2,4,5,10,11,14,19,20","8,9,10,11,13,14,17,18,19,20,23,25,26",10.0,3141,24
1911,85 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-Fluoro,0,"8,9,10,11,13,14,17,18,19,20,23,25,26",10.0,3140,24
1912,88 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-Fluoro,0,"2,4,5,10,11,14,19,20",0,10.0,3139,24
1913,67 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"1,3,6,7,8,9,12,13,15,16,17,18","12,15,16,21,22,24",10.0,3138,24
1914,88 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"12,15,16,21,22,24",10.0,3137,24
1915,92 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,0,"1,3,6,7,8,9,12,13,15,16,17,18",0,10.0,3136,24
1916,91 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,0,"2,4,6,8,10,12,14,16,18",0,10.0,3135,24
1917,83 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","7,9,11,13,15,17,19,21,23,25",10.0,3134,24
1918,92 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"7,9,11,13,15,17,19,21,23,25",10.0,3133,24
1919,80 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","9,11,13,15,17,19,21,23,25",10.0,3132,24
1920,95 percent target mRNA inhibition,Real-time PCR,STAT1 gene,10 nM,HeLa cells,"TriFECTin (Integrated DNA Technologies, Coralville, IA)",GCACCAGAGCCAAUGGAACUUGATG,CAUCAAGUUCCAUUGGCUCUGGUGCUU,0,2-O-Methyl,0,"9,11,13,15,17,19,21,23,25,26,27",10.0,3131,24
1921,98 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUAGUUCAAAUUTT,AAAAUUUGUACUACGUCAGGU,"2,4-Difluorotoluene",0,19,0,2.1,3128,22
1922,18 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAAUUUUGUACAACGUCAGGU,"2,4-Difluorotoluene",0,18,0,2.1,3127,22
1923,75 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUATTTGTACAACGTCAGGT,4-Methylbenzimidazole,0,13,0,2.1,3126,22
1924,88 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,"2,4-Difluorobenzene",0,19,2.1,3125,22
1925,0 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,4-Methylbenzimidazole,0,16,2.1,3124,22
1926,0 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,4-Methylbenzimidazole,0,11,2.1,3123,22
1927,0 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,4-Methylbenzimidazole,0,10,2.1,3122,22
1928,0 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,4-Methylbenzimidazole,0,8,2.1,3121,22
1929,55 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,"2,4-Difluorobenzene",0,7,2.1,3120,22
1930,26 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,"2,4-Difluorobenzene",0,5,2.1,3119,22
1931,45 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,"2,4-Difluorobenzene",0,4,2.1,3118,22
1932,54 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,"2,4-Difluorobenzene",0,3,2.1,3117,22
1933,82 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,ACCUGACGUUGUACAAAUUTT,AAUUUGUACAACGUCAGGUTT,0,4-Methylbenzimidazole,0,1,2.1,3116,22
1934,60 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,4-Methylbenzimidazole,0,7,2.1,3114,22
1935,58 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,"2,3-Di-Chlorobenzene",0,7,2.1,3113,22
1936,92 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,"2,3-Di-Chlorobenzene",0,7,2.1,3112,22
1937,90 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,2.1 ng,HeLa cells,Liposomes,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,"2,4-Difluorobenzene",0,7,2.1,3111,22
1938,IC-50 (Greater than 20 nM) for target mRNA,Luciferase reporter assay,Luciferase gene,20 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTATTAAA,UUAAUUAAAGACTUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,2-Deoxy-2-Fluoroarabinonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",13,20.0,3109,24
1939,IC-50 = 0.87 nM for target mRNA,Luciferase reporter assay,Luciferase gene,0.87 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTAATTAATT,UUAAUUAAAGACTUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,2-Deoxy-2-Fluoroarabinonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,20,21",13,0.87,3108,24
1940,IC-50 = 10.8 nM for target mRNA,Luciferase reporter assay,Luciferase gene,10.8 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTAATTAAGG,UUAAUUAAAGACTUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,2-Deoxy-2-Fluoroarabinonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21",13,10.8,3107,24
1941,IC-50 (Greater than 20 nM) for target mRNA,Luciferase reporter assay,Luciferase gene,20 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTATTAAA,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,2-Deoxy-2-Fluoro-4-Thioarabinonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",13,20.0,3106,24
1942,IC-50 = 0.6 nM for target mRNA,Luciferase reporter assay,Luciferase gene,0.6 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTAATTAATT,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,2-Deoxy-2-Fluoro-4-Thioarabinonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,20,21",13,0.6,3105,24
1943,IC-50 = 17 nM for target mRNA,Luciferase reporter assay,Luciferase gene,17 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTAATTAAGG,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,2-Deoxy-2-Fluoro-4-Thioarabinonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21",13,17.0,3104,24
1944,IC-50 (Greater than 20 nM) for target mRNA,Luciferase reporter assay,Luciferase gene,21 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTATTAAA,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",0,21.0,3103,24
1945,IC-50 = 2.4 nM for target mRNA,Luciferase reporter assay,Luciferase gene,2.4 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTAATTAATT,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,20,21",0,2.4,3102,24
1946,IC-50 = 7.8 nM for target mRNA,Luciferase reporter assay,Luciferase gene,7.8 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCTTGAAGTCTTTAATTAAGG,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21",0,7.8,3101,24
1947,IC-50 = 0.04 nM for target mRNA,Luciferase reporter assay,Luciferase gene,1.04 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAAUUAATT,TTAAUUAAAGACUUCAAGCGG,0,2-Deoxy-2-Fluoroarabinonucleic acid,0,"1,2",0.04,3098,24
1948,IC-50 = 1 nM for target mRNA,Luciferase reporter assay,Luciferase gene,1 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAAUUAATT,TTAAUUAAAGACUUCAAGCGG,0,2-Deoxy-2-Fluoroarabinonucleic acid,0,"1,2",1.0,3097,24
1949,IC-50 = 0.16 nM for target mRNA,Luciferase reporter assay,Luciferase gene,1.16 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAAUUAATT,UUAAUUAAAGACUUCAAGCGG,0,2-Deoxy-2-Fluoro-4-Thioarabinonucleic acid,0,"1,2",0.16,3096,24
1950,IC-50 = 3.6 nM for target mRNA,Luciferase reporter assay,Luciferase gene,3.6 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAAUUAATT,UUAAUUAAAGACUUCAAGCGG,0,2-Deoxy-2-Fluoro-4-Thioarabinonucleic acid,0,"1,2",3.6,3095,24
1951,IC-50 = 0.31 nM for target mRNA,Luciferase reporter assay,Luciferase gene,0.31 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAAUUAATT,UUAAUUAAAGACTUCAAGCGG,0,2-Deoxy-2-Fluoroarabinonucleic acid,0,13,0.31,3094,24
1952,IC-50 = 0.17 nM for target mRNA,Luciferase reporter assay,Luciferase gene,0.17 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAAUUAATT,UUAAUUAAAGACUUCAAGCGG,0,2-Deoxy-2-Fluoro-4-Thioarabinonucleic acid,0,13,0.17,3093,24
1953,IC-50 = 0.2 nM for target mRNA,Luciferase reporter assay,Luciferase gene,0.2 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAATTAATT,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoroarabinonucleic acid,0,"16,17",0,0.2,3092,24
1954,IC-50 = 0.1 nM for target mRNA,Luciferase reporter assay,Luciferase gene,0.1 nM,HeLa X1/5 cells,Lipofectamine-plus reagent (Invitrogen),GCUUGAAGUCUUUAAUUAATT,UUAAUUAAAGACUUCAAGCGG,2-Deoxy-2-Fluoro-4-Thioarabinonucleic acid,0,"16,17",0,0.1,3091,24
1955,92 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"19,20,21",13.0,3088,24
1956,95 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"18,20,21",13.0,3087,24
1957,96 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"17,20,21",13.0,3086,24
1958,83 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGTAAGTT,0,Locked nucleic acid,0,"16,20,21",13.0,3085,24
1959,87 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"15,20,21",13.0,3084,24
1960,56 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid* Methylcytosine,0,"14,20,21 * 1",13.0,3083,24
1961,94 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"12,20,21",13.0,3082,24
1962,70 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"12,20,21",13.0,3081,24
1963,92 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid* Methylcytosine,0,"11,20,21 * 1",13.0,3080,24
1964,60 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACTCAGCGUAAGTT,0,Locked nucleic acid,0,"10,20,21",13.0,3079,24
1965,91 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid* Methylcytosine,0,"9,20,21 * 1",13.0,3078,24
1966,90 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"8,20,21",13.0,3077,24
1967,93 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGTACUCAGCGUAAGTT,0,Locked nucleic acid,0,"7,20,21",13.0,3076,24
1968,85 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"6,20,21",13.0,3075,24
1969,88 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"5,20,21",13.0,3074,24
1970,91 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"4,20,21",13.0,3073,24
1971,90 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"3,20,21",13.0,3072,24
1972,85 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid* Methylcytosine,0,"2,20,21 * 1",13.0,3071,24
1973,52 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,ACUGUCAAACCCGGUAAUUTT,AAUUACCGGGUUUGACAGUTT,Locked nucleic acid,Locked nucleic acid,"1,20,21","20,21",13.0,3070,24
1974,93 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUGGUACGAUUUCGGUGAUTT,AGCACCGAAAUCGUACCAGTT,Locked nucleic acid* Methylcytosine,Locked nucleic acid,"1,20,21 * 1","20,21",13.0,3069,24
1975,50 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,GGAUGAGGAAGGCAAUUUATT,UAAAUUGCCUUCCUCAUCCTT,Locked nucleic acid,Locked nucleic acid,"1,20,21","20,21",13.0,3068,24
1976,50 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,TCCAGAACAAAGGAAACGGTT,CCGUUUCCUUUGUUCUGGATT,Locked nucleic acid,0,"1,20,21",0,13.0,3067,24
1977,82 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,AAACAUGCAGAAAAUGCUGTT,CAGCAUUUUCUGCAUGUUUTT,Locked nucleic acid,0,"1,20,21",0,13.0,3066,24
1978,67 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,TGAGAGAAAGCACAGAAAATT,TUUUCUGUGCUUUCUCUCATT,Locked nucleic acid,Locked nucleic acid,"1,20,21","1,20,21",13.0,3065,24
1979,45 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,UGAGAGAAAGCACAGAAAATT,TUUUCUGUGCUUUCUCUCATT,0,Locked nucleic acid,0,"1,20,21",13.0,3064,24
1980,68 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,TGAGAGAAAGCACAGAAAATT,UUUUCUGUGCUUUCUCUCATT,Locked nucleic acid,0,"1,3,5,9,12,14,17,20,21",0,13.0,3063,24
1981,74 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,TGAGAGAAAGCACAGAAAATT,UUUUCUGUGCUUUCUCUCATT,Locked nucleic acid,0,"1,20,21",0,13.0,3062,24
1982,65 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,TUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"1,20,21","1,20,21",13.0,3061,24
1983,52 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,TUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"20,21","1,20,21",13.0,3060,24
1984,22 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,TUUUUCUCCUUCUUCAGAUTT,0,Locked nucleic acid,0,"1,20,21",13.0,3059,24
1985,93 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"1,20,21","20,21",13.0,3058,24
1986,93 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",13.0,3057,24
1987,90 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,Locked nucleic acid,0,"20,21",13.0,3056,24
1988,19 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGTACTCAGCGTAAGTT,0,Locked nucleic acid,0,"1,7,10,16,20,21",13.0,3055,24
1989,35 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,Locked nucleic acid* Methylcytosine,Locked nucleic acid,"1,20,22 * 1","1,20,21",13.0,3054,24
1990,27 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,Locked nucleic acid,Locked nucleic acid,"20,21","1,20,21",13.0,3053,24
1991,57 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"1,20,21",13.0,3052,24
1992,73 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CTTACGCTGAGTACTTCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid* Methylcytosine,Locked nucleic acid,"1,2,3,8,12,15,16,20,21 * 1","20,21",13.0,3051,24
1993,81 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CTTACGCTGAGTACTTCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid* Methylcytosine,0,"1,2,3,8,12,15,16,20,21 * 1",0,13.0,3050,24
1994,93 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid* Methylcytosine,Locked nucleic acid,"1,20,22 * 1","20,21",13.0,3049,24
1995,97 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid* Methylcytosine,0,"1,20,22 * 1",0,13.0,3048,24
1996,93 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",13.0,3047,24
1997,97 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Locked nucleic acid,0,"20,21",0,13.0,3046,24
1998,93 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,13 nM,"HEK293, rat PC12 and Vero cells",Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Locked nucleic acid,0,"20,21",13.0,3045,24
1999,73 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GCACGACUUCUUCAAGUCCUU,Boranophosphate,0,"5,6,14,20,21",0,25.0,3035,54
2000,58 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GCACGACUUCUUCAAGUCCUU,Boranophosphate,0,"3,8,9,11,12",0,25.0,3034,54
2001,61 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,Boranophosphate,"2,3,4,5,6,7,8,9,11,12,14,15,17,18,19,20,21","2,3,4,7,8,9,10,11,12,15,17,18,19,20,21",25.0,3030,54
2002,82 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,Boranophosphate,"4,6,7,14,15,19","2,3,4,7,8,9,10,11,12,15,17,18,19,20,21",25.0,3029,54
2003,52 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,Boranophosphate,"2,3,4,5,6,7,8,9,11,12,14,15,17,18,19,20,21","4,7,10,19",25.0,3028,54
2004,89 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,Boranophosphate,"4,5,6,7,11,14,15,19","2,3,4,7,8,10,11,12,17,18,19",25.0,3027,54
2005,45 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,Boranophosphate,"2,3,4,6,7,8,9,12,14,15,17,18,19,20,21","4,7,9,10,15,19,20,21",25.0,3026,54
2006,90 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,Boranophosphate,"4,6,7,14,15,19","4,7,10,19",25.0,3025,54
2007,81 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,0,Boranophosphate,0,"9,15,20,21",25.0,3024,54
2008,63 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,0,Phosphorothioate,0,"9,15,20,21",25.0,3023,54
2009,91 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,0,Boranophosphate,0,"4,7,10,19",25.0,3022,54
2010,58 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,0,Phosphorothioate,0,"4,7,10,19",25.0,3021,54
2011,70 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,0,"2,3,8,9,12,17,18,20,21",0,25.0,3020,54
2012,45 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Phosphorothioate,0,"2,3,8,9,12,17,18,20,21",0,25.0,3019,54
2013,98 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Boranophosphate,0,"4,6,7,14,15,19",0,25.0,3018,54
2014,85 percent target mRNA inhibition,FACS and cellular RNA analysis,EGFP gene,25 nM,HeLa cells,Oligofectamine (Invitrogen),GUUCACCUUGAUGCCGUUCUU,GAACGGCAUCAAGGUGAACUU,Phosphorothioate,0,"4,6,7,14,15,19",0,25.0,3017,54
2015,92 percent target mRNA inhibition,Dual luciferase reporter assay,EGFP gene,10 nM,H1299 cells,Lipofectamine 2000,GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",10.0,3015,48
2016,75 percent target mRNA inhibition,Dual luciferase reporter assay,EGFP gene,10 nM,H1299 cells,Lipofectamine 2000,GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,0,O-Methyl,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,22",10.0,3014,48
2017,91 percent target mRNA inhibition,Dual luciferase reporter assay,EGFP gene,10 nM,H1299 cells,Lipofectamine 2000,GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,13,20,21","19,21",10.0,3013,48
2018,84 percent target mRNA inhibition,Dual luciferase reporter assay,EGFP gene,10 nM,H1299 cells,Lipofectamine 2000,GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Altritol nucleic acid,"3,9,15,20,21","5,8,11,14,17,20",10.0,3012,48
2019,0 percent target mRNA inhibition,Dual luciferase reporter assay,EGFP gene,10 nM,H1299 cells,Lipofectamine 2000,GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl,2-Aminoethoxymethyl,"3,5,9,19,20","3,10,18,19",10.0,3011,48
2020,87 percent target mRNA inhibition,Dual luciferase reporter assay,EGFP gene,10 nM,H1299 cells,Lipofectamine 2000,GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,0,Hexitol nucleic acid,0,"8,14,18,19,20",10.0,3010,48
2021,63 percent target mRNA inhibition,Dual luciferase reporter assay,EGFP gene,10 nM,H1299 cells,Lipofectamine 2000,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid* Small internally segmented RNA,Locked nucleic acid,"3,9,13,15,20,21 * 10","3,6,14,18,20,21",10.0,3009,48
2022,64 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,2-Fluoro* 2-Deoxy,"2,5,7,10,11,12,13,14,15,16","1,2,3,11,12,14,16,17,19 * 4,5,6,7,9",50.0,3007,4
2023,91 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-Fluoro* 2-Deoxy,0,"1,2,3,11,12,14,16,17,19 * 4,5,6,7,8",50.0,3006,4
2024,45 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,2-Fluoro* 2-Deoxy,"2,5,7,10,11,12,13,14,15,16","1,2,3,11,12,14,16,17,19 * 15,19",50.0,3005,4
2025,43 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-Fluoro* 2-Deoxy,0,"1,2,3,11,12,14,16,17,19 * 15,18",50.0,3004,4
2026,0 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,N-3 Methyluridine,0,11,50.0,3001,4
2027,0 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,N-3 Methyluridine,0,"2,3,11,14,17",50.0,3000,4
2028,35 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,Diaminopurine,"2,5,7,10,11,12,13,14,15,16","4,5,6,7,8,9,10,13,15,16,18",50.0,2999,4
2029,42 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,5-Iodo-Uridine,"2,5,7,10,11,12,13,14,15,16","2,3,11,14,17",50.0,2998,4
2030,31 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,5-Bromo-Uridine,"2,5,7,10,11,12,13,14,15,16","2,3,11,14,17",50.0,2997,4
2031,51 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,Diaminopurine,0,"4,5,6,7,8,9,10,13,15,16,18",50.0,2996,4
2032,59 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,5-Iodo-Uridine,0,"2,3,11,14,17",50.0,2995,4
2033,70 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,5-Bromo-Uridine,0,"2,3,11,14,17",50.0,2994,4
2034,22 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-Fluoro* Phosphorothioate,0,"1,2,3,11,12,14,16,17,19 * 4,5,6,7,8,9,10,13,15,18",50.0,2993,4
2035,47 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Phosphorothioate,Phosphorothioate,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",50.0,2992,4
2036,62 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,Phosphorothioate,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",0,50.0,2991,4
2037,42 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,Phosphorothioate,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",50.0,2990,4
2038,0 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-O-Methyl,2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",50.0,2989,4
2039,25 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-O-Methyl,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",0,50.0,2988,4
2040,16 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-O-Methyl,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",50.0,2987,4
2041,0 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxy,2-Deoxy,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",50.0,2986,4
2042,38 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Deoxy,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",0,50.0,2985,4
2043,0 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-Deoxy,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",50.0,2984,4
2044,44 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,2-Fluoro* 2-Deoxy,"2,5,7,10,11,12,13,14,15,16","1,2,3,11,12,14,16,17,19 * 4,5,6,7,8,9,10,13,15,18",50.0,2983,4
2045,42 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-Fluoro* 2-Deoxy,0,"1,2,3,11,12,14,16,17,19 * 4,5,6,7,8,9,10,13,15,18",50.0,2982,4
2046,64 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,2-Fluoro* 2-Deoxy,"2,5,7,10,11,12,13,14,15,16","1,2,3,11,12,14,16,17,19 * 9,10,13",50.0,2981,4
2047,85 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-Fluoro* 2-Deoxy,0,"1,2,3,11,12,14,16,17,19 * 9,10,13",50.0,2980,4
2048,83 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,2-Fluoro,"2,5,7,10,11,12,13,14,15,16","1,2,3,11,12,14,16,17,19",50.0,2979,4
2049,92 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,2-Fluoro,0,"2,5,7,10,11,12,13,14,15,16",0,50.0,2978,4
2050,83 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,50 nM,HeLa cells,Lipofectamine (Invitrogen),GCAGCACGACUUCUUCAAGTT,CUUGAAGAAGUCGUGCUGCTT,0,2-Fluoro,0,"1,2,3,11,12,14,16,17,19",50.0,2977,4
2051,50 percent target mRNA inhibition (IC-50 = 4.95 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,3,10.0,2975,24
2052,2 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,2,10.0,2974,24
2053,87 percent target mRNA inhibition (IC-50 = 0.26 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,1,10.0,2973,24
2054,81 percent target mRNA inhibition (IC-50 = 0.56 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,"20,21",10.0,2972,24
2055,82 percent target mRNA inhibition (IC-50 = 1.20 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,19,10.0,2971,24
2056,91 percent target mRNA inhibition (IC-50 = 1.02 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,18,10.0,2970,24
2057,87 percent target mRNA inhibition (IC-50 = 1.29 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,17,10.0,2969,24
2058,29 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,16,10.0,2968,24
2059,86 percent target mRNA inhibition (IC-50 = 0.76 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,15,10.0,2967,24
2060,64 percent target mRNA inhibition (IC-50 = 3.09 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,14,10.0,2966,24
2061,74 percent target mRNA inhibition (IC-50 = 2.17 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,13,10.0,2965,24
2062,59 percent target mRNA inhibition (IC-50 = 6.78 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,12,10.0,2964,24
2063,0 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,11,10.0,2963,24
2064,23 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,10,10.0,2962,24
2065,89 percent target mRNA inhibition (IC-50 = 2.31 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,9,10.0,2961,24
2066,90 percent target mRNA inhibition (IC-50 = 0.15 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,8,10.0,2960,24
2067,86 percent target mRNA inhibition (IC-50 = 0.39 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,7,10.0,2959,24
2068,78 percent target mRNA inhibition (IC-50 = 0.23 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,6,10.0,2958,24
2069,92 percent target mRNA inhibition (IC-50 = 0.21 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,5,10.0,2957,24
2070,94 percent target mRNA inhibition (IC-50 = 0.13 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,4,10.0,2956,24
2071,45 percent target mRNA inhibition (IC-50 = 3.83 nM),Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,3,10.0,2955,24
2072,0 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,2,10.0,2954,24
2073,0 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),GUAUGACCGACUACGCGUATT,UUCAGUGUGAUGACACUUGTT,0,Unlocked nucleic acid,0,1,10.0,2953,24
2074,88 percent target mRNA inhibition,GFP signal 10 minute UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,"2,3,4,25,26,27 * 1,27","2,3,4,25,26,27 * 1,27",1.56,2951,42
2075,89 percent target mRNA inhibition,GFP signal 10 minute UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,"2,27 * 1,27","2,27 * 1,27",1.56,2950,42
2076,13 percent target mRNA inhibition,GFP signal 10 minute UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Dimethoxy-Nitrophenyl Ethyl group,Dimethoxy-Nitrophenyl Ethyl group,"1,27","1,27",1.56,2949,42
2077,93 percent target mRNA inhibition,GFP signal 10 minute UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate,Phosphorothioate,"2,3,4,25,26,27","2,3,4,25,26,27",1.56,2948,42
2078,93 percent target mRNA inhibition,GFP signal 10 minute UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate,Phosphorothioate,"2,27","2,27",1.56,2947,42
2079,40 percent target mRNA inhibition,GFP signal no UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,"2,3,4,25,26,27 * 1,27","2,3,4,25,26,27 * 1,27",1.56,2945,42
2080,27 percent target mRNA inhibition,GFP signal no UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,Phosphorothioate* Dimethoxy-Nitrophenyl Ethyl group,"2,27 * 1,27","2,27 * 1,27",1.56,2944,42
2081,43 percent target mRNA inhibition,GFP signal no UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Dimethoxy-Nitrophenyl Ethyl group,Dimethoxy-Nitrophenyl Ethyl group,"1,27","1,27",1.56,2943,42
2082,93 percent target mRNA inhibition,GFP signal no UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate,Phosphorothioate,"2,3,4,25,26,27","2,3,4,25,26,27",1.56,2942,42
2083,95 percent target mRNA inhibition,GFP signal no UV exposure,GFP gene,1.56 nM,HeLa cells,Lipofectamine (Invitrogen),AAGCUGACCCUGAAGUUCAUCUGCACC,GGUGCAGAUGAACUUCAGGGUCAGCUU,Phosphorothioate,Phosphorothioate,"2,27","2,27",1.56,2941,42
2084,High target mRNA inhibition efficacy,Northern and Western Blot,EGFP gene,0.25 mg/kg/day,EGFP (mRNA) tumor xenografts NMRI nu/nu mice,Osmotic minipumps,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",0,3,0.25,2938,24
2085,High target mRNA inhibition efficacy,Northern and Western Blot,EGFP gene,0.25 mg/kg/day,EGFP (mRNA) tumor xenografts NMRI nu/nu mice,Osmotic minipumps,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid * Locked nucleic acid,21,"6 * 20,21",0.25,2937,24
2086,High target mRNA inhibition efficacy,Northern and Western Blot,EGFP gene,0.25 mg/kg/day,EGFP (mRNA) tumor xenografts NMRI nu/nu mice,Osmotic minipumps,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGUU,UnLocked nucleic acid,Unlocked nucleic acid,21,21,0.25,2936,24
2087,High target mRNA inhibition efficacy,Northern and Western Blot,EGFP gene,0.25 mg/kg/day,EGFP (mRNA) tumor xenografts NMRI nu/nu mice,Osmotic minipumps,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid* Small internally segmented RNA,Locked nucleic acid,"3,9,13,15,20,21 * 14","20,21",0.25,2935,24
2088,High target mRNA inhibition efficacy,Northern and Western Blot,EGFP gene,0.25 mg/kg/day,EGFP (mRNA) tumor xenografts NMRI nu/nu mice,Osmotic minipumps,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",0.25,2934,24
2089,High target mRNA inhibition efficacy,Northern and Western Blot,EGFP gene,0.25 mg/kg/day,EGFP (mRNA) tumor xenografts NMRI nu/nu mice,Osmotic minipumps,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",0.25,2933,24
2090,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,25 nM,MiaPaca II cells,Lipofectamin 2045,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",0,3,25.0,2930,24
2091,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,25 nM,MiaPaca II cells,Lipofectamin 2043,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid * Locked nucleic acid,21,"6 * 20,21",25.0,2929,24
2092,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,25 nM,MiaPaca II cells,Lipofectamin 2041,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGUU,UnLocked nucleic acid,Unlocked nucleic acid,21,21,25.0,2928,24
2093,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,25 nM,MiaPaca II cells,Lipofectamin 2039,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid* Small internally segmented RNA,Locked nucleic acid,"3,9,13,15,20,21 * 14","20,21",25.0,2927,24
2094,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,25 nM,MiaPaca II cells,Lipofectamin 2037,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",25.0,2926,24
2095,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,25 nM,MiaPaca II cells,Lipofectamin 2035,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",25.0,2925,24
2096,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,5 nM,MiaPaca II cells,Lipofectamin 2029,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",0,3,5.0,2922,24
2097,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,5 nM,MiaPaca II cells,Lipofectamin 2027,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid * Locked nucleic acid,21,"6 * 20,21",5.0,2921,24
2098,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,5 nM,MiaPaca II cells,Lipofectamin 2025,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGUU,UnLocked nucleic acid,Unlocked nucleic acid,21,21,5.0,2920,24
2099,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,5 nM,MiaPaca II cells,Lipofectamin 2023,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid* Small internally segmented RNA,Locked nucleic acid,"3,9,13,15,20,21 * 14","20,21",5.0,2919,24
2100,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,5 nM,MiaPaca II cells,Lipofectamin 2021,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",5.0,2918,24
2101,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,5 nM,MiaPaca II cells,Lipofectamin 2019,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",5.0,2917,24
2102,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,1 nM,MiaPaca II cells,Lipofectamin 2013,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",0,3,1.0,2914,24
2103,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,1 nM,MiaPaca II cells,Lipofectamin 2011,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid * Locked nucleic acid,21,"6 * 20,21",1.0,2913,24
2104,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,1 nM,MiaPaca II cells,Lipofectamin 2009,GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGUU,UnLocked nucleic acid,Unlocked nucleic acid,21,21,1.0,2912,24
2105,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,1 nM,MiaPaca II cells,Lipofectamin 2007,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid* Small internally segmented RNA,Locked nucleic acid,"3,9,13,15,20,21 * 14","20,21",1.0,2911,24
2106,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,1 nM,MiaPaca II cells,Lipofectamin 2005,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",1.0,2910,24
2107,High target mRNA inhibition efficacy,Northern Blot,EGFP gene,1 nM,MiaPaca II cells,Lipofectamin 2003,GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",1.0,2909,24
2108,80 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,19,10.0,2907,24
2109,71 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,18,10.0,2906,24
2110,67 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,17,10.0,2905,24
2111,41 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,16,10.0,2904,24
2112,84 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,15,10.0,2903,24
2113,39 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,14,10.0,2902,24
2114,78 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,13,10.0,2901,24
2115,62 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,12,10.0,2900,24
2116,63 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,11,10.0,2899,24
2117,67 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,10,10.0,2898,24
2118,63 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,9,10.0,2897,24
2119,87 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,8,10.0,2896,24
2120,56 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,7,10.0,2895,24
2121,77 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,6,10.0,2894,24
2122,79 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,5,10.0,2893,24
2123,54 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,4,10.0,2892,24
2124,60 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,3,10.0,2891,24
2125,21 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,2,10.0,2890,24
2126,24 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,2-O-Benzyl,0,1,10.0,2889,24
2127,82 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,19 * 19,10.0,2887,24
2128,33 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,18 * 18,10.0,2886,24
2129,71 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,17 * 17,10.0,2885,24
2130,22 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,16 * 16,10.0,2884,24
2131,93 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,15 * 15,10.0,2883,24
2132,11 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,14 * 14,10.0,2882,24
2133,69 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,13 * 13,10.0,2881,24
2134,60 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,12 * 12,10.0,2880,24
2135,11 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,11 * 11,10.0,2879,24
2136,28 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,10 * 10,10.0,2878,24
2137,51 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,9 * 9,10.0,2877,24
2138,73 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,8 * 8,10.0,2876,24
2139,63 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,7 * 7,10.0,2875,24
2140,82 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,6 * 6,10.0,2874,24
2141,92 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,5 * 5,10.0,2873,24
2142,71 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,4 * 4,10.0,2872,24
2143,50 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,3 * 3,10.0,2871,24
2144,21 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,2 * 2,10.0,2870,24
2145,33 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine* 2-O-Benzyl,0,1 * 1,10.0,2869,24
2146,54 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,19,10.0,2867,24
2147,19 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,18,10.0,2866,24
2148,52 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,17,10.0,2865,24
2149,30 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,16,10.0,2864,24
2150,69 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,15,10.0,2863,24
2151,73 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,14,10.0,2862,24
2152,62 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,13,10.0,2861,24
2153,52 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,12,10.0,2860,24
2154,2 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,11,10.0,2859,24
2155,30 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,10,10.0,2858,24
2156,54 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,9,10.0,2857,24
2157,67 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,8,10.0,2856,24
2158,80 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,7,10.0,2855,24
2159,72 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,6,10.0,2854,24
2160,65 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,5,10.0,2853,24
2161,79 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,4,10.0,2852,24
2162,48 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,3,10.0,2851,24
2163,59 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,2,10.0,2850,24
2164,58 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,10 nM,Hepa1-6 cells,Lipofectamine RNAiMAX (Invitrogen),CAAGUGUCAUCACACUGAATT,UUCAGUGUGAUGACACUUGTT,0,Hypoxanthine,0,1,10.0,2849,24
2165,IC-50 = 0.027 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,PTEN,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2011,AAGUAAGGACCAGAGACAATT,UUGUCUCUGGUCCUUACUUTT,"2,4-difluorotoluene ribonucleotide",0,12,0,0.027,2847,35
2166,IC-50 = 0.039 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,PTEN,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2010,AAGUAAGGACCAGAGACAATT,UUGUCUCUGGUCCUUACUUTT,"2,4-difluorotoluene ribonucleotide",0,11,0,0.039,2846,34
2167,IC-50 = 0.04 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,PTEN,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2009,AAGUAAGGACCAGAGACAATT,UUGUCUCUGGUCCUUACUUTT,"2,4-difluorotoluene ribonucleotide",0,10,0,0.04,2845,33
2168,IC-50 = 0.031 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,PTEN,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2008,AAGUAAGGACCAGAGACAATT,UUGUCUCUGGUCCUUACUUTT,"2,4-difluorotoluene ribonucleotide",0,9,0,0.031,2844,32
2169,IC-50 = 0.253 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,GAACGUGAAUUGCUCAACATT,UGUUGAGCAAUUCACGUUCTT,"2-O-Methyl* 2,4-Difluorotoluene* Phosphorothioate",2-O-Methyl* Phosphorothioate,"4,6,10, 11,13,14,15,18 * 12 * 20","8,13 * 20",0.253,2836,24
2170,IC-50 = 0.132 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,GAACGUGAAUUGCUCAACATT,UGUUGAGCAAUUCACGUUCTT,"2-O-Methyl* 2,4-Difluorotoluene* Phosphorothioate",2-O-Methyl* Phosphorothioate,"4,6,10, 13,14,15,18 * 11 * 20","8,13 * 20",0.132,2835,24
2171,IC-50 = 0.141 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,GAACGUGAAUUGCUCAACATT,UGUUGAGCAAUUCACGUUCTT,"2-O-Methyl* 2,4-Difluorotoluene* Phosphorothioate",2-O-Methyl* Phosphorothioate,"4,6,11, 13,14,15,18 * 10 * 20","8,13 * 20",0.141,2834,24
2172,IC-50 = 0.221 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,GAACGUGAAUUGCUCAACATT,UGUUGAGCAAUUCACGUUCTT,"2-O-Methyl* 2,4-Difluorotoluene* Phosphorothioate",2-O-Methyl* Phosphorothioate,"4,6,10,11,13,14,15,18 * 9 *20","8,13 * 20",0.221,2833,24
2173,IC-50 = 0.503 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,GAACGUGAAUUGCUCAACATT,UGUUGAGCAAUUCACGUUCTT,2-O-Methyl* Phosphorothioate,2-O-Methyl* Phosphorothioate,"4,6,10,11,13,14,15,18 * 20","8,13 * 20",0.503,2832,24
2174,IC-50 = 0.052 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAAGUACUUCGAAA,UCGAAGUACUCAGCGUAAGUG,"Phosphorothioate* 2,4-Difluorotoluene",0,9 * 10,0,0.052,2831,24
2175,IC-50 = 0.056 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGAAA,UCGAAGUACUCAGCGUAAGUG,"2,4-Difluorotoluene",0,10,0,0.056,2830,24
2176,IC-50 = 0.129 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGAAA,UCGAAGUACUCAGCGUAAGUG,2-O-Methyl* Phosphorothioate,0,9,0,0.129,2829,24
2177,IC-50 = 0.146 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGAAA,UCGAAGUACUCAGCGUAAGUG,2-O-Methyl,0,9,0,0.146,2828,24
2178,IC-50 = 0.111 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CUCACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,"Mutation* 2-O-Methyl* Phosphorothioate* 2,4-Difluorotoluene",0,3 * 9 * 9 * 10,0,0.111,2826,24
2179,IC-50 = 0.131 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CUCACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,"Mutation* Phosphorothioate* 2,4-Difluorotoluene",0,3 * 9 * 10,0,0.131,2825,24
2180,IC-50 = 0.336 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CUAACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,Mutation* 2-O-Methyl* Phosphorothioate,0,3 * 9 * 9,0,0.336,2824,24
2181,IC-50 = 0.341 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CCUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,Mutation* 2-O-Methyl,0,2 * 9,0,0.341,2823,24
2182,IC-50 = 0.48 nM for target mRNA,Firefly luciferase assay and chemoluminescent assay,Luciferase gene,0.002 to 8.0 nM,HeLa cells,Lipofectamine 2000,CCUACGCUGAGUACUUCGATT,TCGAAGUACUCAGCGUAAGTT,Mutation* Phosphorothioate,0,2 * 9,0,0.48,2822,24
2287,2.75 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUU,UnLocked nucleic acid,0,20,0,10.0,2705,19
2288,2.56 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,0,"17,21",0,10.0,2704,19
2289,2.55 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Locked nucleic acid,"17,21","20,21",10.0,2703,19
2290,2.9 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"17,21","7 * 20,21",10.0,2702,19
2291,2.87 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"17,21","6 * 20,21",10.0,2701,19
2292,2.8 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUU,ACGUGACACGUUCGGAGAAUUU,0,Locked nucleic acid,0,"20,21",10.0,2700,19
2293,2.78 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUU,ACGUGACACGUUCGGAGAAUUU,0,Unlocked nucleic acid* Locked nucleic acid,0,"7 * 20,22",10.0,2699,19
2294,2.26 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUU,ACGUGACACGUUCGGAGAAUUU,0,Unlocked nucleic acid* Locked nucleic acid,0,"6 * 20,21",10.0,2698,19
2295,2.73 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Locked nucleic acid,20,"20,21",10.0,2697,19
2296,2.75 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,20,"7 * 20,21",10.0,2696,19
2297,2.625 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,20,"6 * 20,21",10.0,2695,19
2298,2.73 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,0,21,0,10.0,2694,19
2299,2.93 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,0,Locked nucleic acid,0,"20,21",10.0,2693,19
2300,2.5 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,0,Unlocked nucleic acid* Locked nucleic acid,0,"7 * 20,21",10.0,2692,19
2301,2.73 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,0,Unlocked nucleic acid* Locked nucleic acid,0,"6 * 20,21",10.0,2691,19
2302,2.93 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Locked nucleic acid,21,"20,21",10.0,2690,19
2303,2.625 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"7 * 20,21",10.0,2689,19
2304,2.75 (log-10 CVB-3 titre pfu/ml),Viral titre,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,CVB-3 at a multiplicity of infection (m.o.i.) of 0.1,UUCUCCGAACGUGUCACGUUUU,ACGUGACACGUUCGGAGAAUUU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,2688,19
2305,70 percent target mRNA inhibition,Luciferase reporter assay,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,Lipofectamine 2000,CUAAGGACCUAACAAAGUUUU,AACUUUGUUAGGUCCUUAGUU,UnLocked nucleic acid,0,"16,18,19",0,10.0,2682,19
2306,60 percent target mRNA inhibition,Luciferase reporter assay,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,Lipofectamine 2000,CUAAGGACCUAACAAAGUUUU,AACUUUGUUAGGUCCUUAGUU,UnLocked nucleic acid,0,19,0,10.0,2681,19
2307,70 percent target mRNA inhibition,Luciferase reporter assay,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,Lipofectamine 2000,CUAAGGACCUAACAAAGUUUU,AACUUUGUUAGGUCCUUAGUU,Locked nucleic acid* UnLocked nucleic acid,0,"1 * 16,18,19",0,10.0,2680,19
2308,74 percent target mRNA inhibition,Luciferase reporter assay,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,Lipofectamine 2000,CUAAGGACCUAACAAAGUUUU,AACUUUGUUAGGUCCUUAGUU,Locked nucleic acid* UnLocked nucleic acid,0,1 * 19,0,10.0,2679,19
2309,64 percent target mRNA inhibition,Luciferase reporter assay,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,Lipofectamine 2000,CUAAGGACCUAACAAAGUUUU,AACUUUGUUAGGUCCUUAGUU,Locked nucleic acid,0,1,0,10.0,2678,19
2310,8 percent target mRNA inhibition,Luciferase reporter assay,RNA dependent RNA polymerase (RdRP) gene of CVB-3,10 nM,Vero and COS7 cells,Lipofectamine 2000,CUAAGGACCUAACAAAGUUUU,AACUUUGUUAGGUCCUUAGUU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,20,"6 * 20,21",10.0,2677,19
2311,56 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,Peptide nucleic acids,21,21,0.1,2673,48
2312,56 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,0,Peptide nucleic acids,0,21,0.1,2672,48
2313,70 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,0,21,0,0.1,2671,48
2314,80 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,Peptide nucleic acids,21,21,1.0,2669,48
2315,79 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,0,Peptide nucleic acids,0,21,1.0,2668,48
2316,80 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,0,21,0,1.0,2667,48
2317,75 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,Peptide nucleic acids,21,21,10.0,2665,48
2318,77 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,0,Peptide nucleic acids,0,21,10.0,2664,48
2319,80 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,0,21,0,10.0,2663,48
2320,81 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,100 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,Peptide nucleic acids,21,21,100.0,2661,48
2321,79 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,100 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,0,Peptide nucleic acids,0,21,100.0,2660,48
2322,82 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,100 nM,HeLa cells,Cationic liposomes,UCGAAGUAUUCCGCGUACGTT,CGUACGCGGAAUACUUCGATT,Peptide nucleic acids,0,21,0,100.0,2659,48
2323,85 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Morpholinouridine,0,16,0,25.0,2657,24
2324,88 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Morpholinouridine,0,15,0,25.0,2656,24
2325,82 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Morpholinouridine,0,12,0,25.0,2655,24
2326,84 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Morpholinouridine,0,8,0,25.0,2654,24
2327,85 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Morpholinouridine,0,3,0,25.0,2653,24
2328,88 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,Morpholinouridine,0,2,0,25.0,2652,24
2329,77 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Morpholinouridine,0,16,25.0,2651,24
2330,13 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Morpholinouridine,0,10,25.0,2650,24
2331,67 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Morpholinouridine,0,7,25.0,2649,24
2332,8 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Morpholinouridine,0,1,25.0,2648,24
2333,91 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGAUU,UCGAAGUACUCAGCGUAAGUU,Morpholinouridine,Morpholinouridine,"20,21","20,21",25.0,2647,24
2334,90 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGUU,0,Morpholinouridine,0,"20,21",25.0,2646,24
2335,86 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGAUU,UCGAAGUACUCAGCGUAAGTT,Morpholinouridine,0,"20,21",0,25.0,2645,24
2336,8 percent target mRNA inhibition,Dual luciferase reporter assay,Human SOD1 gene,20 nM,HEK293 cells and Transgenic mice FVB/NJ background (SOD1-G93A),Lipofectamine 2000,CGAAGUUUGGAUUCAUCAUUC,AUGAUGAAUCCAAACUUCGGC,2-Fluoro* Phosphorothioate,2-Fluoro* Phosphorothioate,"6,19,20 * 1,2,19,20","2,17,18 * 1,19,20",20.0,2643,24
2337,66 percent target mRNA inhibition,Dual luciferase reporter assay,Human SOD1 gene,2 nM,HEK293 cells and Transgenic mice FVB/NJ background (SOD1-G93A),Lipofectamine 2000,CGAUGUGUCUAUUGAAGAUUC,AUCUUCAAUAGACACAUCGGC,2-Fluoro* Phosphorothioate,2-Fluoro* Phosphorothioate,"4,6,19,20 * 1,2,3,17,18,19,20","2,3,4,15,17,18 * 16,17,18,19,20",2.0,2642,24
2338,63 percent target mRNA inhibition,Dual luciferase reporter assay,Human SOD1 gene,0.2 nM,HEK293 cells and Transgenic mice FVB/NJ background (SOD1-G93A),Lipofectamine 2000,CGAUGUGUCUAUUGAAGAUUC,AUCUUCAAUAGACACAUCGGC,2-Fluoro* Phosphorothioate,2-Fluoro* Phosphorothioate,"4,6,19,20 * 1,2,3,17,18,19,20","2,3,4,15,17,18 * 16,17,18,19,20",0.2,2640,24
2339,34 percent target mRNA inhibition,Dual luciferase reporter assay,Human SOD1 gene,0.02 nM,HEK293 cells and Transgenic mice FVB/NJ background (SOD1-G93A),Lipofectamine 2000,CGAUGUGUCUAUUGAAGAUUC,AUCUUCAAUAGACACAUCGGC,2-Fluoro* Phosphorothioate,2-Fluoro* Phosphorothioate,"4,6,19,20 * 1,2,3,17,18,19,20","2,3,4,15,17,18 * 16,17,18,19,20",0.02,2638,24
2340,15 percent target mRNA inhibition,Dual luciferase reporter assay,Human SOD1 gene,0.002 nM,HEK293 cells and Transgenic mice FVB/NJ background (SOD1-G93A),Lipofectamine 2000,CGAUGUGUCUAUUGAAGAUUC,AUCUUCAAUAGACACAUCGGC,2-Fluoro* Phosphorothioate,2-Fluoro* Phosphorothioate,"4,6,19,20 * 1,2,3,17,18,19,20","2,3,4,15,17,18 * 16,17,18,19,20",0.002,2636,24
2341,0 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,TUAAGAUCUGUUAUCCGCAUT,TGCGGAUAACAGAUCUUAAUT,Mutation* 5-O-Methyl,Mutation* 5-O-Methyl,1 * 1,1 * 1,25.0,2634,24
2342,60 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,UUAAGAUCUGUUAUCCGCAUT,TGCGGAUAACAGAUCUUAAUT,0,Mutation* 5-O-Methyl,0,1 * 1,25.0,2633,24
2343,4 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,TUAAGAUCUGUUAUCCGCAUT,UGCGGAUAACAGAUCUUAAUT,Mutation* 5-O-Methyl,0,1 * 1,0,25.0,2632,24
2344,68 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,TUAAGAUCUGUUAUCCGCAUT,TGCGGAUAACAGAUCUUAAUT,Mutation* 5-O-Methyl,Mutation* 5-O-Methyl,1 * 1,1 * 1,25.0,2625,24
2345,76 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,UUAAGAUCUGUUAUCCGCAUT,TGCGGAUAACAGAUCUUAAUT,0,Mutation* 5-O-Methyl,0,1 * 1,25.0,2624,24
2346,83 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,TUAAGAUCUGUUAUCCGCAUT,UGCGGAUAACAGAUCUUAAUT,Mutation* 5-O-Methyl,0,1 * 1,0,25.0,2623,24
2347,61 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,TUAGUCGAAUGCAAGACAAUT,TUGUCUUGCAUUCGACUAAUT,Mutation* 5-O-Methyl,Mutation* 5-O-Methyl,1 * 1,1 * 1,25.0,2621,24
2348,87 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,UUAGUCGAAUGCAAGACAAUT,TUGUCUUGCAUUCGACUAAUT,0,Mutation* 5-O-Methyl,0,1 * 1,25.0,2620,24
2349,54 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,TUAGUCGAAUGCAAGACAAUT,UUGUCUUGCAUUCGACUAAUT,Mutation* 5-O-Methyl,0,1 * 1,0,25.0,2619,24
2350,70 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,TGUACGCGGAAUACUUCGAUU,UCGAAGUAUUCCGCGUACGUU,Mutation* 5-O-Methyl,0,1 * 1,0,25.0,2617,24
2351,20 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,25 nM,HeLa and HEK293 cells,Lipofectamine 2000,CGUACGCGGAAUACUUCGAUU,TCGAAGUAUUCCGCGUACGUU,0,Mutation* 5-O-Methyl,0,1 * 1,25.0,2615,24
2352,34 percent target mRNA inhibition,Northern Blot,EGFP gene,10 nM,H1299 cells,TransIT- TKO,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-O-Guanidinoethyl-ribose,2-O-Aminoethyl-ribose,5,"1,20,21",10.0,2612,24
2353,15 percent target mRNA inhibition,Northern Blot,EGFP gene,10 nM,H1299 cells,TransIT- TKO,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-O-Aminoethyl-ribose,2-O-Aminoethyl-ribose,5,"1,20,21",10.0,2611,24
2354,20 percent target mRNA inhibition,Northern Blot,EGFP gene,10 nM,H1299 cells,TransIT- TKO,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-O-Allyl-ribose,2-O-Aminoethyl-ribose,17,"1,20,21",10.0,2610,24
2355,70 percent target mRNA inhibition,Northern Blot,EGFP gene,10 nM,H1299 cells,TransIT- TKO,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-O-Guanidinoethyl-ribose,2-O-Aminoethyl-ribose,5,"20,21",10.0,2609,24
2356,68 percent target mRNA inhibition,Northern Blot,EGFP gene,10 nM,H1299 cells,TransIT- TKO,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-O-Aminoethyl-ribose,2-O-Aminoethyl-ribose,5,"20,21",10.0,2608,24
2357,73 percent target mRNA inhibition,Northern Blot,EGFP gene,10 nM,H1299 cells,TransIT- TKO,GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-O-Allyl-ribose,2-O-Aminoethyl-ribose,17,"20,21",10.0,2607,24
2358,28 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,17 nM,HeLa cells,Lipofectamine 2000,GCGGAUCAAACCUCACCAATT,UUGGUGAGGUUUGAUCCGCTT,0,Difluorotoluyl nucleotide,0,"10,11,12",17.0,2605,24
2359,75 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,17 nM,HeLa cells,Lipofectamine 2000,GCGGAUCAAACCUCACCAATT,UUGGUGAGGUUUGAUCCGCTT,0,Difluorotoluyl nucleotide,0,12,17.0,2604,24
2360,69 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,17 nM,HeLa cells,Lipofectamine 2000,GCGGAUCAAACCUCACCAATT,UUGGUGAGGUUUGAUCCGCTT,0,Difluorotoluyl nucleotide,0,11,17.0,2603,24
2361,74 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,17 nM,HeLa cells,Lipofectamine 2000,GCGGAUCAAACCUCACCAATT,UUGGUGAGGUUUGAUCCGCTT,0,Difluorotoluyl nucleotide,0,10,17.0,2602,24
2362,2 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Difluorotoluyl nucleotide,0,11,10.0,2598,24
2363,57 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Difluorotoluyl nucleotide,0,10,10.0,2597,24
2364,5 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,Difluorotoluyl nucleotide,0,9,10.0,2596,24
2365,IC-50 = 1.2 nM for target mRNA,Luciferase mRNA Expression analysis,Luciferase gene,0.4 to 30 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,"2,4-Difluorotoluene",0,10,1.2,2591,24
2366,IC-50 (Less than than 30 nM) for target mRNA,Luciferase mRNA Expression analysis,Luciferase gene,0.4 to 30 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,"2,4-Difluorotoluene",0,11,0.4,2590,24
2367,IC-50 (Less than than 30 nM) for target mRNA,Luciferase mRNA Expression analysis,Luciferase gene,0.4 to 30 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,"2,4-Difluorotoluene",0,9,0.4,2589,24
2368,IC-50 = 0.58 nM for target mRNA,Luciferase mRNA Expression analysis,Luciferase gene,0.4 to 30 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,"2,4-Difluorotoluene",0,16,0.58,2588,24
2369,IC-50 = 0.27 nM for target mRNA,Luciferase mRNA Expression analysis,Luciferase gene,0.4 to 30 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,"2,4-Difluorotoluene",0,7,0.27,2587,24
2370,IC-50 = 0.27 nM for target mRNA,Luciferase mRNA Expression analysis,Luciferase gene,0.4 to 30 nM,HeLa cells,Lipofectamine 2000,CUUACGCUGAGUACUUCGATT,UCGAAGUACUCAGCGUAAGTT,0,"2,4-Difluorotoluene",0,1,0.27,2586,24
2371,0 percent target mRNA inhibition,mRNA expression profiling (HG-U133 Plus 2 GeneChips),EGFP gene,0.25 mg/kg/d,MiaPaca II cells,Lipofectamine 2000,GCTGACCCUGAAGTTCAUCTT,GAUGAACUUCAGGGUCAGCTT,Locked nucleic acid,Locked nucleic acid,"1,2,3,7,10,14,15,20,21","20,21",0.25,2584,9
2372,61 percent target mRNA inhibition,mRNA expression profiling (HG-U133 Plus 2 GeneChips),EGFP gene,0.25 mg/kg/d,MiaPaca II cells,Lipofectamine 2000,GCUGACCCUGAAGUUCAUCTT,GAUGAACUUCAGGGUCAGCTT,Locked nucleic acid,Locked nucleic acid,"1,20,21","20,21",0.25,2583,7
2373,69 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,6,7,9,12,13,14,15,16,17,18","2,3,4,5,6,7,8,11,13,14,17,18,20,21",20.0,2579,95
2374,83 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","1,9,10,12,15,16,19",20.0,2578,93
2375,71 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","2,3,4,5,6,7,8,11,13,14,17,18,20,21",20.0,2577,91
2376,62 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,6,7,9,12,13,14,15,16,17,18","1,9,10,12,15,16,19",20.0,2576,89
2377,87 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,0,"2,3,4,5,6,7,8,11,13,14,17,18,20,21",20.0,2575,87
2378,81 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,0,"1,9,10,12,15,16,19",20.0,2574,85
2379,87 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"1,4,5,8,10,11,19,20,21",0,20.0,2573,83
2380,83 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,20 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"2,3,6,7,9,12,13,14,15,16,17,18",0,20.0,2572,81
2381,68 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,6,7,9,12,13,14,15,16,17,18","2,3,4,5,6,7,8,11,13,14,17,18,20,21",5.0,2570,77
2382,80 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","1,9,10,12,15,16,19",5.0,2569,75
2383,81 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","2,3,4,5,6,7,8,11,13,14,17,18,20,21",5.0,2568,73
2384,77 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,6,7,9,12,13,14,15,16,17,18","1,9,10,12,15,16,19",5.0,2567,71
2385,76 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,0,"2,3,4,5,6,7,8,11,13,14,17,18,20,21",5.0,2566,69
2386,78 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,0,"1,9,10,12,15,16,19",5.0,2565,67
2387,82 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"1,4,5,8,10,11,19,20,21",0,5.0,2564,65
2388,64 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,5 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"2,3,6,7,9,12,13,14,15,16,17,18",0,5.0,2563,63
2389,38 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,6,7,9,12,13,14,15,16,17,18","2,3,4,5,6,7,8,11,13,14,17,18,20,21",1.0,2561,59
2390,66 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","1,9,10,12,15,16,19",1.0,2560,57
2391,70 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","2,3,4,5,6,7,8,11,13,14,17,18,20,21",1.0,2559,55
2392,60 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,6,7,9,12,13,14,15,16,17,18","1,9,10,12,15,16,19",1.0,2558,53
2393,55 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,0,"2,3,4,5,6,7,8,11,13,14,17,18,20,21",1.0,2557,51
2394,60 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,0,"1,9,10,12,15,16,19",1.0,2556,49
2395,68 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"1,4,5,8,10,11,19,20,21",0,1.0,2555,47
2396,51 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"2,3,6,7,9,12,13,14,15,16,17,18",0,1.0,2554,45
2397,18 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","2,3,4,5,6,7,8,11,13,14,17,18,20,21",0.1,2552,41
2398,39 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","1,9,10,12,15,16,19",0.1,2551,39
2399,40 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","2,3,4,5,6,7,8,11,13,14,17,18,20,21",0.1,2550,37
2400,28 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,2-Deoxy-2-Fluoro,"2,3,6,7,9,12,13,14,15,16,17,18","1,9,10,12,15,16,19",0.1,2549,35
2401,55 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,"1,4,5,8,10,11,19,20,21","2,3,4,5,6,7,8,11,13,14,17,18,20,21",0.1,2548,33
2402,22 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,0,2-Deoxy-2-Fluoro,0,"1,9,10,12,15,16,19",0.1,2547,31
2403,45 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"1,4,5,8,10,11,19,20,21",0,0.1,2546,29
2404,10 percent target mRNA inhibition,Real-time PCR,Human TRACP 5a and 5b gene,0.1 nM,CHO cells,"Mirus Trans IT TKO (MirusBio, USA)",UGGCCAAUGCCAAGGAGAUUU,AUCUCCUUGGCAUUGGCCAUU,2-Deoxy-2-Fluoro,0,"2,3,6,7,9,12,13,14,15,16,17,18",0,0.1,2545,27
2417,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19,21","1,3,5,7,9,11,13,15,17,19",1.0,2529,48
2418,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"7,8,9,10,11,12,13,14,15","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",1.0,2528,48
2419,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"6,7,8,9,10,16,17,18,19,20,21","7,8,9,10,11,17,18,19,20",1.0,2527,48
2420,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"8,9,10,11,12,13,14,15","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",1.0,2526,48
2421,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"12,13,14,15,16,17,18,19,20,21","12,13,14,15,16,17,18,19,20",1.0,2525,48
2422,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11","1,2,3,4,5,6,7,8,9,10,11",1.0,2524,48
2423,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21",0,1.0,2523,48
2424,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,0,2-O-Methyl,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",1.0,2522,48
2425,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"7,8,9,10,11,12,13,14,15","7,8,9,10,11,12,13,14,15",1.0,2521,48
2426,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"5,6,7,8,9,10,11,12,13,14,15,16,17","5,6,7,8,9,10,11,12,13,14,15,16,17",1.0,2520,48
2427,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,20","3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",1.0,2519,48
2428,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUUUGUUUCUGCUAACG,CGUUAGCAGAAACAAAGGAG,2-O-Methyl,2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20",1.0,2518,48
2429,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUUAGCAGAAACAAAAGGAGTT,CUCCUUUUGUUUCUGCUAACG,2-Deoxythymidine* 5-Amino * 3-Amino,0,"22,23 * 1* 23",0,1.0,2517,48
2430,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUUAGCAGAAACAAAAGGAGTT,CUCCUUUUGUUUCUGCUAACGTT,2-Deoxythymidine* 5-Amino * 3-Amino,2-Deoxythymidine,"22,23 * 1* 23","22,23",1.0,2516,48
2431,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUUAGCAGAAACAAAAGGAGTT,CUCCUUUUGUUUCUGCUAACGTT,2-Deoxythymidine* 5-Amino * 3-Amino,2-Deoxythymidine * 3-Amino,"22,23 * 1* 23","22,23 * 23",1.0,2515,48
2432,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUUAGCAGAAACAAAAGGAGTT,CUCCUUUUGUUUCUGCUAACGTT,2-Deoxythymidine* 5-Amino * 3-Amino,2-Deoxyribonucleotide* Inverted abasic,"22,23 * 1* 23","22,23 * 23",1.0,2514,48
2433,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUUAGCAGAAACAAAAGGAGTT,CUCCUUUUGUUUCUGCUAACGTT,2-Deoxyribonucleotide* Inverted abasic,2-Deoxyribonucleotide* Inverted abasic,"22,23 * 1,23","22,23 * 1,23",1.0,2513,48
2434,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUUAGCAGAAACAAAAGGAGTT,CUCCUUUUGUUUCUGCUAACGTT,2-Deoxythymidine* 5-Amino * 3-Amino,2-Deoxythymidine* 5-Amino * 3-Amino,"22,23 * 1* 23","22,23 * 1* 23",1.0,2512,48
2435,High target mRNA inhibition efficacy,Real-time PCR,Akt gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),GCAGGGGAGUACAUCAACUTT,AGUUGAUGUACUCCCCUGCTT,2-Deoxythymidine (Mutation),2-Deoxythymidine (Mutation),"20,21 (1,2,18,19)","20,21 (1,2,18,19)",1.0,2511,48
2436,High target mRNA inhibition efficacy,Real-time PCR,Akt gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),GGAGGGGAGUACAUCAAGUTT,ACUUGAUGUACUCCCCUCCTT,2-Deoxythymidine (Mutation),2-Deoxythymidine (Mutation),"20,21 (1,19)","20,21 (1,19)",1.0,2510,48
2439,High target mRNA inhibition efficacy,Real-time PCR,p110beta gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),TTUGGAAUGAACCACUGGAAUUU,TTAAAUUCCAGUGGUUCAUUCCA,2-Deoxythymidine,2-Deoxythymidine,"1,2","1,2",1.0,2504,48
2440,Low mRNA target inhibition efficacy,Real-time PCR,p110beta gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),UGGUAUCAAGCUCAGGAAUAUTT,AUAUUCCUGAGCUUGAUACCATT,2-Deoxythymidine (Mutation),2-Deoxythymidine,"22,23 (4,7,10,12,14,20)","22,23",1.0,2502,48
2441,High target mRNA inhibition efficacy,Real-time PCR,p110beta gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),UGGAAUGAACCACUGGAAUUUTT,AAAUUCCAGUGGUUCAUUCCATT,2-Deoxythymidine,2-Deoxythymidine,"22,23","22,23",1.0,2501,48
2442,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),TTCGUGAGCACAAAGAAAAUGAG,TTCUCAUUUUCUUUGUGCUCACG,2-Deoxythymidine (Mutation),2-Deoxythymidine,"1,2 (6,11,15,20)","1,2",1.0,2500,48
2443,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),TTCGUUAGCAGAAACAAAAGGAG,TTCUCCUUUUGUUUCUGCUAACG,2-Deoxythymidine,2-Deoxythymidine,"1,2","1,2",1.0,2499,48
2444,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCAUUTTCTTTGTGCUCACG,CGTTUGCAGAAACAAUUGGUG,2-Deoxyribonucleotide* Inverted abasic (Mutation),0,"7,8,9,10,11,12,13,14,15* 1,21 (4,9,13,18)",0,1.0,2496,48
2445,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CUCCUUTTGTTTCTGCUAACG,CGTTUGCAGAAACAAUUGGUG,2-Deoxyribonucleotide,0,"7,8,9,10,11,12,13,14,15",0,1.0,2495,48
2446,Low mRNA target inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUGAGCACAAAGAAAAUGAGTT,CUCAUUUUCUUUGUGCUCACGTT,2-Deoxythymidine (Mutation),2-Deoxythymidine (Mutation),"22,23 (4,9,13,18)","22,23 (4,9,13,18)",1.0,2494,48
2447,High target mRNA inhibition efficacy,Real-time PCR,Human PTEN gene,1 to 40 nM,HeLa cells,Oligofectamine (Invitrogen),CGUUAGCAGAAACAAAAGGAGTT,CUCCUUUUGUUUCUGCUAACGTT,2-Deoxythymidine,2-Deoxythymidine,"22,23","22,23",1.0,2493,48
2448,72 percent target mRNA inhibition,Real-time PCR,5'UTR Enterovirus 71,50 nM,Rhabdomyosarcoma cells,Lipofectamine 2000,CAGAGCAAUUGUUUACCUATT,UAGGUAAACAAUUGCUCUGTT,2-Fluoro,2-Fluoro,"1,6,9,10,12,13,14,16,17,18","1,5,9,12,13,15,16,17",50.0,2491,6
2449,75 percent target mRNA inhibition,Real-time PCR,5'UTR Enterovirus 71,50 nM,Rhabdomyosarcoma cells,Lipofectamine 2000,CAGAGCAAUUGUUUACCUATT,UAGGUAAACAAUUGCUCUGTT,2-O-Methyl,2-O-Methyl,"1,6,9,10,12,13,14,16,17,18","1,5,9,12,13,15,16,17",50.0,2490,6
2450,71 percent target mRNA inhibition,Real-time PCR,5'UTR Enterovirus 71,50 nM,Rhabdomyosarcoma cells,Lipofectamine 2000,CAGCAAACCACGAUCAAUATT,UAUUGAUCGUGGUUUGCUGTT,2-Fluoro,2-Fluoro,"1,4,8,9,11,14,15,18","1,3,4,7,8,10,13,14,15,17,18",50.0,2488,6
2451,5 percent target mRNA inhibition,Real-time PCR,5'UTR Enterovirus 71,50 nM,Rhabdomyosarcoma cells,Lipofectamine 2000,CAGCAAACCACGAUCAAUATT,UAUUGAUCGUGGUUUGCUGTT,2-O-Methyl,2-O-Methyl,"1,4,8,9,11,14,15,18","1,3,4,7,8,10,13,14,15,17,18",50.0,2487,6
2452,High target target mRNA inhibition efficacy,mRNA analysis,Apolipoprotein B gene,2 μg/mL,C57BL/6J mice,Polyethylenimine-pullulan,GTCATCACACUGAATACCAAUTT,AUUGGUAUUCAGUGUGAUGACTT,Locked nucleic acid,"2,4-Locked nucleic acid","1,2,5,15,18,22,23","22,23",2.0,2485,73
2453,83 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Locked nucleic acid,0,"1,20,21",0,1.0,2484,48
2454,86 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Locked nucleic acid,0,1,0,1.0,2483,48
2455,87 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Pyrene modification,0,1,0,1.0,2482,48
2456,87 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Naphthalene modification,0,1,0,1.0,2481,48
2457,90 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Hydroxyphenyl-Conjugated,0,1,0,1.0,2480,48
2458,92 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,Phenyl,0,1,0,1.0,2479,48
2459,13 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Cholesterol* 2-O-Methyl* Fluorouridine* Phosphorothioate,2-O-Methyl* Phosphorothioate,"1 * 1,2,3 * 15,16,17 * 19","2,8,16 * 21",33.0,2477,48
2460,43 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Cholesterol* 2-O-Methyl* Fluorouridine* Phosphorothioate,2-O-Methyl* Phosphorothioate,"1 * 1,2,3 * 15,16,17 * 19","16 * 9,15,16,17,18,19,21",33.0,2476,48
2461,52 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Cholesterol* Fluorouridine* Phosphorothioate,0,"1 * 6,11,15,16,17 * 2,3,19",0,33.0,2475,48
2462,43 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Cholesterol* Fluorouridine* Phosphorothioate,0,"1 * 15,16,17 * 1,2,19",0,33.0,2474,48
2463,37 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Cholesterol* Fluorouridine* Phosphorothioate,0,"1 * 6,11,15,16,17 *19",0,33.0,2473,48
2464,58 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Cholesterol* 2-O-Methyl* Fluorouridine* Phosphorothioate,0,"1 * 1,2,3 * 15,16,17 * 19",0,33.0,2472,48
2465,48 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Cholesterol* Fluorouridine* Phosphorothioate,0,"1 * 2,3,4,14,15,16,17 * 15,16,17",0,33.0,2471,48
2466,14 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,CUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Assymetric siRNA (3-End Overhang),Assymetric siRNA (3-End Overhang),15,1,33.0,2470,48
2467,10 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Assymetric siRNA (3-End Overhang),Assymetric siRNA (3-End Overhang),16,1,33.0,2469,48
2468,16 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Assymetric siRNA (3-End Overhang),Assymetric siRNA (3-End Overhang),17,1,33.0,2468,48
2469,18 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,AGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Assymetric siRNA (3-End Overhang),Assymetric siRNA (3-End Overhang),18,1,33.0,2467,48
2470,74 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,GAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Assymetric siRNA (3-End Overhang),Assymetric siRNA (3-End Overhang),19,1,33.0,2466,48
2471,60 percent target mRNA inhibition,Real-time PCR,Bcl-2 gene,33 nM,HeLa B2 cells,Lipofectamine 2000,CGGAGGCUGGGAUGCCUUUTT,AAAGGCAUCCCAGCCUCCGTT,Assymetric siRNA (3-End Overhang),Assymetric siRNA (3-End Overhang),21,1,33.0,2465,48
2472,72 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACA CUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 19",3.0,2464,340
2473,87 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACA CUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 15",3.0,2463,339
2474,87 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 8",3.0,2462,338
2475,78 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 5",3.0,2461,337
2476,64 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl,"20,21 * 1,21","20,21",3.0,2460,336
2477,92 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 19",3.0,2459,72
2478,97 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 15",3.0,2458,72
2479,96 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 8",3.0,2457,72
2480,94 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl* 2-O-Benzyl,"20,21 * 1,21","20,21 * 5",3.0,2456,72
2481,91 percent target mRNA inhibition,Real-time PCR,Apolipoprotein B gene,3 mg/kg,C57BL/6 mice,Lipid and siRNA injected,CAAGUGUCAUCACACUGAAUU,UUCAGUGUGAUGACACUUGUU,2-O-Methyl* Inverted abasic,2-O-Methyl,"20,21 * 1,21","20,21",3.0,2455,72
2482,IC-50 = 0.027 nM for target mRNA,PAGE non-denaturating,Luciferase gene,0.028 nM,SH-SY5Y and MCF-7 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAAA,UUUUUCUCCUUCUUCAGAUA,N6-ethyl-N6 2-Deoxyadenosine,N6-Ethyl-N6 2-Deoxyadenosine,20,20,0.027,2453,24
2483,IC-50 = 0.033 nM for target mRNA,PAGE non-denaturating,Luciferase gene,0.033 nM,SH-SY5Y and MCF-7 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAAC,UUUUUCUCCUUCUUCAGAUC,N4-Ethyl-N4 2-Deoxy-5-Methylcytidine,N4-Ethyl-N4 2-Deoxy-5-Methylcytidine,20,20,0.033,2452,24
2484,IC-50 = 0.028 nM for target mRNA,PAGE non-denaturating,Luciferase gene,0.028 nM,SH-SY5Y and MCF-7 cells,Lipofectamine 2000,CAUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUA,0,N6-Ethyl-N6 2-Deoxyadenosine,0,20,0.028,2451,24
2485,IC-50 = 0.03 nM for target mRNA,PAGE non-denaturating,Luciferase gene,0.030 nM,SH-SY5Y and MCF-7 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUC,0,N4-Ethyl-N4 2-Deoxy-5-Methylcytidine,0,20,0.03,2450,24
2486,IC-50 = 0.013 nM for target mRNA,PAGE non-denaturating,Luciferase gene,0.013 nM,SH-SY5Y and MCF-7 cells,Lipofectamine 2000,CAUCUGAAGAAGGAGAAAAAA,UUUUUCUCCUUCUUCAGAUTT,N6-Ethyl-N6 2-Deoxyadenosine,0,20,0,0.013,2449,24
2487,IC-50 = 0.013 nM for target mRNA,PAGE non-denaturating,Luciferase gene,0.013 nM,SH-SY5Y and MCF-7 cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAAC,UUUUUCUCCUUCUUCAGAUTT,N4-Ethyl-N4 2-Deoxy-5-Methylcytidine,0,2,0,0.013,2448,24
2488,5 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase antisense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUACUGCCAAUCUCUAGGUUUUU,CCUAGAGAUUGGCAGUAUCCAAAAA,Deoxyadenine* Mismatch,Deoxyadenine* Mismatch,"21,22,23,24,25 * 6,9,12,16","21,22,23,24,25 * 5,9,12,15",1.0,2446,24
2489,60 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase antisense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCUUUUU,5-Fluoro-2-Deoxyuridine,5-Fluoro-2-Deoxyuridine,"21,22,23,24,25","21,22,23,24,25",1.0,2445,24
2490,54 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase antisense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGAAAAA,CCUAAAGACUGACAAUAUCCUUUUU,Deoxyadenine,5-Fluoro-2-Deoxyuridine,"21,22,23,24,25","21,22,23,24,25",1.0,2444,24
2491,83 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase antisense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,5-Fluoro-2-Deoxyuridine,Deoxyadenine,"21,22,23,24,25","21,22,23,24,25",1.0,2443,24
2492,80 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase antisense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,Deoxyuridine,Deoxyadenine,"21,22,23,24,25","21,22,23,24,25",1.0,2442,24
2493,0 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase sense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUACUGCCAAUCUCUAGGUUUUU,CCUAGAGAUUGGCAGUAUCCAAAAA,Deoxyadenine* Mismatch,Deoxyadenine* Mismatch,"21,22,23,24,25 * 6,9,12,16","21,22,23,24,25 * 5,9,12,15",1.0,2440,24
2494,35 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase sense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCUUUUU,5-Fluoro-2-Deoxyuridine,5-Fluoro-2-Deoxyuridine,"21,22,23,24,25","21,22,23,24,25",1.0,2439,24
2495,68 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase sense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGAAAAA,CCUAAAGACUGACAAUAUCCUUUUU,Deoxyadenine,5-Fluoro-2-Deoxyuridine,"21,22,23,24,25","21,22,23,24,25",1.0,2438,24
2496,15 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase sense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,5-Fluoro-2-Deoxyuridine,Deoxyadenine,"21,22,23,24,25","21,22,23,24,25",1.0,2437,24
2497,13 percent target mRNA inhibition,Dual Luciferase reporter assay,Firefly luciferase sense strand,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,Deoxyuridine,Deoxyadenine,"21,22,23,24,25","21,22,23,24,25",1.0,2436,24
2498,0 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUACUGCCAAUCUCUAGGUUUUU,CCUAGAGAUUGGCAGUAUCCAAAAA,5-Fluoro-2-Deoxyuridine* Mismatch,5-Fluoro-2-Deoxyuridine* Mismatch,"21,22,23,24,25 * 6,9,12,16","21,22,23,24,25 * 5,9,12,15",1.0,2434,24
2499,0 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUACUGCCAAUCUCUAGGUUUUU,CCUAGAGAUUGGCAGUAUCCAAAAA,Deoxyadenine* Mismatch,Deoxyadenine* Mismatch,"21,22,23,24,25 * 6,9,12,16","21,22,23,24,25 * 5,9,12,15",1.0,2433,24
2502,25 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,Deoxyuridine,5-Fluoro-2-Deoxyuridine* Deoxyadenine,"21,22,23,24,25","16,18 * 21,22,23,24,25",1.0,2430,24
2503,0 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,Deoxyuridine,5-Fluoro-2-Deoxyuridine* Deoxyadenine,"21,22,23,24,25","10,16,18 * 21,22,23,24,25",1.0,2429,24
2505,31 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGAAAAA,CCUAAAGACUGACAAUAUCCUUUUU,Deoxyadenine,5-Fluoro-2-Deoxyuridine,"21,22,23,24,25","21,22,23,24,25",1.0,2427,24
2506,62 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,5-Fluoro-2-Deoxyuridine,Deoxyadenine,"21,22,23,24,25","21,22,23,24,25",1.0,2426,24
2508,62 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,5-Fluoro-2-Deoxyuridine* Deoxyuridine,Deoxyadenine,"4 * 21,22,23,24,25","21,22,23,24,25",1.0,2424,24
2509,62 percent target mRNA inhibition,Real-time quantitative PCR,Thymidylate synthase gene,1 nM,RKO cells,Lipofectamine 2000,GGAUAUUGUCAGUCUUUAGGUUUUU,CCUAAAGACUGACAAUAUCCAAAAA,Deoxyuridine,Deoxyadenine,"21,22,23,24,25","21,22,23,24,25",1.0,2423,24
2510,78 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,0.1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,Boron cluster,3,20,0.1,2421,24
2511,58 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,0.1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,Boron cluster,20,20,0.1,2420,24
2512,85 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,0.1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,0,Boron cluster,0,20,0.1,2419,24
2513,83 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,0.1 nM,HeLa cells,Lipofectamine 2000,AATCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,0,3,0,0.1,2418,24
2514,46 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,0.1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,0,20,0,0.1,2417,24
2515,97 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,Boron cluster,3,20,1.0,2415,24
2516,92 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,Boron cluster,20,20,1.0,2414,24
2517,95 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,0,Boron cluster,0,20,1.0,2413,24
2518,97 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,1 nM,HeLa cells,Lipofectamine 2000,AATCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,0,3,0,1.0,2412,24
2519,94 percent target mRNA inhibition,Dual fluorescence assay,BACE1 gene,1 nM,HeLa cells,Lipofectamine 2000,AAUCAGACAAGUUCUUCAUTT,AUGAAGAACUUGUCUGAUUTT,Boron cluster,0,20,0,1.0,2411,24
2520,0 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,L-Isonucleoside uracil* 2-Deoxythymidine,"20,21","12* 20,21",10.0,2409,24
2521,26 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,D-Isonucleoside uracil* 2-Deoxythymidine,"20,21","12* 20,21",10.0,2408,24
2522,29 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,L-Isonucleoside adenosine* 2-Deoxythymidine,"20,21","11* 20,21",10.0,2407,24
2523,4 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,D-Isonucleoside adenosine* 2-Deoxythymidine,"20,21","11* 20,21",10.0,2406,24
2524,0 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,L-Isonucleoside uracil* 2-Deoxythymidine,"20,21","5* 20,21",10.0,2405,24
2525,27 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,D-Isonucleoside uracil* 2-Deoxythymidine,"20,21","5* 20,21",10.0,2404,24
2526,40 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,L-Isonucleoside adenosine* 2-Deoxythymidine,"20,21","4* 20,21",10.0,2403,24
2527,31 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,D-Isonucleoside adenosine* 2-Deoxythymidine,"20,21","4* 20,21",10.0,2402,24
2528,63 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,L-Isonucleoside adenosine* 2-Deoxythymidine,"20,21","1* 20,21",10.0,2401,24
2529,63 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,D-Isonucleoside adenosine* 2-Deoxythymidine,"20,21","1* 20,21",10.0,2400,24
2530,0 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,L-Isonucleoside uracil* 2-Deoxythymidine,2-Deoxythymidine,"19* 20,21","20,21",10.0,2399,24
2531,0 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,D-Isonucleoside-uracil* 2-Deoxythymidine,2-Deoxythymidine,"19* 20,21","20,21",10.0,2398,24
2532,0 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,L-Isonucleoside adenosine* 2-Deoxythymidine,2-Deoxythymidine,"15* 20,21","20,21",10.0,2397,24
2533,0 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,D-Isonucleoside adenosine* 2-Deoxythymidine,2-Deoxythymidine,"15* 20,21","20,21",10.0,2396,24
2534,10 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,L-Isonucleoside uracil* 2-Deoxythymidine,2-Deoxythymidine,"9* 20,21","20,21",10.0,2395,24
2535,31 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,D-Isonucleoside uracil* 2-Deoxythymidine,2-Deoxythymidine,"9* 20,21","20,21",10.0,2394,24
2536,22 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,L-Isonucleoside adenosine* 2-Deoxythymidine,2-Deoxythymidine,"8* 20,21","20,21",10.0,2393,24
2537,89 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,D-Isonucleoside adenosine* 2-Deoxythymidine,2-Deoxythymidine,"8* 20,21","20,21",10.0,2392,24
2538,40 percent target mRNA inhibition,Dual luciferase reporter assay,MEK1 gene,10 nM,HEK293 cells,Lipofectamine 2000,GCAACUCAUGGUUCAUGCUTT,AGCAUGAACCAUGAGUUGCTT,2-Deoxythymidine,2-Deoxythymidine,0,"20,21",10.0,2391,24
2539,70 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTTY,CAUGGUCUCGACGAAGAAGTTY,Glucosamine analogue,Glucosamine analogue,22,22,10.0,2390,24
2540,75 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTTX,CAUGGUCUCGACGAAGAAGTTX,Thymidine analogue,Thymidine analogue,22,22,10.0,2389,24
2541,68 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTY,CAUGGUCUCGACGAAGAAGTY,Glucosamine analogue,Glucosamine analogue,21,21,10.0,2388,24
2542,83 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTX,CAUGGUCUCGACGAAGAAGTX,Thymidine analogue,Thymidine analogue,21,21,10.0,2387,24
2543,75 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGY,CAUGGUCUCGACGAAGAAGY,Glucosamine analogue,Glucosamine analogue,20,20,10.0,2386,24
2544,78 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,10 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGX,CAUGGUCUCGACGAAGAAGX,Thymidine analogue,Thymidine analogue,20,20,10.0,2385,24
2545,39 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTTY,CAUGGUCUCGACGAAGAAGTTY,Glucosamine analogue,Glucosamine analogue,22,22,1.0,2383,24
2546,24 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTTX,CAUGGUCUCGACGAAGAAGTTX,Thymidine analogue,Thymidine analogue,22,22,1.0,2382,24
2547,53 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTY,CAUGGUCUCGACGAAGAAGTY,Glucosamine analogue,Glucosamine analogue,21,21,1.0,2381,24
2548,34 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTX,CAUGGUCUCGACGAAGAAGTX,Thymidine analogue,Thymidine analogue,21,21,1.0,2380,24
2549,55 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGY,CAUGGUCUCGACGAAGAAGY,Glucosamine analogue,Glucosamine analogue,20,20,1.0,2379,24
2550,42 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGX,CAUGGUCUCGACGAAGAAGX,Thymidine analogue,Thymidine analogue,20,20,1.0,2378,24
2551,22 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTTY,CAUGGUCUCGACGAAGAAGTTY,Glucosamine analogue,Glucosamine analogue,22,22,0.1,2376,24
2552,11 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTTX,CAUGGUCUCGACGAAGAAGTTX,Thymidine analogue,Thymidine analogue,22,22,0.1,2375,24
2553,13 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTY,CAUGGUCUCGACGAAGAAGTY,Glucosamine analogue,Glucosamine analogue,21,21,0.1,2374,24
2554,15 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGTX,CAUGGUCUCGACGAAGAAGTX,Thymidine analogue,Thymidine analogue,21,21,0.1,2373,24
2555,15 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGY,CAUGGUCUCGACGAAGAAGY,Glucosamine analogue,Glucosamine analogue,20,20,0.1,2372,24
2556,0 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,0.1 nM,HeLa cells,TransFast (Promega),CUUCUUCGUCGAGACCAUGX,CAUGGUCUCGACGAAGAAGX,Thymidine analogue,Thymidine analogue,20,20,0.1,2371,24
2557,93 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,21,10.0,2369,48
2558,93 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,20,10.0,2368,48
2559,93 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,19,10.0,2367,48
2560,93 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,18,10.0,2366,48
2561,93 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,17,10.0,2365,48
2562,86 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,16,10.0,2364,48
2563,92 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,15,10.0,2363,48
2564,92 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,14,10.0,2362,48
2565,84 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,13,10.0,2361,48
2566,88 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,12,10.0,2360,48
2567,88 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,11,10.0,2359,48
2568,93 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,10,10.0,2358,48
2569,90 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,9,10.0,2357,48
2570,92 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,8,10.0,2356,48
2571,92 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,7,10.0,2355,48
2572,94 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,6,10.0,2354,48
2573,93 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,5,10.0,2353,48
2574,92 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,4,10.0,2352,48
2575,91 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,3,10.0,2351,48
2576,94 percent target mRNA inhibition,Luciferase reporter assay,HBx gene of hepatitis B virus,10 nM,Huh7 cells,Lipofectamine 2000,ACCUUGAGGCAUACUUCAATT,UUGAAGUAUGCCUCAAGGUCG,0,2-O-Guanidinopropyl,0,2,10.0,2350,48
2577,78 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.8 nM,HeLa and HuH-cells,Lipofectamine 2009,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,Dodecyl derivative,0,1,0,0.8,2347,24
2578,79 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.8 nM,HeLa and HuH-cells,Lipofectamine 2007,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,"12-[(2,3,4,6-Tetra-O-methyl-b-D-glucopyranosyloxy)]dodecyl (2-cyanoethyl) (N,N-diisopropyl) phosphoramidite derivative",0,1,0,0.8,2346,24
2579,89 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.8 nM,HeLa and HuH-cells,Lipofectamine 2005,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,"12-Hydroxydodecyl 2,3,4,6-Tetra-O-Methyl-b-D-Glucopyranoside",0,1,0,0.8,2345,24
2580,91 percent target mRNA inhibition,Luciferase reporter assay,Luciferase gene,0.8 nM,HeLa and HuH-cells,Lipofectamine 2003,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,"2-Hydroxyethyl 2,3,4,6-tetra-O-Methyl-b-D-Glucopyranoside",0,1,0,0.8,2344,24
2581,0 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,2-Deoxythymidine,Aminoisonucleotide-thymidine* Aminoisonucleotide-adenine* 2-Deoxythymidine,"20,21","1,20* 8,15 * 21",13.0,2342,45
2582,13 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,2-Deoxythymidine,Aminoisonucleotide-thymidine* Aminoisonucleotide-adenine* 2-Deoxythymidine,"20,21",1* 20* 21,13.0,2341,43
2583,2 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,2-Deoxythymidine,Aminoisonucleotide-Adenine* 2-Deoxythymidine,"20,21","8* 20,21",13.0,2340,41
2584,50 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,2-Deoxythymidine,Aminoisonucleotide-Adenine* 2-Deoxythymidine,"20,21","18* 20,21",13.0,2339,39
2585,39 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,2-Deoxythymidine,Aminoisonucleotide-Adenine* 2-Deoxythymidine,"20,21","1* 20,21",13.0,2338,37
2586,39 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CTGGUAAAGCAUUCAGUATT,AUACUGAAUGCUUUACCAGTT,Aminoisonucleotide-thymidine* Aminoisonucleotide-Adenine* 2-Deoxythymidine,2-Deoxythymidine,"2,20* 6,15* 21","20,21",13.0,2337,35
2587,62 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CTGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,Aminoisonucleotide-thymidine* 2-Deoxythymidine,2-Deoxythymidine,"2,20* 21","20,21",13.0,2336,33
2588,78 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,Aminoisonucleotide-Adenine* 2-Deoxythymidine,2-Deoxythymidine,"8* 20,21","20,21",13.0,2335,31
2589,83 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CTGGUAAAGCAUUCAGUATTT,AUACUGAAUGCUUUACCAGTT,Aminoisonucleotide-thymidine* 2-Deoxythymidine,2-Deoxythymidine,"2* 20,21","20,21",13.0,2334,29
2590,85 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUATT,AUACUGAAUGCUUUACCAGTT,Aminoisonucleotide-thymidine* 2-Deoxythymidine,2-Deoxythymidine,"19* 20,21","20,21",13.0,2333,27
2591,82 percent target mRNA inhibition,Dual luciferase reporter assay,Luciferase gene,13 nM,HEK293 cells,Lipofectamine 2000,CUGGUAAAGCAUUCAGUAUTT,AUACUGAAUGCUUUACCAGTT,2-Deoxythymidine,2-Deoxythymidine,"20,21","20,21",13.0,2332,25
2592,81 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AUACAGGCAGCAGUAACUUUTT,AAAGUUACUGCUGCCUGUAUTT,Pseudouridine* Dihydrouridine,Pseudouridine,2 * 20,"18,20",1.0,2331,36
2593,77 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AUACAGGCAGCAGUAACUUUTT,AAAGUUACUGCUGCCUGUAUTT,Pseudouridine* Dihydrouridine,Pseudouridine,2 * 20,20,1.0,2330,36
2594,81 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AUACAGGCAGCAGUAACUUUTT,AAAGUUACUGCUGCCUGUAUTT,Dihydrouridine,Pseudouridine,20,"18,20",1.0,2329,36
2595,77 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AUACAGGCAGCAGUAACUUUTT,AAAGUUACUGCUGCCUGUAUTT,Dihydrouridine,Pseudouridine,20,20,1.0,2328,36
2596,82 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AGCUUUGUGGAGAUGGUGGTT,AAAGUUACUGCUGCCUGUAUTT,Pseudouridine* Dihydrouridine,0,2 * 20,0,1.0,2327,36
2597,76 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AUACAGGCAGCAGUAACUUUTT,AAAGUUACUGCUGCCUGUAUTT,0,2-Thiouridine,0,"18, 20",1.0,2326,36
2598,71 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AUACAGGCAGCAGUAACUUUTT,AAAGUUACUGCUGCCUGUAUTT,Dihydrouridine,0,20,0,1.0,2325,36
2599,72 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,AUACAGGCAGCAGUAACUUUTT,AAAGUUACUGCUGCCUGUAUTT,0,2-Thiouridine,0,20,1.0,2324,36
2600,67 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,5 nM,HeLa cells,Lipofectamine 2000,AGCUUUGUGGAGAUGGUGGTT,CCACCAUCUCCACAAAGCUTT,0,Wobble Base Pair* 2-Thiouridine,0,8 * 9,5.0,2322,36
2601,29 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,5 nM,HeLa cells,Lipofectamine 2000,AGCUUUGUGGAGAUGGUGGTT,CCACCAUCUCCACAAAGCUTT,0,Wobble Base Pair,0,8,5.0,2321,36
2602,20 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,20 nM,HeLa cells,Lipofectamine 2000,GAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,2-Thiouridine,0,"4,7,10,13,14",20.0,2319,36
2603,88 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,20 nM,HeLa cells,Lipofectamine 2000,AUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,2-Thiouridine,0,"4,7,10,13,17,19",20.0,2318,36
2604,89 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,20 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,2-Thiouridine,0,"4,7,10,13,14,17,19",20.0,2317,36
2605,87 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,Dihydrouridine,2-Thiouridine,19,10,1.0,2313,36
2606,89 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,Dihydrouridine,Pseudouridine,19,10,1.0,2312,36
2607,92 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,Dihydrouridine,2-Thiouridine,19,19,1.0,2311,36
2608,90 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,Dihydrouridine,Pseudouridine,19,19,1.0,2310,36
2609,81 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,Wobble Base Pair* 2-Thiouridine,0,9 * 10,1.0,2309,36
2610,60 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,Wobble Base Pair,0,9,1.0,2308,36
2611,86 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,2-Thiouridine,0,10,1.0,2307,36
2612,69 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,Pseudouridine,0,10,1.0,2306,36
2613,60 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,Dihydrouridine,0,10,1.0,2305,36
2614,91 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,2-Thiouridine,0,19,1.0,2304,36
2615,86 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,Pseudouridine,0,19,1.0,2303,36
2616,61 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,0,Dihydrouridine,0,19,1.0,2302,36
2617,76 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,2-Thiouridine,0,19,0,1.0,2301,36
2618,70 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,Pseudouridine,0,19,0,1.0,2300,36
2619,84 percent target mRNA inhibition,Dual fluorescence assay,EGFP gene,1 nM,HeLa cells,Lipofectamine 2000,ACAUGAAGCAGCACGACUUTT,AAGUCGUGCUGCUUCAUGUTT,Dihydrouridine,0,19,0,1.0,2299,36
2620,0 percent target mRNA inhibition,Real-time PCR,Human PTEN gene,1 nM,HeLa cells,Lipofectin (Invitrogen),GGGAAAGUAUCUUGUUUAU,AUAAACAAGAUACUUUCCC,2-Fluoro* 2-O-Methyl,2-O-Methyl* 2-Fluoro,"1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18","1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18",1.0,2298,20
2621,83 percent target mRNA inhibition,Real-time PCR,Human PTEN gene,1 nM,HeLa cells,Lipofectin (Invitrogen),GGGUAAAUACAUUCUUCAU,AUGAAGAAUGUAUUUACCC,2-Fluoro* 2-O-Methyl* 5-Phosphate,2-O-Methyl* 2-Fluoro* 5-Phosphate,"1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18 * 1","1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18 * 1",1.0,2297,20
2622,85 percent target mRNA inhibition,Real-time PCR,Human PTEN gene,1 nM,HeLa cells,Lipofectin (Invitrogen),GGGUAAAUACAUUCUUCAU,AUGAAGAAUGUAUUUACCC,2-Fluoro* 2-O-Methyl,2-O-Methyl* 2-Fluoro,"1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18","1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18",1.0,2296,20
2623,0 percent target mRNA inhibition,Real-time PCR,Human PTEN gene,1 nM,HeLa cells,Lipofectin (Invitrogen),AAGCAACGAGAAGCGAUAA,UUAUCGCUUCUCGUUGCUU,2-Fluoro* 2-O-Methyl,2-O-Methyl* 2-Fluoro,"1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18","1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18",1.0,2295,20
2624,75 percent target mRNA inhibition ( IC-50 = 0.068 nM),Real-time PCR,Human PTEN gene,1 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,2-Fluoro* 2-O-Methyl* 5-Phosphate,2-O-Methyl* 2-Fluoro* 5-Phosphate,"1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18 * 1","1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18 * 1",1.0,2294,20
2625,71 percent target mRNA inhibition (IC-50 = 0.31 nM),Real-time PCR,Human PTEN gene,1 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,2-Fluoro* 2-O-Methyl,2-O-Methyl* 2-Fluoro,"1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18","1,3,5,7,9,11,13,15,17,19 * 2,4,6,8,10,12,14,16,18",1.0,2293,20
2626,IC-50 = 0.15 nM for target mRNA,mRNA analysis,Human PTEN gene,0.15 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,4-Thioribose* 2-O-Methyl,"1,2,18,19","1,2 * 17,18,19",0.15,2286,63
2627,IC-50 = 1.9 nM for target mRNA,mRNA analysis,Human PTEN gene,1.9 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,4-Thioribose* 2-O-Methyl,"4,10,11,17","1,2 * 17,18,19",1.9,2285,61
2628,IC-50 = 0.2 nM for target mRNA,mRNA analysis,Human PTEN gene,0.2 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,2-O-(2-Methoxyethyl),4-Thioribose* 2-O-Methyl,"1,2,3,17,18,19","1,2 * 17,18,19",0.2,2284,59
2629,IC-50 = 0.78 nM for target mRNA,mRNA analysis,Human PTEN gene,0.78 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,0,4-Thioribose* 2-O-Methyl,0,"1,2 * 17,18,19",0.78,2283,57
2630,IC-50 = 0.66 nM for target mRNA,mRNA analysis,Human PTEN gene,0.66 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,2-O-(2-Methoxyethyl),4-Thioribose,"1,2,3,17,18,19","1,2,18,19",0.66,2282,55
2631,IC-50 = 0.58 nM for target mRNA,mRNA analysis,Human PTEN gene,0.58 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,2-O-(2-Methoxyethyl),0,"1,2,3,17,18,19",0,0.58,2281,53
2632,IC-50 = 0.21 nM for target mRNA,mRNA analysis,Human PTEN gene,0.21 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,4-Thioribose,"1,2,18,19","1,2,18,19",0.21,2280,51
2633,IC-50 = 1.7 nM for target mRNA,mRNA analysis,Human PTEN gene,1.7 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,4-Thioribose,"4,10,11,17","1,2,18,19",1.7,2279,49
2634,IC-50 = 1.4 nM for target mRNA,mRNA analysis,Human PTEN gene,1.4 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,Phosphorothioate,"1,2,18,19","2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18",1.4,2278,47
2635,IC-50 = 2.4 nM for target mRNA,mRNA analysis,Human PTEN gene,2.4 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,Phosphorothioate,"4,10,11,17","2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18",2.4,2277,45
2636,IC-50 = 0.28 nM for target mRNA,mRNA analysis,Human PTEN gene,0.28 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,0,"1,2,18,19",0,0.28,2276,43
2637,IC-50 = 1.1 nM for target mRNA,mRNA analysis,Human PTEN gene,1.1 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,4-Thioribose,0,"4,10,11,17",0,1.1,2275,41
2638,IC-50 = 1.2 nM for target mRNA,mRNA analysis,Human PTEN gene,1.2 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAA,UUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"1,2,18,19",1.2,2274,39
2639,IC-50 = 5.9 nM for target mRNA,mRNA analysis,Human PTEN gene,5.9 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"1,2,3,5,16,18,19,20",5.9,2272,35
2640,IC-50 = 0.45 nM for target mRNA,mRNA analysis,Human PTEN gene,0.45 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"1,2,3",0.45,2271,33
2641,IC-50 = 41.5 nM for target mRNA,mRNA analysis,Human PTEN gene,41.5 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"7,8,9",41.5,2270,31
2642,IC-50 = 0.24 nM for target mRNA,mRNA analysis,Human PTEN gene,0.24 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,20,0.24,2269,29
2643,IC-50 = 1.1 nM for target mRNA,mRNA analysis,Human PTEN gene,1.1 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"16,18,19,20",1.1,2268,27
2644,IC-50 = 0.48 nM for target mRNA,mRNA analysis,Human PTEN gene,0.48 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"12,13,14",0.48,2267,25
2645,IC-50 = 14 nM for target mRNA,mRNA analysis,Human PTEN gene,14 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"13,14,15",14.0,2266,23
2646,IC-50 = 0.088 nM for target mRNA,mRNA analysis,Human PTEN gene,0.088 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,4-Thioribose,0,"18,19,20",0.088,2265,21
2647,IC-50 = 1.6 nM for target mRNA,mRNA analysis,Human PTEN gene,1.6 nM,HeLa cells,Lipofectin (Invitrogen),AAGUAAGGACCAGAGACAAA,UUUGUCUCUGGUCCUUACUU,0,Phosphorothioate,0,"2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",1.6,2263,17
2648,77 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-Fluoro* Inverted DeoxyThymidine,"8,9,12,14,15,16,17,18","1,7,9,10,13,14,15,16,17,18,19 *21",2.0,2262,24
2649,74 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"8,9,12,14,15,16,17,18","1,7,13,14,15,16,17,18,19",2.0,2261,24
2650,53 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"8,9,12,14,15,16,17,18","1,7,13,14,15,16,17,18,19",2.0,2260,24
2651,77 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl* Phosphorothioate,Phosphorothioate* 2-O-Methyl,"8,9,12,14,15,16,17,18 * 2,3,4,5,6,7","2,3,4,5,6,7,8,9,10,11,12,13 *14,15,17,18,19",2.0,2259,24
2652,84 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl* Phosphorothioate,2-O-Methyl,"8,9,12,14,15,17,18 * 19","14,15,17,18,19",2.0,2258,24
2653,37 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"8,9,12,14,15,16,17,18","1,7,9,10,13,14,15,16,17,18,19",2.0,2257,24
2654,71 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-Fluoro,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","1,7,13,14,15,16,17,18,19",2.0,2256,24
2655,29 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","1,7,13,14,15,16,17,18,19",2.0,2255,24
2656,76 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,Phosphorothioate,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19",2.0,2254,24
2657,77 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19","18,19",2.0,2253,24
2658,74 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,Phosphorothioate,Phosphorothioate,"2,4,6,8,10,12,14,16,18","2,4,6,8,10,12,14,16,18",2.0,2252,24
2659,61 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18","2,4,6,8,10,12,14,16,18",2.0,2251,24
2660,83 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"2,4,6,8,10,12,14,16,18,","1,3,5,7,9,11,13,15,17,19",2.0,2250,24
2661,65 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","2,4,6,8,10,12,14,16,18,",2.0,2249,24
2662,75 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19","1,3,5,7,9,11,13,15,17,19",2.0,2248,24
2663,38 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"4,5,9,10,11,15,16","1,2,3,6,7,8,12,13,14,17,18,19",2.0,2247,24
2664,45 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"1,2,3,6,7,8,12,13,14,17,18,19","1,2,3,6,7,8,12,13,14,17,18,19",2.0,2246,24
2665,76 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"1,2,3,17,18,19","1,2,3,17,18,19",2.0,2245,24
2666,73 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"17,18,19","17,18,19",2.0,2244,24
2667,60 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,2-O-Methyl,2-O-Methyl,"1,2,3","1,2,3",2.0,2243,24
2668,78 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,Phosphorothioate,Phosphorothioate,"2,3,4,17,18,19","2,3,4,17,18,19",2.0,2242,24
2669,79 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,Phosphorothioate,Phosphorothioate,"17,18,19","17,18,19",2.0,2241,24
2670,75 percent target mRNA inhibition,Real-time PCR,Survivin gene,2 nM,HeLa cells,Lipofectamine 2000,AAGGAGAUCAACAUUUUCATT,UGAAAAUGUUGAUCUCCUUTT,Phosphorothioate,Phosphorothioate,"2,3,4","2,3,4",2.0,2240,24
2671,63 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,0.5 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,0,1,0,0.5,2238,48
2672,63 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,0.5 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,2-Deoxy,0,"24,25",0,0.5,2237,48
2673,86 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,0.5 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,0,1,0,0.5,2236,48
2674,80 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Thio,0,1,0,50.0,2234,168
2675,66 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,0,5-Thio,0,1,50.0,2233,168
2676,68 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Thio,5-Thio,1,1,50.0,2232,168
2677,49 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Cholesterol,3-Amino,1,1,2.0,2231,48
2678,56 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Cholesterol,5-Amino,1,1,2.0,2230,48
2679,70 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Cholesterol,0,1,0,2.0,2229,48
2680,94 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Thio,0,1,0,2.0,2228,48
2681,86.5 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,0,5-Thio,0,1,2.0,2227,48
2682,81 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,2 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Thio,5-Thio,1,1,2.0,2226,48
2683,77 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,3-Amino,5-Amino,27,1,50.0,2225,168
2684,70 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,3-Amino,1,27,50.0,2224,168
2685,72 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,3-Amino,0,27,0,50.0,2223,168
2686,68 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,0,3-Amino,0,27,50.0,2222,168
2687,36 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,3-Amino,3-Amino,27,27,50.0,2221,168
2688,76 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,0,1,0,50.0,2220,168
2689,41 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,0,3-Amino,0,27,50.0,2219,168
2690,51 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,50 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,5-Amino,1,27,50.0,2218,168
2691,67 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,3-Amino,5-Amino,27,1,1.0,2216,48
2692,89 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,3-Amino,1,27,1.0,2215,48
2693,79 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,3-Amino,0,27,0,1.0,2214,48
2694,84 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,0,3-Amino,0,27,1.0,2213,48
2695,58 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,3-Amino,3-Amino,27,27,1.0,2212,48
2696,97 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,0,1,0,1.0,2211,48
2697,76 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,0,3-Amino,0,27,1.0,2210,48
2698,83 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,1 nM,HeLa cells,Lipofectamine 2000,CUGGCCUUUCACUACUCCUACGAGCAC,GUGCUCGUAGGAGUAGUGAAAGGCCAG,5-Amino,5-Amino,1,1,1.0,2209,48
2699,79 percent target mRNA inhibition,Dual Luciferase reporter assay,Luciferase gene,0.5 nM,HeLa cells,Lipofectamine 2000,GGCCUUUCACUACUCCUACGA,GUAGGAGUAGUGAAAGGCCAG,5-Amino,0,1,0,0.5,2207,48
2702,77.23 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,UUCGUCGUGCUGAAGAAGUUC,2-O-Methyl,2-Fluoro,2,2,50.0,2199,65
2703,62.72 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,CUUGAAGAAGUCGUGCUGCUU,2-O-Methyl,2-O-Methyl,2,2,50.0,2198,65
2704,71.74 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,CUUGAAGAAGUCGUGCUGCUU,2-O-Methyl,0,2,0,50.0,2197,65
2705,69.33 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,CUUGAAGAAGUCGUGCUGCUU,Locked nucleic acid,2-Fluoro,1,2,50.0,2196,65
2706,68.59 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,CUUGAAGAAGUCGUGCUGCUU,Locked nucleic acid,2-O-Methyl,1,2,50.0,2195,65
2707,73.23 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,CUUGAAGAAGUCGUGCUGCUU,Locked nucleic acid,0,1,0,50.0,2194,65
2708,73.84 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,CUUGAAGAAGUCGUGCUGCUU,0,2-Fluoro,0,2,50.0,2193,65
2709,71.74 percent target mRNA inhibition,Radioactivity in PAGE,EGFP gene,50 nM,HeLa cells,Lipofectamine 2000,GCAGCACGACUUCUUCAAGUU,CUUGAAGAAGUCGUGCUGCUU,0,2-O-Methyl,0,2,50.0,2192,65
2715,2 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UCCUUUCUUUCUUUCGAAUUT,0,Methyluridine,0,"6,10,13,14,19,20",0.3,2183,22
2716,3 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UCCUUUCUUUCUUUCGAAUTT,0,Methylcytosine,0,"2,3,7,11,15",0.3,2182,22
2717,92 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUUCUUCAGAUUT,0,Methyluridine,0,"10,11,13,14,19,21",0.3,2180,22
2718,76 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUUT,0,Propynyluridine,0,"10,11,13,14,19,20",0.3,2179,22
2719,89 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,Methyluridine,0,"1,2,3,4,5,7",0.3,2178,22
2720,41 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,Propynyluridine,0,"1,2,3,4,5,7",0.3,2177,22
2721,82 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,Methylcytosine* Propynyluridine,0,"6,8,9,12,15 * 2,4,11,14,19",0.3,2176,22
2722,32 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,Propynyluridine,0,"1,2,3,4,5,7,10,11,13,14,19",0.3,2175,22
2723,73 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,Propynyluridine,0,"2,4,11,14,19",0.3,2174,22
2724,86 percent target mRNA inhibition,Renilla luciferase mRNA suppression,Luciferase gene,0.3 nM,HeLa cells,Lipofectamine 2000,AUCUGAAGAAGGAGAAAAATT,UUUUUCUCCUUCUUCAGAUTT,0,Methylcytosine,0,"6,8,9,12,15",0.3,2173,22
2734,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,0,Locked nucleic acid,0,"3,6,14,18,20,21",10.0,2162,72
2735,3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACTUGTGGCCGUUTACGTCGC,Locked nucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,2161,72
2736,1.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,Locked nucleic acid,Locked nucleic acid,"3,8,13,15,20,21","3,6,14,18,20,21",10.0,2160,72
2737,14.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACTUGTGGCCGUUTACGTCGC,UnLocked nucleic acid,Locked nucleic acid,"5,21","3,6,14,18,20,21",10.0,2159,72
2738,12.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACTUGTGGCCGUUTACGTCGC,UnLocked nucleic acid,Locked nucleic acid,21,"3,6,14,18,20,21",10.0,2158,72
2739,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"10 * 21,22","3,6,14,18,20,21",10.0,2157,72
2740,4.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5 * 20,21","3,6,14,18,20,21",10.0,2156,72
2741,9.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5,20 * 21","3,6,14,18,20,21",10.0,2155,72
2742,11.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACTUGTGGCCGUUTACGTCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,21,"3,6,14,18,20,21",10.0,2154,72
2743,10.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,Alfa-L-Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","3,6,14,18,20,21",10.0,2153,72
2744,14.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,Alfa-L-Locked nucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,2152,72
2745,11.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"3,5,9,13,20,21","3,6,14,18,20,21",10.0,2151,72
2746,11.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,2150,72
2747,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","3,6,14,18,20,21",10.0,2149,72
2748,7.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,Locked nucleic acid,Locked nucleic acid,"3,5,7,9,20,21","3,6,14,18,20,21",10.0,2148,72
2749,10.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,Locked nucleic acid,Locked nucleic acid,"5,20,21","3,6,14,18,20,21",10.0,2147,72
2750,11.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGC,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,6,14,18,20,21",10.0,2146,72
2751,6.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGC,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,6,14,18,20,21",10.0,2145,72
2752,12.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGC,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,6,14,18,20,21",10.0,2144,72
2753,17.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACTUGTGGCCGUUTACGTCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","3,6,14,18,20,21",10.0,2143,72
2754,17 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACTUGTGGCCGUUTACGTCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"5,19,20","3,6,14,18,20,21",10.0,2142,72
2755,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACTUGTGGCCGUUTACGTCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"19,20","3,6,14,18,20,21",10.0,2141,72
2756,13.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGC,Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","3,6,14,18,20,21",10.0,2140,72
2757,26.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,2-Aminoethyl,Locked nucleic acid,"5,19,20","3,6,14,18,20,21",10.0,2139,72
2758,16.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,2-Aminoethyl,Locked nucleic acid,19,"3,6,14,18,20,21",10.0,2138,72
2759,15.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,2-Aminoethyl,Locked nucleic acid,20,"3,6,14,18,20,21",10.0,2137,72
2760,1.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,2-Fluoro* 2-O-Methyl,Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,6,14,18,20,21",10.0,2136,72
2761,6.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,Oxetane-Locked nucleic acid,Locked nucleic acid,"2,4","3,6,14,18,20,21",10.0,2135,72
2762,21.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,Oxetane-Locked nucleic acid,Locked nucleic acid,"16,18","3,6,14,18,20,21",10.0,2134,72
2763,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGC,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","3,6,14,18,20,21",10.0,2133,72
2764,13.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGC,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","3,6,14,18,20,21",10.0,2132,72
2765,16.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGC,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","3,6,14,18,20,21",10.0,2131,72
2766,50.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGC,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","3,6,14,18,20,21",10.0,2130,72
2767,7.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGC,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,19,20 * 21","3,6,14,18,20,21",10.0,2129,72
2768,8.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGC,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14 * 21","3,6,14,18,20,21",10.0,2128,72
2769,5.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGC,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2,3,18,19,20 * 21","3,6,14,18,20,21",10.0,2127,72
2770,13.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,Hexitol nucleic acid,Locked nucleic acid,"19,20","3,6,14,18,20,21",10.0,2126,72
2771,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACTUGTGGCCGUUTACGTCGC,Altritol nucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,2125,72
2772,4.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGC,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,17 * 22","3,6,14,18,20,21",10.0,2124,72
2773,17.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGC,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"18,19 * 22","3,6,14,18,20,21",10.0,2123,72
2774,14.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGC,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2 * 22","3,6,14,18,20,21",10.0,2122,72
2775,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGC,Hexitol nucleic acid,Locked nucleic acid,"5,8,14,17,22","3,6,14,18,20,21",10.0,2121,72
2776,3.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,Hexitol nucleic acid,Locked nucleic acid,"2,8,14,17","3,6,14,18,20,21",10.0,2120,72
2777,10.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,2-Guanidinoethyl,Locked nucleic acid,18,"3,6,14,18,20,21",10.0,2119,72
2778,23.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGC,2-Aminoethyl,Locked nucleic acid,18,"3,6,14,18,20,21",10.0,2118,72
2779,72.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Locked nucleic acid,0,"20,21",10.0,2117,72
2780,84.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",10.0,2116,72
2781,84.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,8,13,15,20,21","20,21",10.0,2115,72
2782,66.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Locked nucleic acid,"5,21","20,21",10.0,2114,72
2783,83.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Locked nucleic acid,21,"20,21",10.0,2113,72
2784,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"10 * 21,22","20,21",10.0,2112,72
2785,29 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5 * 20,21","20,21",10.0,2111,72
2786,71.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5,20 * 21","20,21",10.0,2110,72
2787,85 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,21,"20,21",10.0,2109,72
2788,82.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","20,21",10.0,2108,72
2789,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Locked nucleic acid,"20,21","20,21",10.0,2107,72
2790,67 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"3,5,9,13,20,21","20,21",10.0,2106,72
2791,81.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"20,21","20,21",10.0,2105,72
2792,74.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",10.0,2104,72
2793,51.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,5,7,9,20,21","20,21",10.0,2103,72
2794,66.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"5,20,21","20,21",10.0,2102,72
2795,24.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","20,21",10.0,2101,72
2796,15.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","20,21",10.0,2100,72
2797,5.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","20,21",10.0,2099,72
2798,75.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",10.0,2098,72
2799,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"5,19,20","20,21",10.0,2097,72
2800,76.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"19,20","20,21",10.0,2096,72
2801,68.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","20,21",10.0,2095,72
2802,76.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,"5,19,20","20,21",10.0,2094,72
2803,75.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,19,"20,21",10.0,2093,72
2804,84.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,20,"20,21",10.0,2092,72
2805,83.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","20,21",10.0,2091,72
2806,82.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Locked nucleic acid,"2,4","20,21",10.0,2090,72
2807,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Locked nucleic acid,"16,18","20,21",10.0,2089,72
2808,22 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","20,21",10.0,2088,72
2809,85.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","20,21",10.0,2087,72
2810,53 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","20,21",10.0,2086,72
2811,86.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","20,21",10.0,2085,72
2812,71.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,19,20 * 21","20,21",10.0,2084,72
2813,21.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14 * 21","20,21",10.0,2083,72
2814,84.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2,3,18,19,20 * 21","20,21",10.0,2082,72
2815,63 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Locked nucleic acid,"19,20","20,21",10.0,2081,72
2816,71.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Locked nucleic acid,"20,21","20,21",10.0,2080,72
2817,11.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,17 * 22","20,21",10.0,2079,72
2818,75.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"18,19 * 22","20,21",10.0,2078,72
2819,84.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2 * 22","20,21",10.0,2077,72
2820,3.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Locked nucleic acid,"5,8,14,17,22","20,21",10.0,2076,72
2821,62.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Locked nucleic acid,"2,8,14,17","20,21",10.0,2075,72
2822,83.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Locked nucleic acid,18,"20,21",10.0,2074,72
2823,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,18,"20,21",10.0,2073,72
2824,43.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Unlocked nucleic acid,0,"3,21",10.0,2072,72
2825,49.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"20,21","3,21",10.0,2071,72
2826,8.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,8,13,15,20,21","3,21",10.0,2070,72
2827,34.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid,"5,21","3,21",10.0,2069,72
2828,53.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid,21,"3,21",10.0,2068,72
2829,1.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid,"10 * 21,22","3,21",10.0,2067,72
2830,17.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid,"5 * 20,21","3,21",10.0,2066,72
2831,20.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Unlocked nucleic acid,"5,20 * 21","3,21",10.0,2065,72
2832,48.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,21,"3,21",10.0,2064,72
2833,30 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid,"3,9,15,20,21","3,21",10.0,2063,72
2834,49.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid,"20,21","3,21",10.0,2062,72
2835,28.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"3,5,9,13,20,21","3,21",10.0,2061,72
2836,53.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"20,21","3,21",10.0,2060,72
2837,0.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,9,13,15,20,21","3,21",10.0,2059,72
2838,13 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,5,7,9,20,21","3,21",10.0,2058,72
2839,40 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"5,20,21","3,21",10.0,2057,72
2840,7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,21",10.0,2056,72
2841,12 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,21",10.0,2055,72
2842,12.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,21",10.0,2054,72
2843,52.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,9,13,15,20,21","3,21",10.0,2053,72
2844,54.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"5,19,20","3,21",10.0,2052,72
2845,42.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"19,20","3,21",10.0,2051,72
2846,24.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,9,15,20,21","3,21",10.0,2050,72
2847,46.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,"5,19,20","3,21",10.0,2049,72
2848,47.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,19,"3,21",10.0,2048,72
2849,53 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,20,"3,21",10.0,2047,72
2850,9.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Unlocked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,21",10.0,2046,72
2851,52.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid,"2,4","3,21",10.0,2045,72
2852,69.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid,"16,18","3,21",10.0,2044,72
2853,9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid,"3,5,9,19,20 * 21","3,21",10.0,2043,72
2854,57.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid,"19,20 * 21","3,21",10.0,2042,72
2855,25.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid,"3,5,9,19,20 * 21","3,21",10.0,2041,72
2856,53.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid,"19,20 * 21","3,21",10.0,2040,72
2857,28 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"5,8,11,14,19,20 * 21","3,21",10.0,2039,72
2858,15.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"5,8,11,14 * 21","3,21",10.0,2038,72
2859,57.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"1,2,3,18,19,20 * 21","3,21",10.0,2037,72
2860,62.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid,"19,20","3,21",10.0,2036,72
2861,38.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Unlocked nucleic acid,"20,21","3,21",10.0,2035,72
2862,12.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"5,8,11,14,17 * 22","3,21",10.0,2034,72
2863,56.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"18,19 * 22","3,21",10.0,2033,72
2864,54.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"1,2 * 22","3,21",10.0,2032,72
2865,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid,"5,8,14,17,22","3,21",10.0,2031,72
2866,21.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid,"2,8,14,17","3,21",10.0,2030,72
2867,47.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Unlocked nucleic acid,18,"3,21",10.0,2029,72
2868,70.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,18,"3,21",10.0,2028,72
2869,74 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Unlocked nucleic acid,0,21,10.0,2027,72
2870,78.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"20,21",21,10.0,2026,72
2871,71.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,8,13,15,20,21",21,10.0,2025,72
2872,73.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid,"5,21",21,10.0,2024,72
2873,78.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid,21,21,10.0,2023,72
2874,26.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid,"10 * 21,22",21,10.0,2022,72
2875,55.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid,"5 * 20,21",21,10.0,2021,72
2876,61.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Unlocked nucleic acid,"5,20 * 21",21,10.0,2020,72
2877,79.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,21,21,10.0,2019,72
2878,76 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid,"3,9,15,20,21",21,10.0,2018,72
2879,79.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid,"20,21",21,10.0,2017,72
2880,72.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"3,5,9,13,20,21",21,10.0,2016,72
2881,83.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"20,21",21,10.0,2015,72
2882,66.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,9,13,15,20,21",21,10.0,2014,72
2883,56.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,5,7,9,20,21",21,10.0,2013,72
2884,73.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"5,20,21",21,10.0,2012,72
2885,4.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",21,10.0,2011,72
2886,25.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",21,10.0,2010,72
2887,22.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",21,10.0,2009,72
2888,71.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,9,13,15,20,21",21,10.0,2008,72
2889,82.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"5,19,20",21,10.0,2007,72
2890,74.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid,"19,20",21,10.0,2006,72
2891,76.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid,"3,9,15,20,21",21,10.0,2005,72
2892,72.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,"5,19,20",21,10.0,2004,72
2893,77.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,19,21,10.0,2003,72
2894,77.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,20,21,10.0,2002,72
2895,73.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Unlocked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",21,10.0,2001,72
2896,72.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid,"2,4",21,10.0,2000,72
2897,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid,"16,18",21,10.0,1999,72
2898,71.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid,"3,5,9,19,20 * 21",21,10.0,1998,72
2899,80 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid,"19,20 * 21",21,10.0,1997,72
2900,78.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid,"3,5,9,19,20 * 21",21,10.0,1996,72
2901,78 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid,"19,20 * 21",21,10.0,1995,72
2902,73.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"5,8,11,14,19,20 * 21",21,10.0,1994,72
2903,52.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"5,8,11,14 * 21",21,10.0,1993,72
2904,78.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"1,2,3,18,19,20 * 21",21,10.0,1992,72
2905,84.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid,"19,20",21,10.0,1991,72
2906,72 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Unlocked nucleic acid,"20,21",21,10.0,1990,72
2907,38.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"5,8,11,14,17 * 22",21,10.0,1989,72
2908,79.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"18,19 * 22",21,10.0,1988,72
2909,74.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid,"1,2 * 22",21,10.0,1987,72
2910,16.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid,"5,8,14,17,22",21,10.0,1986,72
2911,65.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid,"2,8,14,17",21,10.0,1985,72
2912,78.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Unlocked nucleic acid,18,21,10.0,1984,72
2913,86 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid,18,21,10.0,1983,72
2914,86.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Unlocked nucleic acid* Locked nucleic acid,0,"12 * 20,21",10.0,1982,72
2915,87.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","12 * 20,21",10.0,1981,72
2916,84.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","12 * 20,21",10.0,1980,72
2917,85.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,21","12 * 20,21",10.0,1979,72
2918,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"12 * 20,21",10.0,1978,72
2919,64.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"10 * 21,22","12 * 20,21",10.0,1977,72
2920,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5 * 20,21","12 * 20,21",10.0,1976,72
2921,86.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20 * 21","12 * 20,21",10.0,1975,72
2922,86.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"12 * 20,21",10.0,1974,72
2923,86.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","12 * 20,21",10.0,1973,72
2924,85.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","12 * 20,21",10.0,1972,72
2925,85.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","12 * 20,21",10.0,1971,72
2926,87.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","12 * 20,21",10.0,1970,72
2927,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","12 * 20,21",10.0,1969,72
2928,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","12 * 20,21",10.0,1968,72
2929,86.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20,21","12 * 20,21",10.0,1967,72
2930,66.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","12 * 20,21",10.0,1966,72
2931,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","12 * 20,21",10.0,1965,72
2932,27.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","12 * 20,21",10.0,1964,72
2933,82.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","12 * 20,21",10.0,1963,72
2934,87.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","12 * 20,21",10.0,1962,72
2935,81 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","12 * 20,21",10.0,1961,72
2936,87 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","12 * 20,21",10.0,1960,72
2937,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","12 * 20,21",10.0,1959,72
2938,85.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,19,"12 * 20,21",10.0,1958,72
2939,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,20,"12 * 20,21",10.0,1957,72
2940,85.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","12 * 20,21",10.0,1956,72
2941,86.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,4","12 * 20,21",10.0,1955,72
2942,86.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"16,18","12 * 20,21",10.0,1954,72
2943,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","12 * 20,21",10.0,1953,72
2944,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","12 * 20,21",10.0,1952,72
2945,86.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","12 * 20,21",10.0,1951,72
2946,85.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","12 * 20,21",10.0,1950,72
2947,87 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","12 * 20,21",10.0,1949,72
2948,85.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","12 * 20,21",10.0,1948,72
2949,85.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","12 * 20,21",10.0,1947,72
2950,86.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","12 * 20,21",10.0,1946,72
2951,80.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","12 * 20,21",10.0,1945,72
2952,83.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","12 * 20,21",10.0,1944,72
2953,86.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"18,19 * 22","12 * 20,21",10.0,1943,72
2954,85.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2 * 22","12 * 20,21",10.0,1942,72
2955,41.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,8,14,17,22","12 * 20,21",10.0,1941,72
2956,85.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,8,14,17","12 * 20,21",10.0,1940,72
2957,85.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"12 * 20,21",10.0,1939,72
2958,85.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"12 * 20,21",10.0,1938,72
2959,88.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Unlocked nucleic acid* Locked nucleic acid,0,"18 * 20,21",10.0,1937,72
2960,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1936,72
2961,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","18 * 20,21",10.0,1935,72
2962,84.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,21","18 * 20,21",10.0,1934,72
2963,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"18 * 20,21",10.0,1933,72
2964,60.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"10 * 21,22","18 * 20,21",10.0,1932,72
2965,78.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5 * 20,21","18 * 20,21",10.0,1931,72
2966,84.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20 * 21","18 * 20,21",10.0,1930,72
2967,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"18 * 20,21",10.0,1929,72
2968,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","18 * 20,21",10.0,1928,72
2969,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1927,72
2970,87.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","18 * 20,21",10.0,1926,72
2971,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1925,72
2972,65.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","18 * 20,21",10.0,1924,72
2973,50.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","18 * 20,21",10.0,1923,72
2974,83.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20,21","18 * 20,21",10.0,1922,72
2975,35.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","18 * 20,21",10.0,1921,72
2976,59.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","18 * 20,21",10.0,1920,72
2977,33.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","18 * 20,21",10.0,1919,72
2978,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","18 * 20,21",10.0,1918,72
2979,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","18 * 20,21",10.0,1917,72
2980,83.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","18 * 20,21",10.0,1916,72
2981,82.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","18 * 20,21",10.0,1915,72
2982,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","18 * 20,21",10.0,1914,72
2983,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,19,"18 * 20,21",10.0,1913,72
2984,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,20,"18 * 20,21",10.0,1912,72
2985,81.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","18 * 20,21",10.0,1911,72
2986,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,4","18 * 20,21",10.0,1910,72
2987,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"16,18","18 * 20,21",10.0,1909,72
2988,83.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","18 * 20,21",10.0,1908,72
2989,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","18 * 20,21",10.0,1907,72
2990,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","18 * 20,21",10.0,1906,72
2991,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","18 * 20,21",10.0,1905,72
2992,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","18 * 20,21",10.0,1904,72
2993,86.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","18 * 20,21",10.0,1903,72
2994,87.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","18 * 20,21",10.0,1902,72
2995,84.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","18 * 20,21",10.0,1901,72
2996,81.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1900,72
2997,75.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","18 * 20,21",10.0,1899,72
2998,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"18,19 * 22","18 * 20,21",10.0,1898,72
2999,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2 * 22","18 * 20,21",10.0,1897,72
3000,74.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,8,14,17,22","18 * 20,21",10.0,1896,72
3001,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,8,14,17","18 * 20,21",10.0,1895,72
3002,88.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"18 * 20,21",10.0,1894,72
3003,89.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"18 * 20,21",10.0,1893,72
3004,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Unlocked nucleic acid* Locked nucleic acid,0,"3 * 20,21",10.0,1892,72
3005,77.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","3 * 20,21",10.0,1891,72
3006,65.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","3 * 20,21",10.0,1890,72
3007,77.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,21","3 * 20,21",10.0,1889,72
3008,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"3 * 20,21",10.0,1888,72
3009,45.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"10 * 21,22","3 * 20,21",10.0,1887,72
3010,74.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5 * 20,21","3 * 20,21",10.0,1886,72
3011,70.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20 * 21","3 * 20,21",10.0,1885,72
3012,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"3 * 20,21",10.0,1884,72
3013,72.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","3 * 20,21",10.0,1883,72
3014,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","3 * 20,21",10.0,1882,72
3015,45.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","3 * 20,21",10.0,1881,72
3016,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","3 * 20,21",10.0,1880,72
3017,62.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","3 * 20,21",10.0,1879,72
3018,53.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","3 * 20,21",10.0,1878,72
3019,78.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20,21","3 * 20,21",10.0,1877,72
3020,14.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3 * 20,21",10.0,1876,72
3021,21.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3 * 20,21",10.0,1875,72
3022,3.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3 * 20,21",10.0,1874,72
3023,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","3 * 20,21",10.0,1873,72
3024,85.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","3 * 20,21",10.0,1872,72
3025,76.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","3 * 20,21",10.0,1871,72
3026,77.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","3 * 20,21",10.0,1870,72
3027,66.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","3 * 20,21",10.0,1869,72
3028,79.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,19,"3 * 20,21",10.0,1868,72
3029,80.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,20,"3 * 20,21",10.0,1867,72
3030,71.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3 * 20,21",10.0,1866,72
3031,82.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,4","3 * 20,21",10.0,1865,72
3032,87.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"16,18","3 * 20,21",10.0,1864,72
3033,68.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","3 * 20,21",10.0,1863,72
3034,80 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","3 * 20,21",10.0,1862,72
3035,71.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","3 * 20,21",10.0,1861,72
3036,78.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","3 * 20,21",10.0,1860,72
3037,74.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","3 * 20,21",10.0,1859,72
3038,65.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","3 * 20,21",10.0,1858,72
3039,83.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","3 * 20,21",10.0,1857,72
3040,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","3 * 20,21",10.0,1856,72
3041,75.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","3 * 20,21",10.0,1855,72
3042,35.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","3 * 20,21",10.0,1854,72
3043,81.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"18,19 * 22","3 * 20,21",10.0,1853,72
3044,80.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2 * 22","3 * 20,21",10.0,1852,72
3045,34.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,8,14,17,22","3 * 20,21",10.0,1851,72
3046,67.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,8,14,17","3 * 20,21",10.0,1850,72
3047,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"3 * 20,21",10.0,1849,72
3048,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"3 * 20,21",10.0,1848,72
3049,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Unlocked nucleic acid* Locked nucleic acid,0,"6 * 20,21",10.0,1847,72
3050,90.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1846,72
3051,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","6 * 20,21",10.0,1845,72
3052,88.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,21","6 * 20,21",10.0,1844,72
3053,93.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1843,72
3054,79.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"10 * 21,22","6 * 20,21",10.0,1842,72
3055,85.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5 * 20,21","6 * 20,21",10.0,1841,72
3056,89.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20 * 21","6 * 20,21",10.0,1840,72
3057,89.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1839,72
3058,87.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1838,72
3059,90.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1837,72
3060,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","6 * 20,21",10.0,1836,72
3061,93.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1835,72
3062,87.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1834,72
3063,79 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","6 * 20,21",10.0,1833,72
3064,90.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,20,21","6 * 20,21",10.0,1832,72
3065,77.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","6 * 20,21",10.0,1831,72
3066,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","6 * 20,21",10.0,1830,72
3067,18.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","6 * 20,21",10.0,1829,72
3068,85.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1828,72
3069,93.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1827,72
3070,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1826,72
3071,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1825,72
3072,90 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1824,72
3073,89.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,19,"6 * 20,21",10.0,1823,72
3074,90.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,20,"6 * 20,21",10.0,1822,72
3075,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Unlocked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","6 * 20,21",10.0,1821,72
3076,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,4","6 * 20,21",10.0,1820,72
3077,91 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"16,18","6 * 20,21",10.0,1819,72
3078,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1818,72
3079,90.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1817,72
3080,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1816,72
3081,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1815,72
3082,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","6 * 20,21",10.0,1814,72
3083,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","6 * 20,21",10.0,1813,72
3084,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","6 * 20,21",10.0,1812,72
3085,90.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1811,72
3086,86.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1810,72
3087,82.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","6 * 20,21",10.0,1809,72
3088,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"18,19 * 22","6 * 20,21",10.0,1808,72
3089,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Unlocked nucleic acid* Locked nucleic acid,"1,2 * 22","6 * 20,21",10.0,1807,72
3090,82.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"5,8,14,17,22","6 * 20,21",10.0,1806,72
3091,89.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Unlocked nucleic acid* Locked nucleic acid,"2,8,14,17","6 * 20,21",10.0,1805,72
3092,90.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1804,72
3093,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Unlocked nucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1803,72
3094,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,2-O-Methyl,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1802,72
3095,0.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl,"20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1801,72
3096,6.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl,"3,8,13,15,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1800,72
3097,17 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-O-Methyl,"5,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1799,72
3098,13 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-O-Methyl,21,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1798,72
3099,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl,"10 * 21,22","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1797,72
3100,3.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl,"5 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1796,72
3101,9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-O-Methyl,"5,20 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1795,72
3102,6.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,21,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1794,72
3103,17.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-O-Methyl,"3,9,15,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1793,72
3104,11 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-O-Methyl,"20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1792,72
3105,15.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"3,5,9,13,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1791,72
3106,10.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1790,72
3107,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl,"3,9,13,15,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1789,72
3108,11.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl,"3,5,7,9,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1788,72
3109,16.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl,"5,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1787,72
3110,10.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1786,72
3111,11.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1785,72
3112,29.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1784,72
3113,22.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl,"3,9,13,15,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1783,72
3114,17.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"5,19,20","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1782,72
3115,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"19,20","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1781,72
3116,5.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl,"3,9,15,20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1780,72
3117,15.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl,"5,19,20","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1779,72
3118,25.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl,19,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1778,72
3119,6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl,20,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1777,72
3120,3.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1776,72
3121,14.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-O-Methyl,"2,4","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1775,72
3122,16.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-O-Methyl,"16,18","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1774,72
3123,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl,"3,5,9,19,20 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1773,72
3124,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl,"19,20 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1772,72
3125,62.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl,"3,5,9,19,20 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1771,72
3126,11.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl,"19,20 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1770,72
3127,4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl,"5,8,11,14,19,20 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1769,72
3128,10.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl,"5,8,11,14 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1768,72
3129,40 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl,"1,2,3,18,19,20 * 21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1767,72
3130,15 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl,"19,20","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1766,72
3131,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,2-O-Methyl,"20,21","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1765,72
3132,57 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl,"5,8,11,14,17 * 22","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1764,72
3133,14.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl,"18,19 * 22","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1763,72
3134,16 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl,"1,2 * 22","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1762,72
3135,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl,"5,8,14,17,22","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1761,72
3136,6.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl,"2,8,14,17","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1760,72
3137,1.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,2-O-Methyl,18,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1759,72
3138,18.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl,18,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22",10.0,1758,72
3139,53.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,0,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,0,"18 * 20,21",10.0,1757,72
3140,61.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1756,72
3141,26 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","18 * 20,21",10.0,1755,72
3142,64.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,21","18 * 20,21",10.0,1754,72
3143,67.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"18 * 20,21",10.0,1753,72
3144,23.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"10 * 21,22","18 * 20,21",10.0,1752,72
3145,53.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5 * 20,21","18 * 20,21",10.0,1751,72
3146,57.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20 * 21","18 * 20,21",10.0,1750,72
3147,61.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"18 * 20,21",10.0,1749,72
3148,70.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Alfa-L-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","18 * 20,21",10.0,1748,72
3149,65.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Alfa-L-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1747,72
3150,55.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","18 * 20,21",10.0,1746,72
3151,69 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1745,72
3152,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","18 * 20,21",10.0,1744,72
3153,11.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","18 * 20,21",10.0,1743,72
3154,63.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20,21","18 * 20,21",10.0,1742,72
3155,11.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGTCGCU,2-Deoxy* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","18 * 20,21",10.0,1741,72
3156,8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGTCGCU,2-Deoxy* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","18 * 20,21",10.0,1740,72
3157,16.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGTCGCU,2-Deoxy* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","18 * 20,21",10.0,1739,72
3158,71.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","18 * 20,21",10.0,1738,72
3159,57.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","18 * 20,21",10.0,1737,72
3160,49.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","18 * 20,21",10.0,1736,72
3161,53 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","18 * 20,21",10.0,1735,72
3162,63.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","18 * 20,21",10.0,1734,72
3163,67.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,19,"18 * 20,21",10.0,1733,72
3164,65.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,20,"18 * 20,21",10.0,1732,72
3165,42 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Fluoro* 2-O-Methyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","18 * 20,21",10.0,1731,72
3166,46.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Oxetane-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4","18 * 20,21",10.0,1730,72
3167,54.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Oxetane-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"16,18","18 * 20,21",10.0,1729,72
3168,48.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","18 * 20,21",10.0,1728,72
3169,63.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","18 * 20,21",10.0,1727,72
3170,63.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","18 * 20,21",10.0,1726,72
3171,68.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","18 * 20,21",10.0,1725,72
3172,54.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","18 * 20,21",10.0,1724,72
3173,29.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","18 * 20,21",10.0,1723,72
3174,70.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","18 * 20,21",10.0,1722,72
3175,67.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","18 * 20,21",10.0,1721,72
3176,51 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1720,72
3177,9.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","18 * 20,21",10.0,1719,72
3178,68.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"18,19 * 22","18 * 20,21",10.0,1718,72
3179,67.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2 * 22","18 * 20,21",10.0,1717,72
3180,7.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,14,17,22","18 * 20,21",10.0,1716,72
3181,23.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,8,14,17","18 * 20,21",10.0,1715,72
3182,67.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Guanidinoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"18 * 20,21",10.0,1714,72
3183,67.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"18 * 20,21",10.0,1713,72
3184,62 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,0,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,0,"6 * 20,21",10.0,1712,72
3185,69.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1711,72
3186,28.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","6 * 20,21",10.0,1710,72
3187,68.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,21","6 * 20,21",10.0,1709,72
3188,69.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1708,72
3189,49.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"10 * 21,22","6 * 20,21",10.0,1707,72
3190,62.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5 * 20,21","6 * 20,21",10.0,1706,72
3191,56.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20 * 21","6 * 20,21",10.0,1705,72
3192,70.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1704,72
3193,73.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1703,72
3194,72.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1702,72
3195,62.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","6 * 20,21",10.0,1701,72
3196,75.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1700,72
3197,16.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1699,72
3198,14.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","6 * 20,21",10.0,1698,72
3199,60 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20,21","6 * 20,21",10.0,1697,72
3200,0.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","6 * 20,21",10.0,1696,72
3201,9.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","6 * 20,21",10.0,1695,72
3202,18.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","6 * 20,21",10.0,1694,72
3203,70.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1693,72
3204,71.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1692,72
3205,66.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1691,72
3206,65.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1690,72
3207,58.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1689,72
3208,72.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,19,"6 * 20,21",10.0,1688,72
3209,72.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,20,"6 * 20,21",10.0,1687,72
3210,15.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","6 * 20,21",10.0,1686,72
3211,64.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4","6 * 20,21",10.0,1685,72
3212,78.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"16,18","6 * 20,21",10.0,1684,72
3213,56.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1683,72
3214,69.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1682,72
3215,67 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1681,72
3216,72.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1680,72
3217,63 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","6 * 20,21",10.0,1679,72
3218,28.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","6 * 20,21",10.0,1678,72
3219,73.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","6 * 20,21",10.0,1677,72
3220,82.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1676,72
3221,63.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1675,72
3222,20.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","6 * 20,21",10.0,1674,72
3223,73.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"18,19 * 22","6 * 20,21",10.0,1673,72
3224,67.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2 * 22","6 * 20,21",10.0,1672,72
3225,8.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,14,17,22","6 * 20,21",10.0,1671,72
3226,22.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,8,14,17","6 * 20,21",10.0,1670,72
3227,72 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Guanidinoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1669,72
3228,81.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Pyren-1-yl Methyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1668,72
3229,64.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,0,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,0,"18 * 20,21",10.0,1667,72
3230,63.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1666,72
3231,6.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","18 * 20,21",10.0,1665,72
3232,75.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,21","18 * 20,21",10.0,1664,72
3233,73.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"18 * 20,21",10.0,1663,72
3234,64.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"10 * 21,22","18 * 20,21",10.0,1662,72
3235,75.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5 * 20,21","18 * 20,21",10.0,1661,72
3236,69.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20 * 21","18 * 20,21",10.0,1660,72
3237,70 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"18 * 20,21",10.0,1659,72
3238,77.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Alfa-L-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","18 * 20,21",10.0,1658,72
3239,72.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Alfa-L-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1657,72
3240,63.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","18 * 20,21",10.0,1656,72
3241,78.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1655,72
3242,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","18 * 20,21",10.0,1654,72
3243,14.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","18 * 20,21",10.0,1653,72
3244,70.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20,21","18 * 20,21",10.0,1652,72
3245,8.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGTCGCU,2-Deoxy* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","18 * 20,21",10.0,1651,72
3246,5.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGTCGCU,2-Deoxy* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","18 * 20,21",10.0,1650,72
3247,25.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGTCGCU,2-Deoxy* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","18 * 20,21",10.0,1649,72
3248,78.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","18 * 20,21",10.0,1648,72
3249,72.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","18 * 20,21",10.0,1647,72
3250,63.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","18 * 20,21",10.0,1646,72
3251,63.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGTCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","18 * 20,21",10.0,1645,72
3252,72.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","18 * 20,21",10.0,1644,72
3253,68.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,19,"18 * 20,21",10.0,1643,72
3254,68.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,20,"18 * 20,21",10.0,1642,72
3255,12.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Fluoro* 2-O-Methyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","18 * 20,21",10.0,1641,72
3256,61.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Oxetane-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4","18 * 20,21",10.0,1640,72
3257,59.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Oxetane-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"16,18","18 * 20,21",10.0,1639,72
3258,63.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","18 * 20,21",10.0,1638,72
3259,68.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","18 * 20,21",10.0,1637,72
3260,73 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","18 * 20,21",10.0,1636,72
3261,66.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","18 * 20,21",10.0,1635,72
3262,55.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","18 * 20,21",10.0,1634,72
3263,24.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","18 * 20,21",10.0,1633,72
3264,78.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","18 * 20,21",10.0,1632,72
3265,81.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","18 * 20,21",10.0,1631,72
3266,64.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","18 * 20,21",10.0,1630,72
3267,18.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","18 * 20,21",10.0,1629,72
3268,72.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"18,19 * 22","18 * 20,21",10.0,1628,72
3269,69.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2 * 22","18 * 20,21",10.0,1627,72
3270,10.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,14,17,22","18 * 20,21",10.0,1626,72
3271,17.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,Hexitol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,8,14,17","18 * 20,21",10.0,1625,72
3272,72.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Guanidinoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"18 * 20,21",10.0,1624,72
3273,77.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGTCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"18 * 20,21",10.0,1623,72
3274,86.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,Locked nucleic acid,0,"19,20",10.0,1622,72
3275,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"20,21","19,20",10.0,1621,72
3276,81.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,8,13,15,20,21","19,20",10.0,1620,72
3277,82.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,Locked nucleic acid,"5,21","19,20",10.0,1619,72
3278,86 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,Locked nucleic acid,21,"19,20",10.0,1618,72
3279,41.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"10 * 21,22","19,20",10.0,1617,72
3280,75.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5 * 20,21","19,20",10.0,1616,72
3281,78.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5,20 * 21","19,20",10.0,1615,72
3282,86.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,21,"19,20",10.0,1614,72
3283,84.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","19,20",10.0,1613,72
3284,83.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,Locked nucleic acid,"20,21","19,20",10.0,1612,72
3285,81.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"3,5,9,13,20,21","19,20",10.0,1611,72
3286,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"20,21","19,20",10.0,1610,72
3287,76.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","19,20",10.0,1609,72
3288,63.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,5,7,9,20,21","19,20",10.0,1608,72
3289,83.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"5,20,21","19,20",10.0,1607,72
3290,18 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","19,20",10.0,1606,72
3291,47.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","19,20",10.0,1605,72
3292,1.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","19,20",10.0,1604,72
3293,81.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","19,20",10.0,1603,72
3294,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"5,19,20","19,20",10.0,1602,72
3295,79.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"19,20","19,20",10.0,1601,72
3296,86.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","19,20",10.0,1600,72
3297,82.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Locked nucleic acid,"5,19,20","19,20",10.0,1599,72
3298,84.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Locked nucleic acid,19,"19,20",10.0,1598,72
3299,85.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Locked nucleic acid,20,"19,20",10.0,1597,72
3300,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","19,20",10.0,1596,72
3301,84.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,Locked nucleic acid,"2,4","19,20",10.0,1595,72
3302,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,Locked nucleic acid,"16,18","19,20",10.0,1594,72
3303,77.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","19,20",10.0,1593,72
3304,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","19,20",10.0,1592,72
3305,83.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","19,20",10.0,1591,72
3306,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","19,20",10.0,1590,72
3307,83.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,19,20 * 21","19,20",10.0,1589,72
3308,77.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14 * 21","19,20",10.0,1588,72
3309,84.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2,3,18,19,20 * 21","19,20",10.0,1587,72
3310,83.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,Locked nucleic acid,"19,20","19,20",10.0,1586,72
3311,79.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,Locked nucleic acid,"20,21","19,20",10.0,1585,72
3312,56.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,17 * 22","19,20",10.0,1584,72
3313,85.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"18,19 * 22","19,20",10.0,1583,72
3314,84.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2 * 22","19,20",10.0,1582,72
3315,52 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,Locked nucleic acid,"5,8,14,17,22","19,20",10.0,1581,72
3316,79.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,Locked nucleic acid,"2,8,14,17","19,20",10.0,1580,72
3317,84.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,Locked nucleic acid,18,"19,20",10.0,1579,72
3318,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Locked nucleic acid,18,"19,20",10.0,1578,72
3319,45.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,0,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,0,"6 * 20,21",10.0,1577,72
3320,51.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1576,72
3321,10.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,8,13,15,20,21","6 * 20,21",10.0,1575,72
3322,36.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,21","6 * 20,21",10.0,1574,72
3323,48.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1573,72
3324,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"10 * 21,22","6 * 20,21",10.0,1572,72
3325,29.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5 * 20,21","6 * 20,21",10.0,1571,72
3326,41 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20 * 21","6 * 20,21",10.0,1570,72
3327,46.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1569,72
3328,48 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1568,72
3329,45.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1567,72
3330,24.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,13,20,21","6 * 20,21",10.0,1566,72
3331,53 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1565,72
3332,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1564,72
3333,2.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,7,9,20,21","6 * 20,21",10.0,1563,72
3334,45 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,20,21","6 * 20,21",10.0,1562,72
3335,9.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","6 * 20,21",10.0,1561,72
3336,4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","6 * 20,21",10.0,1560,72
3337,9.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","6 * 20,21",10.0,1559,72
3338,22.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1558,72
3339,43.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1557,72
3340,26.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1556,72
3341,40.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1555,72
3342,33 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1554,72
3343,44.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,19,"6 * 20,21",10.0,1553,72
3344,49.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,20,"6 * 20,21",10.0,1552,72
3345,12.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","6 * 20,21",10.0,1551,72
3346,40.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4","6 * 20,21",10.0,1550,72
3347,31.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"16,18","6 * 20,21",10.0,1549,72
3348,0.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1548,72
3349,46 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1547,72
3350,29.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1546,72
3351,45.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1545,72
3352,33.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","6 * 20,21",10.0,1544,72
3353,24.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14 * 21","6 * 20,21",10.0,1543,72
3354,41.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","6 * 20,21",10.0,1542,72
3355,42.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1541,72
3356,19.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1540,72
3357,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","6 * 20,21",10.0,1539,72
3358,37.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"18,19 * 22","6 * 20,21",10.0,1538,72
3359,34.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"1,2 * 22","6 * 20,21",10.0,1537,72
3360,21.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"5,8,14,17,22","6 * 20,21",10.0,1536,72
3361,30.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,8,14,17","6 * 20,21",10.0,1535,72
3362,47.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Guanidinoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1534,72
3363,48.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1533,72
3364,81.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,0,4-C-Hydroxymethyl Deoxyribonucleic acid,0,21,10.0,1532,72
3365,78.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21",21,10.0,1531,72
3366,67.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,8,13,15,20,21",21,10.0,1530,72
3367,76.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGTU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,21",21,10.0,1529,72
3368,87.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGTU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,21,21,10.0,1528,72
3369,45.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"10 * 21,22",21,10.0,1527,72
3370,67.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5 * 20,21",21,10.0,1526,72
3371,67.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,20 * 21",21,10.0,1525,72
3372,79.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,21,21,10.0,1524,72
3373,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,15,20,21",21,10.0,1523,72
3374,78.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21",21,10.0,1522,72
3375,73.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,13,20,21",21,10.0,1521,72
3376,87.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21",21,10.0,1520,72
3377,60.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,13,15,20,21",21,10.0,1519,72
3378,51.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,7,9,20,21",21,10.0,1518,72
3379,77.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,20,21",21,10.0,1517,72
3380,14.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGTU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",21,10.0,1516,72
3381,38.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGTU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",21,10.0,1515,72
3382,16.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGTU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",21,10.0,1514,72
3383,73.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,13,15,20,21",21,10.0,1513,72
3384,84.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,19,20",21,10.0,1512,72
3385,77.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20",21,10.0,1511,72
3386,76.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,15,20,21",21,10.0,1510,72
3387,69.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,19,20",21,10.0,1509,72
3388,77.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,19,21,10.0,1508,72
3389,79.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,20,21,10.0,1507,72
3390,71.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,2-Fluoro* 2-O-Methyl,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",21,10.0,1506,72
3391,74.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4",21,10.0,1505,72
3392,83.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"16,18",21,10.0,1504,72
3393,75.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGTU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,19,20 * 21",21,10.0,1503,72
3394,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGTU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20 * 21",21,10.0,1502,72
3395,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGTU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,19,20 * 21",21,10.0,1501,72
3396,78.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGTU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20 * 21",21,10.0,1500,72
3397,77 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGTU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14,19,20 * 21",21,10.0,1499,72
3398,66.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGTU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14 * 21",21,10.0,1498,72
3399,79.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGTU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,3,18,19,20 * 21",21,10.0,1497,72
3400,83 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20",21,10.0,1496,72
3401,75.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGTU,Altritol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21",21,10.0,1495,72
3402,45.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGTU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14,17 * 22",21,10.0,1494,72
3403,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGTU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"18,19 * 22",21,10.0,1493,72
3404,78.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGTU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2 * 22",21,10.0,1492,72
3405,50.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGTU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,14,17,22",21,10.0,1491,72
3406,73.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,8,14,17",21,10.0,1490,72
3407,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,2-Guanidinoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,18,21,10.0,1489,72
3408,81.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,18,21,10.0,1488,72
3409,66.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,0,4-C-Hydroxymethyl Deoxyribonucleic acid,0,"20,21",10.0,1487,72
3410,72.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCTTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","20,21",10.0,1486,72
3411,60.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,8,13,15,20,21","20,21",10.0,1485,72
3412,55.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCTTU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,21","20,21",10.0,1484,72
3413,76.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCTTU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,21,"20,21",10.0,1483,72
3414,20.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"10 * 21,22","20,21",10.0,1482,72
3415,47.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5 * 20,21","20,21",10.0,1481,72
3416,57.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,20 * 21","20,21",10.0,1480,72
3417,68.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCTTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,21,"20,21",10.0,1479,72
3418,68.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,15,20,21","20,21",10.0,1478,72
3419,69 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","20,21",10.0,1477,72
3420,57.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,13,20,21","20,21",10.0,1476,72
3421,78.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","20,21",10.0,1475,72
3422,48.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,13,15,20,21","20,21",10.0,1474,72
3423,33.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,7,9,20,21","20,21",10.0,1473,72
3424,65.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,20,21","20,21",10.0,1472,72
3425,0.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCTTU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","20,21",10.0,1471,72
3426,12.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCTTU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","20,21",10.0,1470,72
3427,13.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCTTU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","20,21",10.0,1469,72
3428,52.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCTTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,13,15,20,21","20,21",10.0,1468,72
3429,68.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCTTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,19,20","20,21",10.0,1467,72
3430,65.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCTTU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20","20,21",10.0,1466,72
3431,57.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCTTU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,15,20,21","20,21",10.0,1465,72
3432,51.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,19,20","20,21",10.0,1464,72
3433,60.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,19,"20,21",10.0,1463,72
3434,65.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,20,"20,21",10.0,1462,72
3435,65.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,2-Fluoro* 2-O-Methyl,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","20,21",10.0,1461,72
3436,58.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4","20,21",10.0,1460,72
3437,69.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"16,18","20,21",10.0,1459,72
3438,61.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCTTU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,19,20 * 21","20,21",10.0,1458,72
3439,69.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCTTU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20 * 21","20,21",10.0,1457,72
3440,66.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCTTU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,19,20 * 21","20,21",10.0,1456,72
3441,68.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCTTU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20 * 21","20,21",10.0,1455,72
3442,57.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCTTU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14,19,20 * 21","20,21",10.0,1454,72
3443,49 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCTTU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14 * 21","20,21",10.0,1453,72
3444,73 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCTTU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,3,18,19,20 * 21","20,21",10.0,1452,72
3445,62.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20","20,21",10.0,1451,72
3446,52.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCTTU,Altritol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","20,21",10.0,1450,72
3447,13.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCTTU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14,17 * 22","20,21",10.0,1449,72
3448,59.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCTTU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"18,19 * 22","20,21",10.0,1448,72
3449,66.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCTTU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2 * 22","20,21",10.0,1447,72
3450,30.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCTTU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,14,17,22","20,21",10.0,1446,72
3451,57.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,8,14,17","20,21",10.0,1445,72
3452,62.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,2-Guanidinoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,18,"20,21",10.0,1444,72
3453,56.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCTTU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,18,"20,21",10.0,1443,72
3454,87.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,0,"20,21",0,10.0,1441,72
3455,86.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,0,"3,8,13,15,20,21",0,10.0,1440,72
3456,87.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,0,"5,21",0,10.0,1439,72
3457,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,0,21,0,10.0,1438,72
3458,60.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,0,"10 * 21,22",0,10.0,1437,72
3459,79.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,0,"5 * 20,21",0,10.0,1436,72
3460,85 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,0,"5,20 * 21",0,10.0,1435,72
3461,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,0,21,0,10.0,1434,72
3462,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,0,"3,9,15,20,21",0,10.0,1433,72
3463,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,0,"20,21",0,10.0,1432,72
3464,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,0,"3,5,9,13,20,21",0,10.0,1431,72
3465,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,0,"20,21",0,10.0,1430,72
3466,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,0,"3,9,13,15,20,21",0,10.0,1429,72
3467,81.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,0,"3,5,7,9,20,21",0,10.0,1428,72
3468,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,0,"5,20,21",0,10.0,1427,72
3469,29 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,0,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",0,10.0,1426,72
3470,59.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,0,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",0,10.0,1425,72
3471,30.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,0,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",0,10.0,1424,72
3472,87.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,0,"3,9,13,15,20,21",0,10.0,1423,72
3473,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,0,"5,19,20",0,10.0,1422,72
3474,85.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,0,"19,20",0,10.0,1421,72
3475,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,0,"3,9,15,20,21",0,10.0,1420,72
3476,87.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,0,"5,19,20",0,10.0,1419,72
3477,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,0,19,0,10.0,1418,72
3478,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,0,20,0,10.0,1417,72
3479,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",0,10.0,1416,72
3480,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,0,"2,4",0,10.0,1415,72
3481,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,0,"16,18",0,10.0,1414,72
3482,83.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,0,"3,5,9,19,20 * 21",0,10.0,1413,72
3483,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,0,"19,20 * 21",0,10.0,1412,72
3484,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,0,"3,5,9,19,20 * 21",0,10.0,1411,72
3485,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,0,"19,20 * 21",0,10.0,1410,72
3486,87.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,0,"5,8,11,14,19,20 * 21",0,10.0,1409,72
3487,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,0,"5,8,11,14 * 21",0,10.0,1408,72
3488,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,0,"1,2,3,18,19,20 * 21",0,10.0,1407,72
3489,88.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,0,"19,20",0,10.0,1406,72
3490,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,0,"20,21",0,10.0,1405,72
3491,69.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,0,"5,8,11,14,17 * 22",0,10.0,1404,72
3492,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,0,"18,19 * 22",0,10.0,1403,72
3493,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,0,"1,2 * 22",0,10.0,1402,72
3494,59.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,0,"5,8,14,17,22",0,10.0,1401,72
3495,84.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,0,"2,8,14,17",0,10.0,1400,72
3496,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,0,18,0,10.0,1399,72
3497,89.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,0,18,0,10.0,1398,72
3498,86.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Alfa-L-Locked nucleic acid,0,21,10.0,1397,72
3499,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Alfa-L-Locked nucleic acid,"20,21",21,10.0,1396,72
3500,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Alfa-L-Locked nucleic acid,"3,8,13,15,20,21",21,10.0,1395,72
3501,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Alfa-L-Locked nucleic acid,"5,21",21,10.0,1394,72
3502,89.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Alfa-L-Locked nucleic acid,21,21,10.0,1393,72
3503,70 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Alfa-L-Locked nucleic acid,"10 * 21,22",21,10.0,1392,72
3504,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Alfa-L-Locked nucleic acid,"5 * 20,21",21,10.0,1391,72
3505,87 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Alfa-L-Locked nucleic acid,"5,20 * 21",21,10.0,1390,72
3506,89.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Alfa-L-Locked nucleic acid,21,21,10.0,1389,72
3507,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Alfa-L-Locked nucleic acid,"3,9,15,20,21",21,10.0,1388,72
3508,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Alfa-L-Locked nucleic acid,"20,21",21,10.0,1387,72
3509,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Alfa-L-Locked nucleic acid,"3,5,9,13,20,21",21,10.0,1386,72
3510,90.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Alfa-L-Locked nucleic acid,"20,21",21,10.0,1385,72
3511,83.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Alfa-L-Locked nucleic acid,"3,9,13,15,20,21",21,10.0,1384,72
3512,83.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Alfa-L-Locked nucleic acid,"3,5,7,9,20,21",21,10.0,1383,72
3513,90.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Alfa-L-Locked nucleic acid,"5,20,21",21,10.0,1382,72
3514,38.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Alfa-L-Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",21,10.0,1381,72
3515,66.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Alfa-L-Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",21,10.0,1380,72
3516,48.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Alfa-L-Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",21,10.0,1379,72
3517,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Alfa-L-Locked nucleic acid,"3,9,13,15,20,21",21,10.0,1378,72
3518,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Alfa-L-Locked nucleic acid,"5,19,20",21,10.0,1377,72
3519,84.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Alfa-L-Locked nucleic acid,"19,20",21,10.0,1376,72
3520,88.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Alfa-L-Locked nucleic acid,"3,9,15,20,21",21,10.0,1375,72
3521,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Alfa-L-Locked nucleic acid,"5,19,20",21,10.0,1374,72
3522,90 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Alfa-L-Locked nucleic acid,19,21,10.0,1373,72
3523,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Alfa-L-Locked nucleic acid,20,21,10.0,1372,72
3524,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Alfa-L-Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",21,10.0,1371,72
3525,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Alfa-L-Locked nucleic acid,"2,4",21,10.0,1370,72
3526,89.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Alfa-L-Locked nucleic acid,"16,18",21,10.0,1369,72
3527,83.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Alfa-L-Locked nucleic acid,"3,5,9,19,20 * 21",21,10.0,1368,72
3528,88.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Alfa-L-Locked nucleic acid,"19,20 * 21",21,10.0,1367,72
3529,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Alfa-L-Locked nucleic acid,"3,5,9,19,20 * 21",21,10.0,1366,72
3530,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Alfa-L-Locked nucleic acid,"19,20 * 21",21,10.0,1365,72
3531,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Alfa-L-Locked nucleic acid,"5,8,11,14,19,20 * 21",21,10.0,1364,72
3532,84.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Alfa-L-Locked nucleic acid,"5,8,11,14 * 21",21,10.0,1363,72
3533,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Alfa-L-Locked nucleic acid,"1,2,3,18,19,20 * 21",21,10.0,1362,72
3534,90.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Alfa-L-Locked nucleic acid,"19,20",21,10.0,1361,72
3535,82.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Alfa-L-Locked nucleic acid,"20,21",21,10.0,1360,72
3536,74.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Alfa-L-Locked nucleic acid,"5,8,11,14,17 * 22",21,10.0,1359,72
3537,91 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Alfa-L-Locked nucleic acid,"18,19 * 22",21,10.0,1358,72
3538,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Alfa-L-Locked nucleic acid,"1,2 * 22",21,10.0,1357,72
3539,69.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Alfa-L-Locked nucleic acid,"5,8,14,17,22",21,10.0,1356,72
3540,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Alfa-L-Locked nucleic acid,"2,8,14,17",21,10.0,1355,72
3541,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Alfa-L-Locked nucleic acid,18,21,10.0,1354,72
3542,90.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Alfa-L-Locked nucleic acid,18,21,10.0,1353,72
3543,82.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,4-C-Hydroxymethyl Deoxyribonucleic acid,0,"19,21",10.0,1352,72
3544,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","19,21",10.0,1351,72
3545,69.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,8,13,15,20,21","19,21",10.0,1350,72
3546,82.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,21","19,21",10.0,1349,72
3547,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,21,"19,21",10.0,1348,72
3548,63.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"10 * 21,22","19,21",10.0,1347,72
3549,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5 * 20,21","19,21",10.0,1346,72
3550,74.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,20 * 21","19,21",10.0,1345,72
3551,85.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,21,"19,21",10.0,1344,72
3552,84.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,15,20,21","19,21",10.0,1343,72
3553,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","19,21",10.0,1342,72
3554,82.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,13,20,21","19,21",10.0,1341,72
3555,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","19,21",10.0,1340,72
3556,67.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,13,15,20,21","19,21",10.0,1339,72
3557,49.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,7,9,20,21","19,21",10.0,1338,72
3558,83.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,20,21","19,21",10.0,1337,72
3559,14.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","19,21",10.0,1336,72
3560,41.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","19,21",10.0,1335,72
3561,36.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","19,21",10.0,1334,72
3562,83.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,13,15,20,21","19,21",10.0,1333,72
3563,83.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,19,20","19,21",10.0,1332,72
3564,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20","19,21",10.0,1331,72
3565,81.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,9,15,20,21","19,21",10.0,1330,72
3566,76.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,19,20","19,21",10.0,1329,72
3567,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,19,"19,21",10.0,1328,72
3568,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,20,"19,21",10.0,1327,72
3569,69.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","19,21",10.0,1326,72
3570,79.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4","19,21",10.0,1325,72
3571,86.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"16,18","19,21",10.0,1324,72
3572,80.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,19,20 * 21","19,21",10.0,1323,72
3573,85.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20 * 21","19,21",10.0,1322,72
3574,85.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"3,5,9,19,20 * 21","19,21",10.0,1321,72
3575,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20 * 21","19,21",10.0,1320,72
3576,82.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14,19,20 * 21","19,21",10.0,1319,72
3577,68.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14 * 21","19,21",10.0,1318,72
3578,83.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2,3,18,19,20 * 21","19,21",10.0,1317,72
3579,91.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"19,20","19,21",10.0,1316,72
3580,82 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"20,21","19,21",10.0,1315,72
3581,58.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,11,14,17 * 22","19,21",10.0,1314,72
3582,86.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"18,19 * 22","19,21",10.0,1313,72
3583,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid,"1,2 * 22","19,21",10.0,1312,72
3584,48.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"5,8,14,17,22","19,21",10.0,1311,72
3585,73.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,8,14,17","19,21",10.0,1310,72
3586,84.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,18,"19,21",10.0,1309,72
3587,89.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid,18,"19,21",10.0,1308,72
3588,46.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,0,Locked nucleic acid,0,"3,6,14,18,20,21",10.0,1307,72
3589,47 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,1306,72
3590,6.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,Locked nucleic acid,"3,8,13,15,20,21","3,6,14,18,20,21",10.0,1305,72
3591,39.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid,Locked nucleic acid,"5,21","3,6,14,18,20,21",10.0,1304,72
3592,57.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid,Locked nucleic acid,21,"3,6,14,18,20,21",10.0,1303,72
3593,7.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"10 * 21,22","3,6,14,18,20,21",10.0,1302,72
3594,23.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5 * 20,21","3,6,14,18,20,21",10.0,1301,72
3595,43.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5,20 * 21","3,6,14,18,20,21",10.0,1300,72
3596,56.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,21,"3,6,14,18,20,21",10.0,1299,72
3597,22.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Alfa-L-Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","3,6,14,18,20,21",10.0,1298,72
3598,49.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Alfa-L-Locked nucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,1297,72
3599,16.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"3,5,9,13,20,21","3,6,14,18,20,21",10.0,1296,72
3600,66.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,1295,72
3601,0.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","3,6,14,18,20,21",10.0,1294,72
3602,11 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,Locked nucleic acid,"3,5,7,9,20,21","3,6,14,18,20,21",10.0,1293,72
3603,53.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,Locked nucleic acid,"5,20,21","3,6,14,18,20,21",10.0,1292,72
3604,11.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,6,14,18,20,21",10.0,1291,72
3605,5.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,6,14,18,20,21",10.0,1290,72
3606,16.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,6,14,18,20,21",10.0,1289,72
3607,66 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","3,6,14,18,20,21",10.0,1288,72
3608,44.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"5,19,20","3,6,14,18,20,21",10.0,1287,72
3609,46.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"19,20","3,6,14,18,20,21",10.0,1286,72
3610,32.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","3,6,14,18,20,21",10.0,1285,72
3611,16.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,Locked nucleic acid,"5,19,20","3,6,14,18,20,21",10.0,1284,72
3612,52.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,Locked nucleic acid,19,"3,6,14,18,20,21",10.0,1283,72
3613,55.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,Locked nucleic acid,20,"3,6,14,18,20,21",10.0,1282,72
3614,0.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Fluoro* 2-O-Methyl,Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,6,14,18,20,21",10.0,1281,72
3615,26.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Oxetane-Locked nucleic acid,Locked nucleic acid,"2,4","3,6,14,18,20,21",10.0,1280,72
3616,66.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Oxetane-Locked nucleic acid,Locked nucleic acid,"16,18","3,6,14,18,20,21",10.0,1279,72
3617,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","3,6,14,18,20,21",10.0,1278,72
3618,59.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","3,6,14,18,20,21",10.0,1277,72
3619,9.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","3,6,14,18,20,21",10.0,1276,72
3620,56.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","3,6,14,18,20,21",10.0,1275,72
3621,6.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,19,20 * 21","3,6,14,18,20,21",10.0,1274,72
3622,16.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14 * 21","3,6,14,18,20,21",10.0,1273,72
3623,23.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2,3,18,19,20 * 21","3,6,14,18,20,21",10.0,1272,72
3624,70.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid,Locked nucleic acid,"19,20","3,6,14,18,20,21",10.0,1271,72
3625,43.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid,Locked nucleic acid,"20,21","3,6,14,18,20,21",10.0,1270,72
3626,8.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,17 * 22","3,6,14,18,20,21",10.0,1269,72
3627,48.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"18,19 * 22","3,6,14,18,20,21",10.0,1268,72
3628,54 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2 * 22","3,6,14,18,20,21",10.0,1267,72
3629,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid,Locked nucleic acid,"5,8,14,17,22","3,6,14,18,20,21",10.0,1266,72
3630,9.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid,Locked nucleic acid,"2,8,14,17","3,6,14,18,20,21",10.0,1265,72
3631,63 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Guanidinoethyl,Locked nucleic acid,18,"3,6,14,18,20,21",10.0,1264,72
3632,72.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,Locked nucleic acid,18,"3,6,14,18,20,21",10.0,1263,72
3633,91.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Locked nucleic acid,0,"20,21",10.0,1262,72
3634,90.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"20,21","20,21",10.0,1261,72
3635,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,8,13,15,20,21","20,21",10.0,1260,72
3636,90.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Locked nucleic acid,"5,21","20,21",10.0,1259,72
3637,91.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Locked nucleic acid,21,"20,21",10.0,1258,72
3638,82.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"10 * 21,22","20,21",10.0,1257,72
3639,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5 * 20,21","20,21",10.0,1256,72
3640,90.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Locked nucleic acid,"5,20 * 21","20,21",10.0,1255,72
3641,90.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,21,"20,21",10.0,1254,72
3642,90.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","20,21",10.0,1253,72
3643,89.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Locked nucleic acid,"20,21","20,21",10.0,1252,72
3644,26.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"3,5,9,13,20,21","20,21",10.0,1251,72
3645,90.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"20,21","20,21",10.0,1250,72
3646,91.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",10.0,1249,72
3647,86.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,5,7,9,20,21","20,21",10.0,1248,72
3648,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"5,20,21","20,21",10.0,1247,72
3649,91.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","20,21",10.0,1246,72
3650,33.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","20,21",10.0,1245,72
3651,60.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","20,21",10.0,1244,72
3652,52.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",10.0,1243,72
3653,90.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,13,15,20,21","20,21",10.0,1242,72
3654,91.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Locked nucleic acid,"19,20","20,21",10.0,1241,72
3655,87.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Locked nucleic acid,"3,9,15,20,21","20,21",10.0,1240,72
3656,91.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,"5,19,20","20,21",10.0,1239,72
3657,91 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,19,"20,21",10.0,1238,72
3658,90.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,20,"20,21",10.0,1237,72
3659,90.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","20,21",10.0,1236,72
3660,90.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Locked nucleic acid,"2,4","20,21",10.0,1235,72
3661,90.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Locked nucleic acid,"16,18","20,21",10.0,1234,72
3662,90.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","20,21",10.0,1233,72
3663,87.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","20,21",10.0,1232,72
3664,90.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"3,5,9,19,20 * 21","20,21",10.0,1231,72
3665,90.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Locked nucleic acid,"19,20 * 21","20,21",10.0,1230,72
3666,90.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,19,20 * 21","20,21",10.0,1229,72
3667,90 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14 * 21","20,21",10.0,1228,72
3668,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2,3,18,19,20 * 21","20,21",10.0,1227,72
3669,90 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Locked nucleic acid,"19,20","20,21",10.0,1226,72
3670,90.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Locked nucleic acid,"20,21","20,21",10.0,1225,72
3671,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"5,8,11,14,17 * 22","20,21",10.0,1224,72
3672,85 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"18,19 * 22","20,21",10.0,1223,72
3673,90.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Locked nucleic acid,"1,2 * 22","20,21",10.0,1222,72
3674,90.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Locked nucleic acid,"5,8,14,17,22","20,21",10.0,1221,72
3675,81.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Locked nucleic acid,"2,8,14,17","20,21",10.0,1220,72
3676,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Locked nucleic acid,18,"20,21",10.0,1219,72
3677,91.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Locked nucleic acid,18,"20,21",10.0,1218,72
3679,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,0,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,0,"3,6,14,18 * 20,21",10.0,1216,72
3680,24.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","3,6,14,18 * 20,21",10.0,1215,72
3681,39.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,8,13,15,20,21","3,6,14,18 * 20,21",10.0,1214,72
3682,8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,21","3,6,14,18 * 20,21",10.0,1213,72
3683,28.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,21,"3,6,14,18 * 20,21",10.0,1212,72
3684,29.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"10 * 21,22","3,6,14,18 * 20,21",10.0,1211,72
3685,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5 * 20,21","3,6,14,18 * 20,21",10.0,1210,72
3686,13.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,20 * 21","3,6,14,18 * 20,21",10.0,1209,72
3687,14.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,21,"3,6,14,18 * 20,21",10.0,1208,72
3688,35.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,21,"3,6,14,18 * 20,21",10.0,1207,72
3689,48.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","3,6,14,18 * 20,21",10.0,1206,72
3690,46.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,9,13,20,21","3,6,14,18 * 20,21",10.0,1205,72
3691,24.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","3,6,14,18 * 20,21",10.0,1204,72
3692,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,9,13,15,20,21","3,6,14,18 * 20,21",10.0,1203,72
3693,6.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,7,9,20,21","3,6,14,18 * 20,21",10.0,1202,72
3694,21.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,20,21","3,6,14,18 * 20,21",10.0,1201,72
3695,14.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,6,14,18 * 20,21",10.0,1200,72
3696,17.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,6,14,18 * 20,21",10.0,1199,72
3697,14.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACTUGTGGCCGUUTACGTCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,6,14,18 * 20,21",10.0,1198,72
3698,46.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,9,13,15,20,21","3,6,14,18 * 20,21",10.0,1197,72
3699,34.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,19,20","3,6,14,18 * 20,21",10.0,1196,72
3700,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACTUGTGGCCGUUTACGTCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20","3,6,14,18 * 20,21",10.0,1195,72
3701,11.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACTUGTGGCCGUUTACGTCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,9,15,20,21","3,6,14,18 * 20,21",10.0,1194,72
3702,40.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,19,20","3,6,14,18 * 20,21",10.0,1193,72
3703,12.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,19,"3,6,14,18 * 20,21",10.0,1192,72
3704,26.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,20,"3,6,14,18 * 20,21",10.0,1191,72
3705,32.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Fluoro* 2-O-Methyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,6,14,18 * 20,21",10.0,1190,72
3706,50 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"2,4","3,6,14,18 * 20,21",10.0,1189,72
3707,35.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"16,18","3,6,14,18 * 20,21",10.0,1188,72
3708,5.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","3,6,14,18 * 20,21",10.0,1187,72
3709,34.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20 * 21","3,6,14,18 * 20,21",10.0,1186,72
3710,26.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","3,6,14,18 * 20,21",10.0,1185,72
3711,30.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20 * 21","3,6,14,18 * 20,21",10.0,1184,72
3712,20.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","3,6,14,18 * 20,21",10.0,1183,72
3713,33.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,11,14 * 21","3,6,14,18 * 20,21",10.0,1182,72
3714,29.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","3,6,14,18 * 20,21",10.0,1181,72
3715,5.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20","3,6,14,18 * 20,21",10.0,1180,72
3716,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","3,6,14,18 * 20,21",10.0,1179,72
3717,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","3,6,14,18 * 20,21",10.0,1178,72
3718,5.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"18,19 * 22","3,6,14,18 * 20,21",10.0,1177,72
3719,15.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2 * 22","3,6,14,18 * 20,21",10.0,1176,72
3720,23.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,14,17,22","3,6,14,18 * 20,21",10.0,1175,72
3721,32.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"2,8,14,17","3,6,14,18 * 20,21",10.0,1174,72
3722,26.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Guanidinoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,18,"3,6,14,18 * 20,21",10.0,1173,72
3723,26.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACTUGTGGCCGUUTACGTCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,18,"3,6,14,18 * 20,21",10.0,1172,72
3724,89.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,0,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,0,"6 * 20,21",10.0,1171,72
3725,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1170,72
3726,80.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,8,13,15,20,21","6 * 20,21",10.0,1169,72
3727,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,21","6 * 20,21",10.0,1168,72
3728,93.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1167,72
3729,78.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"10 * 21,22","6 * 20,21",10.0,1166,72
3730,86.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5 * 20,21","6 * 20,21",10.0,1165,72
3731,81.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,20 * 21","6 * 20,21",10.0,1164,72
3732,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,21,"6 * 20,21",10.0,1163,72
3733,87.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1162,72
3734,86.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1161,72
3735,88.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,9,13,20,21","6 * 20,21",10.0,1160,72
3736,94.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1159,72
3737,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1158,72
3738,64.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,7,9,20,21","6 * 20,21",10.0,1157,72
3739,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,20,21","6 * 20,21",10.0,1156,72
3740,20.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","6 * 20,21",10.0,1155,72
3741,34.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","6 * 20,21",10.0,1154,72
3742,14.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGTGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","6 * 20,21",10.0,1153,72
3743,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,9,13,15,20,21","6 * 20,21",10.0,1152,72
3744,92.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1151,72
3745,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGTGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1150,72
3746,89.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGTGGCCGUUUACGUCGCU,Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,9,15,20,21","6 * 20,21",10.0,1149,72
3747,85.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,19,20","6 * 20,21",10.0,1148,72
3748,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,19,"6 * 20,21",10.0,1147,72
3749,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,20,"6 * 20,21",10.0,1146,72
3750,67.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","6 * 20,21",10.0,1145,72
3751,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"2,4","6 * 20,21",10.0,1144,72
3752,91.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"16,18","6 * 20,21",10.0,1143,72
3753,86.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1142,72
3754,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1141,72
3755,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"3,5,9,19,20 * 21","6 * 20,21",10.0,1140,72
3756,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20 * 21","6 * 20,21",10.0,1139,72
3757,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,11,14,19,20 * 21","6 * 20,21",10.0,1138,72
3758,78.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,11,14 * 21","6 * 20,21",10.0,1137,72
3759,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2,3,18,19,20 * 21","6 * 20,21",10.0,1136,72
3760,90.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"19,20","6 * 20,21",10.0,1135,72
3761,86.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"20,21","6 * 20,21",10.0,1134,72
3762,47.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,11,14,17 * 22","6 * 20,21",10.0,1133,72
3763,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"18,19 * 22","6 * 20,21",10.0,1132,72
3764,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"1,2 * 22","6 * 20,21",10.0,1131,72
3765,48.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"5,8,14,17,22","6 * 20,21",10.0,1130,72
3766,83.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,Hexitol nucleic acid,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,"2,8,14,17","6 * 20,21",10.0,1129,72
3767,88.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Guanidinoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1128,72
3768,90.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGTGGCCGUUUACGUCGCU,2-Aminoethyl,4-C-Hydroxymethyl Deoxyribonucleic acid* Locked nucleic acid,18,"6 * 20,21",10.0,1127,72
3769,55.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,2-Aminopropyl,0,1,10.0,1126,72
3770,58.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminopropyl,"20,21",1,10.0,1125,72
3771,12.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminopropyl,"3,8,13,15,20,21",1,10.0,1124,72
3772,38 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-Aminopropyl,"5,21",1,10.0,1123,72
3773,70.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-Aminopropyl,21,1,10.0,1122,72
3774,8.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-Aminopropyl,"10 * 21,22",1,10.0,1121,72
3775,17.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-Aminopropyl,"5 * 20,21",1,10.0,1120,72
3776,35.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-Aminopropyl,"5,20 * 21",1,10.0,1119,72
3777,50.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropyl,21,1,10.0,1118,72
3778,46.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-Aminopropyl,"3,9,15,20,21",1,10.0,1117,72
3779,56.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-Aminopropyl,"20,21",1,10.0,1116,72
3780,50.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropyl,"3,5,9,13,20,21",1,10.0,1115,72
3781,73.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropyl,"20,21",1,10.0,1114,72
3782,8.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminopropyl,"3,9,13,15,20,21",1,10.0,1113,72
3783,8.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminopropyl,"3,5,7,9,20,21",1,10.0,1112,72
3784,30 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminopropyl,"5,20,21",1,10.0,1111,72
3785,16.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-Aminopropyl,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",1,10.0,1110,72
3786,28.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-Aminopropyl,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",1,10.0,1109,72
3787,15.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-Aminopropyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",1,10.0,1108,72
3788,53.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminopropyl,"3,9,13,15,20,21",1,10.0,1107,72
3789,64.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropyl,"5,19,20",1,10.0,1106,72
3790,44 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropyl,"19,20",1,10.0,1105,72
3791,37 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminopropyl,"3,9,15,20,21",1,10.0,1104,72
3792,55.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminopropyl,"5,19,20",1,10.0,1103,72
3793,54.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminopropyl,19,1,10.0,1102,72
3794,62 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminopropyl,20,1,10.0,1101,72
3795,40.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,2-Aminopropyl,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",1,10.0,1100,72
3796,52.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-Aminopropyl,"2,4",1,10.0,1099,72
3797,69.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-Aminopropyl,"16,18",1,10.0,1098,72
3798,41.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-Aminopropyl,"3,5,9,19,20 * 21",1,10.0,1097,72
3799,57.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-Aminopropyl,"19,20 * 21",1,10.0,1096,72
3800,50.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-Aminopropyl,"3,5,9,19,20 * 21",1,10.0,1095,72
3801,60.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-Aminopropyl,"19,20 * 21",1,10.0,1094,72
3802,58 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-Aminopropyl,"5,8,11,14,19,20 * 21",1,10.0,1093,72
3803,48.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-Aminopropyl,"5,8,11,14 * 21",1,10.0,1092,72
3804,60.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-Aminopropyl,"1,2,3,18,19,20 * 21",1,10.0,1091,72
3805,55.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-Aminopropyl,"19,20",1,10.0,1090,72
3806,40.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,2-Aminopropyl,"20,21",1,10.0,1089,72
3807,31.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-Aminopropyl,"5,8,11,14,17 * 22",1,10.0,1088,72
3808,46.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-Aminopropyl,"18,19 * 22",1,10.0,1087,72
3809,49.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-Aminopropyl,"1,2 * 22",1,10.0,1086,72
3810,38.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-Aminopropyl,"5,8,14,17,22",1,10.0,1085,72
3811,59.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-Aminopropyl,"2,8,14,17",1,10.0,1084,72
3812,55.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,2-Aminopropyl,18,1,10.0,1083,72
3813,41 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminopropyl,18,1,10.0,1082,72
3814,86.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,2-Aminoethyl,0,"20,21",10.0,1081,72
3815,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminoethyl,"20,21","20,21",10.0,1080,72
3816,88.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminoethyl,"3,8,13,15,20,21","20,21",10.0,1079,72
3817,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-Aminoethyl,"5,21","20,21",10.0,1078,72
3818,90.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-Aminoethyl,21,"20,21",10.0,1077,72
3819,50.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-Aminoethyl,"10 * 21,22","20,21",10.0,1076,72
3820,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-Aminoethyl,"5 * 20,21","20,21",10.0,1075,72
3821,86.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-Aminoethyl,"5,20 * 21","20,21",10.0,1074,72
3822,88.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethyl,21,"20,21",10.0,1073,72
3823,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-Aminoethyl,"3,9,15,20,21","20,21",10.0,1072,72
3824,89.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-Aminoethyl,"20,21","20,21",10.0,1071,72
3825,87.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethyl,"3,5,9,13,20,21","20,21",10.0,1070,72
3826,89.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethyl,"20,21","20,21",10.0,1069,72
3827,85 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminoethyl,"3,9,13,15,20,21","20,21",10.0,1068,72
3828,84.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminoethyl,"3,5,7,9,20,21","20,21",10.0,1067,72
3829,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminoethyl,"5,20,21","20,21",10.0,1066,72
3830,10.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-Aminoethyl,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","20,21",10.0,1065,72
3831,25.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-Aminoethyl,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","20,21",10.0,1064,72
3832,43.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-Aminoethyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","20,21",10.0,1063,72
3833,90 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminoethyl,"3,9,13,15,20,21","20,21",10.0,1062,72
3834,90.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethyl,"5,19,20","20,21",10.0,1061,72
3835,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethyl,"19,20","20,21",10.0,1060,72
3836,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-Aminoethyl,"3,9,15,20,21","20,21",10.0,1059,72
3837,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminoethyl,"5,19,20","20,21",10.0,1058,72
3838,90.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminoethyl,19,"20,21",10.0,1057,72
3839,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminoethyl,20,"20,21",10.0,1056,72
3840,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,2-Aminoethyl,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","20,21",10.0,1055,72
3841,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-Aminoethyl,"2,4","20,21",10.0,1054,72
3842,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-Aminoethyl,"16,18","20,21",10.0,1053,72
3843,82.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-Aminoethyl,"3,5,9,19,20 * 21","20,21",10.0,1052,72
3844,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-Aminoethyl,"19,20 * 21","20,21",10.0,1051,72
3845,89.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-Aminoethyl,"3,5,9,19,20 * 21","20,21",10.0,1050,72
3846,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-Aminoethyl,"19,20 * 21","20,21",10.0,1049,72
3847,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-Aminoethyl,"5,8,11,14,19,20 * 21","20,21",10.0,1048,72
3848,69.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-Aminoethyl,"5,8,11,14 * 21","20,21",10.0,1047,72
3849,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-Aminoethyl,"1,2,3,18,19,20 * 21","20,21",10.0,1046,72
3850,90.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-Aminoethyl,"19,20","20,21",10.0,1045,72
3851,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,2-Aminoethyl,"20,21","20,21",10.0,1044,72
3852,56.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-Aminoethyl,"5,8,11,14,17 * 22","20,21",10.0,1043,72
3853,90.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-Aminoethyl,"18,19 * 22","20,21",10.0,1042,72
3854,90.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-Aminoethyl,"1,2 * 22","20,21",10.0,1041,72
3855,40 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-Aminoethyl,"5,8,14,17,22","20,21",10.0,1040,72
3856,85 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-Aminoethyl,"2,8,14,17","20,21",10.0,1039,72
3857,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,2-Aminoethyl,18,"20,21",10.0,1038,72
3858,90.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-Aminoethyl,18,"20,21",10.0,1037,72
3859,68.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",0,"3,4,18",10.0,1036,72
3860,70.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,1035,72
3861,10.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,8,13,15,20,21","3,4,18",10.0,1034,72
3862,66.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,21","3,4,18",10.0,1033,72
3863,76.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",21,"3,4,18",10.0,1032,72
3864,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","10 * 21,22","3,4,18",10.0,1031,72
3865,40.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5 * 20,21","3,4,18",10.0,1030,72
3866,40.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,20 * 21","3,4,18",10.0,1029,72
3867,75.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",21,"3,4,18",10.0,1028,72
3868,71.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,15,20,21","3,4,18",10.0,1027,72
3869,71.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,1026,72
3870,41 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,13,20,21","3,4,18",10.0,1025,72
3871,79.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,1024,72
3872,4.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,4,18",10.0,1023,72
3873,1.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,7,9,20,21","3,4,18",10.0,1022,72
3874,72.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,20,21","3,4,18",10.0,1021,72
3875,5.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,4,18",10.0,1020,72
3876,14.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,4,18",10.0,1019,72
3877,28.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,4,18",10.0,1018,72
3878,67.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,4,18",10.0,1017,72
3879,78 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,19,20","3,4,18",10.0,1016,72
3880,73.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20","3,4,18",10.0,1015,72
3881,70.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,15,20,21","3,4,18",10.0,1014,72
3882,62.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,19,20","3,4,18",10.0,1013,72
3883,72.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",19,"3,4,18",10.0,1012,72
3884,77.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",20,"3,4,18",10.0,1011,72
3885,26.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,4,18",10.0,1010,72
3886,70.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","2,4","3,4,18",10.0,1009,72
3887,84.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","16,18","3,4,18",10.0,1008,72
3888,38 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,4,18",10.0,1007,72
3889,76.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20 * 21","3,4,18",10.0,1006,72
3890,50.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,4,18",10.0,1005,72
3891,73.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20 * 21","3,4,18",10.0,1004,72
3892,48.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14,19,20 * 21","3,4,18",10.0,1003,72
3893,32.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14 * 21","3,4,18",10.0,1002,72
3894,75.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,3,18,19,20 * 21","3,4,18",10.0,1001,72
3895,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20","3,4,18",10.0,1000,72
3896,67.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,999,72
3897,16 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14,17 * 22","3,4,18",10.0,998,72
3898,78.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","18,19 * 22","3,4,18",10.0,997,72
3899,73.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2 * 22","3,4,18",10.0,996,72
3900,11 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,14,17,22","3,4,18",10.0,995,72
3901,44.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","2,8,14,17","3,4,18",10.0,994,72
3902,77.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",18,"3,4,18",10.0,993,72
3903,85.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",18,"3,4,18",10.0,992,72
3904,69.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",0,"4,18",10.0,991,72
3905,79.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","4,18",10.0,990,72
3906,1.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,8,13,15,20,21","4,18",10.0,989,72
3907,64.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,21","4,18",10.0,988,72
3908,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",21,"4,18",10.0,987,72
3909,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","10 * 21,22","4,18",10.0,986,72
3910,7.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5 * 20,21","4,18",10.0,985,72
3911,20.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,20 * 21","4,18",10.0,984,72
3912,79.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",21,"4,18",10.0,983,72
3913,61.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,15,20,21","4,18",10.0,982,72
3914,82.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","4,18",10.0,981,72
3915,47.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,13,20,21","4,18",10.0,980,72
3916,67 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","4,18",10.0,979,72
3917,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,13,15,20,21","4,18",10.0,978,72
3918,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,7,9,20,21","4,18",10.0,977,72
3919,28.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,20,21","4,18",10.0,976,72
3920,2.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","4,18",10.0,975,72
3921,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","4,18",10.0,974,72
3922,4.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","4,18",10.0,973,72
3923,78 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,13,15,20,21","4,18",10.0,972,72
3924,22.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,19,20","4,18",10.0,971,72
3925,68.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20","4,18",10.0,970,72
3926,15.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,15,20,21","4,18",10.0,969,72
3927,25.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,19,20","4,18",10.0,968,72
3928,56 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",19,"4,18",10.0,967,72
3929,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",20,"4,18",10.0,966,72
3930,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","4,18",10.0,965,72
3931,45.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","2,4","4,18",10.0,964,72
3932,85.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","16,18","4,18",10.0,963,72
3933,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","4,18",10.0,962,72
3934,80.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20 * 21","4,18",10.0,961,72
3935,74 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","4,18",10.0,960,72
3936,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20 * 21","4,18",10.0,959,72
3937,8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14,19,20 * 21","4,18",10.0,958,72
3938,13.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14 * 21","4,18",10.0,957,72
3939,62 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,3,18,19,20 * 21","4,18",10.0,956,72
3940,36.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20","4,18",10.0,955,72
3941,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","4,18",10.0,954,72
3942,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14,17 * 22","4,18",10.0,953,72
3943,52.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","18,19 * 22","4,18",10.0,952,72
3944,81 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2 * 22","4,18",10.0,951,72
3945,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,14,17,22","4,18",10.0,950,72
3946,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","2,8,14,17","4,18",10.0,949,72
3947,81.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",18,"4,18",10.0,948,72
3948,82.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",18,"4,18",10.0,947,72
3949,72.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",0,"3,18",10.0,946,72
3950,77.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,18",10.0,945,72
3951,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,8,13,15,20,21","3,18",10.0,944,72
3952,71 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,21","3,18",10.0,943,72
3953,80.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",21,"3,18",10.0,942,72
3954,29.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","10 * 21,22","3,18",10.0,941,72
3955,48.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5 * 20,21","3,18",10.0,940,72
3956,16.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,20 * 21","3,18",10.0,939,72
3957,79.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",21,"3,18",10.0,938,72
3958,68.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,15,20,21","3,18",10.0,937,72
3959,80.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,18",10.0,936,72
3960,42.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,13,20,21","3,18",10.0,935,72
3961,82.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,18",10.0,934,72
3962,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,18",10.0,933,72
3963,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,7,9,20,21","3,18",10.0,932,72
3964,66.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,20,21","3,18",10.0,931,72
3965,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,18",10.0,930,72
3966,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,18",10.0,929,72
3967,14.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,18",10.0,928,72
3968,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,18",10.0,927,72
3969,46.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,19,20","3,18",10.0,926,72
3970,73.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20","3,18",10.0,925,72
3971,59.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,9,15,20,21","3,18",10.0,924,72
3972,20.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,19,20","3,18",10.0,923,72
3973,74.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",19,"3,18",10.0,922,72
3974,78.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",20,"3,18",10.0,921,72
3975,16.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,18",10.0,920,72
3976,39.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","2,4","3,18",10.0,919,72
3977,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","16,18","3,18",10.0,918,72
3978,7.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,18",10.0,917,72
3979,79.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20 * 21","3,18",10.0,916,72
3980,29.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,18",10.0,915,72
3981,78.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20 * 21","3,18",10.0,914,72
3982,25.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14,19,20 * 21","3,18",10.0,913,72
3983,11.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14 * 21","3,18",10.0,912,72
3984,77.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2,3,18,19,20 * 21","3,18",10.0,911,72
3985,83.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","19,20","3,18",10.0,910,72
3986,73.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","20,21","3,18",10.0,909,72
3987,25.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,11,14,17 * 22","3,18",10.0,908,72
3988,76.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","18,19 * 22","3,18",10.0,907,72
3989,75.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","1,2 * 22","3,18",10.0,906,72
3990,8.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","5,8,14,17,22","3,18",10.0,905,72
3991,4.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid","2,8,14,17","3,18",10.0,904,72
3992,77.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",18,"3,18",10.0,903,72
3993,85.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Locked nucleic acid-Locked nucleic acid",18,"3,18",10.0,902,72
3994,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",0,"3,4,18",10.0,901,72
3995,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,900,72
3996,69 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,8,13,15,20,21","3,4,18",10.0,899,72
3997,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,21","3,4,18",10.0,898,72
3998,89.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",21,"3,4,18",10.0,897,72
3999,18 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","10 * 21,22","3,4,18",10.0,896,72
4000,67.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5 * 20,21","3,4,18",10.0,895,72
4001,75 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,20 * 21","3,4,18",10.0,894,72
4002,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",21,"3,4,18",10.0,893,72
4003,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,15,20,21","3,4,18",10.0,892,72
4004,89.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,891,72
4005,86.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,13,20,21","3,4,18",10.0,890,72
4006,91.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,889,72
4007,57.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,4,18",10.0,888,72
4008,19.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,7,9,20,21","3,4,18",10.0,887,72
4009,87.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,20,21","3,4,18",10.0,886,72
4010,4.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,4,18",10.0,885,72
4011,5.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,4,18",10.0,884,72
4012,4.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,4,18",10.0,883,72
4013,87.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,4,18",10.0,882,72
4014,91.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,19,20","3,4,18",10.0,881,72
4015,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20","3,4,18",10.0,880,72
4016,85.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,15,20,21","3,4,18",10.0,879,72
4017,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,19,20","3,4,18",10.0,878,72
4018,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",19,"3,4,18",10.0,877,72
4019,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",20,"3,4,18",10.0,876,72
4020,86.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,4,18",10.0,875,72
4021,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","2,4","3,4,18",10.0,874,72
4022,93.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","16,18","3,4,18",10.0,873,72
4023,82.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,4,18",10.0,872,72
4024,89.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20 * 21","3,4,18",10.0,871,72
4025,86.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,4,18",10.0,870,72
4026,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20 * 21","3,4,18",10.0,869,72
4027,84.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14,19,20 * 21","3,4,18",10.0,868,72
4028,49.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14 * 21","3,4,18",10.0,867,72
4029,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,3,18,19,20 * 21","3,4,18",10.0,866,72
4030,92.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20","3,4,18",10.0,865,72
4031,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,4,18",10.0,864,72
4032,34.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14,17 * 22","3,4,18",10.0,863,72
4033,89.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","18,19 * 22","3,4,18",10.0,862,72
4034,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2 * 22","3,4,18",10.0,861,72
4035,10.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,14,17,22","3,4,18",10.0,860,72
4036,57.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","2,8,14,17","3,4,18",10.0,859,72
4037,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",18,"3,4,18",10.0,858,72
4038,93.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",18,"3,4,18",10.0,857,72
4039,80.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",0,"4,18",10.0,856,72
4040,79.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","4,18",10.0,855,72
4041,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,8,13,15,20,21","4,18",10.0,854,72
4042,56.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,21","4,18",10.0,853,72
4043,78.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",21,"4,18",10.0,852,72
4044,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","10 * 21,22","4,18",10.0,851,72
4045,0.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5 * 20,21","4,18",10.0,850,72
4046,21.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,20 * 21","4,18",10.0,849,72
4047,79.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",21,"4,18",10.0,848,72
4048,46.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,15,20,21","4,18",10.0,847,72
4049,80.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","4,18",10.0,846,72
4050,42.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,13,20,21","4,18",10.0,845,72
4051,62.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","4,18",10.0,844,72
4052,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,13,15,20,21","4,18",10.0,843,72
4053,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,7,9,20,21","4,18",10.0,842,72
4054,25.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,20,21","4,18",10.0,841,72
4055,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","4,18",10.0,840,72
4056,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","4,18",10.0,839,72
4057,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","4,18",10.0,838,72
4058,74.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,13,15,20,21","4,18",10.0,837,72
4059,46 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,19,20","4,18",10.0,836,72
4060,65.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20","4,18",10.0,835,72
4061,15.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,15,20,21","4,18",10.0,834,72
4062,14.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,19,20","4,18",10.0,833,72
4063,45 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",19,"4,18",10.0,832,72
4064,76.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",20,"4,18",10.0,831,72
4065,8.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","4,18",10.0,830,72
4066,65.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","2,4","4,18",10.0,829,72
4067,83.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","16,18","4,18",10.0,828,72
4068,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","4,18",10.0,827,72
4069,80.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20 * 21","4,18",10.0,826,72
4070,26.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","4,18",10.0,825,72
4071,79.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20 * 21","4,18",10.0,824,72
4072,5.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14,19,20 * 21","4,18",10.0,823,72
4073,19.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14 * 21","4,18",10.0,822,72
4074,75.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,3,18,19,20 * 21","4,18",10.0,821,72
4075,10.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20","4,18",10.0,820,72
4076,49.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","4,18",10.0,819,72
4077,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14,17 * 22","4,18",10.0,818,72
4078,50 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","18,19 * 22","4,18",10.0,817,72
4079,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2 * 22","4,18",10.0,816,72
4080,0.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,14,17,22","4,18",10.0,815,72
4081,7.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","2,8,14,17","4,18",10.0,814,72
4082,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",18,"4,18",10.0,813,72
4083,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",18,"4,18",10.0,812,72
4084,81.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",0,"3,18",10.0,811,72
4085,82.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,18",10.0,810,72
4086,0.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,8,13,15,20,21","3,18",10.0,809,72
4087,76.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,21","3,18",10.0,808,72
4088,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",21,"3,18",10.0,807,72
4089,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","10 * 21,22","3,18",10.0,806,72
4090,37.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5 * 20,21","3,18",10.0,805,72
4091,44.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,20 * 21","3,18",10.0,804,72
4092,82.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",21,"3,18",10.0,803,72
4093,64.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,15,20,21","3,18",10.0,802,72
4094,82.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,18",10.0,801,72
4095,54.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,13,20,21","3,18",10.0,800,72
4096,82.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,18",10.0,799,72
4097,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,18",10.0,798,72
4098,0.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,7,9,20,21","3,18",10.0,797,72
4099,72.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,20,21","3,18",10.0,796,72
4100,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,18",10.0,795,72
4101,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,18",10.0,794,72
4102,8.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,18",10.0,793,72
4103,80.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,13,15,20,21","3,18",10.0,792,72
4104,67.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,19,20","3,18",10.0,791,72
4105,75.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20","3,18",10.0,790,72
4106,65.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,9,15,20,21","3,18",10.0,789,72
4107,38.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,19,20","3,18",10.0,788,72
4108,78.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",19,"3,18",10.0,787,72
4109,81.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",20,"3,18",10.0,786,72
4110,41.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,18",10.0,785,72
4111,72.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","2,4","3,18",10.0,784,72
4112,79.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","16,18","3,18",10.0,783,72
4113,10.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,18",10.0,782,72
4114,81.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20 * 21","3,18",10.0,781,72
4115,33.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","3,5,9,19,20 * 21","3,18",10.0,780,72
4116,82.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20 * 21","3,18",10.0,779,72
4117,24.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14,19,20 * 21","3,18",10.0,778,72
4118,20.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14 * 21","3,18",10.0,777,72
4119,81.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2,3,18,19,20 * 21","3,18",10.0,776,72
4120,73.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","19,20","3,18",10.0,775,72
4121,72.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","20,21","3,18",10.0,774,72
4122,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,11,14,17 * 22","3,18",10.0,773,72
4123,73.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","18,19 * 22","3,18",10.0,772,72
4124,77.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","1,2 * 22","3,18",10.0,771,72
4125,24.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","5,8,14,17,22","3,18",10.0,770,72
4126,33 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid","2,8,14,17","3,18",10.0,769,72
4127,81.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",18,"3,18",10.0,768,72
4128,82.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2,4-Carbocyclic-Ethylene-bridged nucleic acid-Locked nucleic acid",18,"3,18",10.0,767,72
4129,90.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",0,"3,4,18",10.0,766,72
4130,89.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,4,18",10.0,765,72
4131,63.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,8,13,15,20,21","3,4,18",10.0,764,72
4132,86.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,21","3,4,18",10.0,763,72
4133,93.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",21,"3,4,18",10.0,762,72
4134,2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","10 * 21,22","3,4,18",10.0,761,72
4135,54.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5 * 20,21","3,4,18",10.0,760,72
4136,71.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,20 * 21","3,4,18",10.0,759,72
4137,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",21,"3,4,18",10.0,758,72
4138,86.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,15,20,21","3,4,18",10.0,757,72
4139,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,4,18",10.0,756,72
4140,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,13,20,21","3,4,18",10.0,755,72
4141,93.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,4,18",10.0,754,72
4142,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,13,15,20,21","3,4,18",10.0,753,72
4143,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,7,9,20,21","3,4,18",10.0,752,72
4144,82.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,20,21","3,4,18",10.0,751,72
4145,2.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,4,18",10.0,750,72
4146,1.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,4,18",10.0,749,72
4147,4.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,4,18",10.0,748,72
4148,87.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,13,15,20,21","3,4,18",10.0,747,72
4149,91.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,19,20","3,4,18",10.0,746,72
4150,87.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20","3,4,18",10.0,745,72
4151,78.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,15,20,21","3,4,18",10.0,744,72
4152,66.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,19,20","3,4,18",10.0,743,72
4153,86.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",19,"3,4,18",10.0,742,72
4154,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",20,"3,4,18",10.0,741,72
4155,82.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,4,18",10.0,740,72
4156,87.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","2,4","3,4,18",10.0,739,72
4157,92.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","16,18","3,4,18",10.0,738,72
4158,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,19,20 * 21","3,4,18",10.0,737,72
4159,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20 * 21","3,4,18",10.0,736,72
4160,77.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,19,20 * 21","3,4,18",10.0,735,72
4161,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20 * 21","3,4,18",10.0,734,72
4162,70.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14,19,20 * 21","3,4,18",10.0,733,72
4163,41.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14 * 21","3,4,18",10.0,732,72
4164,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,3,18,19,20 * 21","3,4,18",10.0,731,72
4165,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20","3,4,18",10.0,730,72
4166,86.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,4,18",10.0,729,72
4167,9.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14,17 * 22","3,4,18",10.0,728,72
4168,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","18,19 * 22","3,4,18",10.0,727,72
4169,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2 * 22","3,4,18",10.0,726,72
4170,0.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,14,17,22","3,4,18",10.0,725,72
4171,42.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","2,8,14,17","3,4,18",10.0,724,72
4172,88.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",18,"3,4,18",10.0,723,72
4173,89.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",18,"3,4,18",10.0,722,72
4174,30.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",0,"4,18",10.0,721,72
4175,64.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","4,18",10.0,720,72
4176,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,8,13,15,20,21","4,18",10.0,719,72
4177,40.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,21","4,18",10.0,718,72
4178,43.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",21,"4,18",10.0,717,72
4179,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","10 * 21,22","4,18",10.0,716,72
4180,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5 * 20,21","4,18",10.0,715,72
4181,9.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,20 * 21","4,18",10.0,714,72
4182,28.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",21,"4,18",10.0,713,72
4183,22.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,15,20,21","4,18",10.0,712,72
4184,28.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","4,18",10.0,711,72
4185,25.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,13,20,21","4,18",10.0,710,72
4186,45.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","4,18",10.0,709,72
4187,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,13,15,20,21","4,18",10.0,708,72
4188,3.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,7,9,20,21","4,18",10.0,707,72
4189,5.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,20,21","4,18",10.0,706,72
4190,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","4,18",10.0,705,72
4191,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","4,18",10.0,704,72
4192,5.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","4,18",10.0,703,72
4193,60.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,13,15,20,21","4,18",10.0,702,72
4194,32.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,19,20","4,18",10.0,701,72
4195,6.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20","4,18",10.0,700,72
4196,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,15,20,21","4,18",10.0,699,72
4197,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,19,20","4,18",10.0,698,72
4198,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",19,"4,18",10.0,697,72
4199,12.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",20,"4,18",10.0,696,72
4200,1.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","4,18",10.0,695,72
4201,24.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","2,4","4,18",10.0,694,72
4202,40.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","16,18","4,18",10.0,693,72
4203,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,19,20 * 21","4,18",10.0,692,72
4204,12 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20 * 21","4,18",10.0,691,72
4205,15.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,19,20 * 21","4,18",10.0,690,72
4206,9.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20 * 21","4,18",10.0,689,72
4207,1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14,19,20 * 21","4,18",10.0,688,72
4208,17.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14 * 21","4,18",10.0,687,72
4209,9.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,3,18,19,20 * 21","4,18",10.0,686,72
4210,10.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20","4,18",10.0,685,72
4211,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","4,18",10.0,684,72
4212,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14,17 * 22","4,18",10.0,683,72
4213,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","18,19 * 22","4,18",10.0,682,72
4214,26.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2 * 22","4,18",10.0,681,72
4215,9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,14,17,22","4,18",10.0,680,72
4216,25.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","2,8,14,17","4,18",10.0,679,72
4217,23.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",18,"4,18",10.0,678,72
4218,4.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",18,"4,18",10.0,677,72
4219,36.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",0,"3,18",10.0,676,72
4220,53.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,18",10.0,675,72
4221,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,8,13,15,20,21","3,18",10.0,674,72
4222,42.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,21","3,18",10.0,673,72
4223,54 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",21,"3,18",10.0,672,72
4224,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","10 * 21,22","3,18",10.0,671,72
4225,17.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5 * 20,21","3,18",10.0,670,72
4226,3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,20 * 21","3,18",10.0,669,72
4227,58 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",21,"3,18",10.0,668,72
4228,37.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,15,20,21","3,18",10.0,667,72
4229,61.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,18",10.0,666,72
4230,28.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,13,20,21","3,18",10.0,665,72
4231,54 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,18",10.0,664,72
4232,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,13,15,20,21","3,18",10.0,663,72
4233,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,7,9,20,21","3,18",10.0,662,72
4234,42.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,20,21","3,18",10.0,661,72
4235,0.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,18",10.0,660,72
4236,3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,18",10.0,659,72
4237,6.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,18",10.0,658,72
4238,63.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,13,15,20,21","3,18",10.0,657,72
4239,14.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,19,20","3,18",10.0,656,72
4240,41.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20","3,18",10.0,655,72
4241,22.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,9,15,20,21","3,18",10.0,654,72
4242,0.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,19,20","3,18",10.0,653,72
4243,49.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",19,"3,18",10.0,652,72
4244,58.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",20,"3,18",10.0,651,72
4245,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,18",10.0,650,72
4246,4.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","2,4","3,18",10.0,649,72
4247,35.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","16,18","3,18",10.0,648,72
4248,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,19,20 * 21","3,18",10.0,647,72
4249,60.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20 * 21","3,18",10.0,646,72
4250,8.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","3,5,9,19,20 * 21","3,18",10.0,645,72
4251,62.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20 * 21","3,18",10.0,644,72
4252,1.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14,19,20 * 21","3,18",10.0,643,72
4253,2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14 * 21","3,18",10.0,642,72
4254,50 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2,3,18,19,20 * 21","3,18",10.0,641,72
4255,45.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","19,20","3,18",10.0,640,72
4256,33.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","20,21","3,18",10.0,639,72
4257,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,11,14,17 * 22","3,18",10.0,638,72
4258,43.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","18,19 * 22","3,18",10.0,637,72
4259,59.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","1,2 * 22","3,18",10.0,636,72
4260,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","5,8,14,17,22","3,18",10.0,635,72
4261,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid","2,8,14,17","3,18",10.0,634,72
4262,55 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",18,"3,18",10.0,633,72
4263,53.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,"2-Deoxy-2-N,4-C-Ethylene-Locked nucleic acid",18,"3,18",10.0,632,72
4264,73.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,2-Fluoro* 2-O-Methyl,0,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,631,72
4265,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-Fluoro* 2-O-Methyl,"20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,630,72
4266,10.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-Fluoro* 2-O-Methyl,"3,8,13,15,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,629,72
4267,66.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,2-Fluoro* 2-O-Methyl,"5,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,628,72
4268,81.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,2-Fluoro* 2-O-Methyl,21,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,627,72
4269,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,2-Fluoro* 2-O-Methyl,"10 * 21,22","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,626,72
4270,17 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,2-Fluoro* 2-O-Methyl,"5 * 20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,625,72
4271,26.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-Fluoro* 2-O-Methyl,"5,20 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,624,72
4272,80.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Fluoro* 2-O-Methyl,21,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,623,72
4273,77.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,2-Fluoro* 2-O-Methyl,"3,9,15,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,622,72
4274,81.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,2-Fluoro* 2-O-Methyl,"20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,621,72
4275,67.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Fluoro* 2-O-Methyl,"3,5,9,13,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,620,72
4276,73.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Fluoro* 2-O-Methyl,"20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,619,72
4277,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-Fluoro* 2-O-Methyl,"3,9,13,15,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,618,72
4278,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-Fluoro* 2-O-Methyl,"3,5,7,9,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,617,72
4279,49 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-Fluoro* 2-O-Methyl,"5,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,616,72
4280,4.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,2-Fluoro* 2-O-Methyl,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,615,72
4281,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,2-Fluoro* 2-O-Methyl,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,614,72
4282,2.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,2-Fluoro* 2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,613,72
4283,77.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-Fluoro* 2-O-Methyl,"3,9,13,15,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,612,72
4284,60.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Fluoro* 2-O-Methyl,"5,19,20","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,611,72
4285,71 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Fluoro* 2-O-Methyl,"19,20","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,610,72
4286,28.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-Fluoro* 2-O-Methyl,"3,9,15,20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,609,72
4287,26.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-Fluoro* 2-O-Methyl,"5,19,20","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,608,72
4288,65.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-Fluoro* 2-O-Methyl,19,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,607,72
4289,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-Fluoro* 2-O-Methyl,20,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,606,72
4290,23.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,2-Fluoro* 2-O-Methyl,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,605,72
4291,66.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,2-Fluoro* 2-O-Methyl,"2,4","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,604,72
4292,79.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,2-Fluoro* 2-O-Methyl,"16,18","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,603,72
4293,20.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,2-Fluoro* 2-O-Methyl,"3,5,9,19,20 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,602,72
4294,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,2-Fluoro* 2-O-Methyl,"19,20 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,601,72
4295,50.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,2-Fluoro* 2-O-Methyl,"3,5,9,19,20 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,600,72
4296,81.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,2-Fluoro* 2-O-Methyl,"19,20 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,599,72
4297,23.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,2-Fluoro* 2-O-Methyl,"5,8,11,14,19,20 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,598,72
4298,13.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,2-Fluoro* 2-O-Methyl,"5,8,11,14 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,597,72
4299,81.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,2-Fluoro* 2-O-Methyl,"1,2,3,18,19,20 * 21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,596,72
4300,45.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,2-Fluoro* 2-O-Methyl,"19,20","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,595,72
4301,63 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,2-Fluoro* 2-O-Methyl,"20,21","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,594,72
4302,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,2-Fluoro* 2-O-Methyl,"5,8,11,14,17 * 22","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,593,72
4303,67.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,2-Fluoro* 2-O-Methyl,"18,19 * 22","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,592,72
4304,81.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,2-Fluoro* 2-O-Methyl,"1,2 * 22","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,591,72
4305,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,2-Fluoro* 2-O-Methyl,"5,8,14,17,22","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,590,72
4306,7.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,2-Fluoro* 2-O-Methyl,"2,8,14,17","1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,589,72
4307,81.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,2-Fluoro* 2-O-Methyl,18,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,588,72
4308,82.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-Fluoro* 2-O-Methyl,18,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",10.0,587,72
4309,13.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,0,2-Aminopropoxymethyl* 2-Deoxy,0,"18,19 * 21",10.0,586,72
4310,49.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,585,72
4311,27.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"3,8,13,15,20,21","18,19 * 21",10.0,584,72
4312,4.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"5,21","18,19 * 21",10.0,583,72
4313,28.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,21,"18,19 * 21",10.0,582,72
4314,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"10 * 21,22","18,19 * 21",10.0,581,72
4315,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"5 * 20,21","18,19 * 21",10.0,580,72
4316,12.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"5,20 * 21","18,19 * 21",10.0,579,72
4317,41.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropoxymethyl* 2-Deoxy,21,"18,19 * 21",10.0,578,72
4318,50.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"3,9,15,20,21","18,19 * 21",10.0,577,72
4319,54.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,576,72
4320,34.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"3,5,9,13,20,21","18,19 * 21",10.0,575,72
4321,44.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,574,72
4322,1.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"3,9,13,15,20,21","18,19 * 21",10.0,573,72
4323,9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"3,5,7,9,20,21","18,19 * 21",10.0,572,72
4324,18.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"5,20,21","18,19 * 21",10.0,571,72
4325,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","18,19 * 21",10.0,570,72
4326,1.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","18,19 * 21",10.0,569,72
4327,0.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","18,19 * 21",10.0,568,72
4328,30.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"3,9,13,15,20,21","18,19 * 21",10.0,567,72
4329,54.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"5,19,20","18,19 * 21",10.0,566,72
4330,25.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"19,20","18,19 * 21",10.0,565,72
4331,7.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"3,9,15,20,21","18,19 * 21",10.0,564,72
4332,16.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminopropoxymethyl* 2-Deoxy,"5,19,20","18,19 * 21",10.0,563,72
4333,6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminopropoxymethyl* 2-Deoxy,19,"18,19 * 21",10.0,562,72
4334,42.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminopropoxymethyl* 2-Deoxy,20,"18,19 * 21",10.0,561,72
4335,26.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Fluoro* 2-O-Methyl,2-Aminopropoxymethyl* 2-Deoxy,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","18,19 * 21",10.0,560,72
4336,43.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"2,4","18,19 * 21",10.0,559,72
4337,57.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"16,18","18,19 * 21",10.0,558,72
4338,7.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"3,5,9,19,20 * 21","18,19 * 21",10.0,557,72
4339,53.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"19,20 * 21","18,19 * 21",10.0,556,72
4340,22.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"3,5,9,19,20 * 21","18,19 * 21",10.0,555,72
4341,50.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"19,20 * 21","18,19 * 21",10.0,554,72
4342,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"5,8,11,14,19,20 * 21","18,19 * 21",10.0,553,72
4343,2.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"5,8,11,14 * 21","18,19 * 21",10.0,552,72
4344,54 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"1,2,3,18,19,20 * 21","18,19 * 21",10.0,551,72
4345,45.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"19,20","18,19 * 21",10.0,550,72
4346,3.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,549,72
4347,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"5,8,11,14,17 * 22","18,19 * 21",10.0,548,72
4348,24.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"18,19 * 22","18,19 * 21",10.0,547,72
4349,47.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,2-Aminopropoxymethyl* 2-Deoxy,"1,2 * 22","18,19 * 21",10.0,546,72
4350,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"5,8,14,17,22","18,19 * 21",10.0,545,72
4351,1.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,2-Aminopropoxymethyl* 2-Deoxy,"2,8,14,17","18,19 * 21",10.0,544,72
4352,36.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Guanidinoethyl,2-Aminopropoxymethyl* 2-Deoxy,18,"18,19 * 21",10.0,543,72
4353,61.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminopropoxymethyl* 2-Deoxy,18,"18,19 * 21",10.0,542,72
4354,40.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,0,2-Aminoethoxymethyl* 2-Deoxy,0,"18,19 * 21",10.0,541,72
4355,62.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,540,72
4356,41 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"3,8,13,15,20,21","18,19 * 21",10.0,539,72
4357,14.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"5,21","18,19 * 21",10.0,538,72
4358,51.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,21,"18,19 * 21",10.0,537,72
4359,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"10 * 21,22","18,19 * 21",10.0,536,72
4360,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"5 * 20,21","18,19 * 21",10.0,535,72
4361,23.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"5,20 * 21","18,19 * 21",10.0,534,72
4362,56.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethoxymethyl* 2-Deoxy,21,"18,19 * 21",10.0,533,72
4363,58 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"3,9,15,20,21","18,19 * 21",10.0,532,72
4364,60.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,531,72
4365,35.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"3,5,9,13,20,21","18,19 * 21",10.0,530,72
4366,43.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,529,72
4367,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"3,9,13,15,20,21","18,19 * 21",10.0,528,72
4368,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"3,5,7,9,20,21","18,19 * 21",10.0,527,72
4369,22.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"5,20,21","18,19 * 21",10.0,526,72
4370,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","18,19 * 21",10.0,525,72
4371,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","18,19 * 21",10.0,524,72
4372,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","18,19 * 21",10.0,523,72
4373,35.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"3,9,13,15,20,21","18,19 * 21",10.0,522,72
4374,51.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"5,19,20","18,19 * 21",10.0,521,72
4375,33.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"19,20","18,19 * 21",10.0,520,72
4376,24.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"3,9,15,20,21","18,19 * 21",10.0,519,72
4377,30 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminoethoxymethyl* 2-Deoxy,"5,19,20","18,19 * 21",10.0,518,72
4378,29.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminoethoxymethyl* 2-Deoxy,19,"18,19 * 21",10.0,517,72
4379,57.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminoethoxymethyl* 2-Deoxy,20,"18,19 * 21",10.0,516,72
4380,49.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Fluoro* 2-O-Methyl,2-Aminoethoxymethyl* 2-Deoxy,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","18,19 * 21",10.0,515,72
4381,52.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"2,4","18,19 * 21",10.0,514,72
4382,55.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"16,18","18,19 * 21",10.0,513,72
4383,11.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"3,5,9,19,20 * 21","18,19 * 21",10.0,512,72
4384,63.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"19,20 * 21","18,19 * 21",10.0,511,72
4385,34.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"3,5,9,19,20 * 21","18,19 * 21",10.0,510,72
4386,60.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"19,20 * 21","18,19 * 21",10.0,509,72
4387,16.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"5,8,11,14,19,20 * 21","18,19 * 21",10.0,508,72
4388,10.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"5,8,11,14 * 21","18,19 * 21",10.0,507,72
4389,60.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"1,2,3,18,19,20 * 21","18,19 * 21",10.0,506,72
4390,9.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"19,20","18,19 * 21",10.0,505,72
4391,19.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"20,21","18,19 * 21",10.0,504,72
4392,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"5,8,11,14,17 * 22","18,19 * 21",10.0,503,72
4393,30.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"18,19 * 22","18,19 * 21",10.0,502,72
4394,54.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,2-Aminoethoxymethyl* 2-Deoxy,"1,2 * 22","18,19 * 21",10.0,501,72
4395,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"5,8,14,17,22","18,19 * 21",10.0,500,72
4396,16.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,2-Aminoethoxymethyl* 2-Deoxy,"2,8,14,17","18,19 * 21",10.0,499,72
4397,49.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Guanidinoethyl,2-Aminoethoxymethyl* 2-Deoxy,18,"18,19 * 21",10.0,498,72
4398,46 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,2-Aminoethoxymethyl* 2-Deoxy,18,"18,19 * 21",10.0,497,72
4399,37.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,0,Hexitol nucleic acid* 2-Deoxy,0,"2,9,18,19,20 * 21",10.0,496,72
4400,56.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,9,18,19,20 * 21",10.0,495,72
4401,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,8,13,15,20,21","2,9,18,19,20 * 21",10.0,494,72
4402,1.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,21","2,9,18,19,20 * 21",10.0,493,72
4403,45.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"2,9,18,19,20 * 21",10.0,492,72
4404,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"10 * 21,22","2,9,18,19,20 * 21",10.0,491,72
4405,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5 * 20,21","2,9,18,19,20 * 21",10.0,490,72
4406,2.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20 * 21","2,9,18,19,20 * 21",10.0,489,72
4407,49 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"2,9,18,19,20 * 21",10.0,488,72
4408,21.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","2,9,18,19,20 * 21",10.0,487,72
4409,51.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,9,18,19,20 * 21",10.0,486,72
4410,7.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,9,13,20,21","2,9,18,19,20 * 21",10.0,485,72
4411,39.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,9,18,19,20 * 21",10.0,484,72
4412,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","2,9,18,19,20 * 21",10.0,483,72
4413,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,7,9,20,21","2,9,18,19,20 * 21",10.0,482,72
4414,17.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20,21","2,9,18,19,20 * 21",10.0,481,72
4415,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","2,9,18,19,20 * 21",10.0,480,72
4416,2.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","2,9,18,19,20 * 21",10.0,479,72
4417,1.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","2,9,18,19,20 * 21",10.0,478,72
4418,21.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","2,9,18,19,20 * 21",10.0,477,72
4419,19.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,19,20","2,9,18,19,20 * 21",10.0,476,72
4420,27.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","2,9,18,19,20 * 21",10.0,475,72
4421,18.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","2,9,18,19,20 * 21",10.0,474,72
4422,11.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,"5,19,20","2,9,18,19,20 * 21",10.0,473,72
4423,18.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,19,"2,9,18,19,20 * 21",10.0,472,72
4424,49.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,20,"2,9,18,19,20 * 21",10.0,471,72
4425,35.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Fluoro* 2-O-Methyl,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","2,9,18,19,20 * 21",10.0,470,72
4426,38.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,4","2,9,18,19,20 * 21",10.0,469,72
4427,50.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"16,18","2,9,18,19,20 * 21",10.0,468,72
4428,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","2,9,18,19,20 * 21",10.0,467,72
4429,50.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","2,9,18,19,20 * 21",10.0,466,72
4430,8.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","2,9,18,19,20 * 21",10.0,465,72
4431,50 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","2,9,18,19,20 * 21",10.0,464,72
4432,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,19,20 * 21","2,9,18,19,20 * 21",10.0,463,72
4433,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14 * 21","2,9,18,19,20 * 21",10.0,462,72
4434,35.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2,3,18,19,20 * 21","2,9,18,19,20 * 21",10.0,461,72
4435,1.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","2,9,18,19,20 * 21",10.0,460,72
4436,2.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,9,18,19,20 * 21",10.0,459,72
4437,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,17 * 22","2,9,18,19,20 * 21",10.0,458,72
4438,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"18,19 * 22","2,9,18,19,20 * 21",10.0,457,72
4439,33.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2 * 22","2,9,18,19,20 * 21",10.0,456,72
4440,9.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,8,14,17,22","2,9,18,19,20 * 21",10.0,455,72
4441,9.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,8,14,17","2,9,18,19,20 * 21",10.0,454,72
4442,42.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Guanidinoethyl,Hexitol nucleic acid* 2-Deoxy,18,"2,9,18,19,20 * 21",10.0,453,72
4443,42 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,18,"2,9,18,19,20 * 21",10.0,452,72
4444,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,0,Hexitol nucleic acid* 2-Deoxy,0,"3,18,19,20 * 21",10.0,451,72
4445,80.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","3,18,19,20 * 21",10.0,450,72
4446,73.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,8,13,15,20,21","3,18,19,20 * 21",10.0,449,72
4447,66.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,21","3,18,19,20 * 21",10.0,448,72
4448,87 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"3,18,19,20 * 21",10.0,447,72
4449,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"10 * 21,22","3,18,19,20 * 21",10.0,446,72
4450,19.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5 * 20,21","3,18,19,20 * 21",10.0,445,72
4451,69.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20 * 21","3,18,19,20 * 21",10.0,444,72
4452,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"3,18,19,20 * 21",10.0,443,72
4453,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","3,18,19,20 * 21",10.0,442,72
4454,80.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","3,18,19,20 * 21",10.0,441,72
4455,71.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,9,13,20,21","3,18,19,20 * 21",10.0,440,72
4456,86 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","3,18,19,20 * 21",10.0,439,72
4457,50.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","3,18,19,20 * 21",10.0,438,72
4458,18.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,7,9,20,21","3,18,19,20 * 21",10.0,437,72
4459,65.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20,21","3,18,19,20 * 21",10.0,436,72
4460,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,18,19,20 * 21",10.0,435,72
4461,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,18,19,20 * 21",10.0,434,72
4462,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,18,19,20 * 21",10.0,433,72
4463,75.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","3,18,19,20 * 21",10.0,432,72
4464,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,19,20","3,18,19,20 * 21",10.0,431,72
4465,78.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","3,18,19,20 * 21",10.0,430,72
4466,75.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","3,18,19,20 * 21",10.0,429,72
4467,73.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,"5,19,20","3,18,19,20 * 21",10.0,428,72
4468,76.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,19,"3,18,19,20 * 21",10.0,427,72
4469,82.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,20,"3,18,19,20 * 21",10.0,426,72
4470,79.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Fluoro* 2-O-Methyl,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,18,19,20 * 21",10.0,425,72
4471,78.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,4","3,18,19,20 * 21",10.0,424,72
4472,87.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"16,18","3,18,19,20 * 21",10.0,423,72
4473,68.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","3,18,19,20 * 21",10.0,422,72
4474,82.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","3,18,19,20 * 21",10.0,421,72
4475,67.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","3,18,19,20 * 21",10.0,420,72
4476,82.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","3,18,19,20 * 21",10.0,419,72
4477,51.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,19,20 * 21","3,18,19,20 * 21",10.0,418,72
4478,25.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14 * 21","3,18,19,20 * 21",10.0,417,72
4479,80.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2,3,18,19,20 * 21","3,18,19,20 * 21",10.0,416,72
4480,70.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","3,18,19,20 * 21",10.0,415,72
4481,75.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","3,18,19,20 * 21",10.0,414,72
4482,1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,17 * 22","3,18,19,20 * 21",10.0,413,72
4483,75.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"18,19 * 22","3,18,19,20 * 21",10.0,412,72
4484,77.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2 * 22","3,18,19,20 * 21",10.0,411,72
4485,5.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,8,14,17,22","3,18,19,20 * 21",10.0,410,72
4486,50.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,8,14,17","3,18,19,20 * 21",10.0,409,72
4487,78.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Guanidinoethyl,Hexitol nucleic acid* 2-Deoxy,18,"3,18,19,20 * 21",10.0,408,72
4488,80.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,18,"3,18,19,20 * 21",10.0,407,72
4489,79.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,0,Hexitol nucleic acid* 2-Deoxy,0,"2,18,19,20 * 21",10.0,406,72
4490,79.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,18,19,20 * 21",10.0,405,72
4491,67.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,8,13,15,20,21","2,18,19,20 * 21",10.0,404,72
4492,58.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,21","2,18,19,20 * 21",10.0,403,72
4493,85.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"2,18,19,20 * 21",10.0,402,72
4494,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"10 * 21,22","2,18,19,20 * 21",10.0,401,72
4495,8.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5 * 20,21","2,18,19,20 * 21",10.0,400,72
4496,75.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20 * 21","2,18,19,20 * 21",10.0,399,72
4497,79.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"2,18,19,20 * 21",10.0,398,72
4498,66.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","2,18,19,20 * 21",10.0,397,72
4499,78.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,18,19,20 * 21",10.0,396,72
4500,63.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,9,13,20,21","2,18,19,20 * 21",10.0,395,72
4501,84.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,18,19,20 * 21",10.0,394,72
4502,58.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","2,18,19,20 * 21",10.0,393,72
4503,38.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,7,9,20,21","2,18,19,20 * 21",10.0,392,72
4504,62.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20,21","2,18,19,20 * 21",10.0,391,72
4505,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","2,18,19,20 * 21",10.0,390,72
4506,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","2,18,19,20 * 21",10.0,389,72
4507,70.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","2,18,19,20 * 21",10.0,388,72
4508,70.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","2,18,19,20 * 21",10.0,387,72
4509,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,19,20","2,18,19,20 * 21",10.0,386,72
4510,77.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","2,18,19,20 * 21",10.0,385,72
4511,75.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","2,18,19,20 * 21",10.0,384,72
4512,72 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,"5,19,20","2,18,19,20 * 21",10.0,383,72
4513,74.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,19,"2,18,19,20 * 21",10.0,382,72
4514,79 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,20,"2,18,19,20 * 21",10.0,381,72
4515,79.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Fluoro* 2-O-Methyl,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","2,18,19,20 * 21",10.0,380,72
4516,78.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,4","2,18,19,20 * 21",10.0,379,72
4517,83.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"16,18","2,18,19,20 * 21",10.0,378,72
4518,29.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","2,18,19,20 * 21",10.0,377,72
4519,78.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","2,18,19,20 * 21",10.0,376,72
4520,35.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","2,18,19,20 * 21",10.0,375,72
4521,77 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","2,18,19,20 * 21",10.0,374,72
4522,23.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,19,20 * 21","2,18,19,20 * 21",10.0,373,72
4523,11.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14 * 21","2,18,19,20 * 21",10.0,372,72
4524,77.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2,3,18,19,20 * 21","2,18,19,20 * 21",10.0,371,72
4525,65.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","2,18,19,20 * 21",10.0,370,72
4526,69.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","2,18,19,20 * 21",10.0,369,72
4527,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,17 * 22","2,18,19,20 * 21",10.0,368,72
4528,63.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"18,19 * 22","2,18,19,20 * 21",10.0,367,72
4529,75.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2 * 22","2,18,19,20 * 21",10.0,366,72
4530,6.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,8,14,17,22","2,18,19,20 * 21",10.0,365,72
4531,39.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,8,14,17","2,18,19,20 * 21",10.0,364,72
4532,78.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Guanidinoethyl,Hexitol nucleic acid* 2-Deoxy,18,"2,18,19,20 * 21",10.0,363,72
4533,73.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,18,"2,18,19,20 * 21",10.0,362,72
4534,81.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,0,Hexitol nucleic acid* 2-Deoxy,0,"18,19,20 * 21",10.0,361,72
4535,85.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","18,19,20 * 21",10.0,360,72
4536,83.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,8,13,15,20,21","18,19,20 * 21",10.0,359,72
4537,78.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,21","18,19,20 * 21",10.0,358,72
4538,84.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"18,19,20 * 21",10.0,357,72
4539,6.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"10 * 21,22","18,19,20 * 21",10.0,356,72
4540,45.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,UnLocked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5 * 20,21","18,19,20 * 21",10.0,355,72
4541,78.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20 * 21","18,19,20 * 21",10.0,354,72
4542,84.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,21,"18,19,20 * 21",10.0,353,72
4543,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","18,19,20 * 21",10.0,352,72
4544,86.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Alfa-L-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","18,19,20 * 21",10.0,351,72
4545,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,9,13,20,21","18,19,20 * 21",10.0,350,72
4546,84.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","18,19,20 * 21",10.0,349,72
4547,72.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","18,19,20 * 21",10.0,348,72
4548,52.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,5,7,9,20,21","18,19,20 * 21",10.0,347,72
4549,78.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,20,21","18,19,20 * 21",10.0,346,72
4550,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","18,19,20 * 21",10.0,345,72
4551,15.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","18,19,20 * 21",10.0,344,72
4552,2.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGT,2-Deoxy* Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","18,19,20 * 21",10.0,343,72
4553,83.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,13,15,20,21","18,19,20 * 21",10.0,342,72
4554,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,19,20","18,19,20 * 21",10.0,341,72
4555,81.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGT,4-C-Hydroxymethyl Deoxyribonucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","18,19,20 * 21",10.0,340,72
4556,85.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGT,Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"3,9,15,20,21","18,19,20 * 21",10.0,339,72
4557,83.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,"5,19,20","18,19,20 * 21",10.0,338,72
4558,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,19,"18,19,20 * 21",10.0,337,72
4559,85.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,20,"18,19,20 * 21",10.0,336,72
4560,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Fluoro* 2-O-Methyl,Hexitol nucleic acid* 2-Deoxy,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","18,19,20 * 21",10.0,335,72
4561,85.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,4","18,19,20 * 21",10.0,334,72
4562,86 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Oxetane-Locked nucleic acid,Hexitol nucleic acid* 2-Deoxy,"16,18","18,19,20 * 21",10.0,333,72
4563,73.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","18,19,20 * 21",10.0,332,72
4564,84.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminopropoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","18,19,20 * 21",10.0,331,72
4565,81 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"3,5,9,19,20 * 21","18,19,20 * 21",10.0,330,72
4566,86.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,2-Aminoethoxymethyl* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"19,20 * 21","18,19,20 * 21",10.0,329,72
4567,74.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,19,20 * 21","18,19,20 * 21",10.0,328,72
4568,48.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14 * 21","18,19,20 * 21",10.0,327,72
4569,84.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2,3,18,19,20 * 21","18,19,20 * 21",10.0,326,72
4570,80.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"19,20","18,19,20 * 21",10.0,325,72
4571,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"20,21","18,19,20 * 21",10.0,324,72
4572,19.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"5,8,11,14,17 * 22","18,19,20 * 21",10.0,323,72
4573,84.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"18,19 * 22","18,19,20 * 21",10.0,322,72
4574,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Altritol nucleic acid* 2-Deoxy,Hexitol nucleic acid* 2-Deoxy,"1,2 * 22","18,19,20 * 21",10.0,321,72
4575,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"5,8,14,17,22","18,19,20 * 21",10.0,320,72
4576,63.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,Hexitol nucleic acid,Hexitol nucleic acid* 2-Deoxy,"2,8,14,17","18,19,20 * 21",10.0,319,72
4577,84.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Guanidinoethyl,Hexitol nucleic acid* 2-Deoxy,18,"18,19,20 * 21",10.0,318,72
4578,87.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGT,2-Aminoethyl,Hexitol nucleic acid* 2-Deoxy,18,"18,19,20 * 21",10.0,317,72
4579,75.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Altritol nucleic acid,0,"3,6,14,18,20,21",10.0,316,72
4580,79.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"20,21","3,6,14,18,20,21",10.0,315,72
4581,24.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,8,13,15,20,21","3,6,14,18,20,21",10.0,314,72
4582,77.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Altritol nucleic acid,"5,21","3,6,14,18,20,21",10.0,313,72
4583,82 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Altritol nucleic acid,21,"3,6,14,18,20,21",10.0,312,72
4584,11 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"10 * 21,22","3,6,14,18,20,21",10.0,311,72
4585,44.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5 * 20,21","3,6,14,18,20,21",10.0,310,72
4586,70.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5,20 * 21","3,6,14,18,20,21",10.0,309,72
4587,80.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,21,"3,6,14,18,20,21",10.0,308,72
4588,74.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","3,6,14,18,20,21",10.0,307,72
4589,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"20,21","3,6,14,18,20,21",10.0,306,72
4590,71.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"3,5,9,13,20,21","3,6,14,18,20,21",10.0,305,72
4591,78.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"20,21","3,6,14,18,20,21",10.0,304,72
4592,12.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","3,6,14,18,20,21",10.0,303,72
4593,6.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,5,7,9,20,21","3,6,14,18,20,21",10.0,302,72
4594,68.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"5,20,21","3,6,14,18,20,21",10.0,301,72
4595,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","3,6,14,18,20,21",10.0,300,72
4596,22.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","3,6,14,18,20,21",10.0,299,72
4597,22.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","3,6,14,18,20,21",10.0,298,72
4598,76.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","3,6,14,18,20,21",10.0,297,72
4599,76.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"5,19,20","3,6,14,18,20,21",10.0,296,72
4600,71.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"19,20","3,6,14,18,20,21",10.0,295,72
4601,74.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","3,6,14,18,20,21",10.0,294,72
4602,46.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,"5,19,20","3,6,14,18,20,21",10.0,293,72
4603,78.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,19,"3,6,14,18,20,21",10.0,292,72
4604,80.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,20,"3,6,14,18,20,21",10.0,291,72
4605,12.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Altritol nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","3,6,14,18,20,21",10.0,290,72
4606,76.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Altritol nucleic acid,"2,4","3,6,14,18,20,21",10.0,289,72
4607,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Altritol nucleic acid,"16,18","3,6,14,18,20,21",10.0,288,72
4608,37 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","3,6,14,18,20,21",10.0,287,72
4609,77.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","3,6,14,18,20,21",10.0,286,72
4610,51.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","3,6,14,18,20,21",10.0,285,72
4611,79.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","3,6,14,18,20,21",10.0,284,72
4612,36.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,19,20 * 21","3,6,14,18,20,21",10.0,283,72
4613,30.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14 * 21","3,6,14,18,20,21",10.0,282,72
4614,77 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2,3,18,19,20 * 21","3,6,14,18,20,21",10.0,281,72
4615,74.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"19,20","3,6,14,18,20,21",10.0,280,72
4616,70.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Altritol nucleic acid,"20,21","3,6,14,18,20,21",10.0,279,72
4617,4.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,17 * 22","3,6,14,18,20,21",10.0,278,72
4618,76 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"18,19 * 22","3,6,14,18,20,21",10.0,277,72
4619,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2 * 22","3,6,14,18,20,21",10.0,276,72
4620,1.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"5,8,14,17,22","3,6,14,18,20,21",10.0,275,72
4621,29.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"2,8,14,17","3,6,14,18,20,21",10.0,274,72
4622,78.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Altritol nucleic acid,18,"3,6,14,18,20,21",10.0,273,72
4623,82.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,18,"3,6,14,18,20,21",10.0,272,72
4624,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Altritol nucleic acid,0,"5,8,11,14,17,20",10.0,271,72
4625,6.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"20,21","5,8,11,14,17,20",10.0,270,72
4626,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,8,13,15,20,21","5,8,11,14,17,20",10.0,269,72
4627,21.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Altritol nucleic acid,"5,21","5,8,11,14,17,20",10.0,268,72
4628,6.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Altritol nucleic acid,21,"5,8,11,14,17,20",10.0,267,72
4629,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"10 * 21,22","5,8,11,14,17,20",10.0,266,72
4630,5.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5 * 20,21","5,8,11,14,17,20",10.0,265,72
4631,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5,20 * 21","5,8,11,14,17,20",10.0,264,72
4632,7.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,21,"5,8,11,14,17,20",10.0,263,72
4633,10.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","5,8,11,14,17,20",10.0,262,72
4634,13.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"20,21","5,8,11,14,17,20",10.0,261,72
4635,9.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"3,5,9,13,20,21","5,8,11,14,17,20",10.0,260,72
4636,24 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"20,21","5,8,11,14,17,20",10.0,259,72
4637,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","5,8,11,14,17,20",10.0,258,72
4638,2.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,5,7,9,20,21","5,8,11,14,17,20",10.0,257,72
4639,0.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"5,20,21","5,8,11,14,17,20",10.0,256,72
4640,6.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","5,8,11,14,17,20",10.0,255,72
4641,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","5,8,11,14,17,20",10.0,254,72
4642,11.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","5,8,11,14,17,20",10.0,253,72
4643,29.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","5,8,11,14,17,20",10.0,252,72
4644,25.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"5,19,20","5,8,11,14,17,20",10.0,251,72
4645,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"19,20","5,8,11,14,17,20",10.0,250,72
4646,5.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","5,8,11,14,17,20",10.0,249,72
4647,9.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,"5,19,20","5,8,11,14,17,20",10.0,248,72
4648,11.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,19,"5,8,11,14,17,20",10.0,247,72
4649,12.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,20,"5,8,11,14,17,20",10.0,246,72
4650,5.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Altritol nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","5,8,11,14,17,20",10.0,245,72
4651,6.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Altritol nucleic acid,"2,4","5,8,11,14,17,20",10.0,244,72
4652,33.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Altritol nucleic acid,"16,18","5,8,11,14,17,20",10.0,243,72
4653,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","5,8,11,14,17,20",10.0,242,72
4654,12.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","5,8,11,14,17,20",10.0,241,72
4655,16.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","5,8,11,14,17,20",10.0,240,72
4656,12.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","5,8,11,14,17,20",10.0,239,72
4657,6.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,19,20 * 21","5,8,11,14,17,20",10.0,238,72
4658,2.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14 * 21","5,8,11,14,17,20",10.0,237,72
4659,19.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2,3,18,19,20 * 21","5,8,11,14,17,20",10.0,236,72
4660,37.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"19,20","5,8,11,14,17,20",10.0,235,72
4661,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Altritol nucleic acid,"20,21","5,8,11,14,17,20",10.0,234,72
4662,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,17 * 22","5,8,11,14,17,20",10.0,233,72
4663,7.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"18,19 * 22","5,8,11,14,17,20",10.0,232,72
4664,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2 * 22","5,8,11,14,17,20",10.0,231,72
4665,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"5,8,14,17,22","5,8,11,14,17,20",10.0,230,72
4666,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"2,8,14,17","5,8,11,14,17,20",10.0,229,72
4667,19.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Altritol nucleic acid,18,"5,8,11,14,17,20",10.0,228,72
4668,41.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,18,"5,8,11,14,17,20",10.0,227,72
4669,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,Altritol nucleic acid,0,"20,21",10.0,226,72
4670,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"20,21","20,21",10.0,225,72
4671,88.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,8,13,15,20,21","20,21",10.0,224,72
4672,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Altritol nucleic acid,"5,21","20,21",10.0,223,72
4673,89.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,Altritol nucleic acid,21,"20,21",10.0,222,72
4674,72.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"10 * 21,22","20,21",10.0,221,72
4675,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5 * 20,21","20,21",10.0,220,72
4676,86.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5,20 * 21","20,21",10.0,219,72
4677,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,21,"20,21",10.0,218,72
4678,89 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","20,21",10.0,217,72
4679,88.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"20,21","20,21",10.0,216,72
4680,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"3,5,9,13,20,21","20,21",10.0,215,72
4681,91.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"20,21","20,21",10.0,214,72
4682,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","20,21",10.0,213,72
4683,85.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,5,7,9,20,21","20,21",10.0,212,72
4684,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"5,20,21","20,21",10.0,211,72
4685,25.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","20,21",10.0,210,72
4686,59.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","20,21",10.0,209,72
4687,39.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","20,21",10.0,208,72
4688,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","20,21",10.0,207,72
4689,92.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"5,19,20","20,21",10.0,206,72
4690,86.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"19,20","20,21",10.0,205,72
4691,89.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","20,21",10.0,204,72
4692,87.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,"5,19,20","20,21",10.0,203,72
4693,88.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,19,"20,21",10.0,202,72
4694,88.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,20,"20,21",10.0,201,72
4695,87.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,Altritol nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","20,21",10.0,200,72
4696,89.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Altritol nucleic acid,"2,4","20,21",10.0,199,72
4697,92.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,Altritol nucleic acid,"16,18","20,21",10.0,198,72
4698,85.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","20,21",10.0,197,72
4699,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","20,21",10.0,196,72
4700,88.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","20,21",10.0,195,72
4701,88.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","20,21",10.0,194,72
4702,87.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,19,20 * 21","20,21",10.0,193,72
4703,81 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14 * 21","20,21",10.0,192,72
4704,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2,3,18,19,20 * 21","20,21",10.0,191,72
4705,93.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"19,20","20,21",10.0,190,72
4706,87.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,Altritol nucleic acid,"20,21","20,21",10.0,189,72
4707,68.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,17 * 22","20,21",10.0,188,72
4708,90.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"18,19 * 22","20,21",10.0,187,72
4709,88.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2 * 22","20,21",10.0,186,72
4710,59.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"5,8,14,17,22","20,21",10.0,185,72
4711,82.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,Altritol nucleic acid,"2,8,14,17","20,21",10.0,184,72
4712,88.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,Altritol nucleic acid,18,"20,21",10.0,183,72
4713,93.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,Altritol nucleic acid,18,"20,21",10.0,182,72
4714,59.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,Altritol nucleic acid,0,"1,2",10.0,181,72
4715,60.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Altritol nucleic acid,"20,21","1,2",10.0,180,72
4716,23 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Altritol nucleic acid,"3,8,13,15,20,21","1,2",10.0,179,72
4717,28.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,Altritol nucleic acid,"5,21","1,2",10.0,178,72
4718,62.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,Altritol nucleic acid,21,"1,2",10.0,177,72
4719,7.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"10 * 21,22","1,2",10.0,176,72
4720,8.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5 * 20,21","1,2",10.0,175,72
4721,25.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,Altritol nucleic acid,"5,20 * 21","1,2",10.0,174,72
4722,60.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,21,"1,2",10.0,173,72
4723,54.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","1,2",10.0,172,72
4724,54.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,Altritol nucleic acid,"20,21","1,2",10.0,171,72
4725,44.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"3,5,9,13,20,21","1,2",10.0,170,72
4726,59.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"20,21","1,2",10.0,169,72
4727,3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","1,2",10.0,168,72
4728,2.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Altritol nucleic acid,"3,5,7,9,20,21","1,2",10.0,167,72
4729,36.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Altritol nucleic acid,"5,20,21","1,2",10.0,166,72
4730,3.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21","1,2",10.0,165,72
4731,4.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21","1,2",10.0,164,72
4732,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,Altritol nucleic acid,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21","1,2",10.0,163,72
4733,50.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Altritol nucleic acid,"3,9,13,15,20,21","1,2",10.0,162,72
4734,57.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"5,19,20","1,2",10.0,161,72
4735,47.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,Altritol nucleic acid,"19,20","1,2",10.0,160,72
4736,8.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,Altritol nucleic acid,"3,9,15,20,21","1,2",10.0,159,72
4737,39.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Altritol nucleic acid,"5,19,20","1,2",10.0,158,72
4738,56.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Altritol nucleic acid,19,"1,2",10.0,157,72
4739,60.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Altritol nucleic acid,20,"1,2",10.0,156,72
4740,52.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,Altritol nucleic acid,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20","1,2",10.0,155,72
4741,49.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,Altritol nucleic acid,"2,4","1,2",10.0,154,72
4742,62.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,Altritol nucleic acid,"16,18","1,2",10.0,153,72
4743,22.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","1,2",10.0,152,72
4744,63.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","1,2",10.0,151,72
4745,43.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"3,5,9,19,20 * 21","1,2",10.0,150,72
4746,61.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,Altritol nucleic acid,"19,20 * 21","1,2",10.0,149,72
4747,55.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,19,20 * 21","1,2",10.0,148,72
4748,40 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14 * 21","1,2",10.0,147,72
4749,61.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2,3,18,19,20 * 21","1,2",10.0,146,72
4750,44.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,Altritol nucleic acid,"19,20","1,2",10.0,145,72
4751,36.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,Altritol nucleic acid,"20,21","1,2",10.0,144,72
4752,36.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"5,8,11,14,17 * 22","1,2",10.0,143,72
4753,51.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"18,19 * 22","1,2",10.0,142,72
4754,57.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,Altritol nucleic acid,"1,2 * 22","1,2",10.0,141,72
4755,40.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,Altritol nucleic acid,"5,8,14,17,22","1,2",10.0,140,72
4756,60.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,Altritol nucleic acid,"2,8,14,17","1,2",10.0,139,72
4757,56.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,Altritol nucleic acid,18,"1,2",10.0,138,72
4758,57 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,Altritol nucleic acid,18,"1,2",10.0,137,72
4759,50.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,2-O-Methyl* 2-Cyanoethyl,0,1 * 18,10.0,136,72
4760,57.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"20,21",1 * 18,10.0,135,72
4761,10.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"3,8,13,15,20,21",1 * 18,10.0,134,72
4762,21.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"5,21",1 * 18,10.0,133,72
4763,47.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-O-Methyl* 2-Cyanoethyl,21,1 * 18,10.0,132,72
4764,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"10 * 21,22",1 * 18,10.0,131,72
4765,0.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"5 * 20,21",1 * 18,10.0,130,72
4766,19.1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"5,20 * 21",1 * 18,10.0,129,72
4767,59.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Cyanoethyl,21,1 * 18,10.0,128,72
4768,58.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"3,9,15,20,21",1 * 18,10.0,127,72
4769,45.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"20,21",1 * 18,10.0,126,72
4770,46.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Cyanoethyl,"3,5,9,13,20,21",1 * 18,10.0,125,72
4771,48.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Cyanoethyl,"20,21",1 * 18,10.0,124,72
4772,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"3,9,13,15,20,21",1 * 18,10.0,123,72
4773,3.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"3,5,7,9,20,21",1 * 18,10.0,122,72
4774,30.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"5,20,21",1 * 18,10.0,121,72
4775,5.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",1 * 18,10.0,120,72
4776,6.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",1 * 18,10.0,119,72
4777,0.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",1 * 18,10.0,118,72
4778,18.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"3,9,13,15,20,21",1 * 18,10.0,117,72
4779,45.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Cyanoethyl,"5,19,20",1 * 18,10.0,116,72
4780,37.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Cyanoethyl,"19,20",1 * 18,10.0,115,72
4781,32.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"3,9,15,20,21",1 * 18,10.0,114,72
4782,37.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Cyanoethyl,"5,19,20",1 * 18,10.0,113,72
4783,43 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Cyanoethyl,19,1 * 18,10.0,112,72
4784,55.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Cyanoethyl,20,1 * 18,10.0,111,72
4785,18 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,2-O-Methyl* 2-Cyanoethyl,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",1 * 18,10.0,110,72
4786,39.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"2,4",1 * 18,10.0,109,72
4787,53.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-O-Methyl* 2-Cyanoethyl,"16,18",1 * 18,10.0,108,72
4788,48 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"3,5,9,19,20 * 21",1 * 18,10.0,107,72
4789,60.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"19,20 * 21",1 * 18,10.0,106,72
4790,59 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"3,5,9,19,20 * 21",1 * 18,10.0,105,72
4791,55.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"19,20 * 21",1 * 18,10.0,104,72
4792,51.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"5,8,11,14,19,20 * 21",1 * 18,10.0,103,72
4793,34.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"5,8,11,14 * 21",1 * 18,10.0,102,72
4794,57.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"1,2,3,18,19,20 * 21",1 * 18,10.0,101,72
4795,28.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl* 2-Cyanoethyl,"19,20",1 * 18,10.0,100,72
4796,24.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,2-O-Methyl* 2-Cyanoethyl,"20,21",1 * 18,10.0,99,72
4797,6.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"5,8,11,14,17 * 22",1 * 18,10.0,98,72
4798,33.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"18,19 * 22",1 * 18,10.0,97,72
4799,54.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Cyanoethyl,"1,2 * 22",1 * 18,10.0,96,72
4800,24.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl* 2-Cyanoethyl,"5,8,14,17,22",1 * 18,10.0,95,72
4801,47.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl* 2-Cyanoethyl,"2,8,14,17",1 * 18,10.0,94,72
4802,55 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,2-O-Methyl* 2-Cyanoethyl,18,1 * 18,10.0,93,72
4803,54.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Cyanoethyl,18,1 * 18,10.0,92,72
4804,80.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,0,2-O-Methyl* 2-Aminoethyl,0,1 * 21,10.0,91,72
4805,82.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"20,21",1 * 21,10.0,90,72
4806,81 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"3,8,13,15,20,21",1 * 21,10.0,89,72
4807,55.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-O-Methyl* 2-Aminoethyl,"5,21",1 * 21,10.0,88,72
4808,87.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid,2-O-Methyl* 2-Aminoethyl,21,1 * 21,10.0,87,72
4809,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"10 * 21,22",1 * 21,10.0,86,72
4810,9.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"5 * 20,21",1 * 21,10.0,85,72
4811,64.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"5,20 * 21",1 * 21,10.0,84,72
4812,84.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Aminoethyl,21,1 * 21,10.0,83,72
4813,85.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"3,9,15,20,21",1 * 21,10.0,82,72
4814,80.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Alfa-L-Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"20,21",1 * 21,10.0,81,72
4815,71.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Aminoethyl,"3,5,9,13,20,21",1 * 21,10.0,80,72
4816,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Aminoethyl,"20,21",1 * 21,10.0,79,72
4817,75 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"3,9,13,15,20,21",1 * 21,10.0,78,72
4818,53 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"3,5,7,9,20,21",1 * 21,10.0,77,72
4819,56 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"5,20,21",1 * 21,10.0,76,72
4820,1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",1 * 21,10.0,75,72
4821,1 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",1 * 21,10.0,74,72
4822,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGCU,2-Deoxy* Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",1 * 21,10.0,73,72
4823,60 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"3,9,13,15,20,21",1 * 21,10.0,72,72
4824,88 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Aminoethyl,"5,19,20",1 * 21,10.0,71,72
4825,81 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGCU,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl* 2-Aminoethyl,"19,20",1 * 21,10.0,70,72
4826,72 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGCU,Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"3,9,15,20,21",1 * 21,10.0,69,72
4827,71 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Aminoethyl,"5,19,20",1 * 21,10.0,68,72
4828,75 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Aminoethyl,19,1 * 21,10.0,67,72
4829,83 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Aminoethyl,20,1 * 21,10.0,66,72
4830,83 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Fluoro* 2-O-Methyl,2-O-Methyl* 2-Aminoethyl,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",1 * 21,10.0,65,72
4831,75 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"2,4",1 * 21,10.0,64,72
4832,90 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Oxetane-Locked nucleic acid,2-O-Methyl* 2-Aminoethyl,"16,18",1 * 21,10.0,63,72
4833,77 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"3,5,9,19,20 * 21",1 * 21,10.0,62,72
4834,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"19,20 * 21",1 * 21,10.0,61,72
4835,76 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"3,5,9,19,20 * 21",1 * 21,10.0,60,72
4836,85 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"19,20 * 21",1 * 21,10.0,59,72
4837,75 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"5,8,11,14,19,20 * 21",1 * 21,10.0,58,72
4838,42 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"5,8,11,14 * 21",1 * 21,10.0,57,72
4839,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"1,2,3,18,19,20 * 21",1 * 21,10.0,56,72
4840,72 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl* 2-Aminoethyl,"19,20",1 * 21,10.0,55,72
4841,75 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid,2-O-Methyl* 2-Aminoethyl,"20,21",1 * 21,10.0,54,72
4842,15 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"5,8,11,14,17 * 22",1 * 21,10.0,53,72
4843,74 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"18,19 * 22",1 * 21,10.0,52,72
4844,82 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Altritol nucleic acid* 2-Deoxy,2-O-Methyl* 2-Aminoethyl,"1,2 * 22",1 * 21,10.0,51,72
4845,22 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl* 2-Aminoethyl,"5,8,14,17,22",1 * 21,10.0,50,72
4846,70 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,Hexitol nucleic acid,2-O-Methyl* 2-Aminoethyl,"2,8,14,17",1 * 21,10.0,49,72
4847,82 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Guanidinoethyl,2-O-Methyl* 2-Aminoethyl,18,1 * 21,10.0,48,72
4848,85.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGCU,2-Aminoethyl,2-O-Methyl* 2-Aminoethyl,18,1 * 21,10.0,47,72
4849,76 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,0,2-O-Methyl,0,2,10.0,45,72
4850,81 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-O-Methyl,"20,21",2,10.0,44,72
4851,16 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-O-Methyl,"3,8,13,15,20,21",2,10.0,43,72
4852,56 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,2-O-Methyl,"5,21",2,10.0,42,72
4853,82 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUUU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid,2-O-Methyl,21,2,10.0,41,72
4854,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACCGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl,"10 * 21,22",2,10.0,40,72
4855,11 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,UnLocked nucleic acid* Locked nucleic acid,2-O-Methyl,"5 * 20,21",2,10.0,39,72
4856,35 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,2-N-Adamant-1-yl-Methylcarbonyl-2-Amino-Locked nucleic acid* Locked nucleic acid,2-O-Methyl,"5,20 * 21",2,10.0,38,72
4857,80 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUTU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,21,2,10.0,37,72
4858,71 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,2-O-Methyl,"3,9,15,20,21",2,10.0,36,72
4859,75 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Alfa-L-Locked nucleic acid,2-O-Methyl,"20,21",2,10.0,35,72
4860,56 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"3,5,9,13,20,21",2,10.0,34,72
4861,80 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"20,21",2,10.0,33,72
4862,16 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-O-Methyl,"3,9,13,15,20,21",2,10.0,32,72
4863,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-O-Methyl,"3,5,7,9,20,21",2,10.0,31,72
4864,43.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-O-Methyl,"5,20,21",2,10.0,30,72
4865,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,2-O-Methyl,"1,3,5,7,8,9,11,13,15,17,19,22 * 2,4,6,10,12,14,16,18,20,21",2,10.0,29,72
4866,1.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,2-O-Methyl,"1,2,4,5,7,8,10,11,13,14,16,17,19,22 * 3,6,9,12,15,18,20,21",2,10.0,28,72
4867,0 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTCT,ACUUGUGGCCGUUUACGUCGC,2-Deoxy* Locked nucleic acid,2-O-Methyl,"1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,22 * 20,21",2,10.0,27,72
4868,73 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACG + GCCACAAGUTC,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-O-Methyl,"3,9,13,15,20,21",2,10.0,26,72
4869,74.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGTAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"5,19,20",2,10.0,25,72
4870,74 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGTTC,ACUUGUGGCCGUUUACGUCGC,4-C-Hydroxymethyl Deoxyribonucleic acid,2-O-Methyl,"19,20",2,10.0,24,72
4871,31 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUTCU,ACUUGUGGCCGUUUACGUCGC,Locked nucleic acid,2-O-Methyl,"3,9,15,20,21",2,10.0,23,72
4872,45.9 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-O-Methyl,"5,19,20",2,10.0,22,72
4873,66.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-O-Methyl,19,2,10.0,21,72
4874,80 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-O-Methyl,20,2,10.0,20,72
4875,46.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Fluoro* 2-O-Methyl,2-O-Methyl,"1,3,5,7,9,11,13,15,17,19,21 * 2,4,6,8,10,12,14,16,18,20",2,10.0,19,72
4876,65.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,2-O-Methyl,"2,4",2,10.0,18,72
4877,81.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Oxetane-Locked nucleic acid,2-O-Methyl,"16,18",2,10.0,17,72
4878,49.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl,"3,5,9,19,20 * 21",2,10.0,16,72
4879,80.6 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminopropoxymethyl* 2-Deoxy,2-O-Methyl,"19,20 * 21",2,10.0,15,72
4880,49.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl,"3,5,9,19,20 * 21",2,10.0,14,72
4881,79.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,2-Aminoethoxymethyl* 2-Deoxy,2-O-Methyl,"19,20 * 21",2,10.0,13,72
4882,44.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl,"5,8,11,14,19,20 * 21",2,10.0,12,72
4883,38 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl,"5,8,11,14 * 21",2,10.0,11,72
4884,84 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid* 2-Deoxy,2-O-Methyl,"1,2,3,18,19,20 * 21",2,10.0,10,72
4885,57 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,2-O-Methyl,"19,20",2,10.0,9,72
4886,64.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCU,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid,2-O-Methyl,"20,21",2,10.0,8,72
4887,25.7 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,2-O-Methyl,"5,8,11,14,17 * 22",2,10.0,7,72
4888,71.3 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,2-O-Methyl,"18,19 * 22",2,10.0,6,72
4889,81.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Altritol nucleic acid* 2-Deoxy,2-O-Methyl,"1,2 * 22",2,10.0,5,72
4890,35.4 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUCT,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,2-O-Methyl,"5,8,14,17,22",2,10.0,4,72
4891,54.2 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,Hexitol nucleic acid,2-O-Methyl,"2,8,14,17",2,10.0,3,72
4892,76.8 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Guanidinoethyl,2-O-Methyl,18,2,10.0,2,72
4893,69.5 percent target mRNA inhibition,Luciferase reporter assay,EGFP gene,10 nM,HeLa cells,Interfer (Polypus -Transfection),GACGUAAACGGCCACAAGUUC,ACUUGUGGCCGUUUACGUCGC,2-Aminoethyl,2-O-Methyl,18,2,10.0,1,72
